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Preface to ”Effects of Mycotoxins on the Intestine”
Mycotoxins are secondary metabolites produced by several fungal species. They can contaminate
human food and animal feed, and have been a threat for thousands of years. The gastrointestinal tract
is the first target when ingesting mycotoxin-contaminated food or feed. As unlikely as it sounds,
the investigations concerning the effects of mycotoxins on the intestine are still in their early stages.
This book gathers the most recent advances related to the characterization of the intestinal toxicity
of mycotoxins. The substantial data assembled on the damage caused to a number of histological
structures and functions of the intestine remove any remaining doubt about this organ being a
primary target for the toxicity of mycotoxins. An interesting overview of the detrimental effects of
mycotoxins on the gut-hosted microbiota—now regarded as a fully-fledged organ associated with the
gut—is also given.
The emergence of the intestine as a critical target for mycotoxin toxicity concurrently raises the
question of the suitability of current regulations to protect against alterations of this organ. Finally,
the unavoidable presence of mycotoxins in animal feed, despite continuing efforts to keep the risk
under control, calls for the implementation of new detoxification strategies whose efficacy still needs
to be assessed, especially considering intestinal toxicity as a relevant endpoint. All those questions
are addressed by outstanding contributions in this book.
We hope that this book which correlates papers from the Special Issue “Effect of Mycotoxins on
the Intestine” in the open access journal Toxins from MDPI will further stimulate research interest in
this field and increase our understanding of the toxicity of these fascinating fungal metabolites.
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The gastrointestinal tract is the first physiological barrier against food contaminants, as well
as the first target for these toxicants. As prominent food and feed contaminants, mycotoxins
frequently come into contact with the intestinal mucosa, and awareness of their potentially deleterious
effects is increasing [1,2]. Even though the mucosa is a major functional element of intestinal
integrity, increasing evidence suggests that other constituents, such as mucus and microbiota, are also
involved [3]. This special issue reports on recent progress in the characterization of the intestinal
toxicity of mycotoxins.
Substantial data have been assembled on the damage caused by mycotoxins to a number of
histological structures and functions of the intestinal tissue. Mycotoxins, with chemical structures as
diverse as aflatoxins, ochratoxin, and deoxynivalenol (DON), have been shown to impair intestinal
permeability in species as different as humans, fish, and pigs, removing any remaining doubt about
global mycotoxin-driven alteration of the intestinal barrier function [4–6]. The mucus and its goblet
cell producers are underestimated players that have long escaped the attention of the mycotoxicology
community when assessing the barrier function [3,7]. A light and electron microscopy study by
Przybylska-Gornowicz et al. [8] investigated the fate of goblet cells and their mucus production in a
pig colon exposed to the Fusarium toxins, DON and zearalenone (ZEN), at supposedly non-toxic levels.
Enteric neurons involved in many regulatory processes, connected with all aspects of intestinal
physiology, have also been underestimated, and the question of whether mycotoxins could target the
enteric nervous system (ENS) deserves attention. Makowska et al. [9] demonstrated that following
the exposure of pigs to low doses of the T-2 toxin, even the ENS undergoes adaptive and reparative
processes, possibly resulting in changes in the chemical coding of the neurons and nerve fibers in the
porcine stomach and duodenum.
An overview of the detrimental effects of mycotoxins on the intestine could not ignore the
gut-hosted microbiota that are now regarded as a fully fledged organ associated with the gut [10].
Yang et al. [11] reported dramatic changes in mouse-digestive microbiota, following long-term feeding
with aflatoxin B1. Reddy et al. [12] analyzed the colon content of pigs fed with DON or ZEN and
reported that both mycotoxins favored the abundance of the Lactobacillus genus, suggesting that
members of this genus could play a key role in the detoxification of dietary DON and ZEN in pigs. Also
in pigs, dietary fumonisin B1 (FB1) was shown to hinder the age-related dynamic of fecal microbiota,
starting from 15 days of exposure [13].
The emergence of the intestine as a critical target for mycotoxin toxicity concurrently raises
the question of the suitability of current regulations to protect against alterations of this organ.
Maruo et al. [14] concluded that ergot alkaloids that contaminate feed, but at rates under the current
EU regulatory limits, still damage the intestine. Likewise, Cieplinska et al. [15] reported that the cecal
water obtained from pigs fed ZEN at no-observed-adverse-effect-level (NOAEL) and below, still had a
significant genotoxic effect, highlighting the need for further investigation into the specific sensitivity
of the intestine to mycotoxins.
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Finally, the unavoidable presence of mycotoxins in animal feed, despite continuing efforts to keep
the risk under control, calls for the implementation of new detoxification strategies, whose efficacy still
needs to be assessed [16]. To that end, the intestinal toxicity of mycotoxins offers several possibilities.
Alassane-Kpembi et al. [17] performed a whole-transcriptome analysis to decipher the early response of
the small intestine to the deleterious effects of DON after administration of the Saccharomyces cerevisiae
boulardii strain CNCM I-1079. These authors reported that applying the yeast significantly reduced the
overall impact of DON on the transcriptome, and specifically reversed a number of signaling pathways
triggering inflammation, oxidative stress, and lipid metabolism. Likewise, the oxidative stress and
mitochondrial apoptosis induced by ZEN in pig intestinal epithelial cells were reported to be alleviated
by application of N-Acetylcysteine [18]. Dietary supplementation with the Clostridium sp. WJ06 strain
as a DON detoxification strategy in pigs also appears to be of potential interest, as Li et al. [19] showed
that this bacterial strain significantly attenuated the toxicity of DON, while simultaneously modulating
the intestinal micro-ecosystem of growing pigs. Hypothesizing that the toxicity of mycotoxins can be
counteracted through specific adjustments of the composition of intestinal microflora, Zheng et al. [20]
explored the effects of administering hydrogen-rich water and lactulose, two hydrogen-producing
prebiotics, on the microbiota imbalance induced by Fusarium mycotoxins in piglets. These authors
showed that providing functional hydrogen to the pig gut could protect the animal against the
imbalance of intestinal communities of microbiota, and protect it from a reduction in the production
of short-chain fatty acids and a higher rate of diarrhea induced by a mix of Fusarium mycotoxins.
Conversely, despite their broadly acknowledged gut health promoting action, chito-oligosaccharides
had no remediating effect against the intestinal toxicity of DON [21].
This special issue contains original contributions that advance our knowledge of the intestinal
toxicity of mycotoxins. Most of the studies focus on fusariotoxins, but the toxicity of aflatoxins and ergot
alkaloids is also addressed. Mycotoxin toxicity is investigated on different cellular targets (epithelial
cells, goblet cells, and neurons), markers (oxidative stress, permeability), and the intestinal bacterial
flora. The use of the pig model was recurrent in in vivo studies, making it possible to envisage dual
valorization of the present findings in biomedical and agricultural research. An original contribution
on salmon provides useful information for this breeding species, which remains poorly investigated
in the field of mycotoxicology. The outcomes of this special issue improve the characterization of the
deleterious effects of mycotoxins on the intestine and identify potential solutions to mitigate these
effects. The different detoxification strategies described here will certainly attract the attention of the
scientific community.
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Abstract: Aflatoxin M1 (AFM1) and ochratoxin A (OTA) are mycotoxins commonly found in milk;
however, their effects on intestinal epithelial cells have not been reported. In the present study,
we show that AFM1 (0.12 and 12 μM) and OTA (0.2 and 20 μM) individually or collectively increased
the paracellular flux of lucifer yellow and fluorescein isothiocyanate (FITC)-dextrans (4 and 40 kDa)
and decreased transepithelial electrical resistance values in differentiated Caco-2 cells after 48 h of
exposure, indicating increased epithelial permeability. Immunoblotting and immunofluorescent
analysis revealed that AFM1, OTA, and their combination decreased the expression levels of
tight junction (TJ) proteins and disrupted their structures, namely, claudin-3, claudin-4, occludin,
and zonula occludens-1 (ZO-1), and p44/42 mitogen-activated protein kinase (MAPK) partially
involved in the mycotoxins-induced disruption of intestinal barrier. The effects of a combination of
AFM1 and OTA on intestinal barrier function were more significant (p < 0.05) than those of AFM1
and OTA alone, yielding additive or synergistic effects. The additive or synergistic effects of AFM1
and OTA on intestinal barrier function might affect human health, especially in children, and toxin
risks should be considered.
Keywords: aflatoxin M1; ochratoxin A; intestinal epithelial cells; tight junction; permeability
1. Introduction
Human exposure to mycotoxins not only can occur through direct dermal contact and inhalation of
contaminated agricultural products, but also could occur through the consumption of foods of animal
origin, such as milk and eggs, which were obtained from animals fed with mycotoxin-contaminated
material [1]. Given that milk supplies the general public with a large quantity of essential nutrients,
it is a part of the prevailing diet for all age groups. The largest consumers of milk are children because
milk is vital for their growth and development. Thus, mycotoxin-contaminated milk can produce
detrimental effects on their health [2]. Moreover, the presence of multiple mycotoxins in milk is likely.
In raw milk from China, we identified several mycotoxins, including aflatoxin M1 (AFM1), ochratoxin
A (OTA), zearalenone (ZEA), and α-zearalenol (α-ZOL) [3]. In raw bulk milk produced in northwest
France in 2003, AFM1 was found in 3 out of 264 samples at levels of 26 ng/L or less, and OTA was
detected in three samples at levels of 5 to 8 ng/L [4]. For infant milk formulas produced in Italy, AFM1
Toxins 2018, 10, 13; doi:10.3390/toxins10010013 www.mdpi.com/journal/toxins4
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was found in 2 out of 185 samples (concentration range, 11.8 ng/L to 15.3 ng/L), while OTA was
detected in 133 (72%) samples (concentration range, 35.1 to 689.5 ng/L) [5]. In a recent analysis of
baby food (flours and milk powder) in Portugal, AFM1 and OTA were detected in 2 out of 27 samples,
AFM1 was detected in two samples, OTA was detected in seven samples, and aflatoxin B1 (AFB1) and
OTA were detected in one sample. For these samples, the AFM1 concentration was 0.017–0.041 μg/kg,
and the OTA concentration was 0.034–0.212 μg/kg [6]. Considering the well demonstrated cytotoxic,
genotoxic, and carcinogenic effects of AFM1, the International Agency for Research of Cancer (IARC)
changed its carcinogenicity classification from Group 2 to Group 1 [7]. Furthermore, AFM1 is the only
mycotoxin with an established maximum residue limit (MRL) in milk worldwide. The established
MRL of AFM1 is 0.05 μg/kg in the European Union (EU) and 0.5 μg/kg in China and the United States
of America (USA). We previously showed that OTA exerts a toxicity similar to that of AFM1 on human
intestinal cells [8]. Furthermore, the IARC has classified OTA as a Group 2B carcinogen, suggesting
that it is a possible human carcinogen [7]. Although there is no MRL for OTA in milk, a provisional
tolerable weekly intake (PTWI) of 100 ng kg−1 body weight was established [9]. Hence, it is important
to determine the toxicological effects of AFM1 and OTA on human health.
The gastrointestinal tract (GIT) is the first tissue barrier to come into contact with food
contaminants, such as mycotoxins [10,11], and intestinal epithelial cells are most affected [12,13].
The GIT barrier is constituted by intercellular tight junction (TJ) proteins that localize to the apical
domain of epithelial cells, where they selectively limit the passage of large molecules, ions, solutes,
and water [14,15]. TJs are comprised of several multiprotein complexes that include transmembrane
proteins (e.g., claudin, occludin, and junctional adhesion molecule (JAM) and cytoplasmic scaffolding
proteins (e.g., zonula occludens (ZO)-1, ZO-2, and ZO-3) [16–19]. Therefore, it is likely that the defects
in intestinal epithelial barrier function caused by mycotoxins are associated with the disruption of TJ
integrity. Among the cell lines used as models of TJ function, the Food and Drug Administration (FDA)
has recognized the Caco-2 cell line, originally isolated from human colon adenocarcinoma, as a reference
model to assess the effects of drugs and toxins on intestinal barrier function [20]. A previous study
showed that results obtained from this cell line are reproducible and applicable to in vivo data [21].
After culturing Caco-2 cells for 16–22 days, differentiated monolayers are established, mimicking the
small intestine epithelial layer in that they form a polarized monolayer with functional TJs [22].
Presently, there is a growing awareness of the adverse effects of various mycotoxins on the
intestine and the disruption of intestinal integrity in differentiated Caco-2 cells [23]. Romero et al. [24]
reported that OTA decreased transepithelial electrical resistance (TEER) values and claudin-3, claudin-4,
and occludin mRNA expression levels, and other studies demonstrated that treatment with OTA
reduced intestinal barrier function in humans [25–27]. In addition, low concentrations of AFM1,
added to either the apical or basal compartment of transwell chambers, significantly decreased
TEER values [28]. The effects of mycotoxins on cells can be characterized as synergistic, additive,
or antagonistic, and these effects might adversely affect human health. In addition, the contamination
of aflatoxin B1 (AFB1) and OTA has been frequently observed in cereals and beans, and their
concentrations in such foods are generally higher than that in milk. Wangikar et al. [29] demonstrated
that AFB1 and OTA have antagonistic interaction in New Zealand White rabbits regarding their
teratogenic effect. Huang et al. [30] reported that the mixture of AFB1, OTA, and ZEA exerted the
greatest adverse effects on dairy goats, indicating the serious negative effects of the combinations
of mycotoxins. We previously demonstrated synergistic and additive cytotoxic effects for OTA,
ZEA, and/or α-ZOL with AFM1, except that AFM1 and ZEA produced an antagonistic effect on the
proliferation of Caco-2 cells by isobologram analysis [8]. In recent decades, isobologram analysis
has become the most commonly used approach to evaluate the interactive effects between chemical
substances. Practical limitations exist in the combination analysis based on Loewe Additivity [31].
Estimation of dose–effect curves for the drugs being combined requires a certain amount of data and
can rapidly become expensive as well as experimentally and computationally demanding, and makes
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the analysis of drug combination prohibitive [32]. Loewe Additivity model becomes unusable when a
dose–effect curve is not available or difficult to model [33].
Previous studies have reported an association of epithelial barrier function with mitogen-activated
protein kinases (MAPK) [34,35], which are responsible for intracellular signaling pathway. More
importantly, MAPK are considered to play a vital role in inflammatory responses of epithelial cells
and includes there subfamilies-p44/42 extracellular signal regulated kinase (ERK), p38 and c-Jun
N-terminal Kinase (JNK). A mechanistic study demonstrated that the undermined epithelial barrier
induced by deoxynivalenol (DON), which was reflected by the drop TEER values and reduced
expression level of claudin-4 protein, was associated with the activation of ERK signaling pathway [36].
Though numerous studies have been reported that DON-induced intestinal barrier dysfunction was
seen with the activation of MAPK signaling pathway, the underlying mechanisms of compromised
intestinal barrier caused by AFM1 and OTA yet to be illustrated. With regard to intestinal barrier
integrity, one study focused on the mycotoxin special DON, while another study examined the effects
of DON and FB1 on the intestine of piglets [37,38]. Hence, it is crucial to understand the individual and
combined effects of AFM1 and OTA on the structure and function of the gut. The purpose of this study
was to investigate the individual and combined effects of AFM1 and OTA on intestinal permeability
and to define the underlying mechanism(s). We hypothesized that (i) a combination of AFM1 and OTA,
which frequently occur simultaneously in milk, might significantly affect intestinal permeability and TJ
function and produce a variety of interactive effects, (ii) the decreased expression of TJ proteins leads
to an increased epithelial permeability, and (iii) the decreased TJ proteins expression level mediated
through modulation of MAPK. To address these hypotheses, we carried out TEER measurements,
paracellular tracer flux assays, and related protein expression experiments in differentiated Caco-2
cells exposed to different concentrations of AFM1 and OTA individually and collectively.
2. Results
2.1. Effects of AFM1 and OTA Individually or Collectively on the TEER Values of Caco-2 Cell Monolayers
The baseline TEER values of Caco-2 cell monolayers (on day 21 post-seeding) varied from 1411
to 1645 Ω·cm2. The culture of these monolayers in Dulbecco’s modified Eagle Medium (DMEM)
containing 1% (v/v) methanol (control) did not significantly alter the initial TEER values over a period
of 48 h. After 48 h of exposure to mycotoxins, the TEER values of Caco-2 cells exposed to non-cytotoxic
concentrations of AFM1 (0.12 μM) and OTA (0.2 μM) individually or collectively were not significantly
different (p > 0.05) from those of control cells. However, the TEER values of cells exposed to cytotoxic
concentrations of AFM1 (12 μM) or the combination of AFM1 (12 μM) and OTA (20 μM) collectively
were significantly lower (p < 0.05) than those of control cells. Furthermore, the TEER values of cells
exposed to cytotoxic concentrations of AFM1 and OTA collectively were lower than those of cells
exposed to AFM1 and OTA individually, although the difference between them were not significant
(p > 0.05) (Figure 1).
2.2. Effects of AFM1 and OTA Individually or Collectively on the Permeability of Caco-2 Cell Monolayers
The effects of non-cytotoxic and cytotoxic concentrations of AFM1 and OTA individually or
collectively on intestinal permeability were investigated by measuring the paracellular flux of
fluorescent tracers with different molecular weights (lucifer yellow (LY) and FITC-dextran) across
Caco-2 cell monolayers. Except for the non-cytotoxic concentration of AFM1, which did not
significantly affect (p > 0.05) the paracellular flux of LY (Figure 2a), mycotoxins significantly increased
(p < 0.05) the paracellular flux of LY and FITC-dextran (4 and 40 kDa) across cell monolayers (Figure 2).
For individual mycotoxins, the paracellular flux of LY and FITC-dextran (4 and 40 kDa) across cell
monolayers was significantly higher (p < 0.05) after treatment with non-cytotoxic and cytotoxic
concentrations of OTA than after similar concentrations of AFM1 (Figure 2). With regard to the
combined use of AFM1 and OTA, both mycotoxins exerted a more significant effect (p < 0.05) on
intestinal permeability than the individual mycotoxins (Figure 2).
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Figure 1. Changes in transepithelial electrical resistance (TEER) values in differentiated Caco-2
cells after treatment with different concentrations of aflatoxin M1 (AFM1) and ochratoxin A (OTA)
individually or collectively (AFM1+OTA) for 48 h compared with the initial value. Results are expressed
as the mean ± SEM of three independent experiments. TEER was measured before and after mycotoxin
treatment for each condition. Different letters (a,b) indicate significant differences in TEER (p < 0.05).
TEER, transepithelial electrical resistance. AFM1-0.12 represents AFM1 at 0.12 μM, AFM1-12 represents
AFM1 at 12 μM, OTA-0.2 represents OTA at 0.2 μM, OTA-20 represents OTA at 20 μM, AFM1+OTA-0.12
represents the combination of AFM1 (0.12 μM) and OTA (0.2 μM), AFM1+OTA-12 represents the
combination of AFM1 (12 μM) and OTA (20 μM).
2.3. Effects of ATM1 and OTA Individually or Collectively on TJ Protein Levels in Caco-2 Cell Monolayers
To investigate the mechanism by which mycotoxins increase the permeability of Caco-2 cell
monolayers, the levels of TJ proteins were quantified by Western blot analysis. Occludin and ZO-1
levels in Caco-2 cells exposed to non-cytotoxic and cytotoxic concentrations of AFM1 and OTA
individually or collectively were significantly lower (p < 0.05) than those in control cells. By contrast,
claudin-3 and claudin-4 levels in cells exposed to OTA, but not ATM1, or both mycotoxins were
significantly lower (p < 0.05) than those in control cells (Figure 3). The negative effects of OTA on
the levels of claudin, occludin, and ZO-1 were significantly greater (p < 0.05) than those of AFM1.
Furthermore, the negative effects of AFM1 and OTA collectively were greater than those of AFM1
and OTA individually. The decrease in claudins, occludin, and ZO-1 expression in cells exposed to
non-cytotoxic concentrations of AFM1 and OTA was not significantly different (p > 0.05) from that in




Toxins 2018, 10, 13
 
Figure 2. Mycotoxin increased the permeability of the Caco-2 cell monolayer. Caco-2 cells were
cultured on transwell chambers and stimulated for 48 h with different concentrations of AFM1, OTA,
and AFM1+OTA added to apical and basal compartments. Subsequently, the paracellular flux of lucifer
yellow (LY) (0.457 kDa; (a)) and fluorescein isothiocyanate (FITC)-dextran (4 and 40 kDa; (b)) from
the apical to the basal compartment was assessed. Results are expressed as the mean ± SEM of three
independent experiments with three replicates. Different letters (a–g) indicate significant differences
in FITC (p < 0.05). AFM1-0.12 represents AFM1 at 0.12 μM, AFM1-12 represents AFM1 at 12 μM,
OTA-0.2 represents OTA at 0.2 μM, OTA-20 represents OTA at 20 μM, AFM1+OTA-0.12 represents
the combination of AFM1 (0.12 μM) and OTA (0.2 μM), AFM1+OTA-12 represents the combination of





















































Figure 3. Effects of different concentrations of AFM1, OTA, and AFM1+OTA on TJ protein levels
in Caco-2 cells after 48 h of exposure. (a) Cell proteins (20 μg) were separated by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted first for tight junction
(TJ) proteins, and second for human β-actin; (b) the intensities of the TJ proteins were quantified
with ImageJ software (Version 2.1.0, National Institutes of Health, Bethesda, MD, USA, 2006). Values
were normalized to the loading control (human β-actin) and expressed relative to the negative control
(untreated cells). Results are expressed as the mean ± Standard Error of Mean (SEM), n = 3–5. M-0.12
represents AFM1 at 0.12 μM, M-12 represents AFM1 at 12 μM, O-0.2 represents OTA at 0.2 μM, O-20
represents OTA at 20 μM, M+O-0.12 represents the combination of AFM1 (0.12 μM) and OTA (0.2 μM),
M+O-12 represents the combination of AFM1 (12 μM) and OTA (20 μM). * p < 0.05; ** p < 0.001;
*** p < 0.000.
2.4. Effects of AFM1 and OTA Individually or Collectively on TJ Protein Localization in Caco-2
Cell Monolayers
The localization of TJ proteins was assessed by immunofluorescent staining. In confluent
Caco-2 cells not exposed to mycotoxins, claudin-3, claudin-4, occludin, and ZO-1 localized at the
plasma membrane and resembled a cobblestone pattern. There was no significant difference in the
localization of claudin-3 and ZO-1 in cells exposed to non-cytotoxic concentrations of mycotoxins
individually or collectively. Furthermore, claudin-3 and ZO-1 were hardly detected in cells exposed
to cytotoxic concentrations of AFM1 and OTA individually or collectively, suggesting that claudin-3
and ZO-1 protein synthesis was affected. Mycotoxins also affected claudin-4, as evidenced by a
faint immunofluorescent signal and a discontinuous cobblestone pattern unlike in control cells.
Although there was no difference in the localization of occludin in cells exposed to a non- or cytotoxic
concentration of AFM1 and a non-cytotoxic concentration of OTA, a cytotoxic concentration of OTA
and non- or cytotoxic concentrations of AFM1 and OTA disrupted the continuous cobblestone
pattern. Indeed, the individual use of mycotoxins did not significantly affect the localization of
occludin in differentiated Caco-2 cells, while the combined use of mycotoxins, especially at cytotoxic
concentrations, undermined the integrity of the cobblestone pattern of occludin (Figure 4).
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Figure 4. Effects of AFM1 and OTA on the localization of TJ proteins. Differentiated Caco-2 cells
were cultured on transwell chambers for 21 days. The cells were then treated for 48 h with different
concentrations of AFM1 and OTA added to apical and basal compartments, followed by fixation
and staining with an anti-claudin-3, anti-claudin-4, anti-occludin, or anti-zonula occludens-1 (ZO-1)
antibody, as described in Section 2.
2.5. The Interactive Effects of the Combination of AFM1 and OTA
After assessing the interactive effects of AFM1 and OTA at different concentrations on TEER,
according to the analysis for interactions described in Section 4.10, we found an antagonistic effect
between non-cytotoxic concentrations of AFM1 and OTA, and the measured value was 20.8% (p < 0.05)
higher than the expected value. However, an additive effect was found at cytotoxic concentrations of
the mycotoxins, with a non-significant difference (p > 0.05) between the measured and expected values
(Figure 5a).
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Figure 5. Interactive cytotoxic effects of binary combinations of AFM1 and OTA in differentiated
Caco-2 cells after exposure for 48 h (a–h). After the exposure to mycotoxins, TEER, FITC-dextran
(4 and 40 kDa) paracellular flux, and TJ protein expression were measured. There were no significant
interactive effects for claudin-3, occludin, and ZO-1 expression. Data are expressed as a percentage of
the untreated control for each parameter. White bars represent the measured values, and dark bars
represent the expected values. * p < 0.05; ** p < 0.001; *** p < 0.000 represent both significant synergistic
and antagonist effects.
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Synergistic effects were observed for the paracellular flux of LY after treatment with non-cytotoxic
concentrations of AFM1 and OTA collectively (with a 21.5% difference over the expected values,
p < 0.05), the paracellular flux of FITC-dextran (4 kDa) after treatment with cytotoxic concentrations of
both mycotoxins (with a 357.0% difference over the expected values, p < 0.05), and the paracellular
flux of FITC-dextran (40 kDa) after treatment with non-cytotoxic and cytotoxic concentrations of both
mycotoxins (with a 129.8% and 679.0% difference over the expected values, respectively, p < 0.05)
(Figure 5b–d, respectively). Additive effects were observed for the paracellular flux of LY after
treatment with cytotoxic concentrations of both mycotoxins (p > 0.05) and the paracellular flux of
FITC-dextran (4 kDa) after treatment with non-cytotoxic concentrations of both mycotoxins (p > 0.05)
(Figure 5b,c, respectively).
The additive effects of AFM1 and OTA were evident on claudin-3, occludin, and ZO-1 expression,
with no significant difference between the measured and expected values (Figure 5e,g,h). Synergistic
effects were observed for claudin-4 expression after treatment of Caco-2 cells with a non-cytotoxic
concentration of both mycotoxins, with a 27.4% (p < 0.05) decrease compared with the expected values,
and additive effects were shown at cytotoxic concentrations of both mycotoxins (Figure 5f).
2.6. Correlations between TJ Junction and Intestinal Permeability
To understand the significance of the changes in TJ protein levels and intestinal permeability
following exposure to mycotoxins, the correlations among TEER values, the permeability of fluorescent
tracers (LY, FITC-dextran (4 kDa), and FITC-dextran (40 kDa)), and the levels of TJ proteins (claudin-3,
claudin-4, occludin, and ZO-1) were evaluated. Significantly negative (p < 0.000) correlations were
found between the TEER values and the three fluorescent tracers, and a significantly positive (p < 0.05)
correlation was found between LY and FITC-dextran (40 kDa). In addition, there were significantly
positive (p < 0.000) correlations between the TEER values and the four TJ proteins. There were also
significantly negative (p < 0.05) correlations between FITC-dextran (40 kDa) and the four TJ proteins,
although there were no significant (p > 0.05) correlations between LY or FITC-dextran (4 kDa) and
claudin-3, claudin-4, occludin, or ZO-1. The significant correlations between the TEER values or
FITC-dextran (40 kDa) and the TJ proteins suggest that an increased epithelial permeability associates
with the disruption of TJ integrity (Figure 6).
To further investigate the role of TJs in intestinal epithelial permeability, we silenced occludin,
a representative TJ protein, in Caco-2 cells. Occludin knockdown in transfected cells was confirmed
by immunoblotting (Figure S1a). More specially, the expression level of occludin of siRNA group
were significantly lower than that in control and NC group, indicating that the effects of occludin
knockdown was creditable. In addition, the TEER values in occludin-silenced cells were significantly
lower (p < 0.05) than those in control and NC-silenced cells (Figure S1b), indicating that occludin plays
an important role in TJ integrity. These results also indicate that TJs contribute to the maintenance of
epithelial permeability.
2.7. AFM1 and OTA Induce Barrier Dysfunction via MAPK-Dependent Mechanism
In order to identity intracellular signaling pathways related to AFM1 and OTA-induced
downregulation of TJ proteins, the MAPK pathway was measured in differentiated Caco-2 cells treated
with these mycotoxins individually or collectively. Cells were pretreated specific pharmacological
inhibitors for the related molecules (p44/42 (U-0126), JNK (SP600125), p38 (SB203580)) for 1 h, followed
by a 30 min exposure of AFM1 and OTA. The immunoblotting results showed that the combined
mycotoxins led to a more significant activation of p44/42 MAPK than these individually and the
pretreatment of inhibitor U-0126 prevented individual and combined AFM1 and OTA-induced p44/42
MAPK phosphorylation (Figure 7), while the mycotoxin-induced phosphorylation of p38 and JNK
MAPK was not affected by the corresponding inhibitors (data not shown).
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Figure 6. Heat map showing correlations among TEER, FITC-dextran (4 and 40 kDa), and TJ proteins
(claudin-3, claudin-4, occludin, and ZO-1) for differentiated Caco-2 cells taking into account data from
all of the experiments performed in this study. The heat map is a visual representation of correlated
values between each pair of parameters denoted by the corresponding row and the column of the
matrix. Red represents a positive correlation, yellow represents a low correlation, and blue represents a
negative correlation, as shown in the color key. Statistical significance was analyzed by Spearman’s
correlations. The number scale to the right represents the correlation coefficients. The higher the
number, the higher the correlation. * p < 0.05 and *** p < 0.000. (For an interpretation of the references
to the color in this figure, the reader is referred to the web version of the article.).
Figure 7. U-0126 monoethanolate (U-0126) (10μM) counteracted AFM1 (12μM) and OTA (20μM)-induced
p44/42 mitogen-activated protein kinase (MAPK) (extracellular regulated protein kinases 1/2, [ERK]
1/2). Differentiated Caco-2 cells were either pretreated with U-0126 or complete cultivation medium
for 1 h before addition of individual and combined AFM1 and OTA for 30 min. Phosphorylation of
p44/42 MAPK was determined by immunoblotting.
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3. Discussion
It is common to find co-contamination of mycotoxins in milk, which has been reported worldwide,
instead of the occurrence of individual mycotoxins [3]. However, most studies mainly focused on
the toxic effects of individual mycotoxins. Given that the intestine functions as the initial barrier
against mycotoxins, and that it could be exposed to high doses of these toxins, little is known about the
interaction of mycotoxins with the human intestinal epithelium [39]. Thus, it is essential to determine
the combined effects of mycotoxins on the intestinal barrier. In this study, we investigated the effects
of AFM1 and OTA, which are common mycotoxins found in milk, on differentiated Caco-2 cells
that resemble epithelial cells of the small intestine to determine the underlying mechanisms of the
dysfunction of the intestinal barrier caused by mycotoxins and to discover whether they have additive,
synergistic or antagonistic effects.
TEER values and the paracellular flux of tracers (LY, FITC-dextran) are vital parameters in
the study of epithelial barrier integrity. In this study, a dose-dependent decrease in TEER of the
differentiated Caco-2 monolayer was observed after 48 h of AFM1 and/or OTA treatment. This is
in agreement with previous studies [28,40–42] that reported individual mycotoxins, such as AFM1,
AFB1, OTA, patulin (PAT), and FB1, to decrease TEER values in Caco-2 cells and to disrupt barrier
function. A previous study has illustrated that a reduction in TEER can however be caused by different
events including: (i) increase in paracellular permeability to ions; (ii) changes in transcellular ion
flux through altered plasma membrane channels or pumps; or (iii) uncontrolled cell death within
the monolayer [43]. From this angle, the reduced cell viability induced by AFM1 and OTA at higher
concentration may play a role in the change of TEER values and cell monolayer permeability. Indeed,
after 48 h of exposure, AFM1 and OTA individually or collectively induced a significant increase in the
translocation of LY and FITC-dextran from the apical to the basal compartment. These findings are
consistent with the data of Akbari et al. [44] and Pinton et al. [45], demonstrating that DON increased
the paracellular permeability to FITC-dextran in Caco-2 cells and intestinal epithelial cell lines from
porcine (IPEC-1) cells.
TJs are comprised of multiple protein complexes located at the apical domain of lateral membranes
of intestinal epithelial cells. The integral components of TJ complexes are the four transmembrane
proteins, namely, occludin, claudins, JAMs, and tricellulin, as well as ZO-1, which anchors the
transmembrane proteins to the perijunctional actomyosin ring [15]. To our best knowledge, there
are few studies that report the effects of AFM1 or OTA on the integrity of the intestinal barrier.
Romero et al. [24] showed that, after 24 h of exposure to OTA, claudin-3, claudin-4, and occludin
mRNA expression decreased in differentiated Caco-2 cells. McLaughlin et al. [42] reported that OTA
reduced claudin-3 and claudin-4 protein levels after 24 h of exposure. Although there was a moderate
decrease in TEER values in the presence of low concentrations of AFM1 added to either the apical or
basal compartment of transwell chambers, occludin and ZO-1 localization was relatively unchanged
in Caco-2 cells [28]. By Western blotting and immunofluorescent microscopy, we demonstrate for the
first time the loss of TJ proteins (claudin-3, claudin-4, occludin, and ZO-1) from cells. Furthermore,
the emphasis for Western blotting and immunofluorescent staining of tight junction proteins are
different. The focus of Western blotting analysis is to measure the change of proteins expression level
induced by mycotoxins, while the aim of immunofluorescent staining is to determine the effect of
mycotoxins on the cellular localization of cell adhesion molecules. Thereby, the different objective of
these two experiments could explain that the trend between Figures 3 and 4 is not closely coincident.
The marked loss of ZO-1 could be explained by the fact that ZO-1 links TJ proteins to the actin
cytoskeleton, which is critical for the maintenance of the structure and function of the TJ barrier.
Defective barrier integrity may contribute to various intestinal and systemic inflammatory diseases.
Clinical studies showed that, in patients with Crohn’s disease (CD), the expression of claudin-3 and
occludin was decreased [46]. Thus, further studies are needed to understand the mechanisms behind
this AFM1/OTA-induced decrease in TJ permeability.
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There is considerable evidence showing that disrupted intestinal permeability is related to
the decreased expression and translocation of TJ proteins. Watari et al. [47] demonstrated that
homoharringtonine (HHT) increased the paracellular flux of FITC-dextrans (4 and 40 kDa) and
reduced the protein levels of claudin-3, claudin-5, and claudin-7 in Caco-2 cells. Akbari et al. [41]
reported that DON increased the paracellular flux of LY and FITC-dextran (4 kDa) and decreased
the levels of claudin-1, claudin-3, and claudin-4. Romero et al. [24] reported decreased TEER values
with decreased claudin-3 and occludin mRNA expression levels in Caco-2 cells exposed to AFB1,
FB1, T2, and OTA at concentrations up to 100 μM for seven days. In the present study, the increased
intestinal permeability caused by AFM1 and OTA was concomitant with the reduced expression of
claudin-3, claudin-4, occludin, and ZO-1. Indeed, significant correlations were observed between
TEER values/FITC-dextran (40 kDa) and the four TJ proteins, which were assessed by Spearman’s
correlations. Therefore, we concluded that the mechanism by which these mycotoxins reduce the
barrier properties of Caco-2 cells appears to be via altering the expression levels and/or distribution of
specific TJ proteins, namely, claudin-3, claudin-4, occludin, and ZO-1.
Emerging evidence have demonstrated involvement of MAPK signaling in the compromised
barrier function caused by TJ proteins. For example, the reduced expression of occludin and ZO-1
in human gastric epithelial cells may underlie clopidogrel-induced gastric mucosal injury, which
involves the activation of the p38 MAPK pathway [48]. DON-induced MAPK activation decreased
the expression of claudin in the disrupted intestinal barrier [36]. Recently, one study reported that
arsenic downregulated TJ protein claudin through p38 MAPK in HT29 intestinal epithelial cell line [49].
Thus, it is reasonable to conclude that mycotoxin-induced MAPK pathway activation decreases the
expression of TJ proteins, which in turn reduces the barrier function of the intestine as evaluated
by TEER and paracellular permeability. In the present study, we examined the extent to which the
activation of MAPK regulate barrier disruption of AFM1 and OTA. The results showed that only
p44/42 MAPK play an important role in mediating the expression level of TJs, especially for their
combination, and this finding is in accordance with literature reporting the regulation of TJs structure
and function is often regulated by this MAPK [50]. To further investigate whether p44/42 activation
mediates intestinal barrier effects of AFM1 and OTA individually or collectively, differentiated Caco-2
cells exposed to these mycotoxins in the absence and presence of U-0126. According to our study,
pretreatment with U-0126 in differentiated Caco-2 cells and then subsequent with mycotoxins in
the presence of the inhibitor significantly reduced the adverse effects induced by AFM1 and OTA
individually or collectively, indicating that the activation of p44/42 MAPK is partially involved in
these mycotoxins-induced barrier disruption.
One of the aims of the present study was to assess the combined effects of AFM1 and OTA. In
this study, non-cytotoxic concentrations of AFM1 and OTA exerted antagonistic effects on the TEER,
while these mycotoxins at the same concentrations exerted synergistic effects on the paracellular flux
of LY and FITC-dextran (40 kDa) and the expression of claudin-4. All other interactions of AFM1 and
OTA at different concentrations with regard to epithelial permeability were additive. It is commonly
assumed that mycotoxins with the same mode of action and/or the same cellular target exert a
synergistic or additive effect when present together [51]. Studies demonstrated that exposure to
AFM1 and OTA resulted in oxidative DNA damage, which represents the predominant mechanism
for cytotoxicity [52–54]. This might explain the synergistic and additive interaction effects that we
observed in this study. The antagonistic effect of AFM1 and OTA may be explained by the competition
for glutathione (GSH) in cells. Since electrophiles generated from the metabolism of OTA with
hydroquinone–quinone reduce GSH to produce GSH conjugates, the hydroxyl group of AFM1 can
also be conjugated with GSH [55–57]. Indeed, the interactive effects were different depending on the
concentrations and exposure time used, the endpoint assessed, or the species applied. Furthermore,
the deeper mechanisms underlying the mycotoxin-induced dysfunction of intestinal barrier need to
be explored.
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In summary, we herewith present a detailed in vitro investigation of AFM1 and OTA individually
or collectively on intestinal barrier integrity. Furthermore, the present study for the first time shows that
AFM1 and OTA impaired the intestinal barrier as evaluated by increased TEER values and permeability
tracer flux, which was associated with the perturbation of TJ complexes, including claudins, occludin
and ZO-1, and p44/42 MAPK at least partially involved in the detrimental effects of integrity of TJs
caused by AFM1 and OTA. Indeed, AFM1 and OTA exerted different interactive effects, depending on
the endpoints of intestinal permeability assessed. These findings may explain some of the observed
adverse effects on the GIT in vivo caused by these mycotoxins. The special molecular mechanisms
that p44/42 MAPK influence the mycotoxin-mediated TJ disruption need to be clarified and further
studies would be required to confirm these finding in vivo cases.
4. Materials and Methods
4.1. Chemicals and Reagents
AFM1 (structural formula, C17H12O7; molecular weight, 328) and OTA (structural formula,
C20H18ClNO6; molecular weight, 403) were purchased from Fermentek, Ltd. (Jerusalem, Israel).
Mycotoxins were dissolved in methanol as previously described [58,59]. AFM1 and OTA were
dissolved in methanol to final concentrations of 400 μg/mL and 5000 μg/mL, respectively. Both stock
solutions were stored at −20 ◦C. Dulbecco’s modified Eagle medium (DMEM), fetal bovine serum (FBS),
antibiotics (100 units/mL penicillin and 100 μg/mL streptomycin), nonessential amino acids (NEAA)
were purchased from Life Technologies (Carlsbad, CA, USA). An Enhanced Cell Counting Kit-8, radio
immunoprecipitation assay (RIPA) lysis buffer, immunofluorescent staining blocking buffer, primary
and secondary antibody dilution buffer were purchased from Beyotime Biotechnology (Shanghai,
China). Protease inhibitors, lucifer yellow (LY) and fluorescein isothiocyanate (FITC)-dextran were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Rabbit anti-claudin-3 and rabbit anti-claudin-4
were purchased from Abcam (Cambridge, MA, USA). Rabbit anti-ZO-1 and rabbit anti-occludin were
purchased from Thermo Scientific (Waltham, MA, USA). Rabbit anti-β-actin was purchased from Cell
Signaling Technology (Trask Lane Danvers MA, USA). Goat anti-rabbit IgG conjugated to horseradish
peroxidase and Alexa Fluor 488 mouse anti-rabbit IgG were purchased from Bioss Antibodies (Beijing,
China). Three MAPK-specific inhibitors (SB-203580, U-0126 and SP-600125) were purchased from
Sigma-Aldrich, and their stock solutions were prepared with dimethyl sulfoxide (DMSO).
4.2. Cell Culture and Differentiation
The human colon adenocarcinoma Caco-2 cell line (passage number, 18) was obtained from
American Type Culture Collection (ATCC) (Manassas, VA, USA). The cells were cultured in DMEM
containing 4.5 g/L glucose, 10% FBS, antibiotics (100 units/mL penicillin and 100 μg/mL streptomycin),
and 1% NEAA at 37 ◦C in a humidified atmosphere of 5% CO2 in air.
In the present study, Caco-2 cells plated at a passage number (passage number, 23–35) similar
to that reported by Watari et al. [47] were cultured in 6- or 12-well transwell chambers (Corning, NY,
USA) at a density of 4 × 104 cells/cm2, and the medium was replaced every other day until 21 days.
The mean TEER value was 1528 ± 117 Ω·cm2 (Figure S2), which exceeded the TEER cut-off value
of 300 Ω·cm2, as measured by a Millicell-ERS volt-ohm meter (Millipore, Temecula, CA, USA). The
differentiated Caco-2 cells were then used for TEER measurement, permeability tracer flux assay,
Western blot analysis, and immunofluorescent staining.
4.3. Cytotoxicity Assay
The effects of mycotoxins on the proliferation of intestinal cells were determined using the
Enhanced Cell Counting Kit (CCK)-8 according to the manufacturer’s instructions. Caco-2 cells were
seeded at 6 × 104 cells/well in 100 μL of complete proliferation medium in 96-well plates. After 24 h
of culture, AFM1 (0.012, 0.12, 1.2, 6, and 12 μM) and OTA (0.02, 0.2, 2, 10, and 20 μM), which were
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prepared by adding DMEM, were added. After 48 h, 100 μL of CCK-8 Reagent was added per well,
and the cells were incubated for 2 h. The absorbance was measured at 450 nm using an automated
ELISA reader (Thermo Scientific, Waltham, MA, USA). Results were expressed as the percentage of
cell survival (%) with respect to the control. Based on the cell viability results (Figure S3), 0.12 μM was
selected as the non-cytotoxic AFM1 concentration and 12 μM as the cytotoxic concentration, and the
corresponding concentrations of OTA (0.2 and 20 μM) were chosen. In all subsequent experiments,
AFM1 at 0.12 and 12 μM, and OTA at 0.2 and 20 μM, were used.
4.4. TEER Measurement
The measurement of TEER across epithelial cell monolayers is one of the best ways to evaluate the
integrity of the TJ barrier in Caco-2 models [20]. Caco-2 cells were cultured on transwell chambers as
described in Section 4.2. Cells were challenged for 48 h with increasing concentrations of AFM1 (0.12
and 12 μM) or OTA (0.2 and 20 μM), which were added to apical and basal compartments of transwell
chambers. Binary combinations (AFM1/OTA) were also tested using identical concentrations and
exposure time. Results were expressed relative to the initial TEER value for each insert and presented
as the mean ± standard error of the mean (SEM) of five independent experiments.
4.5. Permeability Tracer Flux Assay
In addition to TEER measurement, the paracellular flux of tracers across the cell monolayer
also reflects the permeability of intestinal barrier. The most common paracellular tracers used
in in vitro models are fluorescent compounds (e.g., LY) or fluorescently labeled compounds (e.g.,
FITC-dextran and FITC-inulin). To determine whether mycotoxins individually and collectively affect
the size selectivity of the permeability barrier, different molecular size tracers were used. Caco-2
cell monolayers were cultured on transwell chambers to confluency and treated with AFM1 and
OTA individually or collectively for 48 h as described in Section 4.4. The membrane-impermeable
tracers LY and FITC conjugated-dextran with a molecular mass of 4 or 40 kDa were dissolved in
phosphate-buffered saline (PBS) to a final concentration of 100 μg/mL. In this study, these tracers
were added to the apical compartment for 4 h. The fluorescent intensity in the basal compartment was
measured with an automated ELISA reader. The excitation and emission wavelengths were 410 and
520 nm, respectively, for LY, and 490 and 520 nm for FITC-dextran.
4.6. Western Blot Analysis
Immunoblot assays were conducted to examine the expression of TJ proteins claudin-3, claudin-4,
occludin and ZO-1 as well as the phosphorylation status of MAPK proteins ERK, p38 and JNK.
For TJ proteins analysis, Caco-2 cell monolayers were cultured on transwell chambers and incubated
for 48 h with increasing concentrations of AFM1 and OTA, which were added to apical and basal
compartments. Caco-2 cells were lysed with RIPA lysis buffer containing protease inhibitors. Equal
amounts of protein were combined with a nonreducing buffer, heat-denatured, electrophoresed on
sodium dodecyl sulfate (SDS)-polyacrylamide gels, and electroblotted onto polyvinylidene difluoride
membranes. The membranes were blocked with 5% skim milk in PBS for 1.5 h at room temperature.
Subsequently, rabbit anti-claudin-3, rabbit anti-claudin-4, rabbit anti-ZO-1, rabbit anti-occludin,
and rabbit anti-β-actin antibodies were diluted according to the manufacturers’ instructions and
incubated with membranes for 3 h at room temperature. Goat anti-rabbit IgG conjugated to horseradish
peroxidase was applied for 1 h at room temperature. Peroxidase activity was visualized on a
radiographic film using enhanced chemiluminescence reagents. Signal intensities were determined
by densitometry using ImageJ 2× software (Version 2.1.0, National Institutes of Health, Bethesda,
MD, USA, 2006), and values were normalized to the loading control (human β-actin). In the kinase
phosphorylation assay, after 21 days for culturing differentiated Caco-2 cells, the cells were treated
with serum-free medium for 12 h. After 12 h, cells were washed and treated first with or without
10 μM three inhibitors for 1 h and then with 12 μM AFM1 or/and 20 μM OTA for 30 min. Whole cell
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lysates were collected, normalized for total proteins, and analyzed for the levels of phosphorylated
ERK, p38 and JNK proteins.
4.7. Immunofluorescent Staining
The localization of TJ proteins was assessed by confocal microscopy. Confluent Caco-2 cells
were incubated for 48 h with AFM1 and OTA individually or collectively by adding to apical and
basal compartments. The cells were fixed with 4% paraformaldehyde for 10 min at 4 ◦C and then
permeabilized with 0.1% Triton X-100 in PBS for 5 min. The cells were incubated in blocking buffer
for 1.5 h, followed by incubation with an anti-claudin-3, anti-claudin-4, anti-occludin, or anti-ZO-1
antibody diluted in primary antibody dilution buffer for 1.5 h. The cells were then incubated with
Alexa Fluor 488 mouse anti-rabbit IgG diluted in secondary antibody dilution buffer for 45 min at
37 ◦C in the dark. The cells were observed under a LSM780 immunofluorescent microscope (Carl Zeiss,
Inc., Thornwood, NY, USA).
4.8. Downregulation of Occludin by siRNA
Occludin small interfering RNA (occludin siRNA; GenePharma) and negative control
(NC) siRNA were transiently transfected into differentiated Caco-2 cells using OptiMEM
siRNA transfection medium and Lipofectin 2000 siRNA transfection reagent according to the
manufacturer’s instructions. The primer sequences were GCGUUGGUGAUCUUUGUUATT (sense)
and UAACAAAGAUCACCAACGCTT (antisense). The transfection medium containing the siRNA
and siRNA transfection reagent was mixed with serum-free culture medium and incubated with
the differentiated Caco-2 cells. The medium was replaced after 6 h, and cells were incubated for
an additional 24 h, and then TEER values were determined. Cells were then collected and lysed,
and occludin expression was examined.
4.9. Comparison between Expected and Measured Endpoints
To compare the expected values (expressed as %) with the measured values (expressed as %),
the expected value was calculated by the addition of the mean after exposure to one (or two)
substance(s) with the mean value obtained after exposure to the second or third substance [60]:
mean (expected for AFM1+OTA) = mean (AFM1) + mean (OTA) − 100%, (1)
% difference = |mean (expected for AFM1+OTA) − mean (measured for AFM1+OTA)|, (2)
Taking the TEER value from the combined use of AFM1 and OTA at non-cytotoxic concentrations
as an example, the mean measured TEER value was 84.9%, and, according to the calculation, the mean
expected TEER value was 64.1%. Hence, the % difference was 20.8%:
SEM (expected for AFM1+OTA) = [(SEM for AFM1)2 + (SEM for OTA)2]1/2, (3)
4.10. Analysis for Interactions and Correlations
We previously used isobologram analysis, which is a quantitative method to measure the
interaction of the combined use of mycotoxins [8]. However, the weakness of this approach is that it
requires specialized software to calculate the combination index (CI) value. To analyze the interactive
effects without this technical tool, expected and measured endpoints were compared.
The impaired intestinal barrier led to the situation that TEER values, as well as the expression of
claudin-3, claudin-4, occludin, and ZO-1, decreased, while LY, FITC-4 kDa, and FITC-40 kDa increased.
Synergistic effects were defined as those produced by various chemicals that were greater than the sum
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of their individual effects. Antagonistic effects were defined as those produced by various chemicals
that were lower than the sum of each role.
The significance of difference in expected and measured values was calculated using an unpaired
t-test, with p < 0.05 being considered statistically significant. The results were interpreted as follows:
Additive effects were defined as measured values for endpoints that were not significantly above
or below the expected values (p > 0.05).
Synergistic effects were defined as measured values that were significantly lower than the expected
values for endpoints TEER, claudin-3, claudin-4, occludin, and ZO-1 and significantly higher than for
endpoints LY, FITC-4 kDa, and FITC-40 kDa.
Antagonistic effects were defined as measured values that were significantly higher than the
expected values for endpoints TEER, claudin-3, claudin-4, occludin, and ZO-1 and significantly lower
than the endpoints LY, FITC-4 kDa, and FITC-40 kDa.
Correlations among TEER values, the paracellular flux of LY, FITC-dextran (4 kDa), or FITC-dextran
(40 kDa), and the levels of claudin-3, claudin-4, occludin, or ZO-1 in differentiated Caco-2 cells treated
with AFM1 and OTA individually or collectively were assessed by Spearman’s correlations (nonparametric).
4.11. Statistical Analysis
Statistical analysis was performed using SAS 9.2 software (Cary, NC, USA). Data were expressed
as the mean ± SEM of three independent experiments. Differences between groups were analyzed by
one-way analysis of variance (ANOVA), followed by the Tukey Honestly Significant Difference (HSD)
test for multiple comparisons. Statistically significant cytotoxic effects are represented by * p < 0.05; **
p < 0.001; and *** p < 0.0001.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/10/1/12/s1,
Figure S1: Mycotoxins disrupt intestinal epithelial permeability by affecting occludin expression, Figure S2:
Transepithelial electrical resistance values (Ω × cm2) in differentiated Caco-2 cells were measured at different
time points until 21 days, Figure S3: Concentration–response bar charts for AFM1 and OTA in Caco-2 cells after
48 h of exposure. Results are expressed as the mean ± SEM of three independent experiments with five replicates.
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Abstract: Impaired growth, immunity, and intestinal barrier in mammals, poultry, and carp have
been attributed to the mycotoxin deoxynivalenol (DON). The increased use of plant ingredients
in aquaculture feed implies a risk for contamination with mycotoxins. The effects of dietary DON
were explored in 12-month-old Atlantic salmon (Salmo salar) (start weight of 58 g) that were offered
a standard feed with non-detectable levels of mycotoxins (control group) or 5.5 mg DON/kg feed
(DON group). Each group comprised two tanks with 25 fish per tank. Five fish from each tank
were sampled eight weeks after the start of the feeding trial, when mean weights for the control
and DON groups were 123.2 g and 80.2 g, respectively. The relative expression of markers for
three tight junction proteins (claudin 25b, occludin, and tricellulin) were lower, whereas the relative
expression of a marker for proliferating cell nuclear antigen was higher in both the mid-intestine
and the distal intestine in fish fed DON compared with fish from the control group. The relative
expression of markers for two suppressors of cytokine signaling (SOCS1 and SOCS2) were higher in
the distal intestine in fish fed DON. There was no indication of inflammation attributed to the feed
in any intestinal segments. Our findings suggest that dietary DON impaired the intestinal integrity,
while an inflammatory response appeared to be mitigated by suppressors of cytokine signaling.
A dysfunctional intestinal barrier may have contributed to the impaired production performance
observed in the DON group.
Keywords: atlantic salmon; deoxynivalenol; feed; intestine; PCR; proliferating cell nuclear antigen;
suppressor of cytokine signaling; tight junctions
Key Contribution: Dietary DON at a level of 5.5 mg/kg feed revealed lower expression of markers
for tight junction proteins and higher expression of a marker for proliferating cell nuclear antigen in
the intestine of Atlantic salmon. A dysfunctional intestinal barrier may have contributed to impaired
production performance.
1. Introduction
Atlantic salmon (Salmo salar) is one of the most important species in aquaculture worldwide.
Salmonids are carnivores by nature, but raw materials of vegetable origin are increasingly used in
feed for farmed salmonids due to a limited supply of fish meal and fish oil [1–3]. The use of cereals in
Toxins 2018, 10, 376; doi:10.3390/toxins10090376 www.mdpi.com/journal/toxins23
Toxins 2018, 10, 376
feeds for farmed fish implies a risk for contamination with mycotoxins that are metabolites of mold
capable of having acute toxic, carcinogenic, mutagenic, teratogenic, immunotoxic, or hormonal effects
in mammals [4]. Deoxynivalenol (DON) is one of the major mycotoxins produced by Fusarium spp. [5].
The current European Union (EU) legislation establishes 8000 μg/kg as a maximum guidance value for
DON in cereals and cereal products (with an exception for maize by-products) intended for animal feed
and 5000 μg/mg as a maximum guidance value for complementary and complete feeding stuffs [6,7].
The surveillance of feeds for salmonids in Norwegian aquaculture shows levels of mycotoxins far
below the current guidance levels [8], but accidental intermixture may occur.
Mycotoxins do not appear to pose a hazard to the consumer, because carry-over is considered
negligible in fillets from gilthead seabream (Sparus aurata) and Atlantic salmon experimentally exposed
to dietary DON at levels up to 5.5 mg/kg feed [9,10]. However, adverse effects in fish ingesting
feed contaminated by mycotoxins have been observed. In Atlantic salmon and rainbow trout
(Oncorhynchus mykiss), there appears to be a linearity between increasing dietary levels of DON
up to 5.5 mg/kg feed and 2.6 mg/kg feed, respectively, and decreasing weight gain and growth
rate [11,12]. Furthermore, dose-related alterations in some blood parameters were shown in Atlantic
salmon and rainbow trout [11,13], and pathological changes in the liver characterized by subcapsular
hemorrhage and edema were observed in a number of DON-exposed rainbow trout [12]. In carp
(Cyprinus carpio), the relative expression of markers for both pro- and anti-inflammatory cytokines
as well as enzymes in different organs including the intestine were activated by feed-borne DON at
a concentration of 953 μg/kg feed with an adaption over time [14].
The intestine is an important barrier for protection against pathogens in addition to its main
task in digestion. Exposure of the intestine to mycotoxins, either via feed or gavage, may impair
the intestinal integrity and consequently alter the absorption of nutrients as well as facilitate the
invasion of microbes. In pigs exposed to dietary DON at levels from 0.9 to 3.5 mg/kg feed, the relative
expression of markers for several tight junction proteins (TJs) and inflammatory markers in intestines
were affected [15–17]. The relative expression of markers for certain cytokines was down-regulated in
the intestines of broiler chickens on a diet contaminated with 10 mg DON/kg feed [18]. Furthermore,
DON predisposes to the development of necrotic enteritis in broiler chickens at a contamination level
of 3 to 4 mg/kg feed [19].
Dose-dependent up-regulation of pro-inflammatory cytokines, followed by up-regulation of
suppressors of cytokine signaling and subsequent basal expression of the cytokines, has been
demonstrated in several organs in mice orally exposed to DON over a dose range of 0.1–12.5 mg/kg
body weight in short-time experiments [20]. Altered transcript levels as well as protein expression for
TJs, decreased transepithelial electrical resistance, and increased permeability as a result of exposure to
DON have been observed in several in vitro and in vivo models indicating functional effects [21].
So far, little is known about the impact of dietary mycotoxins on intestinal health of fish in general
and of Atlantic salmon in particular. The aim of this study was to investigate in Atlantic salmon the
long-term impact of dietary DON at a level of 5.5 mg/kg feed on parameters related to the epithelial
barrier of the intestine (relative expression of markers for tight junction proteins and proliferating cell
nuclear antigen as well as goblet cell density), cytokine-mediated inflammation (relative expression of
a marker for interleukin 1β), and suppression of cytokine signaling (relative expression of markers
for SOCS1 and SOCS2), as well as morphologic responses to intestinal insults. The chosen DON level
was slightly higher than the maximum recommended level (5 mg DON/kg feed) established in the
European Union’s current legislation on animal feed.
2. Results
2.1. Gene Expression Analysis by Real-Time PCR
The relative expression of markers for the tight junction proteins claudin 25b, occludin,
and tricellulin was significantly lower in both the mid-intestine and the distal intestine from fish
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fed DON compared with fish from the control group (see Table 1 and Figure 1). The relative expression
of the marker for occludin was also lower in the pyloric ceca from fish fed DON compared with
the controls.
Figure 1. Relative expression of markers for tight junction proteins in the intestine of salmon fed
deoxynivalenol (DON) (5.5 mg/kg feed) or no DON (controls) for eight weeks. * Significant differences
(unpaired t-test or Mann–Whitney U test, p < 0.05) between the experimental groups in the same
intestinal segment. The relative expression of markers for the tight junction proteins (a) claudin 25b,
(b) occludin, and (c) tricellulin were significantly lower in both the mid-intestine and the distal intestine
from fish fed DON compared with the controls. The relative expression of the marker for occludin was
also significantly lower in the pyloric ceca from fish fed DON compared with the controls.
On the other hand, the relative expression of a marker for proliferating cell nuclear antigen
(PCNA) was significantly higher in all intestinal segments in fish fed DON compared with the controls
(see Table 1 and Figure 2).
Figure 2. Relative expression of a marker for proliferating cell nuclear antigen (PCNA) in the intestine
of salmon fed DON (5.5 mg/kg feed) or no DON (controls) for eight weeks. * Significant differences
(unpaired t-test or Mann–Whitney U test, p < 0.05) between the experimental groups in the same
intestinal segment. The relative expression of a marker for PCNA was significantly higher in all
intestinal segments from fish fed DON compared with the controls.
The relative expression of markers for the suppressors of cytokine 1 and 2 (SOCS1 and SOCS2)
was significantly higher in the distal intestine in fish fed DON compared with the controls. Further,
the relative expression of the marker for SOCS1 was also significantly higher in the pyloric ceca in fish
fed DON compared with the controls (see Table 1 and Figure 3).
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Figure 3. Relative expression of suppressors of cytokine signaling (SOCS) in the intestine of salmon
fed DON (5.5 mg/kg feed) or no DON (controls) for eight weeks. * Significant differences (unpaired
t-test or Mann–Whitney U test, p < 0.05) between the experimental groups in the same intestinal
segment. The relative expression of markers for the suppressors of cytokine signaling (a) SOCS1
and (b) SOCS2 were significantly higher in the distal intestine from fish fed DON compared with the
controls. The relative expression of the marker for SOCS1 was also significantly higher in the pyloric
ceca from fish fed DON compared with the controls.
There was no significant difference between the dietary groups regarding the relative expression
of a marker for the cytokine interleukin 1β in any of the intestinal segments (see Table 1).
Table 1. Relative transcription levels normalized to reference gene EF1AB in the intestine of salmon
fed DON (5.5 mg/kg feed) or no DON (controls) for eight weeks.
Pyloric Ceca Mid-Intestine Distal Intestine
Control DON Control DON Control DON
IL-1β 1 ± 0.27 a 0.96 ± 0.40 1 ± 0.22 a 0.94 ± 0.13 1 ± 0.21 a 1.45 ± 0.25
SOCS1 1 ± 0.23 1.74 ± 0.27 * 1 ± 0.20 a 0.99 ± 0.29 1 ± 0.37 c 6.24 ± 2.17 *,a
SOCS2 1 ± 0.29 1.49 ± 0.28 1 ± 0.16 a 2.26 ± 0.63 1 ± 0.17 7.19 ± 1.01 *
Claudin 25b 1 ± 0.14 1.25 ± 0.57 1 ± 0.22 a 0.49 ± 0.09 * 1 ± 0.20 a 0.27 ± 0.05 *,a
Occludin 1 ± 0.10 0.72 ± 0.32 * 1 ± 0.10 a 0.60 ± 0.26 *,b 1 ± 0.22 0.50 ± 0.07 *
PCNA 1 ± 0.24 2.23 ± 0.31 * 1 ± 0.16 a 2.98 ± 0.47 * 1 ± 0.09 1.70 ± 0.19 *
Tricellulin 1 ± 0.12 1.34 ± 0.54 1 ± 0.17 a 0.32 ± 0.06 * 1 ± 0.11 0.49 ± 0.09 *
The data for the DON group are presented as mean ± standard error of the mean (SEM) relative to the mean ± SEM
for the control group for the same intestinal segment; * Significant differences (unpaired t-test or Mann–Whitney
U test, p < 0.05) between the experimental groups in the same intestinal segment. The values that differ significantly
are highlighted in bold text. n = 10 for each group/gene/intestinal segment unless otherwise stated: a: n = 9,
b: n = 8, and c: n = 7.
2.2. Histology and Immunohistochemistry
Histological examination did not reveal pathological changes in the intestines of any fish
(see Figure 4a). The polarization of the enterocytes seemed non-affected, the density of goblet cells
appeared similar in both dietary groups, while proliferating cells were mainly detected at the base of
the intestinal folds with an equal pattern for both groups (see Figure 4b).
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Figure 4. Micrographs of intestinal tissue. Following a histological evaluation, (a) pathological changes
were not revealed in the intestines of any fish and (b) proliferating cells were detected mainly at the
base of the folds with an equal pattern in the controls and the DON group.
3. Discussion
We found that 5.5 mg DON/kg feed was associated with reduced intestinal expression of
markers for three tight junction proteins (claudin 25b, occludin, and tricellulin), suggesting insufficient
expression of these proteins, which could lead to an epithelial barrier impairment with sequelae
affecting both structure and function of the intestine. The effect was most prominent in the distal
intestine. An assumed functional impairment was confirmed by the fact that feed intake and feed
efficiency were significantly reduced by DON exposure [11], and the body weight gain of the DON
group was only one third of the weight gain of the fish from the control group. It was therefore
surprising that we did not detect indications of intestinal inflammation (expression of a marker for
IL-1β and histological examination) or proliferation of goblet cells (tissue sections stained with Alcian
Blue (AB) and Periodic acid–Schiff (PAS) in combination) and absorptive epithelial cells (tissue sections
stained with an antibody toward proliferating cell nuclear antigen (PCNA)). However, other findings
suggested a subtler mechanism behind the adverse impact of DON on production performance.
We detected that the relative expression of markers for two suppressors of cytokine signaling proteins
(SOCS1 and SOCS2) was increased. These increased levels may have contributed to the suppression of
inflammatory cytokines and morphologic inflammatory responses. We also found that the intestinal
level of an mRNA marker for PCNA was increased by DON, suggesting an attempt at increased
proliferation of epithelial cells. However, for some unknown reason this gene transcription did not
appear to translate into the appropriate protein.
To the best of our knowledge, this is the first study addressing the possible influence of any
mycotoxin on certain parameters of the intestine of Atlantic salmon (Salmo salar). The relative
expression of markers for three tight junction proteins (TJs) was significantly lower in both the
mid-intestine and the distal intestine in fish experimentally exposed to dietary DON for eight weeks
compared with fish fed a standard diet with non-detectable levels of mycotoxins. These findings
suggest that the intestinal permeability was increased leading to a leakage of fluids and a suboptimal
control of paracellular influx of macromolecules as undigested food particles, pathogens, and toxins.
Possible consequences include reduced growth as observed in this trial [10,11] and a number of
infections both locally and systemically. The relatively high expression of the marker for PCNA in all
intestinal segments in fish exposed to DON compared with the controls may be interpreted as a local
response aimed at regenerating intestinal integrity. In pigs experimentally exposed to DON in the
feed, both the up- and down-regulation of markers for TJs have been reported [15,16]. This apparent
response discrepancy might be attributed to different dosages and study periods.
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In carp (Cyprinus carpio), the relative expression of markers for several cytokines was 2–3-fold
higher in the intestine in fish on an experimental diet with DON at a level of 953 μg/kg feed compared
with the controls at day 14 of the experiment, but the relative expression returned to basal levels
at day 26 and day 56 [14]. In mice exposed to DON by oral gavage, both the relative expression of
markers for tumor necrosis factor-α and interleukin 6 as well as the protein expression were rapidly
induced in several organs and plasma, respectively, with a peak of 2 h after exposure and a subsequent
decrease [20]. However, the relative expression of several suppressors of cytokine signaling (SOCS),
a family of intracellular proteins that play critical roles in the regulation of innate and adaptive immune
responses as well as growth and development through negative feedback on cytokine signaling,
remained high for several hours with different kinetics for each SOCS and organ [22]. Functional
conservation between teleosts and mammals for SOCS has been demonstrated [23], and the relatively
high expression of markers for SOCS1 and SOCS2 in the distal intestine in Atlantic salmon exposed to
dietary DON in our study, in combination with the absence of inflammation, suggest a successful and
long-lasting response to DON in orchestrating the complex network of cytokines. Specifically, SOCS1
is central to the regulation of a number of cytokines including interferons (IFNs) and interleukins
in mammals [22], and a strong and negative regulatory effect of salmon SOCS1 on type I and type
II IFN-signaling has been demonstrated in cells originating from Atlantic salmon head kidney [23].
Salmon SOCS2 was only moderately affected by IFN responses in that study; however, given the
analogy with SOCS2 in mammals [22], it can be assumed that in our study, SOCS2 has influenced
growth hormone activity and thus contributed to the reduced growth in fish exposed to DON compared
with the controls [10,11]. These findings underline the importance of taking into consideration the
dynamics and complexity of cytokine signaling when designing studies and interpreting results.
The level of DON in the feed for the DON group was slightly higher than the maximum
recommended level (5 mg DON/kg feed) established in the European Union’s current legislation on
animal feed. The surveillance of feeds for salmonids in Norwegian aquaculture shows in general low
levels of mycotoxins [8], but a negative impact on certain biochemical parameters have already been
observed in Atlantic salmon at 2 mg DON/kg feed [11].
Previous studies have produced findings suggesting that the distal intestine (also designated as
the second segment of the mid-intestine and posterior intestine) is more vulnerable to disease and
dysfunction and particularly important for the immunological defense of Atlantic salmon [24–26].
These works showed that the uptake of gold-labelled bovine serum albumin was restricted to the distal
intestine and that the transcript levels of selected immune parameters in general were higher in this
intestinal segment, where an inflammation associated with soy-bean meal also occurs in this species.
Our results agree with the results from these studies as DON appeared to impair the epithelial barrier
and modulate the cytokine signaling in the distal intestine to a larger degree than the other intestinal
segments examined.
Studies applying real-time PCR have demonstrated that markers for several tight junction
proteins, among these claudin 25b, occludin, and tricellulin, are expressed in the intestine of
Atlantic salmon [27,28], and that the expression levels are elevated when juvenile Atlantic salmon
are transferred to seawater, suggesting that they are involved in the reorganization of intestinal
epithelium and have possibly changed the paracellular permeability. Studies on the protein expression
of junctional proteins to reveal whether there is an association between gene expression and protein
expression would be of great interest. Unfortunately, research in Atlantic salmon is hampered by
the lack of relevant antibodies for performing immunohistochemistry or western blot. However,
our findings demonstrate that DON-containing feed may influence certain parameters in the intestine
in several ways that separately and in combination may have an adverse impact on fish growth and
health. Because the increased use of raw materials of plant origin in aquaculture feed implies a risk for
contamination of mycotoxins, the continued surveillance of feeds for the presence of mycotoxins as
well as more research exploring the effects of mycotoxins on health and productivity are needed.
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4. Materials and Methods
4.1. Animal Ethics and Rearing
The feed trial took place at the Skretting ARC Lerang Research Station that is approved by the
Norwegian Animal Research Authority. The trial was approved by the responsible person for animal
ethics at the facility on 12 April 2011 and carried out in accordance with the recommendations in the
current animal welfare regulations in Norway (FOR-1996-01-15-23).
The trial is described in detail elsewhere [10,11]. Briefly, juvenile post-smolt Atlantic salmon
(Salmo salar) (SalmoBreed, Bergen, Norway, 12 months old, both genders) with an average weight of
approximately 58 g were randomly allocated into tanks supplied by flow-through seawater. All the
fish were vaccinated intraperitonally against Aeromonas salmonicidae three weeks after the start of
the experiment.
4.2. Study Design and Sampling
This experiment was designed with two treatment groups (see Figure 5): a control group fed a standard
pelleted feed (Spirit 3 mm, Skretting, Stavanger, Norway) with non-detectable levels of mycotoxins and
a group offered the same feed coated with pure deoxynivalenol (DON) (Biopure standard DON; lot #06221Z,
degree of purity 99.4%, Romer Labs, Tulln, Austria) to a level of 5.5 mg DON/kg feed. Each group
comprised two tanks with 25 fish per tank. Five fish from each tank were sampled eight weeks after the start
of the feeding trial, when mean weights for the control and DON fish were 123.2 g and 80.2 g, respectively.
Thus, the weight gain of the DON group was only one third of the weight gain in the control group. The feed
efficiency was approximately 0.8 and 1.3, respectively [11].
Figure 5. Design of the study on Atlantic salmon fed DON (5.5 mg/kg diet, red color) or no DON
(controls, green color) for eight weeks. Five fish from each tank were sampled eight weeks after the
start of the feeding trial.
Tissues from the pyloric ceca, the mid-intestine and distal intestine were collected on RNAlater
and formalin (Figure 6). Tissues on RNAlater were stored cool for 24–48 h and then at −20 ◦C until
further processing, while formalin-fixed tissues were routinely processed and embedded in paraffin
after 24–48 h.
Figure 6. Sampling of intestinal tissues. Tissues from the pyloric ceca (PC), the mid-intestine (MI)
and the distal intestine (DI) were collected on RNAlater and formalin. The drawing is a courtesy of
Professor emeritus Inge Bjerkås, NMBU, Oslo, Norway.
4.3. Gene Expression Analysis by Real-Time PCR
Nucleic acids from all intestinal tissues were extracted automatically on easyMag (bioMérieux,
Marcy l’Etoile, France) using the generic protocol. The RNA concentration and purity were determined
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using a NanoDrop™ 2000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA). Purity was
assessed by determining the ratio of absorbance at 260 and 280 nm (A260/A280). All samples had
a ratio between 1.80 and 2.08. The RNA was diluted to 50 ng/μL. The elimination of genomic DNA and
the synthesis of cDNA from 500 ng RNA were performed with the QuantiTect Reverse Transcription Kit
(QIAGEN, Hilden, Germany) according to the manufacturer’s recommendations using the included
RT Primer Mix with an optimized blend of oligo-dT and random primers dissolved in water.
Real-time PCR was carried out using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad,
Hercules, CA, USA) with cDNA template corresponding to ~5 ng RNA in each reaction in a CFX384
Touch™ Real-Time PCR Detection System (Bio-Rad, Herkules, CA, USA) according to the producer’s
instructions with 60 ◦C as annealing temperature and running 40 cycles.
The expression of markers for the following genes was analyzed by real-time PCR: claudin 25b,
interleukin 1β (IL-1β), occludin, proliferating cell nuclear antigen (PCNA), suppressor of cytokine
signaling 1 and 2 (SOCS1 and SOCS2), tricellulin, and finally elongation factor 1AB (EF1AB) as the
reference gene [29] (see Table 2). All analyses were performed in triplicate, and a control lacking
template for each master mix was always included in the experiments.
Table 2. Primers for gene expression analyses.
Target Gene Sequence 5→3′ Reference








4.4. Histology and Immunohistochemistry
Sections from all intestinal tissues were cut at 3 μm and stained with hematoxylin and eosin
(HE) or Alcian Blue (AB) and Periodic acid–Schiff (PAS) in combination, whereas proliferating
cells were detected using a monoclonal mouse antibody against proliferating cell nuclear antigen
(PCNA; M0879, Dako, Glostrup, Denmark) previously used in fish [33]. After deparaffinization,
antigen retrieval, and inhibition as described elsewhere [34], the sections were incubated with horse
serum diluted 1:100 in 5% bovine serum albumin (BSA) in a tris-buffer solution (TBS) for 20 min to
prevent non-specific binding. The antibody against PCNA was diluted 1:5000 in 1% BSA/TBS before
incubation for 60 min. The secondary antibody, horseradish peroxidase-labelled polymer conjugated
to horse anti-mouse Ig, was diluted 1:100 in 1% BSA/TBS before incubation for 30 min, followed
by incubation with Vectastain® Elite ABC Reagent (PK-7100, Vector Laboratories, Burlingame, CA,
USA) for 30 min and ImmPACT™ AEC (SK-4205, Vector Laboratories, Burlingame, CA, USA) for 5
min. The sections were thoroughly rinsed between each step except after the incubation with horse
serum, counterstained with hematoxylin for 15 s and mounted with VectaMount™ AQ Aqueous
Mounting Medium (H-5501, Vector Laboratories, Burlingame, CA, USA). Micrographs were captured
with ACT-1 software (Nikon, Tokyo, Japan) using a digital camera D×1200 configured with a Leica
DM4000 microscope.
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4.5. Calculations and Statistical Analysis
Databases for the results from real-time PCR were established in Excel®for Windows,
and statistical calculations and graphical presentation of gene expression were performed using
Prism 7.0 software (GraphPad Software, La Jolla, CA, USA). Data were given as mean ± standard error
of the mean (SEM) unless otherwise stated. The data for gene expression were analyzed for normality
using the Shapiro–Wilk test. Data with normal distributions were further analyzed using the unpaired
t-test, whereas non-normal data were analyzed using the Mann–Whitney U test. The significance level
was set to 0.05.
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Abstract: We intended to assess how exposure of piglets to deoxynivalenol (DON)-contaminated
feed impacted their growth, immune response and gut development. Piglets were fed traditional
Phase I, Phase II and Phase III diets with the control group receiving 0.20–0.40 ppm DON (referred to
as the Control group) and treatment group receiving much higher level of DON-contaminated wheat
(3.30–3.80 ppm; referred to as DON-contaminated group). Feeding a DON-contaminated diet had no
impact on average daily feed intake (ADFI) (p < 0.08) or average daily gain (ADG) (p > 0.10) but it did
significantly reduce body weight over time relative to the control piglets (p < 0.05). Cytokine analysis
after initial exposure to the DON-contaminated feed did not result in significant differences in serum
interleukin (IL) IL1β, IL-8, IL-13, tumor necrosis factor (TNF)-α or interferon (IFN)-γ. After day 24,
no obvious changes in jejunum or ileum gut morphology, histology or changes in gene expression for
IL-1β, IL-6, IL-10, TNFα, or Toll-like receptor (TLR)-4 genes. IL-8 showed a trend towards increased
expression in the ileum in DON-fed piglets. A significant increase in gene expression for claudin
(CLDN) 7 gene expression and a trend towards increased CLDN 2-expression was observed in the
ileum in piglets fed the highly DON-contaminated wheat. Because CLDN localization was not
negatively affected, we believe that it is unlikely that gut permeability was affected. Exposure to
DON-contaminated feed did not significantly impact weaner piglet performance or gut physiology.
Keywords: ileum; jejunum; deoxynivalenol; piglet; contaminated feed; tight junction
Key contribution: Relative to control piglets receiving 0.20–0.40 ppm deoxynivalenol
(DON)-contaminated feed, weaner piglets fed 3.30–3.80 ppm DON for 24 d had significantly reduced
body weight. However we observed no significant impact on average daily feed intake, average daily
gain, serum or gut cytokine expression (with exception of elevated ileal Claudin-7), gut morpholoyg,
or histology.
1. Introduction
Deoxynivalenol (DON), commonly known as vomitoxin, is a potent mycotoxin produced by the
fungus Fusarium graminearum, and its presence in wheat, corn, and barley crops can lead to them
being downgraded to livestock feed grade. Pigs, and in particular young piglets, are poorly tolerant to
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DON contamination. Although extremely high doses of contamination in feed (20 mg/kg feed) will
induce vomiting [1,2], swine will tolerate lower-level feed contamination to varying degrees in a sex-
and dose-dependent manner [3]. Longer-term exposure to moderate contamination of feed at levels
between 5 and 8 mg/kg will be tolerated but has been shown to considerably decrease daily feed
intake and growth rate [4,5]. As a result, governmental guidelines from the Canadian Food Inspection
Agency, United States Food and Drug Administration and the European Union recommend limiting
dietary inclusion in swine feed to under 1 mg/kg [6], 1 mg/kg [7], and 0.9 mg/kg [8] respectively.
However even at these recommended inclusion levels DON has been shown to significantly decrease
average daily gain (ADG) and alter intestinal morphology [9]. The majority of research to date has
focused on the local effect of DON on the intestine but doses, age of animal, and exposure times
have varied which makes it difficult to compare results. In vivo studies have demonstrated that
chronic exposure to 3 mg/kg DON-contaminated feed altered intestinal morphology including villus
atrophy and reduced villi height, reduced jejunal and ileal goblet cells and lymphocytes counts, as well
as reduced expression of junctional adheren protein E-cadherin and tight-junction protein occludin
in the intestine [10]. Several studies show that piglets fed DON had altered cytokine production
either in the duodenum, jejunum, or the ileum or the mesenteric lymph nodes [9,11,12] indicating
that DON-contaminated feed can alter the innate immune response in a piglet’s gut. With increased
quantities of DON-contaminated grain entering the livestock sector, complete avoidance of DON may
not be possible.
The intestinal tract is the first physical barrier to protect the body from food contaminants,
chemicals and intestinal pathogens. A single layer of epithelial cells separates the apical and basolateral
domains of the gut mucosa. Tight junctions (TJs) between adjacent cells are regulated by structural and
functional proteins including Occluden, Junction Adhesion molecules and Claudin family members,
which together regulate permeability through the intercellular space on epithelial sheets [13–17].
How DON reportedly affects barrier function and specifically the proteins involved in TJ formation
is variable based on experimental design, age of animals, amount of DON present and duration of
exposure [10,18]. It is, therefore, neccessary to better understand the physiological effects underlying
the reduced performance by pigs consuming DON-contaminated diets in order to develop effective
and economical strategies.
We sought to clarify how weaner piglets fed traditional Phase I, Phase II and Phase III diets with
the control group receiving 0.30 ppm DON and treatment group receiving 3.30 ppm DON in Phase I,
control group receiving 0.20 ppm DON and treatment group receiving 3.80 ppm DON in Phase II,
and control group receiving 0.40 ppm DON and treatment group receiving 3.80 ppm DON in Phase
III were affected. We measured ADG, average daily feed intake (ADFI), and gene expression profiles
for innate immune response receptors and cytokines, as well as genes that play a role in intestinal
barrier function. Immunohistofluorescence was performed to establish localization of several proteins
that mediate TJ formation in the jejunum and the ileum. This research will help to establish whether
homeostatic mechanisms compensate for DON exposure in vivo over the long term.
2. Results
2.1. Feed Intake and Growth Performance
No pigs showed any signs of vomiting throughout the trials. One pig from the control diet
died during the study due to reasons unrelated to dietary treatments. Body weight (Table 1) was not
different between groups (p > 0.05) up to day 24 of the study but final body weight was significantly
reduced (p < 0.05) in pigs fed the DON diet.
Average daily gain and average daily feed intake were not affected (Table 2, p > 0.05) in the first
three weeks of the study period. There was a trend (p < 0.08) for average daily feed intake to be
reduced in pigs fed the DON diet in the final days of the study.
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Table 1. Body weight (kg) of piglets assigned to receive either a low-DON control diet or a
DON-contaminated diet for 24 days. Piglets were weaned at 21 days of age (experimental day 0).
Time
Control Diet
(0.20 to 0.40 ppm DON)
DON-Contaminated Diet
(3.30 to 3.80 ppm DON)
Day 0 5.80 5.79
Day 3 5.85 5.77
Day 7 6.09 5.82
Day 14 7.43 6.94
Day 21 9.96 9.28
Day 24 11.43 * 10.39 *
Data are LSMeans. Analysis by repeated measures, overall effect of treatment p = 0.04, SEM 0.144; treatment by day,
p = 0.003, SEM 0.277. * Day 24, p < 0.01.
Table 2. Growth and feed intake of piglets assigned to receive either a low-DON control diet or a
DON-contaminated diet for 24 days. Piglets were weaned at 21 days of age (experimental day 0).
Interval
Control Diet
(0.20 to 0.40 ppm DON)
DON-Contaminated Diet
(3.30 to 3.80 ppm DON)
Average daily gain (d/g)
Day 3–7 63.3 6.4
Day 7–14 190.8 158.3
Day 14–21 358.9 331.6
Day 21–24 367.0 273.6 *
Average daily feed intake (g/d)
Day 3–7 137.6 90.4
Day 7–14 236.9 202.4
Day 14–21 519.7 457.9
Day 21–24 700.8 * 602.3 *
Data are LSMeans. Analysis by repeated measures, ADG, overall effect of treatment, p < 0.001, SEM 14.95, treatment
by day, p = 0.19, SEM 33.28; ADFI, overall effect of treatment p < 0.05, SEM 21.11, treatment by day, p = 0.46,
SEM 33.14. * Day 21–24, ADG, p < 0.05; ADFI, p < 0.10.
2.2. Serum Cytokine Analysis in Acute Period after DON Exposure
Three and seven days after introduction of the Phase I diets, sera were collected and systemic
cytokines levels were assessed (Figure 1). We did not identify a significant difference in serum IL-1β
(Figure 1A), IL-8 (Figure 1B) IL-13 (Figure 1C), TNF-α (Figure 1D) or IFN-γ (Figure 1E) between
animals fed the Control or DON-contaminated diets after 3 or 7 d. We also did not detect a significant
change in any of the serum cytokines over time within each treatment group. These data indicate
that under the current experimental conditions, DON-contaminated feed did not promote a systemic
inflammatory immune response.
2.3. Jejunal and Ileal Immune Response Gene Profile after Exposure to DON
Next, we wanted to assess how DON exposure for 24 days affected piglet cytokine gene expression
in the jejunum and the ileum. In the jejunum, we observed no significant difference in the expression
of IL-1β (Figure 2A), IL-6 (Figure 2B), IL-8 (Figure 2C), IL-10 (Figure 2D), and TNFα (Figure 2E) genes
in control or DON-fed piglets. These same cytokines also showed no change in expression in the ileal
tissue between the Control and DON-fed piglets (p > 0.10), with the exception of IL-8, which showed a
trend towards increased expression in the DON-treated tissues (Figure 2C; p < 0.06). Likewise, the gene
for TLR4 that codes for a receptor that detects lipopolysaccharide from Gram negative bacteria was
not differentially expressed between the Control and DON-fed piglets (Figure 2F).
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Figure 1. Acute but low-level exposure of DON-contaminated feed did not impact serum cytokine
production. Sera were collected on Day 3 and Day 7 and subjected to BioPlex analysis to assess changes
in (A) IL-1β, (B) IL-8, (C) IL-13, (D) TNF-α and (E) IFN-γ in response piglets fed DON-contaminated
feed or Control feed after 3 and 7 days. Each data point represents a unique biological replicate and the
horizontal line represents the median value for the group. Statistical analysis was performed with a
nonparametric Kruskal-Wallis between DON and Control fed piglets on Day 3 and Day 7 as well as
within each treatment group over time.
In recent years, occludens, junctional adhesion molecule proteins, claudin family members and
others have been shown to be responsible for mediating TJ formation [19]. We investigated whether
DON exposure could influence the expression profile of several genes, which encode TJ proteins
including Claudins (CLDNs), Occluden (OCLN) and Zonula occludens-1 (ZO-1) in jejunal and ileal
tissue. CLDN-1 expression (Figure 3A) was not significantly altered in response to DON but CLDN2
(Figure 3B; p < 0.063), CLDN-3 (Figure 3C; p < 0.054), and CLDN-4 (Figure 3D; p < 0.063) showed a
trend towards upregulation in the ileum (but not the jejunum) in the DON-treated animals relative
to age-matched Control-fed piglets. Expression of CLDN-7 was significantly induced in the ileal
tissue from DON-treated animals (Figure 3F; p < 0.031) but no change in expression was observed
in the jejunum relative to the Control-fed piglets. We observed no significant difference in gene
expression for CLDN-10 (Figure 3G), CLDN-23 (Figure 3H), OCLN (Figure 3I) or ZO-1 (Figure 3J)
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in either tissue across treatment groups. Gene expression analysis for CLDN-8 and CLDN-14 were
assessed however expression of these transcripts was below the threshold of detection (data not
shown). DON-contaminated feed had no effect on expression patterns of the indicated genes in the
jejunum and only modest effect on expression in the ileum.
Figure 2. QPCR analysis of cytokines and TLR4 in jejunal and ileal gut tissue. After 24 days of
exposure, jejunal and ileal gut samples from control and DON-fed piglets were investigated for
relative expression of IL-1β (A), IL-6 (B), IL-8 (C), IL-10 (D), TNFα (E) and TLR4 (F) mRNA expression.
The mRNA expression levels of each gene were normalized with the housekeeping genes and were
calculated with 2−ΔΔCt relative quantification. Each data point represents a unique biological replicate.
Horizontal bars represent the median values.
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Figure 3. QPCR analysis of Claudins, Occluden and Zonodulin 1 in jejunal and ileal gut tissue. After
24 days of exposure, jejunal and ileal gut samples from control and DON-fed piglets were investigated
for relative expression of Claudin (CLDN)-1 (A), (CLDN)-2 (B), (CLDN)-3 (C), (CLDN)-4 (D),
(CLDN)-6 (E), (CLDN)-7 (F), (CLDN)-10 (G), (CLDN)-23 (H), Occluden (OCLN) (I), and Zonodulin-1
(ZO1) (J) mRNA expression. The mRNA expression levels of each gene were normalized with the
housekeeping genes and were calculated with 2−ΔΔCt relative quantification. Each data point represents
a unique biological replicate. Horizontal bars represent the median values.
Next, we assessed whether DON-contaminated feed impacted villous or crypt morphology (using
H & E staining) or surface localization of CLDN-1, CLDN-3, CLDN-4, CLDN-7 proteins in ileum
villi (Figure 4A–H) and crypts (Figure 4I–P) and jejunal villi (Figure 5A–H) and crypts (Figure 5I–P)
relative to control fed piglets using immunohistofluorescence. We observed no change in villous or
crypt morphology per villi in piglets fed DON-contaminated or control feed (data not shown). In both
regions of the gut, CLDN1 was localized to the full length of the pericellular junction within the crypts
(Figure 4I,M and Figure 5I,M) where it was found more heavily localized to the apical aspect of the
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pericellular junction at the villus tip (Figure 4A,E and Figure 5A,E). CLDN1 was also expressed in
intestinal endothelial cells (data not shown). CLDN3 stained the length of the pericellular junction
at the villus tip (Figure 4B,F and Figure 5B,F) and within the crypts (Figure 4J,N and Figure 5J,N).
CLDN4 staining at the villus tip was observed along the length of the pericellular junction (Figure 4C,G
and Figure 5C,G) whereas it was found intracellularly localized in the epithelium of the crypt for
both control fed and DON-fed piglets (Figure 4K,O and Figure 5K,O). CLDN7 stained along the
length of the pericellular junction at both the villus tip (Figure 4D,H and Figure 5D,H) and within the
crypts (Figure 4L,M and Figure 5L,M). The figures shown are representative of 4 biological replicates
(Supplementary Figures S1–S8). We note that the IHF staining intensity was strongest for CLDN7
>>> CLDN3 > CLDN4 > CLDN1 which is not obvious from the figures because specific imaging
protocols were used to evaluate each anti-CLDN antibody (data not shown). IHC analysis of this panel
of CLDNs indicates that exposure of piglets to DON-contaminated feed did not negatively impact
CLDN localization in jejunal and ileal villi or crypts relative to those fed control feed.
 
Figure 4. Claudin surface localization in piglet ileal villi and crypts in DON-fed and control fed piglets.
Ileal tissue was obtained 24 days after DON-exposure to half of the piglets. CLDN1 was localized to the
full length of the pericellular junction within the crypts where as it was found more heavily localized
to the apical aspect of the pericellular junction at the villus tip (A,E,I,M). CLDN3 stained the length
of the pericellular junction at the villus tip and within the crypts but was more abundant in the latter
(B,F,J,N). CLDN4 stained the villous surface but was found intracellularly localized in the epithelium
of the crypts (C,G,K,O). CLDN7 stained along the length of the pericellular junction at both the villus
tip and within the crypts (D,H,L,P). Secondary antibody: Alexa555-conjugated goat α rabbit IgG (red)
in incubation buffer for 4 h at room temperature. Nuclear stain: DAPI (blue). Scale bar represents
50 μm.
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Figure 5. Claudin surface localization in piglet jejunal villi and crypts in DON-fed and control fed
piglets. Jejunal tissue was obtained 24 days after DON-exposure to half of the piglets. CLDN1
was localized to the full length of the pericellular junction within the crypts where as it was found
more heavily localized to the apical aspect of the pericellular junction at the villus tip (A,E,I,M).
CLDN3 stained the length of the pericellular junction at the villus tip and within the crypts but
was more abundant in the latter (B,F,J,N). CLDN4 stained the villous surface but was found
intracellularly localized in the epithelium of the crypts (C,G,K,O). CLDN7 stained along the length of
the pericellular junction at both the villus tip and within the crypts (D,H,L,P). Secondary antibody:
Alexa555-conjugated goat α rabbit IgG (red) in incubation buffer for 4 h at room temperature. Nuclear
stain: DAPI (blue). Scale bar represents 50 μm.
3. Discussion
The aim of this study was to determine whether the piglet gut can compensate for
DON-contaminated feed by showing gut health and strong growth kinetics. Most studies show that
piglets fed DON-contaminated feed have altered gut histology and reduced performance. For instance,
jejunal explants from 4 to 5 week old piglets and 9–13 week old pigs exposed to 5 μM DON (corresponds
to 1.5 mg/kg in diet) for 8 hours were shown to have shortened intestinal villi and lysed intestinal cells
however the younger piglets were shown to have better morphological scores [20]. However, no effect
on morphological scores was observed in 4–5 week old piglet gut explants exposed for 4 h to 1 μM
DON (which corresponds to 0.3 mg DON/kg in diet) [20]. In vivo studies showed 0.9–2.29 mg/kg
DON in feed resulted in shortening of villi and morphological effects [21]. In contrast, our results
showed piglets fed up to 3.80 ppm DON-contaminated feed had reduced ADG and a tendency towards
reduced ADFI relative to the control pigs that were exposed to up to 0.40 ppm DON, but only in the last
days of the trial. The jejunum and ileum showed no significant changes in villous or crypt architecture
between our control and DON-fed groups. We speculate that the low level DON contamination in
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the control diet may have had an impact on the gut, which makes it difficult to observe a difference
between this diet and the treatment diet with 3.80 ppm DON.
How DON affects barrier function and specifically the proteins involved in TJ formation is
unknown and results have been variable, possibly due to differences in experimental design, age of
animals, amount of DON present, and duration of exposure. Using Ussing chambers to investigate
jejunal tissues, it was determined that 2–3 month old pigs fed 4–8 mg/mL DON showed inhibited
active transport of nutrient across the small intestinal wall [22]. Others [10] showed that 5-week old
piglets fed 3 mg DON /kg feed for 35 days did not show significantly reduced weight but there was
reduced adherent junction protein E-cadherin and the tight junction protein occludin in the intestine.
Similarly, 4-week old piglets fed 0.9 mg DON/kg feed for 10 days showed reduced mRNA expression
of occludin in the intestine [9]. Immunohistochemistry of the jejunum by Pinton et al. (2009) showed
that 5 week old piglets fed 2.85 mg DON/kg feed had a 40% decrease of Claudin-4 expression (which
was more pronounced in the villi) in samples from DON exposed animals when compared with
controls animals [18]. Together, these studies suggest that DON exposure impacts expression of select
TJ proteins and barrier function. Our research showed that piglets fed 3.80 ppm DON-contaminated
feed starting at weaning for 24 days showed significantly reduced mRNA expression for only CLDN-7
in the ileum (but not for CLDN-1, -2, -3, -4, -6, -10, -23 or OCLN or ZO1) compared to piglets
fed the control diet. However, the surface localization of CLDN-1, -3, -4 and -7 (as analyzed by
immunohistofluorescence) did not show a difference in the villi or the crypts of jejunal or ileal tissues,
regardless of the diet. Consequently, we speculate that any alteration in the intestinal architecture
induced by both low level DON exposure (control diet) and higher-level DON exposure may be largely
ameliorated over time.
The effect of DON on the piglet immune system in the gut is also unknown and variable results are
described in the literature. An in vivo study showed that feeding 2.2–2.5 mg/kg DON-contaminated
diet to pigs (starting weight approx. 11 kg) for 5 weeks had no notable effect on the mRNA expression of
TGF-β, IFN-γ, IL-4 and IL-6 in the ileum [11]. In contrast, Becker et al showed that piglets (11.4 kg) fed
1.2 mg DON/kg for 41 days and then 2 mg DON/kg feed for 42 days responded with down-regulation
in the expression of IL-1β, IL-8 and TNFα in the blood and down-regulation of IL-1β and IL-8 in the
ileum [12]. This result again conflicts with another study where 4-week old piglets fed 0.9 mg/kg
DON for 10 days had increased expression of IL-10 and IL-1β genes in the duodenum but expression
was slightly down-regulated in the jejunum compared to piglets fed a control diet [9]. Others showed
that 5-week old piglets fed a diet artificially contaminated with DON (3 mg/kg) for 35 days did
not significantly modulate animal weight but they did result in significant upregulation of immune
response genes IL-1β, IL-2, IL-6, IL-12p40 and MIP-1β in the jejunum and a significant induction of
the expression of TNF-α, IL-1β and IL-6 in the ileum revealing the presence of active inflammation
in the intestine [10]. Consistent with our results, Lessard et al., 2015 showed that 4-week-old piglets
fed control diet or diet contaminated with 3.5 mg DON/kg did not show altered mRNA expression
levels of proinflammatory cytokines IL1β, IL10, IL12β, and TNF-α in intestinal tissues [23]. In contrast
to our study, they showed that pigs fed DON diet had significant up-regulated IFNγ and IL-8 in the
ileum compared to control group [23] whereas our data shows that IL-8 showed a trend towards
increased expression in DON-fed piglets in ileum after 7 days relative to the control diet fed piglets
(p < 0.0535). IL-8 is a pro-inflammatory cytokine, which transmits the danger signals to the underlying
local antigen-presenting cells and lymphocytes in the gut tissue. Together, these studies may suggest
that the duration of DON exposure, as well as the dose and age of initial exposure, may significantly
affect the modulation of genes regulating intestinal immune function.
4. Conclusions
This study indicates that feeding weaner piglets a diet with a high level of DON contamination
(3.30 to 3.80 ppm) resulted in only modest effects on piglet gut health, immune response and body
weight, compared to a diet with 0.20 to 0.40 ppm. With the exception of serum cytokine levels,
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the majority of the molecular analysis in the present study was performed on tissue collected at the end
of a dietary treatment period, and as such the effect of DON on other molecular physiology in the acute
period is not known. Our results do however suggest that if such an early effect occurred, subsequent
compensatory mechanisms were capable of re-establishing intestinal homeostasis. It may, therefore be
necessary to evaluate slow introduction of DON-contaminated feed to allow animal sufficient time to
adapt without a negative impact on growth and performance.
5. Materials and Methods
5.1. Animal Care and Selection
All animals used in these experiments were cared for and monitored according to Prairie Swine
Centre, Inc.’s (Saskatoon, SK, Canada) Standard Operating Procedures and the experiment was
approved by the University of Saskatchewan Animal Research Ethics Board (Protocol #20130054) for
adherence to guidelines outlined by the Canadian Council on Animal Care (2009). Date of approval:
8 March 2016.
A total of 24 newly weaned pigs (Camborough Plus x C3378; PIC Canada Ltd., Winnipeg, MB,
Canada) were used for this experiment over 4 blocks (12 pigs/treatment). Piglets were weaned at
21 ± 2 (mean ± SD) days of age and 5.89 ± 0.33 kg body weight from sows consuming a commercial
lactation diet (Prairie Swine Centre, Inc, Saskatoon, SK, Canada). Upon weaning pigs were placed on a
common commercial starter diet for the first 3 d. The pigs were checked twice daily for any signs of ill
health. On d 4 post-weaning, pigs were moved to metabolic crates (1.5 × 1.5 m) with plastic-coated,
expanded metal floors, polyvinyl chloride walls (0.9 m high) and Plexiglas windows (0.3 × 0.3 m).
Pigs were housed individually and remained in the metabolic crates for the duration of the study.
Each pen had a bowl drinker and a single-spaced dry feeder providing ad libitum access to water
and feed. Lights were on from 07:00 h to 19:00 h. The initial room temperature of 26 ◦C was decreased
to 24 ◦C after 2 weeks and this temperature was maintained for the following 3 weeks.
5.2. Dietary Treatments and Preparation
Pigs were randomly assigned to 1 of the 2 dietary treatments within each block in a randomized
complete block design. Diets were wheat and barley-based and were formulated based on a 3-phase
feeding program to meet or exceed nutrient requirements according to NRC (2012). Pigs were fed a
control diet formulated to contain 0 mg/kg DON or treatment diets formulated to contain 4 mg/kg
DON (Table 3).
Phase I was fed for the first 4 days, phase II for the subsequent 2 weeks and phase III for
4 days. The DON-contaminated diet was produced by replacing clean wheat with an amount of
DON-contaminated wheat to achieve a final concentration of 4 mg/kg feed. The DON-contaminated
wheat was obtained from a single contaminated field in Saskatchewan, Canada. The DON content
of the wheat was concentrated by sorting with a BoMill TriQ (BoMill AB, Vintrie, Sweden) NIR
seed sorter which produces a wheat fraction with highly consistent level of DON contamination
(Kautzman et al., 2015). DON content was determined using HPLC-tandem MS at Prairie Diagnostic
Services (Saskatoon, SK, Canada). The mycotoxin composition of DON wheat used for the study is
described in Table 4. Samples of each diet were obtained throughout the feeding trial and a composite
sample was analyzed (Central Testing Laboratory in Winnipeg, Winnipeg, MB, Canada) for moisture
(AOAC 930.15), dry matter, crude protein (AOAC 990.03), Ca (AOAC 968.08), P (AOAC 968.08),
Na (AOAC 968.08), NDF (ANKOM) and DON (ELISA DON-V, Vicam, Nixa, MO, USA. 65714).
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Table 3. Ingredient composition (%, as-fed) and calculated and analyzed nutrient content of
experimental diets.
Ingredient













Wheat (clean) 58.1 20.3 42.6 4.3 44.4 6.2
Wheat (DON) - 34.8 - 34.8 - 34.8
Soybean meal 22.0 25.0 21.0 24.6 18.6 22.1
Barley - - 27.9 27.9 31.9 31.9
Whey 11.4 11.4 - - - -
Fish meal 3.9 3.9 3.2 3.2 - -
Canola oil 1.9 1.9 2.4 2.4 2.0 2.0
Limestone 1.05 1.05 1.30 1.30 1.55 1.55
Salt 0.40 0.40 0.40 0.40 0.40 0.40
L-Lys, HCl 0.615 0.568 0.573 0.508 0.637 0.575
DL-Met 0.125 0.180 0.105 0.105 0.050 0.050
L-Thr 0.180 0.125 0.175 0.175 0.130 0.130
L-Trp 0.057 0.057 0.004 0.004 0.021 0.021
Choline chloride 0.08 0.08 0.08 0.08 0.08 0.08
Copper sulfate 0.04 0.04 0.04 0.04 0.04 0.04
Vit/min premix 1 0.20 0.20 0.20 0.20 0.20 0.20
Calculated nutrient content
DM (%) 88.7 88.8 87.6 87.7 87.8 87.9
CP (%) 23.5 23.1 22.1 21.8 19.7 19.4
ME (kcal/kg) 3323 3323 3270 3273 3225 3228
Lys (% SID) 1.50 1.50 1.35 1.35 1.23 1.23
Ca (%) 0.73 0.74 0.72 0.73 0.66 0.67
P (%) 0.58 0.59 0.51 0.52 0.42 0.43
DON (ppm) 0.00 4.00 0.00 4.00 0.00 4.00
Analyzed nutrient content
DM (%) 89.2 89.2 89.5 89.2 89.1 89.4
CP (%) 22.4 23.4 21.8 22.7 19.6 20.8
Ca (%) 0.80 0.88 0.82 1.00 0.86 0.94
P (%) 0.61 0.61 0.53 0.51 0.45 0.46
DON (ppm) 0.30 3.30 0.20 3.80 0.40 3.80
DM, dry matter; ME, metabolizable energy; CP, crude protein. 1 Provided per kg of complete diet: Vitamin A,
12,000 IU/kg; Vitamin D 1500 IU/kg; Vitamin E, 70 IU/kg); menadione, 5 mg/kg; Vitamin B12, 0.04 mg/kg;
thiamine, 2 mg/kg; biotin, 0.2 mg/kg; niacin, 40 mg/kg; riboflavin, 8 mg/kg; pantothenate, 24 mg/kg; folic acid,
1 mg/kg; pyridoxine, 10 mg/kg; Fe, 150 mg/kg, Zn, 150 mg/kg; Mg, 40 mg/kg; Cu, 20 mg/kg; Se, 0.3 mg/kg;
I, 1 mg/kg.
Table 4. Mycotoxin content of DON-contaminated wheat 1.













1 Analyzed by HPLC/MS (Prairie Diagnostic Services, Inc., Saskatoon, SK, Canada). 2 Values of <25.0 and
<66.0 indicates mycotoxin was below limit of detection.
Analyzed DON concentrations were 0.3, 0.2 and 0.4 mg/kg for the control diets for Phase I,
II and III, and 3.3, 3.8 and 3.8 for the contaminated diets for Phase I, II and III, respectively. This level
of variation among diets is typically observed in trials similar to this and attributed to sampling.
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5.3. Animal Sampling and Weight Calculations
Body weight and feed intake (adjusted for wastage) were determined on day 0, 4, 7, 14, 21,
and 24 of the study for the calculation of ADG and ADFI. Blood samples were obtained via jugular
venipuncture on d 3, 7, 14, 21, and 25 for the determination of serum cytokine levels (IFN-γ, TNF-α,
IL-1β, Il-6, IL-8, IL-10, IL-13) as a measure of overall immune status. On d 25, pigs were euthanized
via non-penetrating captive bolt followed by exsanguination. Tissues were obtained from the small
intestine (jejunum and ileum). Jejunum was defined as the mid-point of the small intestine and the
ileum was defined as 1 m from the ileo-caecal junction.
5.4. Histology and Immunohistoflourescence
Two samples of gut tissue were obtained per site and stored in 10% neutral buffered formalin or
snap frozen in dry ice and stored at −20 ◦C until further analysis. Tissue sections were fixed in 10%
neutral buffered formalin for 36 h prior to processing and paraffin embedding. Samples were sectioned
at 0.4 μm and mounted on slides (Superfrost Plus, ThermoFisher Scientific, Burlington, ON, Canada),
deparaffinized in xylene and rehydrated to distilled water through decreasing concentrations
of ethanol.
For histology, tissues were stained with hematoxylin and eosin following standard procedures.
Villous height and width were measured and crypt depth was recorded for representative images
(data not shown).
For immunohistofluorescence, heat-induced antigen retrieval was carried out in Tris-EDTA buffer
(10 mM Tris, 1 mM EDTA Solution, 0.05% Tween 20, pH 9.0) for 30 min at 90 ◦C prior to blocking
in 5% (w/v) skim milk in PBS for 3hrs at room temperature. Immunohistofluorescent staining was
carried out on two non-concurrent tissue sections from each sample with either 1:100 rabbit αCLDN1
(ab15098), 1:200 rabbit αCLDN3 (ab15102), 1:400 dilution of rabbit αCLDN4 (ab53156) or 1 in 200 rabbit
αCLDN7 (ab27487). Primary antibodies were diluted in an incubation buffer consisting of 1% w/v BSA,
1% v/v Donkey Serum, 0.5% v/v triton X-100 in PBS and samples stained over night at 4 ◦C. Slides
were then washed three times in PBS and incubated in a 1:400 dilution of Alexa555-conjugated goat α
rabbit IgG (ab150082) in incubation buffer for 4 hrs at room temperature. Slides were again washed
before counter staining in 0.5 μg/mL DAPI in methanol for 10 min at room temperature prior to
cover slipping with Mowiol. Imaging was carried out on an Axiovert 200 M with a 63X neoFluor
objective (Zeiss, Oberkochen, Germany) under oil immersion, with a minimum of 4 representative
images captured of both the intestinal villi and crypt. Fluorescent images had their background
fluorescence subtracted using ImageJ [24].
5.5. Bioplex Cytokine Assays
Bioplex bead coupling was performed as per the manufacturer’s instructions. The reagents are
listed in Table 5. The multiplex assay was carried out in a 96 well Grenier Bio-One Fluotrac 200 96F
black (VWR, #82050-754), which allows washing and retention of the Luminex beads. The 5 beadsets
conjugated with the capture antibodies were vortexed for 30 s followed by sonication for another 30 s to
ensure total bead dispersal. Bead density was 1200 beads per μl in PBS-BN (1x PBSA pH 7.4 + 1% BSA
(Sigma-Aldrich A7030) + 0.05% sodium azide (Sigma-Aldrich, Oakville, ON, Canada). One μL of each
beadset was added to 45 μL of diluent (PBSA + 1% New Zealand Pig Serum (Sigma-Aldrich P3484) +
0.05% sodium azide), which was added to each well. The plate was then washed using the Bio-Plex
Pro II Wash Station (BioRad, Mississauga, ON, Canada; wash 2 X 100 μL PBST). The porcine IL1β,
porcine IL8, porcine IL13, porcine TNFα and porcine IFNγ protein standards were added to the wells
at 50 μL per well at a starting concentration of 5000 pg/mL, 200 pg/mL, 5000 pg/mL, 5000 pg/mL
and 5000 pg/mL respectively with 2.5 fold dilutions done to produce the standard curve. Sera were
pre-diluted 1:4 in diluent and added to the wells at 50 μL per well.
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The plate was sealed with plate sealer (ThermoFisher Scientific, #12565491) and covered with
a foil lid. The plate was agitated at 800 rpm for 1 h at room temperature. After 1 h incubation with
serum, the plate was washed (3 × 150 μL PBST). Fifty μl of a biotin cocktail consisting of commercially
purchased biotins each at 0.5 μg/mL, in house biotinylated anti IL8 at 1/500 and in house biotinylated
anti IFNγ at 1/400 was added to each well. The plate was again sealed, covered and agitated at 800 rpm
for 30 min at room temperature then washed again as indicated above. Fifty μL of Streptavidin RPE
(ProZyme (Cedarlane) PJRS20, Burlington, ON, Canada); diluted to 5 μg/mL) was added to each well.
The plate was again sealed, covered and agitated at 800 rpm for 30 min at room temperature and
washed as indicated above. A 100 μL of 1x Tris-EDTA was added to each well and then the plate was
vortexed for 5 min before reading on the BioRad BioPlex 2000 instrument following the manufacturer’s
instructions as described in (Anderson et al., 2011). The instrument was configured to read beadsets
in regions 26, 27, 34, 43, and 52 for IL1β, IL8, TNFα, IFNγ and IL13, respectively. A minimum of
60 events per beadset were read and the median value obtained for each reaction event per beadset.
For all samples the multiplex assay MFI data was corrected by subtracting the background levels.
The lower limit of detection for each cytokine was 32 pg/mL for IFNγ, 80 pg/mL for IL1β and IL-13,
8 pg/mL for IL-8 and 200 pg/mL for TNFα.
5.6. Quantitative Gene Expression Analysis
We reduced the number of animals used in the molecular portion of this experiment to allow a
greater number of targets to be assessed with both qPCR and by IHF. Animals used for molecular
assessment were selected randomly from each of the 4 experimental batches. Jejunal and Ileal tissues
samples were ground with mortar and pestle to a fine powder under liquid nitrogen. Total RNA was
then extracted using Trizol (Life Technologies, Carlsbad, CA, USA) as per the manufacturer’s directions.
DNA contamination was removed using the TURBO DNA-free kit (Life Technologies) before RNA
quantity was determined on a NanoDrop spectrophotometer ND-1000 (NanoDrop, Wilmington,
DE, USA). RNA integrity was then evaluated on a 1.2% (w/v) denaturing agarose gel to verify a
clear ribosomal RNA banding pattern. Reverse transcription (RT) was done on 2 μg of total RNA
using the High Capacity cDNA Reverse Transcription Kit (Life Technologies) before diluting to a final
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concentration of 10 ng/μL equivalent cDNA. Quantitative real-time polymerase chain reaction (qPCR)
was then carried out, in duplicate, using 20 ng of equivalent cDNA, Kappa SYBR fast mastermix
(Kapa Biosystems, Wilmington, MA USA) and a primer concentration of 0.75 μM on a Step-One-Plus
real time system (Life Technologies, (ThermoFisher Scientific)). Real time primer sets for each gene of
interest were designed against RefSeq data obtained from NCBI (Table 6). Where possible, primers were
designed to span exon-exon junctions as identified by BLAST Like Alignment Tool (BLAT) comparison
with SusScrofa10.2 genomic build. The PCR efficiency for each primer probe set was evaluated against
a serial dilution of pooled samples, and found to be greater than 95% for targets. Finally, the data was
normalized to the geometric mean of four stable housekeeping genes (ACTB, B2MI, HPRT and RPL19).
Data are presented in the form of fold change (2−ΔΔCt) relative to the control group within tissue.
5.7. Statistics
Growth performance data was analyzed using the MIXED procedure of the SAS statistical program
(SAS 9.4, SAS Institute Inc., Cary, NC, USA). Treatment and block were included as fixed effects, pig was
included as a random effect, and data were analyzed as repeated measures. The optimal variance
structure was determined using the fit statistics within SAS. Differences were between means were
determined using the Tukey test and considered statistically significant at p ≤ 0.05. A trend towards
significant was considered at p < 0.10. Statistical analysis of gene expression and serum cytokine results
was carried out with a nonparametric Kruskal-Wallis examining preselected comparison of means of
the treatment vs. control within tissue or sera or across time.
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Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/10/1/40/s1,
Figure S1: Claudin-1 surface localization in piglet ileal villi and crypts in DON-fed and control fed piglets,
Figure S2: Claudin-3 surface localization in piglet ileal villi and crypts in DON-fed and control fed piglets,
Figure S3: Claudin-4 surface localization in piglet ileal villi and crypts in DON-fed and control fed piglets,
Figure S4: Claudin-7 surface localization in piglet ileal villi and crypts in DON-fed and control fed piglets,
Figure S5: Claudin-1 surface localization in piglet jejunal villi and crypts in DON-fed and control fed piglets,
Figure S6: Claudin-3 surface localization in piglet jejunal villi and crypts in DON-fed and control fed piglets,
Figure S7: Claudin-4 surface localization in piglet jejunal villi and crypts in DON-fed and control fed piglets,
Figure S8: Claudin-7 surface localization in piglet jejunal villi and crypts in DON-fed and control fed piglets.
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Abstract: The contamination of feed with mycotoxins results in reduced growth, feed refusal,
immunosuppression, and health problems. Deoxynivalenol (DON) and zearalenone (ZEN) are
among the most important mycotoxins. The aim of the study was to examine the effects of low doses
of these mycotoxins on the histological structure and ultrastructure of the large intestine in the pig.
The study was performed on 36 immature gilts of mixed breed (White Polish Big × Polish White
Earhanging), which were divided into four groups administrated per os with ZEN at 40 μg/kg BW,
DON at 12 μg/kg BW, a mixture of ZEN (40 μg/kg BW) and DON (12 μg/kg BW) or a placebo.
The pigs were killed by intravenous overdose of pentobarbital after one, three, and six weeks of
treatment. The cecum, ascending and descending colon samples were prepared for light and electron
microscopy. Administration of toxins did not influence the architecture of the mucosa and submucosa
in the large intestine. ZEN and ZEN + DON significantly decreased the number of goblet cells in
the cecum and descending colon. The mycotoxins changed the number of lymphocytes and plasma
cells in the large intestine, which usually increased in number. However, this effect differed between
the intestine segments and toxins. Mycotoxins induced some changes in the ultrastructure of the
mucosal epithelium. They did not affect the expression of proliferative cell nuclear antigen and the
intestinal barrier permeability. The obtained results indicate that mycotoxins especially ZEN may
influence the defense mechanisms of the large intestine.
Keywords: mycotoxins; zearalenone; deoxynivalenol; histology; ultrastructure; large intestine; pig
Key contribution: Administration of mycotoxins decreases the amount of goblet cells and increases
the number of lymphocytes and plasma cells in the large intestine. The large intestine should be
considered as a place of mycotoxin action.
1. Introduction
Zearalenone (ZEN) and deoxynivalenol (DON) are mycotoxins produced by Fusarium fungi.
Their wide distribution in nature and negative effects of consumption of food and feed contaminated
with ZEN and DON for human and animal health mean that they have become a subject of
extensive research [1]. The toxic outcome of these mycotoxins includes feed refusal, reduced growth,
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gastrointestinal lesions, immunosuppression, and reproductive disorders [2]. At the cellular level,
ZEN and DON can negatively affect numerous pathways and processes. Many aspects of mycotoxins
impacting on humans and animals especially in the case of mixed mycotoxicosis are still not fully
recognized. Animal species show differential sensitivity to mycotoxins.
Deoxynivalenol (DON, IUPAC name: (3α,7α)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one)
belongs to type B trichothecene mycotoxins and is the most commonly detected toxin of this group.
DON in acute and moderate to low doses induces toxic and immuno-toxic effects in a variety of cell
systems and animal species [3]. The differential susceptibility to DON in animal species evaluated
to date presumably depends on differences in metabolism, absorption, distribution, and elimination
of DON among animal species [4]. Pig is the most sensitive livestock species to DON. Absorption
of DON in pigs is rapid and the toxin reaches peak plasma concentrations within 30 min of oral
administration [5]. Results of Dänicke et al. [6] showed that, in pigs, a majority of the ingested DON
is absorbed in the proximal part of the small intestine. In the large intestine, de-epoxidation takes
place, which does not contribute much to detoxification. DON is primarily excreted in urine in free
and conjugated forms and much smaller amounts of the toxin are excreted in feces as de-epoxidase
and free forms [6,7]. Research provides evidence that the chronic ingestion of DON, also in low
doses, alters the small intestine morphology affecting the mucosal epithelial cells and the villi [8–10].
DON modulates the immune responsiveness of the intestinal mucosa, the cytokine production, and the
cross-talk between epithelial cells and the intestinal immune cells [11]. DON reduces the expression
of the adherent junction protein and the tight junction protein in the small intestine [12]. In the large
intestine, DON in a dosage of 1008 μg/kg of feed modified the local immune response by changing
the expression of toll-like receptors [13].
Zearalenone (ZEN, IUPAC name: (3S,11E)-14,16-dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-
2-benzoxacyclotetradecine-1,7(8H)-dione) and its metabolites have estrogenic activity and compete
with endogenous hormones for the binding sites of estrogen receptors [14]. ZEN also influences
the activities of enzymes involved in steroid metabolism: 3-β-hydroxysteroid dehydrogenase type
1, cytochrome P450 side-chain cleavage enzyme, and P450 aromatase. Treatment with ZEN leads
to precocious puberty, reproductive disorders, and hyperestrogenizm [15]. ZEN and its derivatives
impair the inflammatory response and, therefore, may affect the capacity of organisms to both eradicate
injurious stimuli and initiate the healing process [16]. The small intestine absorbs ZEN first so it is
exposed to a high concentration of the toxin, which has the deleterious effect on its morphology even in
the case of low doses [17,18]. In pig, the total biological recovery of ZEN in feces is about 34% ± 3% [19]
and taking into account the slow passage of digestion in the large intestine ZEN can influence the
structure and function of this part of the gastrointestinal tract as well. However, this aspect of ZEN
intoxication has not been investigated.
The toxicity of mycotoxins needs to be addressed in the context of mycotoxins mixtures to assess
health risks [20], however the effects of mycotoxin combination are poorly known. Existing data
indicate that the type of interaction depends on the type of toxins, the ratio between toxins, and the
concentration of the toxin mixture at a constant ratio [20,21].
In many cases, a diet contains DON and ZEN together [22]. However, the effects of concurrent
exposition to these mycotoxins are still poorly recognized and difficult to predict [8,23]. So far, both
additive and non-additive effects were found when DON and ZEN were administrated together [24].
DON + ZEN in combination were toxic on swine jejunal epithelial cells at concentrations nontoxic
when administrated individually [20,24]. On the other hand, no additive effects of these toxins on the
height of villi and the percentage of goblet cells in crypts of the pig jejunum were observed [18].
The intestinal tract is the main barrier to ingested feed contaminants. The intestine possesses
three basic protective mechanisms—physical, chemical, and immunological. Several reports have
demonstrated that mycotoxins are able to compromise these mechanisms. Most of the studies concern
the small intestine, but very little is known about the effect of mycotoxins on the large intestine. On the
other hand, the presence of DON and ZEN derivatives and non-metabolized mycotoxins in digesta of
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the large intestine along with the slow passage of content through this part of the gastrointestinal tract
result in a long-time of mucosa exposure to the toxins [25].
The aim of the present study was to determine the effects of DON (12 μg/kg BW) and ZEN
(40 μg/kg BW) when fed, individually and in combination, to the pigs for one, three, or six weeks
on the cecum and colon histology and ultrastructure. Moreover, the effect of mycotoxins on the
permeability of the intestinal epithelial barrier was studied using the lanthanum method. Additionally,
immunocytochemical study of proliferative cell nuclear antigen (PCNA) was performed to assess the
effect of toxins on the proliferation of the intestinal epithelial cell.
The selection of doses used in our experiment was previously widely discussed [17,18,26]. Briefly,
the dosage of DON used in our study, 12 μg/kg BW, was much lower than No Observed Adverse Effect
Level (NOAEL) proposed for pigs [27]. The dose of ZEN used in this study, 40 μg/kg BW, was the same
as the NOAEL established by—The joint FAO/WHO Expert Committee on Food Additives for pigs [28].
2. Results and Discussion
2.1. Light Microscopy Study
2.1.1. Architecture of the Mucosa
The cecum, colon ascending and descending of the control pigs were characterized by numerous,
well-developed mucosal crypts that span the depth of the lamina propria. The columnar epithelium
lining the crypts and covering the luminal surface comprised primarily goblet cells and absorptive
cells. The lamina propria consisted of the stromal elements and cells of the immune system.
The well-developed muscularis mucosa separated the mucosa from the tunica submucosa, which had
loose arrangement and contained numerous adipocytes. The muscularis and the serosa were typical
for these segments of the large intestine in pigs. No noticeable qualitative differences were observed in
the architecture of the cecum and both colon regions between the control group and the groups of pigs
treated with mycotoxins.
Morphometric analysis demonstrated no significant differences in the thickness of mucosa and
submucosa between the investigated groups of pigs (see Figure 1).
Figure 1. Cont.
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Figure 1. Morphometric characteristic of the mucosa and submucosa of the large intestine segments.
Thickness of the cecum mucosa (A) and submucosa (B), ascending colon mucosa (C) and submucosa
(D), and descending colon mucosa (E) and submucosa (F). Values presented are means and the standard
errors of the mean (SEM). The capital letters under horizontal axis, C—control group, Z—group treated
with zearalenone (ZEN), D—group treated with deoxynivalenol (DON), and M—group treated with
ZEN + DON.
The obtained data showed that ZEN and DON as well as ZEN + DON had no effect on the
qualitative and quantitative characteristics of the mucosa and submucosa in all regions of the large
intestine investigated. Previous studies indicated that the dosages of mycotoxin used in our experiment
affected histology of the small intestine. However, the significant quantitative changes were noted
exclusively after six weeks of the treatment [17,18]. The thickness of the duodenum submucosa was
significantly higher in the pigs receiving DON + ZEN for six weeks than in the control pigs [17]. In the
jejunum, the thickness of the mucosa was affected in the groups treated by DON and ZEN + DON for
six weeks [18]. So far, there has been no research regarding the effects of ZEN and DON on the large
intestine architecture.
2.1.2. Goblet Cells
The percentage of goblet cells after ZEN treatment for one, three, and six weeks in the cecum
along with one and three weeks in the descending colon were significantly decreased (see Figure 2).
The effect of DON was significant only in the descending colon after one and three weeks of
treatment. Administration of ZEN + DON also resulted in a decrease in the percentage of goblet cells.
The statistically significant effects were observed in the descending colon after one, three, and six
weeks of the experiment.
Our results demonstrate that the mycotoxins used in the experiment especially ZEN decrease
the number of goblet cells in the large intestine. It should be noted that mycotoxins have the most
adverse influence on goblet cells in the descending colon. However, results indicate the complexity of
this action and its dependence on many factors.
Figure 2. Cont.
54
Toxins 2018, 10, 148
Figure 2. The percentage of goblet cells in the mucosal epithelium of the cecum (A), ascending colon
(B), and descending colon (C). Values presented are means and SEM. Means annotated with different
lower case letters above the bars are significantly different at p ≤ 0.05. For other explanations, see
Figure 1.
Goblet cells are mucin-secreting cells forming the mucus layer that protects the mucosal surface.
This layer is a result of the dynamic balance between the secretion of mucin by goblet cells and the
degradation of mucin. Reduction in the goblet cell number is associated with disorders of intestinal
protection [29,30]. The number of goblet cells changes under various factors [31]. Dietary components
modulate the function of goblet cells and affect composition of mucin [30,31].
There are no data concerning the influence of mycotoxins on goblet cells in the epithelium of the
large intestine. In the small intestine epithelium, the ingestion of the DON contaminated diets induced
a significant decrease in the number of goblet cells in the pig jejunum and ileum [9,10,12]. On the
other hand, more numerous goblet cells were found after administration of a diet containing ZEN [32].
Our previous results concerning the small intestine in the pigs treated with the same doses of ZEN and
DON demonstrated that the effect of toxins is dependent on the part of the intestine and the duration
of treatment [17,18]. No changes in goblet cells were found in the duodenum including the villus
epithelium and the crypt epithelium [17]. However, in the jejunum, the percentage of goblet cells was
transiently increased in the villus epithelium, but not in the crypt epithelium [18]. The differences
between these two parts of the small intestine could be explained by the fact that large amounts of
mucous are produced in the duodenum by Brunner’s glands. These glands showed hypertrophy after
administration of DON + ZEN for six weeks [18]. It should be noted that the mucous system differs
substantially between the small and large intestine and these differences concern both goblet cells and
regulation of their secretion [33].
The decrease in the number of goblet cells observed in the present study suggests some
discrepancy in mucous secretion and, as a consequence, the depletion in the protective mechanism in
the large intestine was a result of mycotoxin treatment. The recent discoveries placed goblet cells at the
center position of our understanding of mucosal biology and the immunology of the intestinal tract [33].
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The mucous layer is stratified and organized as a filter that physically separates the bacteria from the
epithelial cell [34]. Several studies lead to the conclusion that goblet cells form the major line of defense
at the intestinal mucosa. However, this is far from a full understanding of the phenomenon [33,35,36].
2.1.3. Lymphocytes and Plasma Cells
The effect of mycotoxins on the number of lymphocytes in the epithelium covering lumen and
crypts of the large intestine, and in the lamina propria showed regional differences.
In the cecum, quantitative analysis revealed a significant increase (compared to the corresponding
control groups) in the number of lymphocytes in the epithelium after the treatment with ZEN for one,
three, and six weeks. However, the administration of DON and ZEN + DON did not cause significant
changes (see Figure 3). In the lamina propria of the cecum, significantly higher counts of lymphocytes
were found after treatment with ZEN for one and three weeks, DON for one and six weeks, and ZEN
+ DON for three and six weeks. The plasma cell number was also influenced by mycotoxins in the
cecum (see Figure 4). The significant increase in their number in the lamina propria was noted after
treatment with ZEN for three weeks, with DON for one, three, and six weeks, and with ZEN + DON
for one and three weeks (see Figure 4).
Figure 3. Number of lymphocytes in the mucosal epithelium (A) and in the lamina propria (B) of the
cecum, in the mucosal epithelium (C) and in the lamina propria (D) of the ascending colon, in the
mucosal epithelium (E) and in the lamina propria (F) of the descending colon. Number of lymphocytes
in the mucosal epithelium was expressed per 50 epithelial cells and in the lamina propria was expressed
per 10,000 μm2. Values presented are means and SEM. Means annotated with different lower case
letters above the bars are significantly different at p ≤ 0.05. For other explanations, see Figure 1.
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Figure 4. Number of plasma cells per 10,000 μm in the lamina propria of the cecum (A), the ascending
colon (B), and the descending colon (C). Values presented are the means and SEM. Means annotated
with different lower case letters above the bars are significantly different at p ≤ 0.05. For other
explanations, see Figure 1.
In the ascending colon, the relative number of lymphocytes in the mucosal epithelium showed
a significant increase after three weeks of the treatment with ZEN and ZEN + DON (see Figure 3).
Similarly, a significant increase in the number of lymphocytes was observed after ZEN and ZEN + DON
treatment for three weeks in the lamina propria of the ascending colon (see Figure 3). Surprisingly,
the number of plasma cells in the lamina propria of the ascending colon was lower than in the control
pigs after three and six weeks of ZEN + DON administration (see Figure 4).
The administration of ZEN for three weeks and ZEN + DON for one week and three weeks
resulted in a significant increase in the relative number of lymphocytes in the mucosal epithelium of
the descending colon (see Figure 3). No significant changes were noted in the number of lymphocytes
in the lamina propria of the descending colon (see Figure 3). In contrast, the number of plasma cells
was significantly elevated in this part of the large intestine after one and three weeks of ZEN and
ZEN + DON treatments (see Figure 4).
Based on the obtained results, it could be stated that ZEN stimulates the local immune system in
the large intestine as indicated by the increase in the lymphocyte number in the mucosal epithelium as
well as lymphocytes and plasma cells numbers in the lamina propria. The response of the intestinal
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immune system was unambiguous and clear in the cecum while more variable and sometimes
difficult-to-interpret results were obtained in the ascending colon and the descending colon. It is a
well-known phenomenon that the response of the immune system including the local subsystems to
immunomodulators is dependent on several factors. Such variability was also reported in a case of
mycotoxin effects on intestinal immune response in vivo and in vitro [37,38].
Mechanism of ZEN action on the intestinal immune system is poorly understood. ZEN in vivo
and in vitro could activate the ROS-mediated NLRP3 inflammasome and, in turn, contribute to the
caspase-1-dependent activation of the inflammatory cytokines Il-1β and IL-18 [39]. The direct effect of
ZEN on lymphocytes by estrogen receptors presented in these cells was also postulated [16,40]. The studies
concerning the effect of ZEN on the intestinal immune system were concentrated almost exclusively on the
small intestine [18,41]. ZEN at the daily dose of 40 μg/kg BW caused increase in lymphocyte number in
the villus epithelium of the jejunum after one week of treatment [18]. On the other hand, the toxin had no
effect on lymphocytes in the villus epithelium after three and six weeks of the treatment. The same results
were found in the lamina propria. In the duodenum, no effects of ZEN on lymphocytes in the epithelium
covering the villi were observed. However, the toxin caused an increase in the lymphocyte number in the
lamina propria [17]. The most recent histological study revealed inflammatory cell infiltration and tissue
damage in the colon of mice fed by gavage with ZEN [39].
The results of quantitative analyses revealed that DON has no effect on the number of lymphocytes
in the epithelium of the examined parts of the large intestine. However, the treatment with DON
increased the number of lymphocytes and plasma cells in the lamina propria of the cecum and the
ascending colon. This effect was dependent on the duration of treatment. Previous studies demonstrate
the modulatory effects of DON on the mucosal immune response [3,42]. DON has been found to
stimulate the production of mucosal antibodies [43] and IgA by Peyer’s patches lymphocytes [44].
The mechanism of the DON-induced increase in the lymphocyte number in the epithelium and the
lamina propria as well as plasma cells in the lamina propria is likely related to the activation of cytokine
synthesis by this mycotoxin [8,11,45]. In porcine jejunal explants, DON (10 μM) caused a significant
increase in expression of mRNA encoding for Il-8, Il-1α, Il-1β, and TNF-α [11]. A phenomenon that
DON induces an increase in the number of lymphocytes may also be related to the reduction of claudin
and occludin production by this toxin, which enhanced permeability of the epithelial barrier [8,12].
In vitro, DON (0.5–1 μg/mL) contributed to the increase in permeability of Salmonella Typhimurium
through the intestinal epithelium [46]. On the other hand, in our previous in vivo study, DON
(12 μg/kg BW) did not disturb the intestinal barrier in the jejunum [18]. It was observed that DON
causes changes in the basal membrane composition that facilitate the migration of lymphocytes from
the lamina propria [47]. In some studies, the decrease of lymphocyte infiltration in the pig jejunum
was found after DON administration (1.5–3 mg/kg feed) for four to five weeks.
When the experimental pigs received DON + ZEN, different types of interactions were noted
depending on the segment of the large intestine and the duration of treatment. In the cecum, they were
antagonistic in the case of lymphocytes in the mucosal epithelium or less than additive in the
case of lymphocytes and plasma cells in the lamina propria. In the ascending colon, they were
antagonistic-lymphocytes in the mucosal epithelium and plasma cells in the lamina propria or less
than additive—lymphocytes in the lamina propria. In the descending colon, they were additive or less
than additive-lymphocytes in the mucosal epithelium and plasma cells in the lamina propria.
From previous studies on the small intestine it appears that a co-contaminated diet can cause
several types of interactions. Bracarense et al. [12] investigated the effect of food contaminated with
low doses of DON + FB (fumonisin) on the small intestine (jejunum and ileum) and stated synergistic
(immune cells), additive (cytokines and junction protein expression), less than additive (histological
lesions and cytokine expression), antagonistic (immune cells and cytokine expression) interactions
of these mycotoxins. The authors’ [12] data provide strong evidence that chronic ingestion of low
doses of mycotoxins alters the intestine and, therefore, may predispose animals to infections by enteric
pathogens. Our results concerning the jejunum showed that the effect of ZEN and DON administered
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in combination is antagonistic on plasma cells after one, three, and six weeks of treatment, and on
lymphocytes in the villus epithelium and the lamina propria after one week of treatment as well
as less than additive on lymphocytes in the villus epithelium and in the lamina propria after three
and six weeks of treatment [18]. In the duodenum, distinct effects were noted including additive on
lymphocytes in the villus epithelium after one week of treatment, less than additive on lymphocytes in
the epithelium and the lamina propria after three and six weeks, and on plasma cells in the lamina
propria after six weeks, and antagonistic on lymphocytes (after one week) and plasma cells (after one
and three weeks) in the lamina propria [17].
2.1.4. Expression of the Proliferating Cell Nuclear Antigen (PCNA) in the Mucosa Epithelium
PCNA positive cells were observed in the mucosal epithelium and in the lamina propria in
all samples (see Figure 5A). The quantitative study performed on the samples taken at the end of
the experiment did not show significant differences in the percentage of PCNA-positive cells in the
mucosal epithelium between the control pigs and the animals treated with mycotoxins (see Figure 5B).
Figure 5. Effects of toxins on the proliferating cell nuclear antigen labeling index in the mucosal
epithelium of the cecum, ascending colon, and descending colon in pigs after six weeks of treatment.
(A) Immunopositive cells. (B) Percentage of proliferating cell nuclear antigen (PCNA) positive cells in
the cecum, ascending colon, and descending colon. Values presented are means and SEM. For other
explanations, see Figure 1.
The PCNA index is generally considered a valid measure of cell proliferation. Mycotoxins show
an anti-proliferative effect on different cells. A significant decrease in expression of the proliferation
marker PCNA was noted as effects of beta-zearalenol and DON on porcine endometrial cells
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in vitro [48]. DON in vitro inhibited the proliferation of human intestinal Caco-2 cells in a dose
dependent manner with a significant effect appearing at 0.2 μg/mL [49]. The PCNA indexes for the
jejunum and ileum in the piglets receiving DON (basal diet + 4 mg/kg of toxin) were significantly
lower (p < 0.05) than those in the piglets that received the basal diet only [50]. In the present study,
no negative effects of DON and ZEN on the PCNA labeling index were observed.
2.2. Electron Microscopy Study
2.2.1. Ultrastructure of the Mucosa
In the control pigs, the mucosal epithelium of the cecum, ascending colon, and descending colon
comprised mainly absorptive cells and goblet cells. Enteroendocrine cells and regenerative cells were
less frequently observed. Lymphocytes were present between epithelial cells. The absorptive cells
were columnar with a basally situated, oval nucleus. Their cytoplasm contained numerous ribosomes,
profiles of rough and smooth endoplasmic reticulum, mitochondria, the moderately-developed Golgi
apparatus, and a network of microtubules and filaments. Some of these cells comprised small,
round granules with a content of variable electron density located in the upper part of the cell.
The absorptive cells formed microvilli on the apical surface, whose number varied from cell to cell.
The goblet cells were more or less elongated with a cup-shaped upper part, which was filled with
large granules showing moderate electron density. The tall, lower part of these cells contained a cell
nucleus, numerous cisterns of rough endoplasmic reticulum, the well-developed Golgi apparatus,
mitochondria, and some secretory granules. The absorptive cells and goblet cells created junctional
complexes in their upper parts. The intercellular spaces were frequently dilated beneath the junctional
complexes and cells formed numerous irregular processes. Usually, the epithelium was covered with
a layer of mucous. The lamina propria and the muscularis mucosae showed typical organization.
Abundant lymphocytes, plasma cells, and macrophages were observed in the lamina propria.
In the pigs treated with mycotoxins, the ultrastructure of mucosal epithelium showed some
differences in comparison with the control animals. The most prominent changes concerned the goblet
cell in the cecum and the descending colon of pigs receiving ZEN and ZEN + DON for one, three, or six
weeks. In these pigs when compared to the control pigs, the goblet cells frequently contained much fewer
granules in their apical parts (see Figure 6) and did not show a goblet-like shape. Our ultrastructural
studies were only qualitative, however, it should be noted that the goblet cells were less frequently found
in the group of pigs treated with ZEN and ZEN + DON than in two other investigated groups.
Figure 6. Goblet cell in the cecum of a pig receiving ZEN + DON for six weeks. Note the presence of
sparse secretory granules in the apical part of the cell.
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The alternations were also observed in the absorptive cells in the pigs treated with ZEN and ZEN
+ DON for one, three, and six weeks. As in the case of the goblet cells, they were most prominent in
the cecum and descending colon. The apical surface of the absorptive cells of these pigs frequently
formed only sparse microvilli, which usually were short and irregular (see Figure 7). Moreover,
numerous small granules with moderate to high electron density were found in the upper parts of
many absorptive cells (see Figure 7). In the group receiving ZEN + DON, some absorptive cells
contained numerous electron dense bodies (see Figure 8).
Figure 7. The transverse section through the intestinal crypt in the descending colon in a pig treated
with ZEN + DON for three weeks. The apical surfaces of absorptive cells contain only single microvilli.
Note the presence of numerous round granules in some absorptive cells (arrows).
Figure 8. Dilated intercellular spaces between the epithelial cells in a pig treated with ZEN + DON
for six weeks (ascending colon). Note presence of electron dense bodies in cytoplasm of the absorptive
cell (arrows).
The intercellular spaces between the epithelial cells were frequently largely dilated in pigs
treated with DON and ZEN + DON for three and six weeks in the ascending and descending colon
(see Figure 7). The damaged or dead epithelial cells were noted in all studied groups, but they were
more frequently found in pigs treated with ZEN + DON for three and six weeks. The lamina propria of
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the large intestine in the animals treated with ZEN + DON for three and six weeks contained numerous
macrophages, which were much less frequently observed in other groups of pigs.
Summing up, the results obtained in ultrastructural studies showed that ZEN and ZEN + DON
affected mainly goblet cells, which often contained fewer secretory granules than in the control animals.
Further studies are needed to determine if the synthesis of granules is decreased or the release of their
content is increased. Both toxins also induced some changes in absorptive cells.
The literature data about effects of mycotoxins on the intestine ultrastructure are sparse and
concerned almost exclusively with the small intestine. The administration of ZEN, DON, and ZEN
+ DON in the same dosages and according to the same schedule as in the present study did not
cause changes in the ultrastructure of the mucosa of the jejunum with exception for adsorptive cells
with drop-like protrusions of apical cytoplasm in the pigs receiving ZEN and DON + ZEN [17].
The treatment of gilts with ZEN at doses of 200 and 400 μg/kg BW for seven days had no effect on
the ultrastructure of the jejunal epithelium [10]. In in vitro studies, incubation of jejunal explants
with 10 μM DON resulted in an increase in intercellular spaces, a decrease in the size and number of
microvilli, and a loss of junction complexes [51].
2.2.2. Permeability of the Intestinal Barrier: Studies Using Lanthanum Ions
For evaluation of the effect of studied mycotoxins on the permeability of the epithelial barrier,
we applied the lanthanum technique, which is commonly used in examining tight junctions at the
ultrastructural level [52,53]. In the investigated material, electron dense lanthanum particles were
observed on the surface of intestine epithelium between the microvilli and in intercellular spaces
higher up in the tight junctions. The presence of deposits was never observed in intercellular spaces
beneath the tight junctions (see Figure 9).
Figure 9. The mucosal epithelium in the samples of the descending colon in control pigs (A) and pigs
treated with ZEN (B), DON (C), ZEN + DON (D) for six weeks. Note numerous precipitates on the
epithelium surface and their lack beneath the tight junctions. The intercellular spaces did not contain
any precipitates.
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The obtained results demonstrated that the treatment of DON, ZEN, and ZEN + DON did not
change the permeability of epithelium in the examined segments of the large intestine. The lack
of junction complexes on enterocytes exposed to mycotoxins was reported by Basso et al. [51].
Pinton et al. [54] associated alterations of barrier function in the pig jejunum after treatment with DON
with a specific reduction in the expression of claudin. It should be stressed that the doses of toxins
used in our study had no effects on the epithelial barrier in the jejunum [18].
3. Experimental Section
3.1. Toxins, Animals, and Experimental Design
Deoxynivalenol and zearalenon were synthesized and standardized at the Department of
Chemistry, Faculty of Wood Technology, Poznań University of Life Sciences, Poland. Assessment
of toxin purity was made using mass spectrometry (UPLC/TQD, Waters, Milford, MA, USA).
The analytical purity of ZEN and DON were higher than 99.9%.
The study was performed on 36 clinically healthy gilts of mixed breed (White Polish Big × Polish
White Earhanging) with body weights of 25 ± 2 kg at the beginning of the experiment. The animals
were purchased from a farm where they received feed without detectable amounts of ZEN, DON,
α-zearalenol, aflatoxin, and ochratoxin. The serological test excluded the presence of Auyeski’s
disease, mycoplasmosis, parvovirosis, actinobacillosis, and porcine reproductive-respiratory syndrome.
The pigs were fed twice daily and had free access to water. The tests for the presence of mycotoxins in
feed were performed as described previously [55].
The animals were divided into four experimental groups (Z, D, and M; n = 9 in each group) and a
control group (C; n = 9). The animals of the group Z received ZEN at a dose of 40 μg/kg BW per day,
the animals of the group D—DON at a dose of 12 μg/kg BW per day, and the animals of group M—
a mixture of ZEN and DON (40 μg ZEN/kg BW + 12 μg DON/kg BW per day). The mycotoxins were
administrated per os during the morning feeding in water-soluble capsules containing oat bran as a
vehicle. The gilts were weighed every week to establish the amount of DON and ZEN given for each
animal. The animals of group C received capsules without mycotoxins.
Three animals from each experimental group were killed by intravenous (marginal vein of the
ear) administration of sodium pentobarbital (Vetbutal, Biowet, Poland) at a dose of 140–150 mg/kg
and exsanguination after 1, 3, and 6 weeks of the experiment. The tissue samples were taken 3 min
after cardiac arrest.
All procedures were carried out in compliance with Polish legal regulations, which determine the
terms and methods for performing experiments on animals, and the European Community Directive
for the ethical use of experimental animals. The protocol was approved by the Local Ethical Council in
Olsztyn (opinion No. 88/N of 16 December 2009).
3.2. Histological Examinations
The tissue samples (approximately 1 × 0.5 cm) were cut from the middle parts of the cecum and
the ascending and descending colon. They were flushed in saline and fixed in 4% paraformaldehyde
in 0.1 M phosphate buffer (pH 7.4) for 48 h, dehydrated in ethanol (TP 1020, Leica, Wetzlar, Germany),
and embedded in paraffin (EG1150, Leica, Wetzlar, Germany). The 4-μm-thick sections were prepared
with the use of HM 340E microtome (Microm, Lugo, Spain) and stained with the hematoxylin and
eosin method (HE), periodic acid Schiff method (PAS), and methyl green-pyronine method (MGP)
using automated multistainer ST 5020 (Leica, Wetzlar, Germany). The slides were signed in a way
that prevented the people involved in their microscopic analysis from knowing the kind and duration
of the animal treatment. The specimens were analyzed and photographed in an Axioimager light
microscope equipped with an AxioCam MRc5 camera (Carl Zeiss, Oberkochen, Germany).
For morphometrical evaluations, the sections were scanned in a Mirax Desk scanner (Carl Zeiss,
Oberkochen, Germany). The following parameters were determined: the thickness of mucosa and
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submucosa, the percentage of goblet cells in the surface epithelium covering the mucosa, the number
of lymphocytes per 50 epithelial cells, the number of lymphocytes, and the number of plasma cells per
10,000 μm2 of the lamina propria. Goblet cells were counted in PAS-stained sections and plasma cells
in MPG stained sections. All other measurements were performed on HE-stained sections. The linear
measurements were repeated 20 times per animal. The percentage of lymphocytes and goblet cells
were determined by counting their number per 50 epithelial cells in 10 randomly selected areas and
the density of lymphocytes and plasma cells in the lamina propria were measured by counting the
cells in 10 randomly selected areas of 6000 to 12,000 μm2 each. The measurements were performed
using Pannoramic Viewer software (Version 1.15.3 RTM, 3D-Histech, Budapest, Hungary, 2012) and
AxioVision software (Version 4.6.3, Carl Zeiss, Oberkochen, Germany, 2007).
3.3. Immunohistochemical Staining
The staining was performed on paraffin sections mounted on Superfrost Plus slides prepared from
the tissue samples taken for histological examinations after 6 weeks of the treatment. After dewaxing
in xylene and rehydration in graded alcohols (96%, 70%, 50%), tissue sections were subjected to heat
antigen retrieval in a microwave oven (600 W, 15 min) in 0.01 mol·L−1 0.03% H2O2. Then slices
were washed in phosphate buffered saline (PBS) and incubated for 20 min with 10% normal goat
serum. The sections were then incubated overnight with primary antibodies anti-PCNA (clone PC10,
M0879, Dako Agilent Technologies, Santa Clara, CA, USA) at a dilution 1:200 in a humidified chamber.
Next, they were incubated with secondary antibodies for 30 min at a room temperature (EnVision
System-HRP/AEC, Dako K4004, Santa Clara, CA, USA). For visualization of antigen-antibody
complexes, the sections were immersed in 3-amino-9-ethyl-carbazole substrate-chromogenic (EnVision
System-HRP/AEC, Dako K4004, Santa Clara, CA, USA) for 20 min. Afterwards, they were
counterstained with Mayer’s hematoxyline (Sigma-Aldrich, St. Louis, MO, USA) and mounted
using Mounting Glycergel (C0563, Dako Agilent Technologies, Santa Clara, CA, USA). The specimens
were analyzed and photographed in a motorized Axioimager light microscope equipped with an
AxioCamMRc5 camera (Carl Zeiss, Oberkochen, Germany). The PCNA labeling index (LI) was
expressed as the ratio of cell positively stained for PCNA to all epithelial cells in at least 5 areas
randomly selected for counting. The positive cell nuclei were counted on the images with AxioVision
software (Version 4.6.3, Carl Zeiss, Oberkochen, Germany, 2007).
3.4. Ultrastructural Examinations
The samples of the mucous membrane from the cecum, ascending colon, and descending colon
were collected from sites adjacent to the sites of sampling for histological examination. The tissues were
immersion-fixed in a mixture of 1% paraformaldehyde and 2.5% glutaraldehyde in 0.2 M phosphate
buffer (pH 7.4) for 2 h at 4 ◦C, washed, and post-fixed in 2% osmium tetroxide for 2 h. After dehydration,
the samples were embedded in Epon 812. Semithin sections were cut from each block of tissue,
stained with 1% toluidine blue, and examined under a light microscope in order to choose the sites
for preparing ultrathin sections. Ultrathin sections contrasted with uranyl acetate and lead citrate
were examined with a Tecnai 12 Spirit G2 BioTwin transmission electron microscope (FEI, Hillsboro,
OR, USA) equipped with two digital cameras: Veleta (Olympus, Tokyo, Japan) and Eage 4k (FEI,
Hillsboro, OR, USA).
3.5. Lanthanum Procedure
The mucosal specimens were fixed for 2 h in a freshly prepared mixture of 2.5% glutaraldehyde
and 1% lanthanum nitrate, La(NO3)·6H2O, in cacodylate buffer (pH 7.2). Next, the samples were rinsed
for 30 min in the cacodylate buffer containing 1% lanthanum nitrate and postfixed for 2 h in a freshly
prepared mixture of 1% osmium tetroxide and 1% of lanthanum nitrate in the cacodylate buffer. Then,
the tissues were dehydrated and embedded in Epon 812. Unstained, ultrathin sections were examined
with a Tecnai 12 Spirit G2 BioTwin transmission electron microscope (FEI, Hillsboro, OR, USA).
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3.6. Statistical Analysis
The data were analyzed using two-way or one-way ANOVA with the Duncan test as a post-hoc
procedure. Statistical analyses were performed by using Statistica software (Version 10.0 PL, StatSoft,
Tulsa, OK, USA, 2011).
4. Conclusions
Taken together, the obtained data provide evidence that administration of low doses of DON and
ZEN as well as a mixture of both toxins does not affect the architecture of the mucosa and submucosa
in the large intestine of the pig. However, the treatment with toxins alters the system of goblet cells and
the amount of lymphocytes and plasma cells in the mucosa. Modifications caused by mycotoxins vary
depending on the duration of intoxication, the toxin, and the part of the large intestine. ZEN and ZEN
+ DEN significantly decrease the number and modify the ultrastructure of goblet cells. Taking into
consideration the position of goblet cells in the mucosal biology especially in the mucosal protective
mechanisms, the observed changes should be considered unfavorable for large intestine homeostasis.
The results concerning lymphocytes and plasma cells are not unequivocal. However, they point to the
influence of toxins on immune processes in the large intestine and pay attention to their complexity.
Examinations of the PCNA labeling index and permeability of the intestinal epithelium show no
significant effects of the examined mycotoxins on these parameters. The obtained results indicate that
mycotoxins especially ZEN may influence the defense mechanisms of the large intestine.
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intestine mucosa in gilts with zearalenone mycotoxicosis. Pol. J. Vet. Sci. 2005, 8, 301–307. [PubMed]
33. Birchenough, G.M.H.; Johansson, M.E.W.; Gustafsson, J.K.; Bergström, J.H.; Hansson, G.C. New developments
in goblet cell mucus secretion and function. Mucosal Immunol. 2015, 8, 712–719. [CrossRef] [PubMed]
34. Johansson, M.E.V.; Phillipson, M.; Petersson, J.; Holm, L.; Velcich, A.; Hansson, G.C. The inner of the two
Muc2 mucin dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 2008, 105,
15064–15069. [CrossRef] [PubMed]
35. Brown, P.J.; Miller, B.G.; Stokes, C.R.; Blazquez, N.B.; Bourne, F.J. Histochemistry of mucins of pig intestinal
secretory epithelial cells before and after weaning. J. Comp. Pathol. 1988, 98, 313–323. [CrossRef]
36. Che, C.; Pang, X.; Hua, X.; Zhang, B.; Shen, J.; Zhu, J.; Wei, H.; Sun, L.; Chen, P.; Cui, L.; et al. Effects
of human fecal flora on intestinal morphology and mucosal immunity in human flora-associated piglet.
Scand. J. Immunol. 2009, 69, 223–233. [CrossRef] [PubMed]
37. Pierron, A.; Alassane-Kempi, I.; Oswald, I.P. Impact of two mycotoxins deoxynivalenol and fumisin on pig
intestinal health. Porcine Health Manag. 2016, 2, 21. [CrossRef] [PubMed]
38. Marin, D.E.; Motiu, M.; Taranu, I. Food contaminant zearalenone and its metabolites affect cytokine synthesis
and intestinal epithelial integrity of porcine cells. Toxins 2015, 7, 1979–1988. [CrossRef] [PubMed]
39. Fan, W.; Lv, Y.; Ren, S.; Shao, M.; Shen, T.; Huang, K.; Zhou, J.; Yan, L.; Song, S. Zearalenone (ZEA)-induced
intestinal inflammation is mediated by the NLRP3 inflammasome. Chemosphere 2018, 190, 272–279. [CrossRef]
[PubMed]
40. Törnwall, J.; Carey, A.B.; Fox, R.I.; Fox, H.S. Estrogen in autoimmunity: Expression of estrogen receptors in
thymic and autoimmune T cells. J. Gend. Specif. Med. 1999, 2, 33–40. [PubMed]
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Abstract: To explore AFB1-induced damage of the small intestine, the changes in structure
and expression of TLRs (Toll-like Receptors) in the small intestine of chickens were
systematically investigated. Ninety healthy neonatal Cobb chickens were randomized into a control
group (0 mg/kg AFB1) and an AFB1 group (0.6 mg/kg AFB1). The crypt depth of the small
intestine in the AFB1 group was significantly increased in comparison to the control chickens,
while the villus height and area were evidently decreased, as well as the villus:crypt ratio and
epithelial thickness. The histopathological observations showed that the villi of the small intestine
exposed to AFB1 were obviously shedding. Based on ultrastructural observation, the absorptive cells
of small intestine in the AFB1 group exhibited fewer microvilli, mitochondrial vacuolation and the
disappearance of mitochondrial cristae, and junctional complexes as well as terminal web. Moreover,
the number of goblet cells in the small intestine in the AFB1 group significantly decreased. Also,
AFB1 evidently decreased the mRNA expression of TLR2-2, TLR4, and TLR7 in the small intestine.
Taken together, our study indicated that dietary 0.6 mg/kg AFB1 could induce histopathological
injuries and ultrastructural changes, and depress levels of TLR mRNA in the chicken small intestine.
Keywords: aflatoxin B1; small intestine; histopathological lesions; ultrastructural changes;
toll-like receptors
Key contribution: The aim of this paper is to comprehend the damaged innate immunity of small
intestine induced by AFB1. The results could provide important insights for the future studies of
AFB1 related to animals and humans.
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1. Introduction
Aflatoxins, secondary metabolites produced by some Aspergillus species [1,2], are important
mycotoxins since about 0.5 to 4.5 billion people are exposed to high levels of aflatoxins. [3,4].
Aflatoxin B1 (AFB1) is the main source and most toxic type of aflatoxins [5]. The liver is the main target
organ for aflatoxins [6,7]. The negative effects of AFB1 have also been well-documented, including
reduced performance, decreased immune system function, and increased susceptibility to diseases in
several animal species [8–10].
Conversion and absorption of food components mainly take place in the gastrointestinal tract.
Normal nutrient supply is supported by several factors, including absorptive surfaces, residing
microorganisms, and host-derived physiological processes [10]. Meanwhile, the intestinal mucosa is
continually exposed to a series of antigens, especially the bacterial antigens. Intestinal epithelial cells
(IECs) act as a defense system between the intestinal lumen and the lamina propria [11]. The entire
structure and function of IECs, which possess tight junction and goblet cells producing mucus, prevent
luminal antigens from translocating to the subepithelial tissue [12,13].
The immunotoxicity of AFB1 to the intestine has drawn research attention. It has been reported
that AFB1 decreased the proportion of T-cell subset and number of IgA+ cells in the small intestine
of chickens [14,15]. The literature, however, is scanty and controversial as to the effects of AFB1 on
the morphology and histopathology of the gastrointestinal tract [10]. After exposure to 0.02 mg/kg
or 0.7 mg/kg AFB1 for three weeks, the density (weight/length) of the whole intestine in chickens
was evidently decreased [16,17]. Grozeva et al. found that 0.5 mg/kg AFB1 induced generalized
hyperaemia and mononuclear cell infiltration in the small intestine of broilers within the 42 days of an
experiment [18], but, at a higher level of 4 mg/kg diet, Ledoux et al. revealed no histological damage
to male broilers’ small intestine after a three-week exposure [19].
The pattern recognition receptors (PRRs) have been confirmed to be associated with immunity,
inflammation, and cancer [20]. TLRs, one type of the PRRs, have been studied in different areas,
including immunotoxicity, inflammation, oxidative stress and cell survival [21]. A few in vitro studies
reported that mycotoxins affected TLRs’ expression or TLRs-associated pathways. Mixed aflatoxins
B and G up-regulated TLR2 and TLR4 transcript in human peripheral blood mononuclear cells [21],
while deoxynivalenol led to the inhibition of TLR-MyD88 signaling in RAW264 cells [22].
The gastrointestinal tract is the first organ by which AFB1 comes into the body of human
and animals; thus, compared with other organs, this toxin should exert greater impacts on the
small intestine. However, the effects of AFB1 on the small intestine are often neglected and
inconclusive [10]. And the doses and exposure time of AFB1 to cause histopathological changes
of the intestine were controversial in chickens [16–19]. Our team’s research has shown that 0.15 mg/kg,
0.3 mg/kg and 0.6 mg/kg AFB1 could cause obvious toxic effects on chichen immune organs with
dose-response [9,23,24]. In our previous study, 0.3 mg/kg AFB1 decreased jejunal villus height, villus
height/crypt ratio, and induced shedding of epithelial cells on the tip of chicken jejunal villus from 7
to 21 days of age [25]. To observe whether 0.6 mg/kg AFB1 would cause more serious damage to the
whole small intestine in the same exposure time, we determined to use a higher dose (0.6 mg/kg AFB1)
to do the further systemic research. Furthermore, TLRs play vital roles in the innate immune system,
and several studies on the effects of different mycotoxins on TLR gene expression were focused on
TLR2, TLR4 and TLR7 [21,22,26–28]. Thus, these three TLRs were chosen for this research in order to
compare the AFB1-induced effects on TLR2, TLR4 and TLR7 with other mycotoxins.
Therefore, this research was conducted to systematically study the histopathological damages and
TLR expression in the small intestine of chickens caused by dietary 0.6 mg/kg AFB1 through multiple
technologies, such as hematoxylin and eosin staining, histological chemistry, microscopic analyses of
the villus, crypt depth and goblet cells, the mucosal epithelium observation by transmission electron
microscope, and TLR2, TLR4, and TLR7 mRNA expression by qRT-PCR.
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2. Results
2.1. Morphological Measurements in the Small Intestine
At three different time points, compared with the control group, the villus height of duodenum
in the AFB1 group was significantly decreased (p < 0.05 or p < 0.01), while the villus width was
significantly increased (p < 0.05 or p < 0.01). Overall, the villus area of the duodenum in the AFB1
group was evidently decreased (p < 0.01). Although the crypt depth of duodenum in the AFB1 group
was significantly increased (p < 0.01), the villus:crypt ratio in the AFB1 group dropped significantly
(p < 0.01). Moreover, the epithelial thickness of duodenum in the AFB1 group significantly declined
(p < 0.05) (Figure 1).
 
Figure 1. The data of villus height, crypt depth, villus width, epithelial thickness, villus area, and
villus/crypt ratio in the duodenum. * p < 0.05, ** p < 0.01.
Compared with the control group, the jejunum of the AFB1 group exhibited lower villus height,
width, and area (p < 0.05 or p < 0.01). The jejunal crypt depth in the AFB1 group, moreover, was
significantly increased (p < 0.05 or p < 0.01), in addition, the villus:crypt ratio was evidently lower
(p < 0.01). At all three time points, the epithelial thickness of jejunum in the AFB1 group was
significantly decreased (p < 0.05 or p < 0.01) (Figure 2).
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Figure 2. The data of villus height, crypt depth, villus width, epithelial thickness, villus area, and
villus/crypt ratio in the jejunum. * p < 0.05, ** p < 0.01.
Compared with the control group, the ileum of broilers exposed to AFB1 showed lower villus
height, width, and area (p < 0.05 or p < 0.01). The ileac crypt depth in the AFB1 group, moreover, was
significantly increased (p < 0.05 or p < 0.01), and the villus:crypt ratio had evidently dropped (p < 0.01).
On day 14, the epithelial thickness of the ileum in the AFB1 group was significantly decreased (p < 0.05)
(Figure 3).
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Figure 3. The data of villus height, crypt depth, villus width, epithelial thickness, villus area, and
villus/crypt ratio in the ileum. * p < 0.05, ** p < 0.01.
2.2. Histopathological Analysis
The apical epithelia of villi in the small intestine in the AFB1 group were shedding (Figure 4).
No other obvious pathological damage to the chicken intestine in the AFB1 group was observed.
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Figure 4. The representative microstructure of intestinal villi at 21 days of age. Note: The enlarged box
shows the shedding of epithelial cells; H.E. stain, scale bar = 200 μm.
2.3. Ultrastructure Changes
The mucosal epithelium of the small intestine consists predominately of absorptive cells and
goblet cells (Figure 5). In the duodenum, jejunum, and ileum of the control group on day 21 of the
experiment, there are closely packed microvilli in the apical border of absorptive cell. Also, abundant
mitochondria with normal ultra-structure were located in the apical cytoplasm of this cell. Junctional
complexes including tight junction, intermediate junction, and desmosome were distributed between
the epithelial cells at the luminal surface. A terminal web containing many micro-filaments was well
organized under the microvilli.
In the duodenum of the AFB1 group on day 21, reduced mitochondrial cristae and mitochondrial
vacuolation and lysis of mitochondrial contents in the apical portion of some absorptive cells were the
most obvious ultrastructural pathological changes (Figure 5).
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In the jejunum of the AFB1 group, the microvilli on the surface of some absorptive cells
were completely shed, and the junctional complexes and terminal web were partly or completely
disappeared. In addition, the number of mitochondria had evidently decreased (Figure 5).
Also, the microvilli of some ileac absorptive cells in the AFB1 group on day 21 were fewer or
shorter, or even completely shed, and the junctional complexes and terminal web had partially or
entirely disappeared. Finally, fewer mitochondria, a decreased electron density, and lysis contents of
apical cytoplasm were observed (Figure 5).
 
Figure 5. The representative ultrastructure of absorptive cells and goblet cells in the small intestine
at 21 days of age. Note: M: mitochondria (), V: microvilli ( ), G: Goblet cells, LY: lysosomes (),
N: nucleus, JC: Junctional complexes (→), TW: terminal web. Scale bar = 3 μm.
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2.4. Number of Goblet Cells Shown by Alcian Blue/PAS
By Alcian Blue/PAS stain, goblet cells locating in mucosal epithelia and crypt were blue or purple
in the small intestine of both groups. Compared with the control group, on day 7, the number of
goblet cells in jejunum of the AFB1 group was significantly decreased (p < 0.05). On days 14 and 21,
the numbers of goblet cells in the AFB1 group were evidently decreased (p < 0.05 or p < 0.01) (Figures 6
and 7).
Figure 6. The numbers of goblet cells in the small intestine. Note: 0.064 mm2 was the area of one field
under 400× magnification. * p < 0.05, ** p < 0.01.
Figure 7. The representative goblet cells in the mucous epithelial cells of villi in the small intestine on
day 21 (Alcian Blue/PAS stain, scale bar = 50 μm).
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2.5. mRNA Expression of TLR2-2, TLR-4 and TLR-7
The mRNA expression of TLR2-2, TLR-4, and TLR7 in both the duodenum and jejunum in the
AFB1 group significantly decreased in comparison to the control group on day 14 and 21 (p < 0.05 or
p < 0.01), except for duodenal TLR2-2 mRNA expression on day 14. The value of ileac TLR2-2 was
evidently decreased in the AFB1 group on days 14 and 21 (p < 0.05 or p < 0.01), and the values of ileac
TLR-4 and TLR-7 in the AFB1 group significantly declined during the experiment (p < 0.05 or p < 0.01)
(Figure 8).
 
Figure 8. mRNA expression levels (fold of the control) of the TLR2-2, TLR4, and TLR7 in the
small intestine. * p < 0.05, ** p < 0.01.
3. Discussion
Aflatoxin B1, the most common aflatoxin, commonly contaminates various kinds of human
food and animal feed elements in tropical and subtropical areas [10]. AFB1 can enter into animals
and humans by consumption of AFB1-contaminated feed or food, so the gastrointestinal is the first
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site to contact AFB1, especially the small intestine [18]. The mucosal layer of the small intestine,
including the lining epithelium, lamina propria with gland, and lamina muscularis, has the specificity
to be structured in a way that provides a large surface, thus maximizing the absorption of nutrients.
The surface of the mucosa is studded with finger-like projections, the intestinal villi, which are the
most characteristic feature of the small intestine [29]. The crypts opening between the bases of the
villi penetrate the mucosa as far as the lamina muscularis [29]. The intestinal villus and crypt play a
crucial role in nutritional absorption and animal growth [30]. The continuous regeneration of the small
intestinal epithelium is ensured by the migration of proliferating crypt cells up the villi [31]. Therefore,
the height, width, and area of villus, but especially the area, are positively related with the absorptive
efficiency of the small intestine in chickens, as well as epithelium thickness and villus:crypt ratio, while
the crypt depth is negatively related. Our study showed decreased villus height and area as well
as villus:crypt ratio in the three parts of the small intestine in the AFB1 group in comparison with
the control chickens, suggesting that AFB1 reduced the small intestine’s surface area for absorption
in chickens. Our morphological measurements were similar to most previous studies, e.g., one in
which Zhang et al. found that 0.3 mg/kg AFB1 could induce slightly decreased jejunal villus height
and shedding of epithelial cells on the tip of the jejunal villus [25]; Aboutalebi reported that 0.7 mg/kg
AFB1-treatment induced more serious damage in the duodenum than 0.35 mg/kg AFB1-treatment [32].
Thus, AFB1 may have a dose-dependent effect. However, Feng et al. reported that AFB1 could increase
the villus height and area in the duodenum and jejunum [33], which may result from differences in
animal species and doses of AFB1 used for experiments.
In this study, moreover, AFB1 caused the shedding of the apical epithelia of villi in the small
intestine, which was also observed by other researchers in chickens [18,25]. In murine models, AFB1
has been found to lead to pathological damage of the intestinal mucosa [34], and to decreased cell
proliferation [35]. Furthermore, Akinrinmade et al. observed leucocyte, lymphocyte, and mononuclear
cell infiltration in the lamina propria of rats when AFB1 was administered intraperitoneally [36],
which was not observed in our study. These discrepancies may be attributed to different methods of
administration and different animal models.
In addition, to explore the relationship between AFB1 and damage to absorptive cells in the
small intestine, we used a transmission electron microscope to examine the ultrastructure of the
epithelial cells of the small intestine following AFB1 exposure. In the duodenum, fewer mitochondrial
cristae of absorptive cells and lysis of mitochondrial contents were observed in the AFB1 group. Also,
microvilli on the surface of absorptive cells in the jejunum and ileum of the AFB1 group were decreased
or shedding. Mitochondria play important roles not only in producing ATP, but in controlling apoptosis
and contributing to the calcium homeostasis process of cells [37,38]. The involvement of microvilli
has been established in various functions such as secretion, mechanotransduction, absorption, and
cellular adhesion. Junctional complexes prevent fluid intestinal contents from diffusing into the lamina
propria without going through the cells [29]. A terminal web is thought to be responsible for the
movement of the microvilli. Damage to the mitochondria and microvilli, along with the disappearance
of junctional complexes and the terminal web in some absorptive cells, induced by AFB1, showed that
AFB1 could cause dysfunction of these structures, resulting in functional disorders of absorptive cells
in the small intestine.
To further explore how AFB1 impaired the epithelial cells of small intestine, we investigated the
number of goblet cells by Alcian Blue/PAS staining. Goblet cells are presumed to protect the mucous
membrane in the intestine through the synthesis and secretion of several mediators, such as the mucin
MUC2 and the small peptide trefoil factor 3 [39,40]. In this research, AFB1 could decrease the numbers
of goblet cells, which may contribute to the damage to small intestine epithelia. Furthermore, the
mucins production in goblet cells could be up-regulated by TNF-α [41]. Studies have showed that
AFB1 inhibited the expression of cytokines in the small intestine, including TNF-α [14,42], by which
we speculated that the contents of mucins secreted by goblet cells were depressed in the AFB1 group.
Moreover, goblet cells delivered luminal antigen to CD103+ dendric cells in the small intestine [43].
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Thus, the decreased goblet cells caused by AFB1 may be associated with repressed immunity in the
small intestine.
Previous in vivo research has shown that AFB1 impaired the adaptive immunity of the small
intestine in chickens. Jiang et al. found that AFB1 decreased the T cell subset, cytokine expression,
IgA+ cell numbers, and the expression of immunoglobulin in the small intestine of broilers [14,15].
It is still unknown, however, whether AFB1 impaired the innate immunity of the small intestine
of chickens in vivo. In this study, we determined the innate immunity of the small intestine of
chickens through the expression levels of three toll-like receptors. By qRT-PCR, we found that the
expression levels of TLR2-2, TLR4, and TLR7 mRNA were evidently suppressed by AFB1 exposure,
similarly to zearalenone-induced decrease of TLR-4 in IPEC-1 cells [26] and pig splenocyte [27], and to
T2-toxin-induced decrease of TLR-7 in porcine alveolar macrophages [28]. However, mixed aflatoxins B
and G could up-regulate TLR2 and TLR4 transcripts in human peripheral blood mononuclear cells [21].
These opposite results may be the consequence of the use of different cell types. Toll-like receptors,
expressed on the membranes of immune and non-immune cells, assisted the immune system with the
recognition of molecules shared by pathogens, and played vital roles in the innate immune system [44].
TLR2 mediated the host response to Gram-positive bacteria [45], and the functional properties of type 2
TLR2 (TLR2-2) were alike in chickens, humans, and mice [46]. TLR4 could identify lipopolysaccharides
(LPS), various viral proteins, polysaccharides, and different kinds of endogenous proteins [47]. TLR7,
recognizing single-stranded RNA of viruses such as HCV, played a significant role in the regulation of
antiviral immunity [48]. Based on the results of this research, we speculated that AFB1 may impair
the innate immunity of the small intestine in chickens by depressing TLR2-2, TLR4, and TLR7 mRNA
levels. Moreover, the activation of NF-κB in various cell types was triggered by the downstream
signaling pathway of TLR2 and TLR4 [49,50]. Following NF-κB activation, various cytokines were
released, like IL-6 and TNF-α [51]. Our previous data demonstrated that 0.6 mg/kg AFB1 in the
broilers’ diet could reduce the expression level of cytokine (like IL-2, IL-4, IL-6, IL-10, IL-17, IFN-γ,
and TNF-α) mRNA in the small intestine, implying that the immune function of the intestinal mucosa
might be affected [14]. Therefore, the suppressed expression of TLR2 and TLR4 induced by AFB1 may
contribute to the decreased levels of various cytokines [14,42].
4. Conclusions
In conclusion, feed contaminated with 0.6 mg/kg AFB1 could induce shedding of intestinal
epithelial cells; decrease villus height and area, along with villus:crypt ratio; impair the microvilli
and mitochondria of absorptive cells; decrease the goblet cell number; and depress the expression
of TLR2-2, TLR4, and TLR7 in the chicken small intestine. These findings indicate that AFB1 may
decrease the absorptive capacity and partially impair the innate immunity of the small intestine.
5. Materials and Methods
5.1. Animals and Groups
Ninety healthy male neonatal Cobb chickens, bought from the Chia Tai Group (Wenjiang, Sichuan,
China), were randomized into control and AFB1 groups. There were three replicates/group and
15 animals/replicate. Housed in cages with electrically heated units for 21 days, chickens were
provided with water as well as the aforementioned diet ad libitum. The animal protocols and all
procedures of the experiment in this research were carried out according to the laws and guidelines of
Animal Care and Use Committee of Sichuan Agricultural University (Approval No. 2012-024). As the
chickens were fed with AFB1 after hatching, the day of age is the same as the day of the experiment.
5.2. Diets
According to the National Research Council (NRC, 1994) [52] and Chinese Feeding Standard of
Chicken (NY/T33-2004), the basal diet was made the control diet. The AFB1 (Sigma-Aldrich, St. Louis,
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MO, USA, A6636) contaminated diet was formulated basically the same as reported earlier [53].
In short, after 27 mg AFB1 farinose solid was completely dissolved into 30 mL methanol, the 30-mL
mixture was mingled into 45 kg corn-soybean basal diet to formulate the AFB1 diet. For the control
diet, equivalent methanol was also added into corn-soybean basal diet. Next, the methanol of both
food supplies was evaporated at 98 ◦F (37 ◦C). Based on analyses by HPLC (Waters, Milford, MA,
USA) with fluorescence detection (Waters, Model 2475, Milford, MA, USA), the AFB1 concentration
was under 0.001 mg/kg in the control group, and 0.601 mg/kg in the AFB1 group, respectively.
5.3. Histopathological Observation and Microscopic Analyses
The duodenum, jejunum, and ileum from six broilers in each group were collected and fixed in
4% paraformaldehyde on days 7, 14, and 21, and then were dehydrated and embedded in paraffin wax.
The sample blocks were sectioned (5 μm) with a microtome (Leica, Wetzlar, Germany, RM2135).
The tissue sections were stained with hematoxylin and eosin (H·E), and observed and photographed
with a digital camera (Nikon DS-Ri1, Tokyo, Japan).
Five sections of each tissue in a chicken were taken, and five pictures (400×) of each section were
taken randomly. The epithelial thickness and villus height, width, and area, as well as crypt depth,
were determined by image analysis software (Image-Pro Plus 5.1, Media Cybernetics, Inc., Rockville,





5.4. Transmission Electron Microscope Observation
On day 21, three chickens from each group were humanely killed. At necropsy, the duodenum,
jejunum, and ileum were carved into small pieces and immediately put into 2.5% glutaraldehyde
for fixation, and in 2% veronal acetate-buffered OsO4 for post-fixation. After dehydrating in acetone
gradient, the sample tissues were embedded in Epon 812. The sample blocks were sectioned (65–75 nm)
in a microtome with a glass knife and put in uncoated copper grids. The tissue sections were stained
with uranyl acetate and lead citrate. The ultrastructural architectures of the duodenum, jejunum, and
ileum were observed by transmission electron microscope (Hitachi, H-600 transmission, Tokyo, Japan).
5.5. Alcian Blue/Periodic Acid-Schiff (PAS) Stain
De-waxed sections were stained in 1% Alcian blue for 5 min, oxidized in 1% periodic acid,
immersed in Schiff’s reagent, and mounted and observed by light microscope. With each step, the
section was washed in water. The stain showed the goblet cells containing acidic mucins (blue), neutral
mucins (magenta), or mixtures of acidic and neutral mucins (purple). Five sections of each tissue in
one bird were performed, and five pictures (400×) of each section were taken randomly. The number
of goblet cells was calculated on the tip of the villus and the principle for choosing goblet cells was to
select the one with more secretion and intact section. All goblet cells in the pictures were counted for
further analysis.
5.6. qRT-PCR
The small intestines from six chickens in each group on days 7, 14, and 21 were obtained and
stored in liquid nitrogen. Then all samples were transferred and stored at −80 ◦C. Total RNA
was extracted using TriPure isolation reagent (Roche Diagnostics GmbH, Mannheim, Germany).
The mRNA was reverse-transcribed into cDNA byTranscription First Strand cDNA Synthesis (Roche
Diagnostics GmbH). The cDNA was amplified with primers TLR2-2, 4, 7, and β-actin (specified in
Table 1) using methods similar to those described by Jiang et al. [14]. Expression of TLR2-2, 4 and 7
transcripts is shown relative to that of β-actin using the 2−ΔΔCt method of Livak and Schmittgen [54].
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Table 1. Primers of TLRs and house-keeping genes.














The results were expressed as the mean ± standard deviation, and the significant difference
between the two groups was analyzed by variance analysis, which was performed by the independent
sample test of SPSS 17.0 software for Windows. Differences were considered to be statistically
significant at p < 0.05.
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Abstract: T-2 toxin is a secondary metabolite of some Fusarium species. It is well-known that this
substance can harmfully impact living organisms. Among others, thanks to the ability of crossing
the blood–brain barrier, T-2 toxin can affect the central nervous system. Mycotoxins mostly get
into the organism through the digestive tract; therefore, first of all they have to break the intestinal
barrier, wherein the important component is the enteric nervous system (ENS). However, knowledge
about the impact of T-2 toxin on the ENS is rather scant. As a result of the influence of various
physiological and pathological agents, ENS can undergo adaptive and reparative processes which
manifest as changes in the immunoreactivity of perikaryons for neuronal active substances. So, the
aim of the present investigation was to study how low doses of T-2 toxin affect vasoactive intestinal
polypeptide-like immunoreactive (VIP-LI) nervous structures in the ENS of the porcine stomach and
duodenum. Obtained results have shown that T-2 toxin causes an percentage increase of VIP-LI
nerve cells and nerve fibers in every enteric plexus in both fragments of gastrointestinal tract studied.
This shows that even low doses of T-2 toxin can have an influence on living organisms.
Keywords: T-2 toxin; enteric nervous system; pig; vasoactive intestinal polypeptide
Key contribution: The administration of low doses of T-2 toxin causes the increase in the number of
nervous structures immunoreactive to vasoactive intestinal polypeptide (VIP) located in the porcine
stomach and duodenum.
1. Introduction
Mycotoxins are secondary fungal metabolites that may have a multidirectional negative impact on
living organisms. Depending on the type of toxic substance, they may show carcinogenic, mutagenic,
allergenic, estrogenic, and/or neurotoxic activities [1–4]. Moreover, due to their widespread presence
in the environment, mycotoxins cause not only acute, but also chronic poisoning. Another dangerous
consequence of long or intense exposure to these secondary fungal metabolites is the possibility of
kidney and/or liver damage resulting in their failure [3,5,6].
Among a broad range of mycotoxins, one of the more dangerous is T-2 toxin, which is synthetized
by fungi of the genus Fusarium, namely Fusarium sporotrichioides, langsethiae, acuminatum, and poae,
and occurs ubiquitously in various food products of vegetable origin, including wheat, sorghum, rye,
corn, oats, and rice [2,4,7].
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T-2 toxin mostly exhibits cytotoxic and immunosuppressive activities [4,8]. Till now, it has been
established that this mycotoxin contributes to such gastrointestinal disorders as alimentary toxic
aleukia (ATA) and inflammatory bowel disease [7,9]. Moreover, T-2 toxin can cause thymus and
spleen impairments [7,8]. However, one of the most dangerous effects of this toxin is the neurologic
toxicity caused by its ability to cross the blood–brain barrier, which results in changes within the
central nervous system [4,10]. Because of the above-mentioned negative effects, a high resistance to
temperature, and its widespread occurrence in food, T-2 toxin constitutes a serious threat to the health
and life of both humans and animals [3,6].
Due to the fact that mycotoxins mostly enter into the organism through the digestive tract, first of
all they have to break the intestinal barrier, wherein the important component is the enteric nervous
system (ENS). The ENS is situated within the digestive tract, from the esophagus to the rectum, in all
mammal species and regulates most stomach and intestine activities. The structure of the ENS varies
depending on both the animal species as well as the part of the gastrointestinal (GI) tract. Within
the stomach of large mammals, including pigs, the ENS is formed of two intramural ganglionated
plexuses: the myenteric plexus (MP), which is situated betwixt the longitudinal and circular muscle
layers, and the submucous plexus (SP), which is located between the muscularis mucosa and circular
muscle layer [7]. Contrary to the stomach, the ENS in the intestine of big mammals species forms three
intramural plexuses: MP, which is situated the same as in the stomach, and two submucous plexuses:
the outer submucous plexus (OSP), which is located close to the internal side of the circular muscle
layer, and the inner submucous plexus (ISP), which lies between the muscularis mucosa and lamina
propria [11,12].
On account of the huge amount of enteric neurons, as well as their significant differentiation
and autonomy, the ENS is called the “second” or “intestinal” brain [13]. Because the enteric neurons
take part in very different regulatory processes connected with all aspects of intestinal physiology,
they may contain a vast number of neuronal active substances [14,15]. Till now, several dozen of such
substances have been described. Among them, vasoactive intestinal polypeptide (VIP) deserves special
attention. This peptide is known to be a non-noradrenergic, non-cholinergic transmitter (NANC)
and the most important inhibitory factor within the GI tract [12,16,17]. First of all, VIP causes the
relaxation of gastrointestinal muscles and sphincters [18,19]. Moreover, this substance suppresses
secretory activity of the stomach and intestine and dilates blood vessels within the wall of the GI tract
and mesentery [20,21]. Some previous studies have revealed the neuroprotective and/or adaptive
activity of VIP-positive enteric neurons during pathological processes and after toxic substances
administration [22–25], but these functions of VIP have not been fully elucidated.
On the other hand, although the knowledge about the negative effects of T-2 toxin is not negligible,
many aspects connected with the impact of this substance on living organisms still remain unexplored.
One of them is the impact of this toxin on the ENS [4,7], which is known to undergo structural,
functional, or chemical changes as a result of some physiological and pathological stimuli [26–29].
So, the present study has been conducted to describe the impact of low doses of T-2 toxin on
the distribution of VIP within the enteric perikaryons in the porcine GI tract. Because of the major
sensitivity of the ENS to the occurrence of harmful factors in the digestive tract [12,14,26,27,29] and
the well-known functions of VIP in intestinal regulatory processes [14,30,31], changes observed during
investigations can signify the first subclinical signs of the damage effected by T-2 toxin. The obtained
results on the one side can result in a better understanding of the mechanisms connected with the
impact of this mycotoxin on living organisms, and on the other side can contribute to an explanation
of the roles of VIP during intoxications.
Moreover, the choosing the domestic pig as the laboratory mammal in the investigation allows
us to estimate the changes which can occur under the impact of low doses of T-2 toxin in the
human enteric nervous system. This assumption is in agreement with previous studies where the
neurochemical, histological, and physiological similarities between the human and porcine ENS have
been described [12,29,32]. For this reason, the domestic pig seems to be a better animal model for
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investigations on pathological changes in the human ENS than rodents, which are commonly used for
this purpose.
2. Results
During the present investigation, no clinical symptoms were observed after T2 toxin administration.
Moreover, there were no differences in the food intake between control and experimental groups.
In this experiment, VIP-positive neurons and nerve fibers were observed in the ENS of the stomach
and the duodenum in both control as well as experimental groups of animals. The number of these
structures fluctuated depending on the part of the ENS and the fragment of digestive tract studied
(Tables 1 and 2, Figures 1–4).
Table 1. Vasoactive intestinal polypeptide (VIP)-positive nerve cells and fibers in the stomach of the pig.
CML: circular muscle layer; MP: myenteric plexus; CB: cell bodies; NF: nerve fibers; SP: submucous
plexus; S/ML: submucosal/mucosal layer.
STOMACH Group C Group T2
CML 1 4.26 ± 0.21 5.17 ± 0.11 *
MP
CB 2 37.56± 0.84 42.85 ± 0.74 *
NF 3 + +
SP
CB 2 36.78 ± 0.4 43.83 ± 1.18 *
NF 3 − +
S/ML 1 2.84 ± 0.07 4.15 ± 0.15 *
1 Mean number of VIP-positive nerves per microscopic field (mean ± standard error of the mean (SEM)); 2 The
percent of VIP-positive nerve cells (mean ± SEM) in regard to perikarya immunoreactive to protein gene-product
9.5 (PGP 9.5) (pan neuronal marker); 3 the consistence of intraganglionic VIP-positive fibers shown in mean units on
the scale from (-), presenting the absence of VIP-positive nerves, to (++++), indicating a very dense meshwork of
fibers studied. Statistically significant differences (p ≤ 0.05) are marked with *.
Table 2. VIP-positive nerve cells and fibers in the duodenum of the pig. CML: circular muscle layer;
MP: myenteric plexus; CB: cell bodies; NF: nerve fibers; OSP: outer submucous plexus; ISP: inner
submucous plexus; S/ML: submucosal/mucosal layer.
DUDODENUM Group C Group T2
CML 1 17.08 ± 0.08 21.22 ± 0.24 *
MP
CB 2 31.45 ± 0.77 39.24 ± 1.02 *
NF 3 + ++
OSP
CB 2 32.43 ± 1.83 40.59 ± 0.67 *
NF 3 ++ ++
ISP
CB 2 28.50 ± 1.17 35.42 ± 1.52 *
NF 3 + ++
S/ML 1 32.35 ± 0.32 39.97 ± 1.23 *
1 Mean number of VIP-positive nerves per microscopic field (mean ± SEM); 2 The percent of VIP-positive nerve
cells (mean ± SEM) in regard to perikarya immunoreactive for PGP 9.5 (pan neuronal marker); 3 the consistence of
intraganglionic VIP-positive fibers shown in mean units on the scale from (-), presenting the absence of VIP-positive
nerves, to (++++), indicating a very dense meshwork of fibers studied. Statistically significant differences (p ≤ 0.05)
are marked with *.
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The percentage of vasoactive intestinal polypeptide-like immunoreactive (VIP-LI) neurons with
regard to the number of protein gene-products 9.5 (PGP 9.5) LI cells in both the fundus of the stomach
as well as the duodenum of control pigs was substantial. However, in the stomach of C group animals
this number was higher and amounted to 37.56 ± 0.84% in the muscular plexus and 36.78 ± 0.4% in
the submucous plexus (Figure 1, Table 1). In the same GI tract fragment, unlike nerve cells, the number
of VIP-positive nerves was very slight. There has been observed only a single intraganglionic VIP-LI
nerve in the MP, whereas such nerves were absent in most of the SP in the stomach of pigs under
physiological conditions. Similarly, in case of the fibers situated in the stomachic wall, the number
of these neuronal structures was also low and reached only 4.26 ± 0.21 per observation field in the
circular muscle layer and 2.84 ± 0.07 in the submucous/mucous layer (Figure 2, Table 1).
In the duodenum from C group, the number of VIP-LI nerve cells was slightly lower than in the
case of the stomach. The percentage of these nerve cells amounted to 31.45 ± 0.77%, 32.43 ± 1.83%,
and 28.50 ± 1.17% in the MP, OSP, and ISP, respectively (Figure 3, Table 2). Although the number of
VIP-positive neurons was comparable in the both GI tract parts studied, the amount of VIP-positive
nerve fibers was completely different. The number of intraganglionic nerves was higher than in the
stomach, and contrary to the gastric SP, in the submucous plexuses of the duodenum were observed
single (in the ISP) and rare (in the OSP) VIP-LI nerve fibers. However, the main difference concerned
nerve fibers located in the wall of the studied organs. In contrast to a few VIP-positive nerves in the
gastric wall, in the duodenum their number was high and amounted to 17.08 ± 0.08 per observation
field in the circular muscle and 32.35 ± 0.32 in the submucous/mucous layers (Figure 4, Table 2).
Treatment with T-2 toxin caused changes in the percentage of VIP-LI enteric perikaryons and the
density of nerve fibers positive for the studied substance. These alterations consisted mainly in an
increase in the number of VIP-positive nerve structures. However, the intensity of these deviations
clearly depended on both the GI tract fragment and part of the ENS studied. The biggest changes
concerned the MP and OSP in the duodenum, where the percentage of VIP-positive perikaryons
increased about eight percentage points (pp). Considerably lower alterations were observed in the
duodenal inner submucous plexus (about a seven pp increase) (Figure 3, Table 2). Similar changes
have been noted in the gastric MP (increase of five pp) and SP (increase of six pp) (Figure 1, Table 1).
In the experimental group, the concentration of intraganglionic VIP-positive nerves was also greater
than in the C group; however, these alterations were not so significant and were noted in the stomachic
SP and the duodenal MP and ISP. Furthermore, marked changes in the density of VIP-LI nerves in
the muscle and mucous layers were noted in the T2 group. The clearest increase in the number of
nerves per observation field was noted in the duodenal submucous/mucous layer: from 32.35 ± 0.32
to 39.97 ± 1.23, whereas in the stomach, these values accelerated from 2.84 ± 0.07 to 4.15 ± 0.15.
Alterations in the amount of VIP-LI nerve fibers in the muscle layer were less observable and reached
about 5.17 ± 0.11 in the duodenum and about 21.22 ± 0.24 within the stomach (Tables 1 and 2,
Figures 2 and 4).
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Figure 1. Nerve cell bodies containing the protein gene-product 9.5 (PGP 9.5) pan-neuronal marker
(a) and vasoactive intestinal polypeptide (VIP) (b) within the porcine gastric wall in control animals
(I, III) and after T-2 toxin giving (II, IV). I, II: submucous plexus; III, IV: myenteric plexus. Arrows
indicate VIP-positive neurons. Photos Ic, IIc, IIIc, and IVc came from the merger of green (PGP 9.5) and
red (VIP) fluorescent channels. The pictures were captured with an Olympus XM10 camera.
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Figure 2. Vasoactive intestinal polypeptide (VIP)-positive nerve fibers in the porcine stomach in control
animals (I, III) and after T-2 toxin giving (II, IV). I, II: mucosal layer; III, IV: muscle layer. VIP-positive
nerve fibers are indicated by arrows. The pictures were captured with an Olympus XM10 camera.
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Figure 3. Nerve cell bodies containing the protein gene-product 9.5 (PGP 9.5) pan-neuronal marker (a)
and vasoactive intestinal polypeptide (VIP) (b) within the porcine duodenal wall in control animals
(I, III) and after T-2 toxin giving (II, IV). I, II: submucous plexus; III, IV: myenteric plexus. Arrows
indicate VIP-positive neurons. Photos Ic, IIc, IIIc, and IVc came from the merger of green (PGP 9.5) and
red (VIP) fluorescent channels. The pictures were captured with an Olympus XM10 camera.
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Figure 4. Vasoactive intestinal polypeptide (VIP)-positive nerve fibers in the porcine duodenum in
control animals (I, III) and after T-2 toxin giving (II, IV). I, II: mucosal layer; III, IV: muscle layer.
VIP-positive nerve fibers are indicated by arrows. The pictures were captured with an Olympus
XM10 camera.
3. Discussion
The present observations have confirmed that VIP is present in the enteric neurons and nerve
fibers of the porcine stomach and duodenum. It is compatible with previous investigations describing
this substance as an important neurotransmitter in the ENS of a wide range of mammals species,
including humans [22,24,31,33,34]. It is known that enteric neurons capable of VIP synthesis first of all
have inhibitory effects and their stimulation causes the relaxation of the intestinal smooth muscles and
a decrease in the secretory activity of the digestive tract. Inhibitory effects on gastrointestinal activities
are not the only functions of VIP, because this substance also takes part in the regulation of immune
processes [35,36] and intestinal blood flow [12,37] as well as may influence intestinal commensal and
pathogenic bacteria populations [38]. Moreover, some studies have described the presence of VIP in
enteric sensory neurons [39]. In spite of the relatively numerous studies concerning VIP in the GI
tract, some aspects connected with the functions of this peptide remain unexplained. One of them is
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the physiological factors that influence the number of VIP-positive enteric neurons. The percentage
of neurons immunoreactive to VIP observed in control animals during the present study differ from
the values described in previous studies [22,24,31,33,34], which suggests that the synthesis of this
peptide by enteric neuronal cells depends on unidentified stimuli that would probably include (apart
from individual variations) type of diet, farming conditions, and/or environmental factors. Moreover,
differences in the number of VIP-LI enteric nerve cells between the stomach and duodenum observed
during the present experiment strongly imply that the precise roles of VIP in the digestive tract vary
depending on the part of the GI tract studied.
During the present study, the impact of low doses of T-2 toxin on the number of neurons
immunoreactive to VIP was noted in all parts of the ENS within the stomach and duodenum. Due to
the fact that knowledge about the impact of T-2 toxin on the ENS is extremely scant, and VIP may
have multidirectional functions in enteric neurons, the exact elucidation of the observed fluctuations is
rather difficult. Moreover, observed changes may arise from various processes, including disorders in
the transcription and/or translation stage of VIP synthesis as well as from disturbance of the peptide
inside neuronal cells.
These changes are probably connected with the neurotoxic effects of this mycotoxin, which are
the result of reactions of epoxides included in the molecules of the described substance with DNA
and proteins of neuronal cells [40]. Furthermore, T-2 toxin is a commonly known inhibitor of cellular
protein synthesis and a factor causing changes in the metabolism of membrane phospholipids [41,42].
Admittedly, the knowledge concerning T-2 toxin-induced changes in the ENS is extremely scant.
Namely, our previous observations have shown that even low dosages of this mycotoxin may influence
the number of enteric neurons immunoreactive to cocaine- and amphetamine-regulated transcripts
in various parts of the GI tract [7] as well as affect the neurochemical characterization of calcitonin
gene-related peptide-positive structures of the ENS within the descending colon [4]. Nevertheless,
the mechanisms underlying the above-mentioned fluctuations in chemical coding of the enteric
neurons remain unknown. On the other hand, it can be expected that processes connected with
the neurotoxicity of T-2 toxin in the ENS are similar to those observed in the other parts of the
nervous system. According to previous investigations, it is known that T-2 toxin causes alterations
in the levels of brain biogenic monoamines [43] and induces apoptosis in brain neuronal cells [44].
The reason of the exacerbation of apoptotic reactions in the nervous tissue is probably connected with
dysfunction of mitochondria caused by a T-2 toxin-induced decrease in the levels of mitochondrial
NADH-dehydrogenase and cytochrome oxidase enzymes occurring in mitochondria-related genes [45].
The thesis about connections of observed changes with neurotoxic effects of T-2 toxin is strongly
supported by the fact that VIP is known to be an important neuroprotective factor. Some previous
works have described that this peptide has multidirectional neurotrophic activities. Among others,
VIP stimulates mitosis within the astrocytes [46], supports neuronal differentiation of embryonic stem
cells [47], and increases neuronal survival under various pathological factors [48]. Furthermore, it
is known that VIP has neuroprotective functions during excitotoxicity, i.e., pathological processes
consisting in neuronal cell damage by excessive stimulation by some neurotransmitters [49], and
therefore inhibits the lesion of neurons in the brain cortex [50]. The neuroprotective effects of VIP are
probably connected with direct actions on microglial cells, which are the main source of inflammatory
factors damaging neurons in the central nervous system [51,52]. The above-mentioned VIP properties
have caused this substance as well as its analogs to be tested as drugs to treat neurodegenerative
diseases [48]. Contrary to the central nervous system, knowledge about the neuroprotective roles
of VIP within the enteric nervous system is more limited. Nevertheless, the previous investigations
have shown that this substance increases the survival of cultured enteric nerve cells undergoing
some pathological factors, including axotomy or bacterial lipopolysaccharide [23,53]. In view of the
foregoing, it is very likely that dissimilarities in VIP-LI observed during the present investigation are
an effect of neurotoxic activity of T-2 and are the result of neuroprotective and/or adaptive processes
within the ENS, which aim to maintain homeostasis in the GI tract under the influence of the toxin.
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The other mechanisms connected with observed changes may result from pro-inflammatory
and damaging properties of T-2. T-2 toxin may cause multidirectional disorders, among which is
alimentary toxic aleukia (ATA). During these processes, inflammatory changes and GI tract injuries
occur, which result in intestinal epithelial barrier disruption and manifest by vomiting, nausea, and
diarrhea [2,54]. It should be pointed out that inflammatory changes in the intestine have been also
observed after relatively low doses of T-2 toxin administration [55]. These changes may influence
indirectly the ENS. This is all the more likely as the interdependences between intestinal epithelial
cells and the ENS are commonly known [56]. Moreover, VIP is one of the factors that is are involved
in gastrointestinal inflammatory processes, and enteric neurons respond to these processes with the
growth of VIP expression [22–24,36,37].
Changes in VIP expression observed during this investigation can be also caused by the
stimulation of the gastrointestinal immune system, because this substance is considered to be a major
immunoregulatory neuropeptide. Previous investigations have described VIP as an anti-inflammatory
factor, which first of all, through the VPAC1 type of receptor, inhibits macrophage activity [57].
These effects on the one side lead to a decrease in the synthesis of pro-inflammatory cytokines,
including TNFα, IL-6, and IL-12, and on the other side result in a simultaneous increase in the levels of
IL-10, which is the main anti-inflammatory factor [57,58]. Moreover, it is known that VIP may affect
the phagocytosis, migration, and adherence of macrophages, but the exact mechanisms connected
with these activities have not been fully elucidated. Some studies have described that VIP stimulates
the above-mentioned processes, whereas other investigations have reported inhibitory effects [59].
The described polypeptide also inhibits the synthesis and activity of the inducible isoform of nitric
oxide synthase (iNOS) within immunological cells [57].
The second type of immune cells that may be subject to the influence of VIP are lymphocytes.
Previous studies have reported that this polypeptide influences Th1/Th2 cells’ balance by the inhibition
of Th1 cells, the support of Th2 cells [57], and the reduction of T cells migration through intestinal
Peyer’s patches [59]. Moreover, as in the case of macrophages, VIP changes the levels of cytokines
synthesized in Th1 and Th2 cells. For example, VIP suppresses the production of IL-2 but increases IL-5
synthesis [59]. The above-mentioned immunoregulatory functions of VIP have made this polypeptide
a potential therapeutic agent during various inflammatory and autoimmune diseases, including
lupus, autoimmune thyroiditis, and arthritis [57]. The hypothesis that fluctuations in the VIP-like
immunoreactivity observed during the present investigation are the result of the cooperation of
the ENS with the gastrointestinal immune system and may be the answer of the enteric nervous
structures to the inflammatory processes induced by T-2 toxin is probable in the light of previous
studies. These studies have shown the described mycotoxin to have an influence on the number of
types of lymphocytes and the expression of cytokines within the porcine ileal Peyer’s patches [60].
Since during the present study low doses of T-2 toxin have been used, and symptoms of inflammation
in the experimental animals were not observed, it cannot be excluded that the observed fluctuations
were the first sign of a subclinical inflammatory process.
4. Conclusions
The obtained results have shown that even low doses of T-2 toxin are not neutral for mammal
organisms and may change the chemical coding of the neurons and nerve fibers in the stomach and
duodenum. Moreover, they confirm the important roles of VIP within the ENS under physiological
conditions and after administration of T-2 toxin. The fluctuations of VIP-like immunoreactivity
observed during the study are probably connected with neuroprotective functions of this substance
and/or its participation in immune processes. Nevertheless, due to the multidirectional negative
activities of T-2 toxin and the various functions of VIP within the digestive tract, the exact elucidation
of mechanisms taking part in observed changes remains for further studies.
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5. Materials and Methods
The experiment was performed on 10 immature female pigs of the Large White Polish breed
(8 weeks old, 20 kg body weight (b.w.)). Both the division of animals into groups as well as doses of
T-2 toxin were performed as described previously by Makowska et al. [4]. In short, after a five-day
adaptation period, animals were randomly divided into two equal groups (five animals in each).
Animals of both groups received capsules per os, once a day for 42 days. In the control group (C
group), the administrated capsules were empty, while in the experimental group (T2 group), capsules
contained T-2 toxin (12 μg/kg b.w. per day).
All animals were fed with feed appropriate for age and species “WIGOR 3” (WIPASZ S.A,
Olsztyn, Poland) of known composition, which is available on the producer’s website. Furthermore, to
eliminate additional mycotoxins contamination of the feed, the presence of Aflatoxin B1, T-2 toxin,
ochratoxin A (OTA ), ZEN, alpha-zearalenol (α-ZEL), and deoxynivalenol (DON) were evaluated using
common separation techniques with immunoaffinity columns (Afla-TestR P Aflatoxin testing system,
G1010, VICAM, Watertown, MA, USA; T-2-TestTM HPLC Mycotoxin Testing System G1028, VICAM,
Watertown, MA, USA; Ochra-TestTM WB Mycotoxin Testing System, G1033, VICAM, Watertown, MA,
USA; Zearala-Test™ Zearalenone Testing System, G1012, VICAM, Watertown, MA, USA; DON-Test™
DON Testing System, VICAM, Watertown, MA, USA) and high performance liquid chromatography
(HPLC) (Hewlett Packard, type 1050 and 1100) with fluorescent and/or UV detection methods. All of
the above-mentioned mycotoxins were absent in the studied feed.
Throughout the duration of the investigation, gilts stayed under standard experimental conditions
and all procedures were conducted in agreement with the directions of the Local Ethical Committee
for Animal Experiments in Olsztyn (Poland) (decision from 28 November 2012, No. 73/2012/DTN).
After 42 days, animals from both groups were premedicated with Stressnil (Janssen, Beerse,
Belgium, 75 μL/kg b.w.) then, after 15 min, euthanized with high doses of sodium thiopental
(Thiopental, Sandoz, Kundl-Rakúsko, Austria). Directly after euthanasia, the fragments (with a length
of about 2 cm) of the stomach fundus (20 cm before the pylorus) and duodenum (5 cm after the pylorus)
were collected from all pigs and fixed for one hour in a solution of 4% buffered paraformaldehyde
(pH 7.4). Afterward, the taken fragments of the stomach and duodenum were put in phosphate buffer
(0.1 M, pH 7.4, at 4 ◦C). This procedure lasted for three days with a daily exchange of the buffer.
Later on, the tissues were inserted into 18% phosphate-buffered sucrose and storage for 3 weeks at
4 ◦C. Then, after freezing at −22 ◦C, the tissue fragments of both stomach and duodenum were cut
perpendicular to the lumen of the digestive tract into 14-μm-thick sections with freezing microtome
(Microm, HM 525, Walldorf, Germany).
Such prepared tissue fragments were subjected to a routine double-labelling immunofluorescence
method as previously described by Gonkowski 2013 [29].
In brief, the immunofluorescence labelling was carried out as follows. Frozen fragments of the
stomach and duodenum were dried (45 min, room temperature (rt)) and incubated with blocking
solution (10% goat serum, 0.1% bovine serum albumin (BSA), 0.01% NaN3, Triton X-100, and thimerosal
in PBS) for 1 h at rt. Next, fragments of the GI tract were incubated with a mixture of two antibodies:
mouse monoclonal antibody directed towards protein gene-product 9.5 (PGP 9.5, Biogenesis, UK,
catalogue No. 7863-2004, working dilution 1:2000, used here as a pan-neuronal marker) and rabbit
polyclonal anti-VIP antibody (Cappel, Aurora, OH, USA, catalogue No. 11428, working dilution
1:5000). For the incubation process, slices covered with antibodies mixture were left overnight at rt in
a humid chamber. The next day, for visualization of the primary antibodies connected with suitable
antigens, an incubation with the mixture of species-specific secondary antisera conjugated to selected
fluorochromes (Alexa fluor 488 donkey anti-mouse IgG and Alexa fluor 546 donkey anti-rabbit IgG,
both antibodies from Invitrogen, Carlsbad, CA, USA, working dilution 1:1000) has been performed.
This incubation process lasted 1 h at rt. After every stage of the immunofluorescence method, samples
were rinsed with PBS (3 × 15 min, pH 7.4).
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During the present investigation, routine specificity tests of antibodies were performed.
Pre-absorption of the antibodies with appropriate antigens and omission and replacement tests were
performed to eliminate non-specific labelling.
To evaluate the percentage of VIP-like immunoreactive perikaryons in relation to all enteric
neurons, no less than 500 cells labelled with PGP-9.5 (treated as 100%) in the particular type of enteric
plexus from each part of the digestive tract and each animal were examined for the presence of VIP.
Only nerve cells with clearly visible nuclei were considered in the present study. The received results
were pooled and presented as mean ± SEM. To obviate double counting of the same perikaryons, the
investigated sections of the GI tract were located no less than 150 μm apart.
To define the density of intraganglionic nerves positive for VIP, an arbitrary scale was used. In this
scale, (-) indicated the absence of nerve fibers, (+) single fibers, (++) rare fibers, (+++) a dense network
of fibers, and (++++) a very dense meshwork of VIP-LI fibers. The evaluation of VIP-LI nerve fibers
in the muscular and mucosal layers in the stomach and duodenum was carried out on the basis of
the counting of all VIP-positive nerves per area studied (0.1 mm2). Such evaluation was carried out
in four sections per animal (in five fields per section) and the obtained results were presented as a
mean ± SEM.
All indications during the present study were performed using an Olympus BX51 microscope
with epi-fluorescence and appropriate filter sets connected with an Olympus XM10 camera.
Statistical analysis was performed with Student’s t-test (Statistica 12, StatSoft, Inc., Cracow,
Poland). The differences were considered statistically significant at p <0.05.
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Abstract: In order to investigate the influence of aflatoxin B1 (AFB1) on intestinal bacterial flora,
24 Kunming mice (KM mice) were randomly placed into four groups, which were labeled as control,
low-dose, medium-dose, and high-dose groups. They were fed intragastrically with 0.4 mL of 0 mg/L,
2.5 mg/L, 4 mg/L, or 10 mg/L of AFB1 solutions, twice a day for 2 months. The hypervariable region
V3 + V4 on 16S rDNA of intestinal bacterial flora was sequenced by the use of a high-flux sequencing
system on a Miseq Illumina platform; then, the obtained sequences were analyzed. The results
showed that, when compared with the control group, both genera and phyla of intestinal bacteria
in the three treatment groups decreased. About one third of the total genera and one half of the
total phyla remained in the high-dose group. The dominant flora were Lactobacillus and Bacteroides
in all groups. There were significant differences in the relative abundance of intestinal bacterial
flora among groups. Most bacteria decreased as a whole from the control to the high-dose groups,
but several beneficial and pathogenic bacterial species increased significantly with increasing dose of
AFB1. Thus, the conclusion was that intragastric feeding with 2.5~10 mg/mL AFB1 for 2 months
could decrease the majority of intestinal bacterial flora and induce the proliferation of some intestinal
bacteria flora.
Keywords: mice; aflatoxin B1; intestinal bacterial flora; response
1. Introduction
Intestinal microflora play important roles in affecting the health of hosts through many aspects,
including nutrition decomposition and transformation, immunity intrusion, biological antagonism
and anti-aging [1,2]. Some degree of internal and external stimulation or interference of the body may
trigger a change in the numbers or the components of intestinal microflora, cause physiochemical
reactions, and lead to diseases [3,4]. Intestinal microflora were proved to be able to bind, transform,
degrade, and transfer mycotoxins [5–7]. Some intestinal bacterial strains isolated from intestines and
other environments were able to transform and degrade some mycotoxins in vitro [8–10]. Considering
the functional influences, scientists attempted to find methods which could balance or optimize
intestinal microflora communities to achieve normal or active levels in intestinal tracts and keep the
body healthy. For instance, one could feed hosts with curing drugs, nutritional elements, probiotics
or symbiotic foods, etc. To a large extent, the normality of intestinal microflora could symbolize the
health level of the body [11–13].
Aflatoxins are highly hazardous contaminants in common food and feed, mainly originating from
secondary metabolites in Aspergillus flavus and Aspergillus parasiticus [14,15]. Aflatoxin B1 (AFB1) is
the predominant type in aflatoxins and was demonstrated to be highly toxic, mutagenic, teratogenic,
and carcinogenic to many animals [16,17]. As a potent carcinogen, AFB1 reacts mainly with liver
DNA and serum albumin in a dose-dependent manner [18]. Toxicity from AFB1 can lead to a
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reduction in production, hepatotoxicity, nephrotoxicity, disturbance in the gastrointestinal tract and
reproduction, immune suppression, and disease susceptibility. Contamination of feed with aflatoxins,
especially AFB1, is one of the major concerns in poultry industry [19,20]. Because of its high toxicity,
strict regulations are placed on foods and feeds containing AFB1, on a world-wide basis [21].
Like most mycotoxins, AFB1 not only damages body organs directly but also disturbs the normal
activities of intestinal microflora in animals [22,23]. While previous studies have mainly focused on
its toxicology and binding and while some have also attempted to transform and remove AFB1 to
decrease the toxicity in some poultry species [24,25], the influential mechanism underlying the effect
of AFB1 on intestinal microflora has not been found so far. Based on this investigation, a continuous
feeding procedure was performed with KM mice in this study by using AFB1 solutions with various
concentrations, which was designed comprehensively according to the dose of chronic aflatoxicosis in
mice [26–29]. The research results might lay a foundation for discovering whether the disturbance of
intestinal microflora under the toxicity of AFB1 is related to liver cancer or for finding feasible ways to
reduce the toxicity through modulating intestinal bacterial flora.
2. Results
2.1. Operational Taxonomic Units (OTUs) and Rarefaction Curves
The OTUs of each group and the overlapped OTUs among groups were drawn as a Venn
picture [30]. The similarity of overlapped OTUs between or among groups was ≥97%. There were
167 OTUs contained in all groups, whereas the specific OTUs in the control, low, medium, and high
dose groups were 31, 16, 3, and 7, respectively. Although the high-dose group had slightly higher
OTUs than the medium-dose group, the OTUs in each group showed a decrease tendency as a whole
(Figure 1).
When the measured Operational Taxonomic Units (OTUs) [31] reached about 250, the rarefaction
curves for the control and low-dose groups plateaued. However, when the measured OTUs were about
200 and 150, the rarefaction curves plateaued for the high- and medium-dose groups, respectively
(Figure 2). All rarefaction curves of the four groups plateaued, which meant that the majority of
sequences were involved in the analysis process for each group. Both OTUs and sequence numbers
of the medium-dose group (less than 20,000 reads) were lower than those of the remaining groups
(about 20,000 reads) based on Figure 2. The changing trend of the rarefaction curves was consistent
with OTUs among groups.
Figure 1. Venn map of OTU distribution in each group and between and among groups (97% similarity
of OTUs). Different colors represent different samples. If, for instance, figure 100 was simultaneously
marked in two different circles, this meant that the two samples had the same sequences categorized in
the same OTUs, and the OTUs were 100.
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Figure 2. Rarefaction curves (97% similarity of OTUs). Horizontal ordinate: Sequences sampled
randomly; Vertical ordinate: Measured OTUs. Rarefaction curves could estimate the depth
of sequencing; the plateau indicates that the measured OTUs could reasonably represent the
sampled sequences.
2.2. Genera and Phyla Performances
The genus and phylum types and the relative abundances of intestinal bacteria were clustered
as a Heatmap [32], where darker colors indicate a higher abundance of the bacterial flora. According
to the Heatmap, the control and the low-dose groups had higher abundances and also more types of
genera and phyla than the medium- and high-dose groups (Figure 3). The high-dose group had the
fewest types of genera. Although there were more genera for both the control and low-dose groups,
the genera types differed greatly between the two groups. The two genera with high abundance in the
four groups were Lactobacillus and Bacteroides. The four genera with the second highest abundance
in the four groups were Candiatus, Desulfovibrio, Bacteroides and Acinetobacter (Figure 3A). Except for
the control group, which had an extra phylum Tenericutes, there were 4 phyla with high relative
abundances in each group. These 4 phyla were Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria.
There was no evident difference for each phylum among all the groups, and Firmicutes had the highest
abundance in each group (Figure 3B).
The genus and phylum types and relative abundances of intestinal bacteria were drawn as column
pictures [33]. These pictures contain similar information as in the Heatmap, showing that Lactobacillus
and Bacteroides had high abundances in the four groups, while the other 4 genera mentioned in Figure 3
were also present as the second highest. There were visually fewer genera in the high-dose group
compared with the rest of groups, and especially with respect to the control group. There was an
interesting phenomenon that the abundance of Lactobacillus decreased, but the abundance of Bacteroides
increased evidently in the medium-dose group, while the two genera increased, reaching a large
proportion in the high-dose group that was nearly the same as in the control group (Figure 4A).
With respect to the phyla, more than six phyla were present in the control and the low-dose groups,
whereas only 4 phyla were present in the medium- and high-dose groups (Figure 4B).
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(A)
(B)
Figure 3. Heatmap of genus and phylum types and relative abundance of intestinal bacteria flora.
(A) Heatmap of genus types; (B) Heatmap of phylum types. Different colors represent the relative
abundances of different intestinal bacteria; the darker color indicates higher abundance.
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(A) (B)
Figure 4. Column pictures of genus and phylum types and relative abundance of intestinal bacteria.
Others: Intestinal bacterial flora with relative abundance <1% were included as others. (A) Column
pictures of genera; (B) Column pictures of phyla. Different colors represent different intestinal bacteria;
the percentage on the vertical ordinate indicates the relative abundance of intestinal bacteria.
2.3. Phylogenetic Tree
The phylogenetic tree was built based on the Hierarchical clustering method [34]. The intestinal
bacteria of the control and the low-dose groups were clustered together (Figure 5), indicating that most
bacteria in the two groups had a relatively close genetic relationship. The intestinal bacteria of the
medium- and high-dose groups were clustered together, showing a close genetic relationship.
Figure 5. Phylogenetic clustering tree based on the Hierarchical clustering method. Branch size
represents the genetic distance between samples; different colors represent different samples.
2.4. Differences in Relative Abundance of Bacterial Flora
The significance of the difference in the relative abundance of bacterial flora between groups is
shown in Figure 6. Compared with the control, Lactobacillus increased significantly in the low-dose
and the high-dose groups but decreased significantly in the medium-dose group. Bacteroides showed
a significant decrease in the low-dose group and a slight decrease in the high-dose group, while no
evident change occurred in the medium-dose group. Bifidobacterium showed a significant increase in
the high-dose group. Candidatus, Turicibacter, Allobaculum, Clostridium, and Peptostreptococcaceae had
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a significant increase in the medium-dose group and then decreased dramatically in the high-dose
group. Escherichia and Lachnospiraceae increased significantly in the low-dose group and then decreased
dramatically in the medium-dose and the high-dose groups (Figure 6A). The majority of the intestinal
bacterial flora at the genus level decreased as a whole, and the results in Figure 6 confirm the results in
Figures 3 and 4. At the phylum level, Firmicutes showed a significant increase in all treatment groups,
Bacteroidetes showed a significant decrease in the low-dose group, while no evident change occurred
in the other two treatment groups, and Actinobacteria showed an increase in all treatment groups,
especially in the high-dose group. The remaining phyla showed a decreasing tendency from the
control to the high-dose groups (Figure 6B). The statistical data of the relative abundance of intestinal
microflora are shown in Table 1.
(A)
(B)
Figure 6. Difference in relative abundance of intestinal microflora between the control and the treatment
groups. (A) Difference in relative abundance of intestinal microflora at the genus level; (B) Difference
in relative abundance of intestinal microflora at the phylum level. ** means a significant difference
(p < 0.01). Data were analyzed using one-way ANOVA. Difference between the control and the
treatment groups was assessed by Duncan’s test.
Table 1. Relative abundance of intestinal microflora in mice treated with different doses of AFB1.
Taxon Control Low-Dose Medium-Dose High-Dose
Lactobacillus 34.45 ± 0.69 52.99 ± 1.91 ** 21.16 ± 2.01 ** 49.40 ± 2.20
Bacteroides 32.32 ± 1.86 16.27 ± 1.64 ** 33.36 ± 2.21 29.91 ± 1.80
Candidatus 2.52 ± 0.10 5.65 ± 0.13 ** 8.80 ± 0.14 ** 1.32 ± 0.05
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Table 1. Cont.
Taxon Control Low-Dose Medium-Dose High-Dose
Bifidobacterium 0.11 ± 0.04 1.71 ± 0.15 5.98 ± 0.42 ** 10.19 ± 0.75 **
Turicibacter 0.96 ± 0.06 0.05 ± 0.01 8.70 ± 0.33 ** 0.11 ± 0.03
Desulfovibrio 2.57 ± 0.11 2.97 ± 0.12 1.07 ± 0.05 2.89 ± 0.14
Bacteroides-unclassified 2.63 ± 0.10 0.57 ± 0.05 1.83 ± 0.06 1.98 ± 0.10 **
Acinetobacter 4.20 ± 0.01 1.56 ± 0.01 0.55 ± 0.01 ** 0.66 ± 0.01 **
Allobaculum 0.07 ± 0.00 0.08 ± 0.00 6.20 ± 0.20 ** 0.03 ± 0.00
Clostridiium 3.52 ± 0.08 0.01 ± 0.00 4.83 ± 0.05 ** 0.02 ± 0.00 **
Helicobacter 4.23 ± 0.15 0.66 ± 0.01 0.08 ± 0.00 0.01 ± 0.00 **
Enterorhabdus 1.15 ± 0.10 0.54 ± 0.02 0.43 ± 0.02 1.43 ± 0.04
Peptostreptococcaceae-unclassified 0.00 ± 0.00 0.00 ± 0.00 3.22 ± 0.50 ** 0.00 ± 0.00
Lachnospiraceae-unclassified 0.26 ± 0.01 2.52 ± 0.07 0.03 ± 0.00 0.04 ± 0.01
Escherichia 0.03 ± 0.01 2.62 ± 0.05 ** 1.25 ± 0.02 0.02 ± 0.00
Lachnospiraceae 0.03 ± 0.00 2.36 ± 0.12 ** 0.05 ± 0.01 0.04 ± 0.00
Lachnospiraceae-uncultured 0.30 ± 0.01 1.64 ± 0.02 0.14 ± 0.01 0.04 ± 0.00
Mycoplasma 2.03 ± 0.07 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
Bacillus 1.04 ± 0.07 0.48 ± 0.02 0.12 ± 0.01 0.17 ± 0.00
Staphylococcus 0.29 ± 0.00 1.38 ± 0.12 0.09 ± 0.00 0.03 ± 0.00
Rikenella 1.31 ± 0.05 0.18 ± 0.01 0.02 ± 0.00 0.05 ± 0.00 **
Others 05.90 ± 0.17 5.63 ± 0.15 1.32 ± 0.05 ** 1.6 ± 0.08 **
Each value is the mean ± standard deviation (n = 3). Data were analyzed using one-way ANOVA. Differences
between control and treatment groups were assessed by Duncan’s test. ** means values are significantly different
(p < 0.01).
3. Discussion
Although knowledge of microflora in animal intestinal tracts is very limited, the view about their
mediation and maintenance roles in host health is highly agreeable. Many important immune and
metabolic disorders, including diabetes, obesity, behavioral disorders, and chronic inflammation,
are known to be partially caused by the imbalance of interactions between host and intestinal
microflora [35–37]. It is crucial to keep intestinal microflora in balance for host health.
It is well accepted that the two dominant normal intestinal microflora in mammalians belong to
the phyla Firmicutes and Bacteroidetes, which are strict anaerobic bacteria [38]. Bacteroides, Lactobacillus,
Streptococcus, Clostridium, Enterococcus, Bifidobacterium, Candidatus, etc. are the main genera with
a larger quantity of microflora which inhabit the intestines [39–41]. However, major mycotoxins
including deoxynivalenol, zearalenone, ochratoxin A, fumonisin B1 and aflatoxin B1 are proven
to be able to disturb the stability of mammalian intestinal microflora [42]. Feeding with a certain
dose of deoxynivalenol for 4 weeks by oral gavage increased Bacteroides and Prevotella but decreased
Escherichia coli in rat intestines [43]. Zearalenone, given by oral gavage, reduced the total cultivable
aerobic bacteria in pig intestines [44]. Ochratoxin A enhanced the Lactobacilliaceae family, increased
the facultative anaerobes and decreased the microbial α-diversity in rat intestines [45]. Fumonisin B1
changed the similarity between microbial CE-SSCP profiles in pigs after a fumonisin-based feeding [46].
In our study, both genus and phylum showed a decreasing tendency from the control to the
high-dose group as a whole, which was consistent with the finding that there was a reduction in
microbial diversity in the colon from the healthy rats exposed chronically to AFB1 for 4 weeks [47].
There were about 8 genera with higher relative abundances in the high-dose group, which contained
the least genera among all the groups (Figure 3A). Compared with the control group, the high-dose
group had about one third of the total genera and nearly half of the total microflora (Figure 4A).
There were about 4 phyla in both the medium-dose and the high-dose groups (Figure 4B). Compared
with the control group, the high-dose group had about one half of the total phyla. The statistical
analysis showed the same decreasing tendency for most bacterial flora except for several special ones
(Table 1, Figure 6). However, a chronic exposure to AFB1 could not change the proportion of Firmicutes
and Bacteroidetes [47].
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The two dominant flora in mice were Lactobacillus and Bacteroides. However, their relative
abundances were different among the groups. This observation might be explained that AFB1 with
different doses disturbed the two dominant bacteria and led to different results. These two dominant
bacteria showed similar total proportions in the control, the low-dose, and the high-dose groups but
displayed the lowest proportion in the medium-dose group (Figure 4). Different abundance with a
similar total proportion under different AFB1 doses meant that these two types of bacteria finally
recovered to the normal proportion, even though they were fed with AFB1 at a high dose for 2 months.
They showed strong viabilities, indicating that the two bacteria were tolerant and adaptable to a
certain dose of AFB1. Wang et al. also found that different bacterial flora had different tolerances to
AFB1, three Clostridiales species had the largest increase while 2 Lactobacillales species had the largest
decrease with increasing AFB1 dose in their study [47]. Using a cultural method, Galarza-Seeber et al.
discovered that the facultative anaerobe (coliforms) population was 10-fold higher than the control in
cecum of broilers exposed to AFB1, whereas there was only a numerical non-significant rise observed
for other microbial populations [48].
There were five genera with high relative abundances in the medium-dose group but not in
other 3 groups, especially not in the high-dose group. They were Peptostreptococcaceae, Allobaculum,
Clostridium, Turicibacter, and Cadidatus (Figures 3A and 6A). Among these genera, Clostridium contains
several significant human pathogens, including the causative agent of botulism and an important
cause of diarrhea [49,50]. A high-fat diet can lead to the expansion of the cluster XI of genus
Clostridium, which could produce secondary bile acid, causing a phenotypic change in hepatic stellate
cells to secrete proinflammatory cytokines, and eventually resulting in hepatocellular carcinoma in
mice [51]. Turicibacter spp. has been strongly associated with immune function and bowel disease [52].
The proportion of Turicibacter was significantly more abundant in Inflammatory Colorectal Polyps
(ICRPs)-affected in miniature dachshunds [53]. The high abundances of these bacteria may have
resulted from the animals been maintained under unhealthy conditions. However, all these genera
were not found in the high-dose group. The mechanism needs to be further explored to understand
whether a high dose of AFB1 killed these genera or other factors led to the phenomenon.
Since there are only two research papers published that are relevant to the influence of AFB1 on
gut microflora [47,48], more studies are required.
4. Conclusions
In conclusion, the intestinal bacterial flora in mice could be strongly disturbed by intragastric
feeding with AFB1 solutions ranging from 2.5 mg/L to 10.0 mg/L for 2 months. Lactobacillus and
Bacteroides were the two dominant bacterial flora, which could be induced to the same level as the
control group under a high dose of AFB1 in this study. Nearly two thirds of the total genera and two
more phyla finally disappeared. There might be several tolerant, adaptable, and inducible bacterial
flora in mouse intestines under a certain dose of AFB1, but this possibility needs be investigated further.
5. Materials and Methods
5.1. Diet Information
With no antibiotics, hormones, and preservatives, the food ingredients were 27.0% corn starch,
19.0% wheat bran, 16% rice starch, 16.0% soybean dreg, 13.0% fish powder, 3.0% bone powder,
2.3% yeast powder, 0.5% salt, 0.1% compound vitamin and 0.1% trace elements; sterile water was
added to ensure a 10% water content. After being mixed evenly, the mixture was sterilized at 121 ◦C
for 20 min in a high pressure steam sterilizer.
5.2. AFB1 Solutions Preparation
The AFB1 stock solution was prepared by dissolving 0.01g AFBI powder (99.9% of purity, Solarbio
Company, Beijing, China) in 500 mL of 2% sterile aqueous ethanol. The solution was stirred with a
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magnet stirring bar at 150 rpm under 50 ◦C for 30 min and then diluted with sterile water to reach the
concentrations of 2.5 mg/L, 4 mg/L, and 10 mg/L.
5.3. Animal Trial
All animal experiments were approved by the Animal Care and Use Committee of Institute of
Bast Fiber Crops, Chinese Academy of Agricultural Sciences (Changsha, Hunan). A total of 24 KM
mice (SPF grade, Silaida Co., Ltd.. Hunan, China) with no specific pathogens were used in this study.
Their average weight was about 20 ± 2 g. Equal numbers of males and females were adaptively
fed in a quiet environment at 24 ◦C temperature and 65% humidity. The mice were then randomly
divided into 4 groups, which were labeled as the control, low-dose, medium-dose, and high-dose
groups. Each group was consisted of an equal number of males and females. The control group
was fed intragastrically with sterile water, while the low-dose, the medium-dose, and the high-dose
groups were fed intragastrically with 2.5 mg/L, 4 mg/L, and 10 mg/L of AFB1 solutions, respectively.
The feeding dosage was 0.4 mL per mouse each time and 2 times a day for 2 months. Other conventional
food was administered normally.
5.4. Sample Collection
The animals were killed by cervical dislocation and dissected aseptically on a laminar flow bench
after the feeding treatment was over. Small intestinal contents (from jejunum to rectum) were collected
from 2 randomly chosen mice (one male and one female) in each group, then stirred evenly with a
sterile glass rod under a sterile environment, and considered as one replicate. Three replicates were
used to analyze intestinal bacteria.
5.5. Intestinal Bacterial Flora Information
The total DNA was extracted from the obtained intestinal contents according to the instruction
of the FastDNA® Spin Kit for Feces (MP Company, CA, USA) and then tested by electrophoresis
on a 1% agarose gel. After being recycled and purified with AxyPrepDNA (Axygen Company,
CA, USA), the bands were amplified with primers 338F: ACTCCTACGGGAGGCAGCA and 806R:
GGACTACHVGGGTWTCTAAT, which were specifically designed for testing the hypervariable region
V3 + V4 zones of intestinal bacteria DNA. The PCR reaction mixture contained 4 μL of 5 × Fast Pfu
buffer, 2 μL of 2.5 mM dNTPs, 0.8 μL of 5 μM Forward Primer, 0.8 μL of 5 μM Reverse Primer, 0.4 μL
FastPfu Polymerase, 0.2 μL BSA, and 10 ng Template DNA. Dd H2O was added to reach the final
volume to 20 μL. The reaction conditions as follows: an initial denaturing cycle at 95 ◦C for 3 min,
with 28 cycles, denaturation at 95 ◦C for 30 s, annealing at 55 ◦C for 30 s, and extension at 72 ◦C for
45 s, with a final extension step at 72 ◦C for 10 min. Electrophoresis on 2% agarose gels was used to
test the PCR products, the gene library was built, and the sequences were analyzed by Frasergene
company (Wuhan, Hubei, China) with the Miseq Illumina System.
5.6. Statistical Analysis
SPSS software 22.0 (IBM Corp, Armonk, NY, USA) was used to analyze the significance of
differences in the relative abundances of intestinal bacterial flora between groups.
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Abstract: Deoxynivalenol (DON) and zearalenone (ZEN) can seriously affect animal health, with
potentially severe economic losses. Previous studies have demonstrated that gut microbiota plays a
significant role in detoxification. We analyzed the colon contents from three groups of pigs (fed either
a standard diet, or a diet with 8 mg/kg DON or ZEN). Bacterial 16S rRNA gene amplicons were
obtained from the colon contents, and sequenced using next-generation sequencing on the MiSeq
platform. Overall, 2,444,635 gene sequences were generated, with ≥2000 sequences examined.
Firmicutes and Bacteroidetes were the dominant phyla in all three groups. The sequences of
Lactobacillus, Megasphaera, and Faecalibacterium genera, and the unclassified Clostridiaceae family,
represented more than 1.2% of the total, with significantly different abundances among the groups.
Lactobacillus was especially more abundant in the DON (7.6%) and ZEN (2.7%) groups than in the
control (0.2%). A total of 48,346 operational taxonomic units (OTUs) were identified in the three
groups. Two OTUs, classified as Lactobacillus, were the most dominant in the DON and ZEN groups.
The abundances of the remaining OTUs were also significantly different among the groups. Thus,
the mycotoxin-contaminated feed significantly affected the colon microbiota, especially Lactobacillus,
which was the most abundant. Therefore, we speculate that Lactobacillus plays a major role in
detoxification of these mycotoxins.
Keywords: deoxynivalenol; zearalenone; pig; colon microbiota; Lactobacillus; detoxification
Key contribution: Collectively, our results indicate that Lactobacillus was the most abundant in the
DON and ZEN dietary groups and less abundant in the control, suggesting that members of this
genus may play a key role in the detoxification of dietary DON and ZEN in pigs.
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1. Introduction
Deoxynivalenol (DON) and zearalenone (ZEN) are Fusarium mycotoxins that cause significant
economic losses of crops globally, and frequently contaminate food and animal feed, such as maize,
wheat, barley, rice, rye, oats, sorghum, and triticale. DON and ZEN cause damage to the gastrointestinal
and immune systems in both humans and farm animals, resulting in vomiting, diarrhea, hemorrhage,
leukopenia, and shock [1–3]. Among animal species, pigs show a comparatively high sensitivity to
DON and ZEN, likely because of a high percentage of cereals in the porcine diet, posing a greater
risk of exposure to these two mycotoxins. Furthermore, the front portion of the pig small intestine
lacks microorganisms that are able to degrade mycotoxins before they are absorbed by the small
intestine [4,5].
DON has been known to cause toxic effects in both animals and humans. Following DON
exposure, the initial adverse effect in pigs is a reduced feed intake. DON adversely affects
the growth performance, immune response, and reproductive performance in growing pigs [6,7].
A DON-contaminated diet influences the gastrointestinal tract, causing epithelial wounds in the
stomach and intestine and, foremost, an intestinal inflammatory response in pigs [8,9]. According
to Pierron et al. [10], in vitro and in vivo studies confirmed that DON severely inhibited intestinal
nutrient absorption, changed the intestinal cell functions, and caused severe intestinal barrier damage.
ZEN and its metabolites clinically cause hyperestrogenism and reproductive disorders. ZEN
metabolites compete with endogenous estrogens for estrogen receptor binding sites, and ultimately
affect RNA and protein synthesis, leading to the deregulation of estrogenic activities [11]. Compared to
chickens and ruminants, pigs are more sensitive to ZEN exposure, even at low levels [12]. According
to Dänicke et al. [13], ZEN is regularly found in piglets under normal conditions, and these animals
are initially exposed to ZEN in the uterus through placental transfer from the exposed sow, or through
release of stored ZEN via suckling. ZEN also shows numerous genotoxic and cytotoxic effects in vitro
and ex vivo, and is potentially carcinogenic [14]. Further, ZEN is recognized to be immunotoxic;
nonetheless, its function in the inflammatory response is not yet completely understood [15].
The animal gastrointestinal tract is colonized by a rich variety of microorganisms, and quantitative
and qualitative permanence of these organisms is an important factor in the maintenance of animal
health [16]. The gut microbiota exerts obvious effects on basic host physiology and metabolism [17].
According to Richards et al. [16], the animal intestinal microbiota exhibits nutritional and protective
functions, stimulates the immunity, produces fermentation products, and prevents colonization by
pathogens. Bauer and his team [18] have demonstrated that the gut microbiota is influenced by various
factors, such as the animal health, individual characteristics of the animal, and the feed type and quality.
Microorganisms may also prevent harmful effects on animal health; in fact, it has been suggested
that intestinal microbiota may play a protective role against mycotoxins as potential risk factors for
inflammatory bowel disease [19]. As shown by Bauer and Williams [18], pathogenic microorganisms
produce toxic metabolites and fecal enzymes that may increase the levels of carcinogenic substances,
or convert procarcinogenic compounds into carcinogenic ones.
However, studies of the effects of the DON and ZEN mycotoxins on the pig gastrointestinal
microbiota are lacking; in particular, the effect of ZEN on the pig gut microbiota remains unclear.
Recently, Li et al. [20] have studied the intestinal microbial diversity in pigs fed a basal diet, naturally
DON-contaminated wheat, and a feed contaminated with Clostridium sp. WJ06. In another study, DON
and ZEN, separately and together, induced negative effects on the microbial diversity in the ascending
colon of pigs [21].
Recently, 16S rRNA gene (rrs) sequencing using the Illumina MiSeq platform was used to compare
the intestinal bacterial biota in DON-contaminated wheat-fed pigs and the rumen microbiota of
steers fed various diets, demonstrating that DON and different diets greatly affected the microbiota
of pigs and cattle, respectively [20,22]. However, direct effects of purified DON and ZEN on the
colon microbiota composition have not yet been reported in pigs. Therefore, the main aim of this
study was to comparatively investigate the abundance of unculturable microorganisms in control
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and mycotoxin-treated groups of pigs to gain insights into the community structure of the pig colon
microbiota. We hypothesized that the community structure of the colon microbiome of pigs would be
influenced by toxic effects of DON and ZEN.
2. Results
2.1. Sequencing and Bacterial Abundance
Quality control of clean rrs sequences, obtained from the colon contents of the control, DON,
and ZEN dietary groups, resulted in a total of 2,444,635 sequences, with read lengths averaging
500 nucleotides. Of these, 740,744 sequences represented control feces, while 884,437 and 819,454
represented DON and ZEN feces (Table 1). The numbers of rrs sequences from individual control
samples ranged from 158,817 to 192,996; those from DON-treated samples ranged from 166,967 to
196,160, while those from ZEN-treated samples ranged from 140,276 to 195,822.


















Control (n = 4) Subsampledreads 100,000 16,961
a 58,020 a 791 a 9.805 a 0.990 a
DON (n = 5) Subsampledreads 100,000 16,003
a 52,108 a,b 772 a 9.692 a 0.991 a
ZEN (n = 5) Subsampledreads 100,000 14,565
a 45,882 b 696 a 9.353 a 0.989 a
1 The number of operational taxonomic units (OTUs) was normalized by subsampling 100,000 sequences from each
colon contents. Means among the three groups were compared using analysis of variance, followed by Duncan’s
test. Values with different superscript letters in the same row are significantly different (p < 0.05).
Almost 99.8% of all rrs sequences from the colon contents of the three groups were classified
into known phyla. As shown in Figure 1 and Supplementary Table S1, the phyla Firmicutes and
Bacteroidetes were highly abundant, and were represented by 57.3% and 35.00% of all rrs sequences,
respectively. The next most abundant phylum was Proteobacteria, which was represented by 3.2%
of the total sequences; the remaining phyla were each represented by <2.00% of all rrs sequences.
The phyla Spirochaetes and Actinobacteria were represented by 1.7% and 1.0% of all rrs sequences,
respectively. Planctomycetes, Tenericutes, and candidate division TM7 were represented by less than
1.00% of all rrs sequences. The genus Prevotella comprised 23.7% of the 5,279,245 rrs sequences.
At the genus level, Prevotella was highly abundant, being represented by 18.8% of the 2,444,635 rrs
sequences. Other genera, represented by at least 0.5% of the total sequences, were Lactobacillus (3.8%),
Dialister (2.3%), Bacteroides (2.3%), Megasphaera (2.1%), Phascolarctobacterium (1.6%), Treponema (1.6%),
Ruminococcus (1.4%), Faecalibacterium (1.2%), CF231 (1.2%), Oscillospira (1.1%), Lachnospira (1.0%),
Bulleidia (0.9%), Coprococcus (0.8%), Parabacteroides (0.8%), Blautia (0.8%), Campylobacter (0.8%),
Shuttleworthia (0.7%), p-75-a5 (0.5%), Dorea (0.5%), Roseburia (0.5%), Acidaminococcus (0.5%), Clostridium
(0.5%), and Desulfovibrio (0.5%). Some taxa were not classified at the genus level but showed high
abundance at the phylum level, such as Firmicutes and Bacteroidetes. The orders Clostridiales (8.5%)
and Bacteroidales (2.8%) were dominant, and at the family level, Ruminococcaceae (14.4%) was highly
abundant, followed by S24-7 (5.7%), Lachnospiraceae (3.9%), Veillonellaceae (2.7%), Paraprevotellaceae
(2.5%), Clostridiaceae (1.3%), Christensenellaceae (0.5%), and Erysipelotrichaceae (0.5%).
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Figure 1. Microbial taxonomic profiles from the colon contents of the three dietary treatment groups
at the phylum (A) and genus (B) levels, classified by the representation of >1% of the total sequences.
Taxonomic compositions of the colon microbiota among the control, deoxynivalenol (DON), and
zearalenone (ZEN) groups were compared based on the relative abundance (taxon reads/total reads in
the colon contents).
A total of 192,724 operational taxonomic units (OTUs) were identified at a 0.03 dissimilarity cutoff
level for all samples. All reads were normalized and analyzed using the Shannon diversity index,
Chao1 richness estimator, and the Simpson index. OTUs of normalized samples did not vary (p > 0.05)
among the three dietary treatment groups. The data of the richness estimate showed significant
differences (p < 0.05) in the numbers of OTUs among the groups (Table 1).
2.2. Taxonomic Composition
Analysis of the taxonomic abundance in samples from the control, DON, and ZEN dietary
groups showed differences at the phylum and genus levels (Figure 1A,B and Supplementary Table
S1). The microbial data for all three dietary treatment groups were analyzed to determine the mean
comparative abundance (taxon reads/total reads in a sample). At the genus level, Lactobacillus
(p = 0.002), Megasphaera (p = 0.01), and Faecalibacterium (p = 0.045), as well as the order Clostridiales
(p = 0.05), showed significant differences in the abundance among the DON, ZEN, and control groups.
Analysis of the abundances at the taxonomic levels from the phylum to genus revealed differences
among the DON, ZEN, and control groups. These variations were most obvious for Firmicutes,
Bacteroidetes, Prevotella, Lactobacillus, the family Ruminococcaceae, and the order Clostridiales.
As shown in Figure 2A, the phyla Firmicutes and Bacteroidetes were highly abundant, while the
remaining phyla were represented by <5% of all sequences. Furthermore, no significant differences
were observed at the phylum level among the three dietary treatment groups. Prevotella was the
most abundant known genus, represented by 18.8% of all sequences. The abundance of Prevotella
was higher (p = 0.72) in the control group (21.7%) than in the DON (17.5%) and ZEN (17.7%) groups
(Figure 2B). The abundance of Lactobacillus, which was represented by 3.8% of the total sequences,
was significantly different (p = 0.002) among the groups. Interestingly, Lactobacillus was significantly
(p = 0.002) more abundant in the DON group (7.6%), compared to 2.7% and 0.2% in the ZEN and control
groups, respectively. The abundance of Megasphaera, which was represented by 2.1% of all sequences,
was significantly higher (p = 0.01) in the ZEN group (3.0%) than in the control group (1.7%), but no
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significant difference was observed between the DON (1.6%) and control groups. The abundance of
Faecalibacterium, which was represented by 1.2% of the total sequences, was also significantly different
(p = 0.045) among the three dietary treatment groups; compared with that in the control group (1.3%),
the abundance was lower (0.7%) in the DON group, and slightly higher (1.5%) in the ZEN group.
The abundance of the unclassified family Clostridiaceae was significantly different (p = 0.05) among
the three dietary treatment groups, being much lower in the DON group (0.6%) and moderately lower
in the ZEN group (1.2%) than that in the control group (2.1%).
Figure 2. Relative abundances of the colon microbiota between the control and deoxynivalenol (DON)
and zearalenone (ZEN) mycotoxin groups. (A) Variations in the relative abundance of the colon
microbiota at the phylum level. (B) Variations in the relative abundance of the colon microbiota at
the genus level. Different letters indicate significant differences (p < 0.05). Data were analyzed using
one-way analysis of variance, followed by Duncan’s test.
116
Toxins 2018, 10, 347
Approximately 60% of the Firmicutes sequences could not be classified at the genus level.
The following five unclassified groups were dominant: Ruminococcaceae (14.4%), Clostridiales (8.5%),
Lachnospiraceae (3.8%), Veillonellaceae (2.7%), and Clostridiaceae (1.3%). Similar results have been
reported for the feces of cattle fed different diets [23]; however, in the present study, none of the
unclassified groups showed significant differences (p > 0.05) among the three dietary treatments.
Approximately 32% of Bacteroidetes could not be classified at the genus level either, including S24-7,
Bacteroidales, and Paraprevotellaceae, nor did these taxa show any differences (p > 0.05) among the
dietary treatments.
2.3. Analysis of Diversity
The diversity of the pig colon microbiota was compared among the control and two
mycotoxin-treated groups. We analyzed the species-level OTUs at a cutoff of 0.03 from all the samples
to evaluate the diversity of the colon microbiota from the three dietary groups, and identified a total
of 48,346 OTUs from all the samples. Nine of the 48,346 OTUs were represented by ≥0.1% of all
sequences in at least one dietary group, but three of the nine OTUs could not be classified into known
genera (Table 2).
Table 2. Relative abundances of significantly different operational taxonomic units (OTUs), calculated
for the control, deoxynivalenol (DON), and zearalenone (ZEN) dietary groups.
OTU ID 1 Classification
Percentage of Total Sequences 2
Collective Data Control DON ZEN SEM p-Value
denovo28392 Lactobacillus 1.03 0.01 b 2.77 a 0.29 a,b 0.005 0.006
denovo31941 UnclassifiedRuminococcaceae 2.32 2.39
a,b 1.34 b 3.23 a 0.005 0.025
denovo47686 Prevotella 0.17 0.06 b 0.14 a,b 0.31 a 0.001 0.001
denovo63294 UnclassifiedClostridiales 0.21 0.32
a 0.10 b 0.21 a,b 0.001 0.005
denovo92866 Megasphaera 1.13 0.63 b 1.88 a 0.89 b 0.002 0.006
denovo218634 Lactobacillus 0.90 0.07 b 1.57 a 1.05 a,b 0.004 0.049
denovo231303 UnclassifiedClostridiaceae 0.39 0.77
a 0.04 b 0.34 a,b 0.002 0.019
denovo254063 Bulleidia 0.18 0.29 a 0.04 b 0.22 a,b 0.001 0.011
denovo274039 Faecalibacterium 0.39 0.45 a,b 0.21 b 0.52 a 0.001 0.001
1 A total of 192,724 de novo OTUs were numbered in consecutive order. 2 Values represent the means. Values with
different superscript letters in the same row are significantly different (p < 0.05).
OTU denovo31941, classified into Ruminococcaceae, was the most dominant among the nine
OTUs in the collective data, and its abundance was the highest (p = 0.025) in the ZEN group and the
lowest (p = 0.025) in the DON group (Table 2). The second most dominant OTU was that representing
the genus Megasphaera (denovo92866), and it showed the highest abundance (p = 0.006) in the DON
group and the lowest abundance (p = 0.006) in the control group. The next most abundant OTU was
that representing the genus Lactobacillus (denovo28392), which was the most abundant (p = 0.006) in
the DON group, moderately abundant (p = 0.006) in the ZEN group, and of the lowest abundance
(p = 0.006) in the control group. Moreover, another OTU, also belonging to Lactobacillus (denovo218634),
was highly, moderately, and lowly abundant (p = 0.049) in the DON, ZEN, and control groups,
respectively. The abundances of three additional OTUs, representing Clostridiaceae (denovo231303;
p = 0.019), Bulleidia (denovo254063; p = 0.011), and Clostridiales (denovo63294; p = 0.005), were
much lower in the DON and ZEN groups than in the control group. An OTU of the genus Prevotella
(denovo47686) was highly abundant in the ZEN group, moderately abundant in the DON group, and
of the lowest abundance in the control group (p = 0.001). One OTU, classified as Faecalibacterium, was
highly abundant in the ZEN group, and of relatively low abundance in the DON group compared
with that in the control group (p = 0.001).
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3. Discussion
Until now, few studies have been conducted to investigate the effects of the DON and
ZEN mycotoxins on the pig gastrointestinal microbiota; in particular, the effects of ZEN on the
gastrointestinal microbiota are largely unknown. Previous studies have examined the effects of
naturally mycotoxin-contaminated feeds on the gut microbiota, but no reports are available on the
microbial composition of the colonic contents of pigs fed commercially purified DON and ZEN [20,24].
Therefore, we analyzed the colon contents of pigs fed commercially purified DON and ZEN, to compare
microbial abundances in the control, DON, and ZEN dietary groups, for the first time.
The animal digestive tract is suitable for microbial mass reproduction. Usually, various bacterial
species are preferentially localized in different regions of the gastrointestinal tract, and not all
regions are heavily colonized. According to Jia et al. [25], microbial communities in the small
and large intestines play an important role in managing the host’s health, including the energy
intake from food, immune system function, generation of important metabolites, and the response
to gastrointestinal diseases. Swanson et al. [26] have reported the function of fecal and intestinal
microbiota in the metabolism of trichothecenes, which was studied by anaerobically incubating
microbial suspensions from the feces of swine, cattle, horses, dogs, chickens, and rats with
diacetoxyscirpenol (DAS). The microbiota from pigs, cattle, and rats fully transformed DAS, primarily
to de-epoxy monoacetoxyscirpenol and de-epoxy scirpentriol. This research clearly indicated that the
function of intestinal microbiota involves more than just binding DAS. A study by McCormick [27]
has reported anaerobic bacterial degradation of trichothecenes in animal systems. The toxic impact
of trichothecenes on animals was mitigated by intestinal or rumen bacteria that could detoxify the
compounds. Kabak and Dobson [28,29] have also discussed in their reviews the role of microorganisms
in detoxification.
In the present study, Firmicutes (57.3%) and Bacteroidetes (35.0%) were the most abundant
groups of bacteria in the colon contents from the DON, ZEN, and control groups at the phylum level,
but their levels were not significantly different between the control and treatment groups. By contrast,
abundances of Firmicutes and Bacteroidetes were significantly different in the ileum, cecum, and colon
of growing pigs fed naturally DON-contaminated wheat [20]. Feeding a diet with a 100 μg/kg body
weight dose of DON for 4 weeks by oral gavage increased the abundances of Bacteroides and Prevotella
in rat intestines [30]. In another study, compared with the control group, the DON-treated mouse
group showed significantly lower species abundances of Bacteroidetes and higher abundances of
Proteobacteria [31]. According to Scaldaferri et al. [32], the abundance of Bacteroidetes significantly
decreased as a result of intestinal ulceration or inflammation in humans. We speculated that these
inconsistencies were due to variations in the type and age of animals, dietary concentrations of DON
and ZEN, conditions of toxins (natural contamination or a purified powder), the duration of treatment,
weather conditions, and the diet composition.
At the genus level, Lactobacillus was significantly more abundant in the DON and ZEN groups,
particularly in the DON group, than in the control. Similar to our findings, Lactobacillus was the most
abundant in the ileum, cecum, and colon of growing pigs fed a diet naturally contaminated with
DON [20]. Some studies have already proven the many physiological effects of Lactobacillus on the
host, including microbial interference, antimicrobial effects, nutritional supplementation, a decrease
in the serum cholesterol, antitumor effects, a decrease in the necessary antibiotic treatments, and
immunomodulatory effects, among others [20,33,34]. Investigators have previously found that the
pig small intestine is commonly dominated by Lactobacillus, and generally, the bacterial density
increases quickly as the animal grows [35,36]. Lactobacillus is an important natural constituent of the
intestinal microbiota in healthy animals and humans; in fact, bacteria of this genus have been shown
in in vitro and in vivo studies to bind various mycotoxins [37,38]. Lactobacillus spp. are also able to
rapidly form a complex bacterial community, which protects the host from infections by pathogenic
bacteria [39]. Lactobacillus can successfully remove trichothecenes, such as DON, fusarenon, and
DAS from liquid media [40]. Lactobacillus species are potential probiotics, shown to participate in the
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removal of ZEN in an in vitro study [41]. El-Nezami and his team [42] have investigated the binding
affinity interactions of ZEN and its derivative α-zearalenol with two food-grade strains of Lactobacillus.
Lactobacillus spp. can produce lactic acid as a byproduct of carbohydrate fermentation, and have
been reported to extracellularly bind ZEN, DON, and aflatoxins [42–44]. Cell wall polysaccharides
and peptidoglycans are two key elements accountable for the binding of mutagens to Lactobacillus
cells [45]. Consequently, the high proportion of Lactobacillus, detected in the current study, might have
resulted from a competitive advantage related to the capability of Lactobacillus to metabolize DON and
ZEN. Many investigators have examined the interactions between bacteria and trichothecenes and
revealed that those can occur through metabolic degradation and the conversion of trichothecenes
into considerably less toxic forms [46–48]. The effects of DON on the intestinal microbial abundance
and diversity in mice have also been explored using an Illumina MiSeq high-throughput sequencing
method [31]. Robert et al. [49] have demonstrated that the mucus and microbiota are important
targets for dietary mycotoxins, especially DON. Using in vitro and ex vivo models, Pinton et al. [50]
demonstrated that the inhibitory effect of DON on mucus secretion by human and porcine goblet cells
relies on its ability to suppress the expression of the resistin-like molecule beta (RELM-beta). Generally,
the presence of the gastrointestinal mucus can lower the capacity of probiotics to bind mycotoxins
because the mucus may interfere with the adsorption of a mycotoxin to the bacterial cell wall of the
probiotic. However, in the current study, the regular administration of the probiotic Lactobacillus during
the dietary treatment period may have reduced the effect of the mucus. Consequently, it could be
hypothesized that, as the number of colony-forming units increased, the effect of the mucus on the
adsorption of DON and ZEN by the Lactobacillus cell wall was reduced. Previously, similar results
have been reported by Gratz et al. [51] who used the probiotic Lactobacillus in aflatoxin B1-fed rats.
In the present study, the abundances of Faecalibacterium and the family Clostridiaceae were
significantly lower in the DON and ZEN groups than in the control group. However, the relative
abundances of these two bacterial taxa differed between the DON and ZEN dietary groups.
This difference might have been caused by the use of DON and ZEN at different doses, which
led to different effects on these two dominant bacterial taxa. These results suggest that the growth
of these bacteria was inhibited by the highly toxic DON, and slightly inhibited by the low-toxic
ZEN. Similarly, the abundance of Clostridium significantly decreased in the ileum and colon of
DON-treated pigs, but increased in the colon of pigs fed DON-contaminated wheat in combination
with Clostridium sp. WJ06, which is used as a detoxicant [20]. According to a study by Rotter et al. [52],
before mycotoxin-contaminated food enters the small intestine of poultry and ruminants, DON comes
into contact with high concentrations of microbes, which can change DON to de-epoxy-deoxynivalenol
(DOM-1). These results suggest that DON may have induced intestinal lesions by destroying the
integrity of the intestinal barrier in pigs, consistent with the data from previous studies on DON-fed
pigs [20,53]. In the current study, bacteria of the genus Megasphaera were highly abundant in the ZEN
and DON treatment groups, with no significant difference between the dietary groups. This genus is
an important member of the gut microbiota, and exerts useful effects on the host [54]. Shetty et al. [55]
have reported that Megasphaera plays a key role in the complex gut environment and performs the
complete metabolic functions of the human gut microbiome. We assumed that because of the low
concentration of ZEN, Megasphaera may have developed resistance to the low-toxic condition and,
therefore, was abundant in the ZEN dietary group. Currently, there has been no published research on
the microbial effects in ZEN-fed pigs. The absorption rates of DON and ZEN show substantial variance
among animals; pigs show the highest absorption rate (82%), followed by chickens (19%), sheep (9.9%),
and cows (1%) [56,57]. Frey et al. [58] have demonstrated that differences in absorption are mostly
associated with the distribution of microorganisms before or after the small intestine. In particular,
in monogastric animals and humans, bacteria are absent in the front portion of the small intestine;
thus, compared to ruminants and poultry, pigs and humans are highly sensitive to DON [59,60].
Waché et al. [2] have revealed that DON-contaminated feed could increase the abundance of anaerobic
bacteria in pigs, while decreasing the number of anaerobic sulfite-reducing bacteria. Based on the
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above observations, we speculated that the colon microbial structure and composition were mainly
affected by the DON and ZEN doses, animal type, age, and health, as well as by environmental
conditions and the duration of treatment.
To date, no OTU information has been available for intestinal or fecal samples from DON-
or ZEN-treated pigs. In the present study, nine OTUs were identified whose abundances were
significantly different among the three dietary treatment groups. Among these OTUs, two represented
Lactobacillus and one each represented Prevotella, Megasphaera, Bulleidia, Faecalibacterium, unclassified
Ruminococcaceae, unclassified Clostridiales, and unclassified Clostridiaceae. Similarly, except for
Megasphaera and Bulleidia, the remaining seven OTU species were found in the colon contents of cattle
fed different diets [23]. Species related to these nine main OTUs may have considerably contributed
to the colon bacterial ecosystem, irrespective of the dietary treatment group. In particular, two
OTUs representing Lactobacillus and Megasphaera were highly abundant in the DON group, and three
OTUs, including Prevotella, Faecalibacterium, and Ruminococcaceae, were dominant in the ZEN group.
Species associated with these OTUs may have played a major role in the metabolism of DON and
ZEN. In particular, the Lactobacillus species corresponding to the two OTUs were shown to be highly
abundant in the DON and ZEN groups, compared with their abundances in the control, and might
have bound the DON and ZEN mycotoxins and detoxified them, protecting the pig immune system.
For further clarification, isolation and characterization of Lactobacillus species will need to be performed
to reveal their function in the pig gastrointestinal microbial community.
In summary, our results showed that the abundances of microbiota components were significantly
different in the pig colon contents from the control, DON, and ZEN groups; in particular, the DON
group showed the highest abundance of Lactobacillus among the treatment groups, possibly indicating
a major role of Lactobacillus in detoxification. Based on the El-Nezami et al. [42] data, we believe
that our results are due to the physical phenomenon of the binding of the DON and ZEN toxins to
Lactobacillus via weak non-covalent bond interactions, such as those related to hydrophobic pockets
on the bacterial surface. Consistent with this phenomenon, the Lactobacillus abundance was higher
in the DON- and ZEN-treated groups than in the control group. There may be numerous tolerant,
adaptable, and inducible members of the microbiota in the pig gastrointestinal tract following exposure
to particular doses of DON and ZEN, but this possibility needs to be examined further. Additional
studies are needed to investigate the chemical nature of mycotoxin-binding sites of Lactobacillus,
and the types of chemical interactions involved in the binding mechanism. These future studies may
also clarify the potential relationships between DON and ZEN, and the gut microbiota, facilitating the
development of effective therapeutic methods to control DON- and ZEN-induced diseases.
4. Materials and Methods
4.1. Ethics Statement
The protocols for the animal experimental procedures were reviewed and approved by the
Institutional Animal Care and Use Committee of the National Institute of Animal Science, South Korea
(No. 2015-147, 29 May 2015).
4.2. Animals
The current study was carried out with 14 castrated 8-week-old male piglets (Landrace ×
Yorkshire = Large White Landrace; ~19 kg) obtained from a commercial pig farm. All piglets, which
originated from different litters, were randomly selected. Each piglet was housed in a separate pen
(2.1 m × 1.4 m) with free access to water from drinking nipples, and they were fed individually.
The piglets were allowed to acclimate to their new housing conditions for 1 week at 25 ± 1 ◦C,
and were subsequently allocated to three dietary groups, the control (n = 4), DON (n = 5), and ZEN
(n = 5) groups, with approximately equal body weights. Piglets in the control group were supplied a
standard diet (Table 3) to meet their nutritional requirements [61], and those in the treatment groups
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were supplied the control diet with added DON or ZEN. Commercially available purified DON and
ZEN powders (Biomin Singapore Pte. Ltd., Singapore) were properly mixed into the feed at 8 mg/kg
and 0.8 mg/kg, respectively. During the entire 4-week experimental period, the control and DON- and
ZEN-contaminated diets, as well as water, were supplied to the pigs ad libitum. Ethical guidelines for
animal protection rights were observed.




Soybean meal (46% crude protein) 14.00
Extruded soybean meal 12.00








Choline chloride (50%) 0.20
Sodium chloride 0.32
Vitamin–trace mineral premix 1 0.50
Calculated nutrients (%)









1 The following quantities (per kilogram of complete diet) were provided: vitamin A, 11,000 IU; vitamin
D3, 1500 IU; vitamin E, 44.1 IU; vitamin K3, 4.0 mg; vitamin B1, 1.4 mg; vitamin B2, 5.22 mg; vitamin B5,
20.0 mg; vitamin B12, 0.01 mg; niacin, 26.0 mg; pantothenic acid, 14 mg; folic acid, 0.8 mg; biotin, 44 mg;
Fe, 100.0 mg (as iron sulfate); Cu, 16.50 mg (as copper sulfate); Zn, 90.0 mg (as zinc sulfate); Mn, 35.0 mg
(as manganese sulfate); I, 0.30 mg (as calcium iodate).
4.3. Mycotoxin Analysis
The DON and ZEN quantities in the DON- and ZEN-supplemented corn feed were examined by
ultra-performance liquid chromatography (UPLC). A homogenized DON-contaminated grain sample
(1 g) was extracted with 20 mL of distilled water by shaking for 30 min. A ZEN-contaminated corn
sample (1 g) was mixed with 0.5 g of NaCl and 20 mL of acetonitrile (ACN), and then shaken for 1 h.
After filtering the extracts through Whatman No. 1 paper, 5 mL of the DON-contaminated filtrate
was diluted in 20 mL of phosphate-buffered saline (PBS), and 5 mL of the ZEN-mixed grain filtrate
was diluted in 20 mL of a 1% Tween 20 solution. The extracted DON- and ZEN-mixed samples were
loaded separately onto immunoaffinity chromatography columns. The DON column was allowed to
dry, then washed with 10 mL each of PBS and distilled water, and eluted with 0.5 mL of methanol
(MeOH) and 1.5 mL of ACN. In the case of ZEN, the column was washed with 10 mL of distilled water
and eluted with 1.5 mL of MeOH. The eluates were dried under N2 gas, and 10 μL of each sample was
injected into a UPLC instrument (Acquity UPLC® H Class; Waters, Milford, MA, USA). The mobile
phase used to separate DON and ZEN consisted of water/ACN/MeOH (90:5:5 for DON and 43:35:22
for ZEN). The samples were separated isocratically at a flow rate of 0.3 mL/min. Photodiode array and
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fluorescence detectors were used to detect DON and ZEN, respectively. Waters Acquity UPLC® BEH
C18 columns (2.1 × 100 mm, 1.7 μm particle size) were used for both DON and ZEN toxin analyses.
The complete details of the mass spectrometry system running method, the excitation and emission
wavelengths, and the limits of detection and quantification, were as described by Reddy et al. [7].
We found that the amounts of DON and ZEN in the mixed corn feed were 7.38 and 0.67 mg/kg,
respectively; these values were close to the original concentrations. No DON and ZEN contamination
was found in the control feed.
4.4. Sampling and Processing
A total of 14 male piglets were used to examine the colon microbiota composition in the standard
diet and DON and ZEN mycotoxin-contaminated feed groups. After 4 weeks of treatment, all pigs
were euthanized by an overdose of the anesthetic pentobarbital. After cardiac arrest, the colon contents
of all pigs were aseptically collected directly into sample containers, rapidly frozen in liquid nitrogen,
and then stored at −80 ◦C for further analysis.
4.5. DNA Extraction and 16S rRNA Gene Sequencing
Total community DNA was extracted from the 14 samples of colon contents using the repeated
bead beating plus column method [62], and stored at −20 ◦C before sequencing. From each DNA
sample, 14 amplicon libraries were generated using the 341F (5′-CCTACGGGNGGCWGCAG-3′) and
805R (5′-GACTACHVGGGTATCTAATCC-3′) primers, which produce approximately 450 bp products.
The resultant 14 amplicon libraries were sequenced using a 2 × 300 bp paired-end protocol with the
MiSeq platform (Illumina, San Diego, CA, USA) at the Macrogen sequencing facility (Macrogen, Inc.,
Seoul, Korea). Paired reads were assembled using the FLASH program [63]. The assembled sequences
were demultiplexed using the default parameters and quality filtered using a Q20 minimum value
with the QIIME software package 1.9.1 [64]. Taxa were identified using the Greengenes reference
database [65], while OTUs were determined at 97% sequence similarity using the uclust program [66].
After 100,000 sequences were subsampled from each colon sample to normalize the number of OTUs,
alpha diversity indices (number of OTUs, Chao1, PD_whole_tree distance, and Shannon diversity
index) were determined.
4.6. Statistical Analysis
Taxa (or OTUs) representing, on average, ≥0.2% of the total sequences were regarded as major
taxa (or OTUs), and used for statistical analysis. The mean proportion of each taxon or OTU in the
total sequences was compared among the three diet groups using analysis of variance, followed by
Duncan’s test, in the XLSTAT statistical software version 18.07 (Addinsoft, New York, NY, USA).
A significant difference was considered at p < 0.05.
4.7. Nucleotide Sequence Accession Number
The 16S rRNA gene sequence data used in the current study are available from the EMBL
European Nucleotide Archive under accession number PRJEB27663.
Supplementary Materials: The following is available online at http://www.mdpi.com/2072-6651/10/9/347/s1,
Table S1: Relative abundance of taxa in the control and DON and ZEN mycotoxin dietary treatment groups.
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Abstract: Pigs are highly affected by dietary mycotoxin contamination and particularly by fumonisin.
The effects of fumonisin on pig intestinal health are well documented, but little is known regarding
its impact on gut microbiota. We investigate the effects of the fumonisin (FB1, 12 mg/kg feed) on
the fecal microbiota of piglets (n = 6) after 0, 8, 15, 22, and 29 days of exposure. A control group
of six piglets received a diet free of FB1. Bacterial community diversity, structure and taxonomic
composition were carried out by V3–V4 16S rRNA gene sequencing. Exposure to FB1 decreases
the diversity index, and shifts and constrains the structure and the composition of the bacterial
community. This takes place as early as after 15 days of exposure and is at a maximum after 22 days of
exposure. Compared to control, FB1 alters the ecological succession of fecal microbiota species toward
higher levels of Lactobacillus and lower levels of the Lachnospiraceae and Veillonellaceae families,
and particularly OTUs (Operational Taxonomic Units) of the genera Mitsuokella, Faecalibacterium and
Roseburia. In conclusion, FB1 shifts and constrains age-related evolution of microbiota. The direct or
indirect contribution of FB1 microbiota alteration in the global host response to FB1 toxicity remains
to be investigated.
Keywords: fumonisin; microbiota; pigs; MiSeq 16S rDNA sequencing
Key contribution: Dietary fumonisin (FB1) exposure in pigs hinders age-related dynamic of fecal
microbiota. FB1 shifts and constrains the structure, the diversity and the taxonomic composition of
the fecal bacterial community as early as after 15 days of exposure.
1. Introduction
Food safety is a major issue throughout the world. Therefore, much attention needs to be
paid to the possible contamination of food and feed by fungi and the potential risk of mycotoxin
production. Mycotoxins are fungal secondary metabolites, potentially hazardous to human and animal
health following consumption of contaminated food or feed. These metabolites are very resistant to
technological treatments and difficult to remove. Therefore, they can be present in human food and
animal feed [1]. Feed materials are often contaminated with fungi and their metabolites, which pose
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a potential threat to human and animal health [2,3]. Contamination of cereals with mycotoxin is a
worldwide problem leading to important economic losses for the agricultural industry. Cereals and
soybean are the main components of pig diets and due to the high ingestion of cereals and their
sensitivity, pigs are highly impacted by the presence of mycotoxins [4]. The toxicological syndromes
caused by ingestion of mycotoxins range from sudden death to reproductive disorders and growth
impairment. Consumption of fungal toxins may also decrease resistance to infectious diseases. Pigs are
considered to be the farm animals that are the most affected by mycotoxins in general and horses
and pigs are the animals that are the most sensitive to fumonisins in particular [5]. Mycotoxin
contamination levels in pig feedstuffs are usually not high enough to cause a clinical disease but may
result in economic loss through changes in growth, production and immunosuppression [4].
From an intestinal health perspective, the most notorious mycotoxins are fumonisins, especially
fumonisin B1 (FB1), and trichothecenes, deoxynivalenol and zearalenone [6]. FB1 is the diester
of propane-1,2,3-tricarboxylic acid and 2-amino-12,16-dimethyl-3,5,10,14,15-pentahydro xyeicosane.
Pierron et al. [5], reported the toxicity of FB1 and the effects of this mycotoxin on pig intestine, because
the intestinal tract is the first barrier and, consequently, the first target of mycotoxins ingested with
food. The toxicity of FB1 differs according to several parameters such as the dose, the duration of
exposure, the age and the sex of the animal, in additional to nutritional factors. Performances and
health are most impacted in young animals and males [7]. The main effects of FB1 are a reduction of
feed intake and animal growth, an alteration of the absorptive functionality of the intestine, histological
damages on intestinal tissue, an impairment of intestinal barrier functions, a systemic decrease and/or
local immune response, as well as lung and liver damages [8].
Gut microbiota plays a key role in physiological, developmental, nutritional and immunological
processes of the host, and impacts host health and performance [9]. An appropriate composition
of the intestinal microbiota of animals, as well as the quantitative and qualitative stability of that
ecosystem, is an essential factor to guarantee animal health. Microbiota provides nutritional and
protective functions to animals, by stimulating of host immunity, producing fermentation outputs,
and preventing colonization by pathogens [10].
The effect of mycotoxins on the intestinal microbiota is gaining interest [11–13]. Nevertheless,
the effect of mycotoxins, especially FB1 on the intestinal microbiota is poorly documented [14,15].
The aim of this work was to study the impact of adding FB1 (12 mg/kg) in the diet of piglets on
their fecal microbiota during a four-week period of time using high throughput Illumina MiSeq 16S
V3–V4 amplicon sequencing. These results complete the data previously published on fumonisin diet
contamination host response [8].
2. Results
2.1. Diversity and Structure Dynamics of the Fecal Bacterial Community
The effect of fumonisin (FB1) on the gut microbiota of piglets was first assessed on the fecal
bacterial community diversity using the Shannon and the InvSimpson indexes (Table 1 and Figure 1).
After 4 weeks of exposure to a control diet or a fumonisin-contaminated diet (12 mg/kg) the Shannon
and the InvSimpson diversity indexes tended (p = 0.057) or was (p = 0.003) lower, respectively, in feces
from fumonisin-exposed animals compared to those in the Control group. However, for both indexes,
significant interaction between age and treatment reveals a differential evolution with age according
to groups. In contrast to the Control group where bacterial community diversity is stable over the
4 weeks, the InvSimpson and Shannon indexes decreases after 15 and 22 days of exposure respectively
(Figure 1) in fumonisin-exposed piglets.
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Table 1. Effect of FB1 exposure in the diet on piglet fecal microbiota Shannon and InvSimpson
diversity indexes.
Diversity Index Treatment p Value
Control FB1 SEM Group Day Group × Day
Shannon 4.00 3.67 0.062 0.057 0.067 0.010
InvSimpson 21.9 11.0 1.28 0.003 0.052 0.037
Figure 1. Time effect of dietary FB1 exposure on piglet fecal microbiota Shannon and InvSimpson
diversity indexes. In blue, control animals (n = 6) and in red, FB1-exposed piglets. (Mean ± SD).
LS-means with a common superscript did not differ at p = 0.05 level according to linear mixed model
analysis of variance.
The principal coordinate analysis (PCoA) based on the Bray–Curtis distance (Figure 2a) segregates
samples into two groups corresponding to the treatment. Percentages of variance explained by the
principal coordinates 1, 2 and 3 are 32.7%, 12.7% and 8.3% respectively. Pairwise ADONIS tests
performed on the Bray-Curtis distance matrix (Table S1) indicate that the bacterial community evolves
slightly throughout the days of the experiment in both groups of piglets (R2-ADONIS < 0.27, p < 0.05).
When the PCoA axis 1 is plotted against age (Figure 2b) a complete separation of FB1 and Control
group can be observed after 22 days of treatment (ADONIS-R2 = 0.51, p < 0.01, Table S1). To compare
the stability of the bacterial community, the distance within two consecutive ages for both groups is
calculated (Figure 2c). Except for the 0–8 day interval, the distance between two consecutive ages is
lower in the FB1 group than in Control one, suggesting that ingestion of fumonisin contaminated diet
hinders the normal rate of age-related evolution of microbiota. Moreover, in the FB1 group, the lowest
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variation between two consecutive ages is observed for the intervals 15–22 and 22–29 days (p < 0.05)
suggesting a constraint effect of FB1 on microbiota evolution. Finally, we calculated within-group
dispersion, which is the variation of the distance between piglets within an age group (Figure 2d).
Individual variations within the group remain unchanged with age in the Control group whereas
they sharply decrease in the FB1 group. After 15 days of treatment, the FB1 group exhibits lower
within-group distance compared to the Control group. The highest similarity between individuals in
the FB1 group is observed at 22 days of age. This result demonstrates that fumonisin exposure exerts a
constraint on piglet fecal microbiota evolution that strongly decreases inter-individual variability.
Figure 2. (a) Principal coordinate analysis (PCoA) ordination 3D-plot based on the Bray-Curtis distance
matrix. Circles and squares are for samples from FB1–exposed and Control animals, respectively.
(b) PCoA axis1 coordinates plotted against days of treatment. (c) Stability between two consecutive
age groups calculated from the Bray-Curtis distance for pairwise comparison. (d) Age evolution of the
individual dispersion within each group using the Bray-Curtis distance. Red triangles: FB1-exposed
animals; blue circles: Control animals. * = (p < 0.05), † = (p < 0.1) and ns = (p > 0.1) between groups.
a,b = mean with unlike superscripts in a group are significantly different from each other (p < 0.05)
(n = 6 pigs per group, mean ± SEM).
2.2. Taxonomic Assignation
Concerning the taxonomic composition of the bacterial community, the Firmicutes phylum is the
most abundant one in the microbiota of animals from both groups, with 82% of relative abundance
(Figure 3 and Table S2). Bacteroidetes is the second most abundant phylum (14%) followed by
Proteobacteria (1.8%) Spirochaetes (1.5%) and Actinobacteria (0.7%). Tenericutes and Fibrobacteres
are detected at abundances lower than 0.05% below a quantitative statistical analysis threshold.
Actinobacteria and Proteobacteria tend to be observed in higher proportion in Control fecal microbiota
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than in that of FB1 (1.12% vs. 0.25% and 2.29% vs. 1.18%, respectively, p-adjusted < 0.10). Spirochaetes
tends to be higher in FB1 than in Control (2.03% vs. 1.01%, p-adjusted < 0.10).
Figure 3. Relative abundance of main phyla in fecal microbiota from Control vs. FB1-exposed pigs.
Between treatments: † = p-adjusted < 0.10.
The most abundant families in the samples are Lactobacillaceae, Lachnospiraceae, Ruminococcaceae
and Prevotellaceae with more than 10%, Clostridiaceae (4.38%), Peptostreptococcaceae (4.37%) and
Veillonellaceae (4.21%) (Figure 4 and Table S3). Compared to Control piglets, fumonisin exposure increases
the relative abundance of Lactobacillaceae (p-adjusted = 0.031), Peptococcaceae (p-adjusted = 0.001),
the Bacteroidales RF16 group (p-adjusted < 0.001) and the Rickettsiales Incertae Sedis (p-adjusted < 0.001)
families, and decrases Lachnopiraceae (p-adjusted = 0.006), Veillonaceae (p-adjusted = 0.005) Eubacteriaceae
(p-adjusted = 0.009), Succinivibrionaceae (p-adjusted = 0.006) and Coriobacteriaceae (p-adjusted = 0.031)
in fecal microbiota. Among the most abundant families, there is an effect of day on the proportion of
Lachnospiraceae that decreases with time, respectively, whereas Veillonaceae increases until day 15 and
return to initial values afterward in control group (Figure S1, p-adjusted < 0.05).
The 10 most abundant genera (Figure 5) are Lactobacillus with (30.3%), Prevotella (7.5%),
Blautia (5.3%), Terrisporobacter (3.5%), Mitsuokella (3.3%), Faecalibacterium (3.0%), Roseburia (2.7%),
the Prevotellaceae NK3B31 group (2.4%), Sarcina (2.4%) and Ruminococcaceae UCG-008 (2.3%),
respectively. Out of the 20 genera whose proportions are affected by FB1 exposure (p-adjusted < 0.05;
Table S4), Lactobacillus and Ruminococcaceae UCG-005 are increased while Mitsuokella, Succinivibrio,
Roseburia and Ruminococcus proportions are depressed (p < 0.05).
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Figure 4. Relative abundance of main families in fecal microbiota from Control vs. FB1-exposed pigs.
Between treatments: † = p adjusted < 0.10 and * = p adjusted < 0.05.
Figure 5. Relative abundance of main genera in fecal microbiota from Control vs. FB1-exposed pigs.
Between treatments: † = p adjusted < 0.10 and * = p adjusted < 0.05.
2.3. OTU Differential Abundance
To further investigate the FB1-related shift effect on the fecal bacterial community structure,
we explored the differential abundance at the OTU (Operational Taxonomic Unit) level. Of the
765 OTUs detected, in the three last days of sampling, 220, 249 and 197 OTUs were differentially
abundant between feces from Control and fumonisin-exposed animals (p < 0.05, Figure 6). A total
of 70 differential abundant OTUs are common to the three days of sampling. Among the 30 most
abundant OTUs (Figure 7), consecutive to FB1 exposure, the relative abundance of three of them
(OTUs 6, 11 and 17 assigned to the genera Lactobacillus, Prevotella and Treponema, respectively) was
increased, whereas the relative abundance of six others was decreased (OTUs 5, 9 12, 13, 16 and 19,
assigned to the genera Faecalibacterium, Roseburia, Prevotella, Mitsuokella and Dialister, respectively).
On day 22, the OTU 1 assigned to the Lactobacillus genus, reached more than 40% of abundance
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in FB1 samples (Figure 7b). Thus, the FB1-related shift effect on the fecal bacterial community is
mainly explained by the significant abundance changes in the major OTUs that make up fecal bacterial
community and that leads to the installation of some dominant OTUs which at least include the
two main OTUs assigned to the Lactobacillus genera.
Figure 6. Venn diagram of the number of Operational Taxonomic Units (OTUs) with (a) differential
lower abundance and (b) higher abundance after 15, 22 and 29 days of FB1exposure compared
to control.
 
Figure 7. Differential abundance of the 30 most abundant OTUs, (a) for day 15, (b) for day 22 and
(c) for day 29. Left panel: log2Fold change abundance, bar color of each OTU are given according
to their family assignation, right panel: stacked barplot of the differential abundant OTUs. Each box
represent one OTU abundance and color of each OTU are given according to their genus assignation.
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In total, the taxonomic composition analysis of the fecal bacterial community reveals that FB1
alters the ecological succession of fecal microbiota species toward higher levels of Lactobacillus and
lower levels of the Lachnospiraceae and Veillonellaceae families and, particularly OTUs of genera
Roseburia, Mitsuokella and Faecalibacterium.
3. Discussion
In spite of the economic and health impact of fumonisin diet contamination on livestock and
particularly in pigs, to our knowledge, this study is the first to investigate the dynamic effect of FB1
exposure in feed on fecal microbiota in young weaned pigs. In a companion paper, the detrimental
effect of FB1 on the same animals was demonstrated, decreasing the growth rate, increasing the ratio
Sa/So (which is a marker of the exposure to this mycotoxin in the liver) and decreasing villi length [8].
In the present study, we clearly demonstrate that FB1 exposure in feed impairs age-related evolution
of gut microbiota.
In agreement with the literature [16–20], Firmicutes and Bacteroidetes phyla represent more than
90% of the bacterial community OTUs. The bacterial community is dominated by the Lactobacillaceae,
Lachnospiraceae, Ruminococcaceae and Prevotellaceae families and Lactobacillus, Prevotella and
Blautia genera. Over the time of the experiment (from 35 to 57 days of age), Lachnospiraceae
decreased corresponding mainly to a decrease in Blautia and Roseburia genera. Over the 4 weeks
of the experiment, the diversity indexes were stable in the Control group and the structure of
the community evolved slightly with high inter-individual variations. Indeed, major changes in
diversity occur at birth when the colonization process takes place in neonates in contact with a
microbial metacommunity provided by the mother during and after the passage through the birth
canal and the surrounding environment [21]. The gut microbiota then undergoes a progressive
species age-related succession [17,19,22] driven by both extrinsic factors and intrinsic factors [23].
The extrinsic factors concern surrounding conditions such as housing [24,25], congener proximity [26]
and nutritional factors that act throughout the development of the animal. The most impacting one
is related to the feed transition from milk to solid feed [19]. The intrinsic factors are those related
to the host physiological state, the qualitative and quantitative availability of endogenous nutrients,
the motility of the intestinal tract, bile salts and other endogenous secretions, immune tolerance and
host-microbiota interactions through PRR and PAMPs (Pattern-Recognition Receptors and Pathogen
Associated Molecular Pattern) [27]. All these extrinsic and intrinsic factors shape each individual gut
microbial pattern, explaining the inter and intra-individual variability of gut microbiota.
Studies on mycotoxin actions on gut microbiota are rare [11,13] and they mainly concern the
effect of deoxynivalenol [12,28–30] and aflatoxins [31,32]. After two weeks of dietary exposure
to FB1, the diversity of the fecal bacterial community decreases. Concomitantly, a shift in the
structure together with a decrease in the rate of the evolution of the bacterial community is observed.
In agreement, exposure to FB1 for 29 days in 11 week-old specific pathogen-free pigs modifies the
CE-SCCP (Capillary Electrophoresis Single Strand Conformation Polymorphism) bacterial community
profiles [14]. Additionally, exposure to FB1 constrains the bacterial community evolution, driving
it in a new extremely homogenous equilibrium with low inter-individual variations. Altogether,
these results indicate the establishment of some dominant species in the fecal bacterial community
that adapt to FB1-related conditions. Considering taxonomic composition of major genera, exposure
to FB1 leads to a sharp increase in Lactobacillus and Ruminococcaceae UCG-005 and a decrease in
Mitsuokella, Roseburia, Ruminococcus and Succinivibrio. Several hypothesis might explain solely or in
combination these microbiota modifications following FB1 exposure: a direct effect of FB1 on gut
microbiota, and/or a direct or an indirect host mediated effect.
One hypothesis to explain the constraint effect of FB1 on piglet fecal microbiota would be an
intrinsic antimicrobial effect of mycotoxin. The addition of FB1 to in vitro incubation of cecal chime
decreased the anaerobic bacteria, whereas Lactobacillus and total bacteria increased [15]. In contrast,
20 years ago, Becker et al. [33] used culture techniques and observed no inhibition of bacterial
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growth including Lactobacillus acidophilus, Lactobacillus johnsoni, Lactobacillus plantarum and Lactobacillus
reuteri. Finally, two independent studies [34,35] found no antibiotic effect of FB1, thus excluding an
antimicrobial effect to explain a fumonisin-related shaping action on gut microbiota.
Considering bacterial community structure evolution and inter individual dispersion criteria
and the number of OTUs found to be differentially abundant, the greatest effect of fumonisin
on fecal microbiota seems to occur after 22 days of exposure in the diet, whereas at 29 days of
exposure, this effect seems to be alleviated, although taxa relative abundance has not yet recovered
to levels similar to those observed in the Control group. It may be speculated that the bacterial
community might evolve toward a new equilibrium adapted to the exposure to fumonisin. In this latter
perspective, microorganisms might metabolize this mycotoxin. Although, 20 years ago, under culture
conditions, there was no indication that fumonisin was metabolized by intestinal bacteria [33], it is now
admitted that some bacteria isolated from soil and plants are known to degrade and thereby detoxify
fumonisins [36]. It was recently reported in pigs that an oral single dose exposure of fumonisin leads
to a 47% fumonisin degradation into their partially hydrolyzed forms in the gastro-intestinal tract,
thus indicating the ability of the microbiota to hydrolyze fumonisin [37]. The capacity to degrade
or remove FB1 in vitro was emphasized for Lactobacillus brevis, L. plantarum L. pentosus and some
yeasts [38,39]. The mechanism of action of Lactobacillus to remove FB1 was related to a process of
physical adsorption involving various components of cell wall [39]. Peptidoglycans was the main
binding sites, and its structural integrity was necessary. Therefore, the high proportion of Lactobacillus
in our work might result from a competitive advantage linked to their ability to metabolize FB1.
In addition to a direct effect on gut microbiota, FB1 might shape microbial composition through
its well-known actions on the host. In pigs, exposure to mycotoxins reduces feed intake [1]. Reducing
feed intake has been shown to affect both functioning and composition of microbiota [40]. Indeed,
reduction of nutrient supply decreases short-chained fatty acid concentration which in turn affect the
microbiota composition. In pigs, a favorable effect of feed restriction was observed on Lactobacillus
abundance [24]. Although, after oral exposure, FB1 is poorly absorbed in the intestine and feces is the
main excretory route [37], it induces abdominal pain and diarrhea [1]. In piglets in the present study,
it reduced villi length [8]. Impairment of the intestinal barrier function [41] has also been reported.
In the jejunum and the ileum of piglets fed deoxynivalenol alone or with fumonisin, the number of
goblet cells that synthesize and secrete mucins decreased significantly [42]. Mucins can be an important
factor in the shaping of the bacterial community since mucins provide attachment sites and are an
endogenous carbon and energy source for intestinal bacteria [43]. Altogether, the reduced feed intake
of host and alteration of its intestinal barrier function following exposure to FB1 might modify host
control of its symbiotic microbial community.
4. Conclusions
The present study investigated the effects of a 4-week dietary exposure to fumonisin on piglet fecal
microbiota. We demonstrate that dietary exposure to fumonisin in pigs hinders age-related dynamics
of fecal microbiota. Fumonisin decreases the diversity, and shifts and constrains the structure and
taxonomic composition of the fecal bacterial community as early as after 15 days of exposure and is
at a maximum at 22 days. Dietary exposure to fumonisin promotes the installation of an ecological
dominance since it decreases diversity and increases the abundance of Lactobacillus at the expense of
the abundance of Lachnospiraceae groups, Roseburia and Mitsuokella genera. The action mechanisms of
fumonisin that drive microbiota to this new equilibrium are not known and need further investigations.
5. Materials and Methods
5.1. Animals, Housing and Experimental Design
This work was done at the same time and with the same animals as the experiment made by
Régnier et al. [8]. The study was carried out with twelve 7-week-old weaned castrated male pigs.
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Animals were obtained from a local farm (Gaec de Calvignac, St. Vincent d’Autejac, France). They were
individually identified and divided into two groups and were acclimatized for one week in the animal
facility of the INRA ToxAlim Unit (Toulouse, France) prior to being used in experimental protocols.
The two groups of six animals, were housed in a separate block of the housing unit with free access to
feed and water. Pigs were randomly distributed within pens in order to avoid the effect of the lineage
(11.8 ± 1.0 kg and 13.9 ± 1.0 kg, p < 0.05, for FB1 and control pigs respectively). Pigs were examined
daily for body temperature and feces aspect. No morbidity or mortality was recorded during the
study. Room temperature and air velocity were automatically controlled, and pens were cleaned daily.
The experiments were carried out in accordance with European Guidelines for the Care and Use of
Animals for Research Purposes (accreditation number APAFIS#5917-2016070116429578 v3).
5.2. Experimental Diet, Growth Rate and Sample Collection
Diets were formulated as already described [44]. The detailed composition is provided in Table S5.
A control diet, and a diet supplemented with fumonisin enriched extract were prepared [8]. Fumonisin
extract was obtained from Dr Bailly at the Veterinary School of Toulouse. In brief, F. verticilliodes
strain NRRL 34281 was cultured on maize grains for 4 weeks at 25 ◦C. After incubation culture
material was dryed and grounded into powder and fumonisin extract content was determined by
HPLC/MS-MS. Required quantity of powder was then included in the premix before its inclusion
in the final diet. After an acclimation week, pigs were fed with the control or the experimentally
contaminated diet (10.2 mg FB1 + 2.5 mg FB2 + 1.5 mg FB3/kg), which constituted day 0 of the trial.
Because deoxynivalenol and zearalenone were naturally present in the cereals used, this results in
concentrations of 0.12 and 0.015 mg/kg feed, respectively. All other mycotoxins, including aflatoxins,
T-2 toxin, HT-2 toxin, and ochratoxin A, were below the limits of detection. Mycotoxins were analyzed
in the final diet in the Laboca laboratory (Ploufragan, France) with a LC-MS/MS method described [44].
5.3. DNA Extraction and PCR
Total genomic DNA was extracted from 0.5 g of fecal sample, combining a mechanical lysis with a
TissueLyser II instrument (Qiagen, Hilden, Germany) and the Quick-DNA™ Fecal/Soil Microbe 96 Kit
Zymo Research, Irvine, CA, USA), according to the manufacturer’s instructions [45]. The quality and
quantity of DNA extracts were checked using a NanoDrop ND-1000 spectrophotometer (NanoDrop
Technologies, Wilmington, DE, USA).
The V3–V4 regions of 16S rRNA genes of samples were amplified from purified genomic DNA
with the primers F343 (5′-CTTTCCCTACACGACGCTCTTCCGATCTTACGGRAGGCAGCAG-3′; [46])
and reverse R784 (5′-GGAGTTCAGACGTGTGCTCTTCCGATCTTACCAGGGTATCTAATC CT-3′; [47]).
The PCR was carried out with an annealing temperature of 65 ◦C for 30 amplification cycles. Since
MiSeq sequencing machine enables paired 250-bp reads, the ends of each read are overlapped and
can be stitched together to generate high-quality, reads of the entire V3 and V4 region in a single run
412 ± 11 nucleotides. At the Genomic and Transcriptomic Platform (INRA, Toulouse, France) single
multiplexing was performed using 6 bp index sequences, which were added to R784 during a second
PCR with 12 cycles. The resulting PCR products were purified and loaded onto the Illumina MiSeq
cartridge (Illumina, San Diego, CA, USA) according to the manufacturer’s instructions. Each pair-end
sequence was assigned to its sample with the help of the previously integrated index. Sequencing
reads were deposited in the National Center for Biotechnology Information Sequence Read Archive
(NCBI SRA; SRP139897).
5.4. Sequence Analysis
A total of 1,810,933 16S ribosomal DNA amplicon sequences were sorted based on their respective
barcodes, representing the 59 fecal samples. Using FROGS [48], in keeping with the SOP, sequences
were filtered by removing sequences that did not match both proximal PCR primer sequences
(no mismatch allowed), erroneous sequencing length (<400 or >500 nucleotides), with at least one
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ambiguous base. Chimeric DNA sequences were detected using VSEARCH and removed. Reads were
clustered into OTUs using SWARM [49]. OTU taxonomic assignment was performed using the BLAST
algorithm against the SILVA SSU Ref NR 128 database [50]. A phyloseq R package [51] object was
generated to perform further statistical analysis.
5.5. Statistical Analyses
All statistical analyses were carried out using R software, version 3.4.2 [52] in RStudio software,
version 1.1.383 [53]. Shannon and InvSimpson diversity indexes were calculated and the structure of
the bacterial community was investigated after calculation of a Bray-Curtis distance matrix that was
plot using a Principal Coordinate Analysis, after matrix rarefaction normalization. Using a pairwise
Bray Curtis distance calculation, bacterial community stability and inter-individual variability within
a group were evaluated between two consecutive day group using the principle of moving window
analysis and within each day group respectively [54]. To check group differences an ADONIS pairwise
test with the Bray-Curtis distance was carried out. The differential abundance analysis for sequence
count data between groups was performed using the DESeq package [55]. Venn diagrams were
obtained with the jvenn plug-in [56]. The linear model used had treatment, time and the interaction
treatment x time as fixed effects and animal as the random effect.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/10/6/230/s1,
Table S1. Pairwise ADONIS tests between treatments for each day of sampling. Table S2. Phylum relative
abundance (%) in fecal microbiota from Control and FB1-exposed piglets. Table S3. Percentage (%) of main
bacterial families in fecal microbiota from Control vs. FB1-exposed pigs. Table S4. Percentage (%) of main genera
in fecal microbiota from Control vs. FB1-exposed pigs. Table S5. Diet composition in percentage (%). Figure S1
Relative abundance of main bacterial families in fecal microbiota from Control (blue) vs. FB1-exposed pigs (red).
Figure S2. Relative abundance of main bacterial genera in fecal microbiota from Control (blue) vs. FB1-exposed
pigs (red).
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Abstract: An increase in the occurrence of ergot alkaloids (EAs) contamination has been observed
in North America and Europe in recent years. These toxins are well known for their effects on
the circulatory and nervous systems. The aim of this study was to investigate the effect of EAs on
the liver and on the intestine using the pig both as a target species and as a non-rodent model for human.
Three groups of 24 weaned piglets were exposed for 28 days to control feed or feed contaminated with
1.2 or 2.5 g of sclerotia/kg, i.e., at doses close to EU regulatory limits. Contaminated diets significantly
reduced feed intake and consequently growth performance. In the liver, alteration of the tissue,
including development of inflammatory infiltrates, vacuolization, apoptosis and necrosis of hepatocytes
as well as presence of enlarged hepatocytes (megalocytes) were observed. In the jejunum, EAs reduced
villi height and increased damage to the epithelium, reduced the number of mucus-producing cells and
upregulated mRNA coding for different tight junction proteins such as claudins 3 and 4. In conclusion,
in term of animal health, our data indicate that feed contaminated at the regulatory limits induces
lesions in liver and intestine suggesting that this limit should be lowered for pigs. In term of human
health, we establish a lowest observed adverse effect level (LOAEL) of 100 μg/kg body weight (bw)
per day, lower than the benchmark dose limit (BMDL) retained by European Food Safety Authority
(EFSA) to set the tolerable daily intake, suggesting also that regulatory limit should be revised.
Keywords: Claviceps; liver; digestive tract; mycotoxin; sclerotia; ergot alkaloids; toxicity
Key contribution: In term of pig, our data indicate that feed contaminated at the regulatory limits
(1 g sclerotia/kg) induces liver and intestine suggesting that the limit should be lowered. In term of human
health; the present experiment established a LOAEL of 100 μg EAs/kg bw per day; lower than the BMDL
associated with a 10% response of 330 μg/kg bw per day retained by EFSA to set the tolerable daily intake.
1. Introduction
Ergot is a parasitic fungus that belongs to the Claviceps genus. It forms on various grains and
grasses a dark mass of mycelium called sclerotia producing toxic secondary metabolites, the ergot
alkaloids (EAs). These mycotoxins gained notoriety in the Middle Ages because of mass poisonings in
Europe, characterized by gangrene and convulsions [1].
More than 50 different EAs have been identified so far. The main EAs produced by Claviceps species
are ergometrine, ergotamine, ergosine, ergocristine, ergocryptine and ergocornine. Their toxicity is linked
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to their structural similarity with dopamine, noradrenaline, adrenaline and serotonin, enabling binding to
the biogenic amine receptor and the interruption of neurotransmission [2]. Typical clinical symptoms of
ergot poisoning are vasoconstriction, which may progress into gangrene, disruption of reproduction,
abortion, neurotoxic signs including feed refusal, dizziness and convulsions, agalactia and adverse
effects to the cardiovascular system [1,3–5]. Although acute poising has become rare, EAs are still
a source of concern because they continue to be detected in cereals and cereal products in Europe and
North America [6,7]. Moreover, the occurrence of Claviceps purpurea (C. purpurea) infections has been
increasing in the last few years [8–11].
Currently, regulations are based on the quantities of ergot sclerotia. Codex Alimentarius established
maximum levels for sclerotia of C. purpurea in wheat and durum wheat intended for processing for human
consumption at 0.5 g/kg and 5 g/kg, respectively [12]. In animal feed, the European Commission fixed
the maximum content at 1 g/kg of feed stuff containing unground cereals [13]. Recently, the EFSA Panel
on Contaminants in the Food Chain conducted a risk assessment and proposed a tolerable daily intake
(TDI) of 0.6 μg total EA/kg body weight (bw) per day [1] for humans.
The aim of this study was to investigate the effects of ingestion of EA-contaminated feed at
concentrations close to the regulatory limits. We chose to perform the experiment in pigs as they
may be exposed to EAs. In addition, they represent a choice species as a biomedical model for human
toxicology, due to their similarities in anatomy, genetics and pathophysiology [14].
We mainly focused on the effects of EAs on the intestine and the liver. The intestine is of
particular importance since it represents the first barrier against food contaminants and foreign antigens.
The jejunum is one of the major intestinal sites of absorption, including the absorption of toxins.
Intestinal epithelium integrity plays a critical role in the maintenance of the physical and immune
barrier that is achieved by an ensemble of well-organized structural and secretory components including
tight junctions, mucus and cytokines [15]. Most of the metabolization processes for xenobiotics, including
mycotoxins, occur in the liver [16]. The metabolizing enzymes of the cytochrome P450 family are
involved in and induced by ergot metabolism [17]. Moreover, certain hepatic enzymatic activities were
found to be inhibited by ergotamine and ergometrine [18]. Reports in the literature on the effects of ergot
on the intestine and the liver are rare, especially concerning biochemical and morphological parameters.
2. Results
2.1. Effects of Ergot Alkaloids on Clinical Signs, Growth and Feed Intake
The effects of ergot were first investigated in pigs exposed for 28 days at doses of 1.2 and 2.5 g
sclerotia/kg feed, which are just above the European regulatory limit. When assessing clinical signs,
no typical symptoms of acute toxicity, such as convulsions or muscle spasms, or necrosis of the extremities
were observed. Similarly, no vomiting or fever was observed in animals exposed to ergot.
The effects of ergot on feed intake were already detected the second week in animal exposed to
the highest dose. For animals exposed to the lower dose of ergot, this reduction only appeared in
the last 14 days of treatment (Figure 1). During the experimental period, the daily feed intake of animals
exposed to the higher dose of ergot was reduced by about 18% in comparison with control group
(Figure 1). Taking into account the whole period of treatment, the daily feed intake was significantly
reduced as a function of ergot content (Figure 1).
The reduction in feed ingestion led to a decrease of animal weight gain that was significant in
the group exposed to the higher dose of EA (data not shown).
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Figure 1. Daily feed intake of piglets fed ergot sclerotia for 28 days (n = 24/group). Values are means
with standard errors of the mean represented by vertical bars. a, b, c mean values with different letters
are statistically different (p < 0.05).
2.2. Effects of Ergot Alkaloids on Hematology and Blood Chemistry
Hematology and serum biochemical analysis were performed at the end of the experiment.
When animals were exposed to ergot, the percentage of neutrophils was reduced and the decrease
was significant in the group exposed to the lower dose (Table 1). The percentage of lymphocytes also
increased in animals exposed to ergot, with a significant difference in animals exposed to the higher dose
(Table 1).
Table 1. Hematological analysis of pigs fed 1.2 or 2.5 g ergot sclerotia/kg feed (n = 24/group).
Parameters
Contamination of the Diet (g of Sclerotia/kg Feed)
0 1.2 2.5
Red blood cells (T/L) 7.75 ± 0.12 7.80 ± 0.13 8.08 ± 0.13
Hemoglobin (g/dL) 10.45 ± 0.22 a,b 10.09 ± 0.21 a 10.97 ± 0.19 b
Hematocrit (%) 36.6 ± 0.70 a,b 35.52 ± 0.87 a 38.31 ± 0.63 b
Mean corpuscular volume (fL) 47.46 ± 0.93 45.67 ± 0.93 47.58 ± 0.91
White blood cells (103/mm3) 14.5 ± 0.6 14.2 ± 0.9 16.5 ± 0.9
Neutrophils (%) 40.92 ± 2.51 a 30.67± 1.84 b 36.17 ± 2.55 a,b
Eosinophils (%) 0.38 ± 0.15 0.54 ± 0.30 0.29 ± 0.14
Basophils (%) 0.08 ± 0.08 0.08 ± 0.08 0.00 ± 0.00
Lymphocytes (%) 53.96 ± 2.66 a 63.96 ± 1.95 b 58.79 ± 2.77 a,b
Monocytes (%) 4.67 ± 0.42 4.75 ± 0.68 4.75 ± 0.63
Platelets/mm3 521.58 ± 32.67 465.00 ± 28.08 533.04 ± 32.39
a, b mean values with different letters are statistically different (p < 0.05).
Biochemical analysis revealed a significant dose-dependent reduction in the levels of creatine
kinase in animals exposed to ergot. In addition, the level of cholesterol decreased and that of glucose
increased upon exposure to ergot (Table 2).
Table 2. Serum biochemical analysis of pigs fed 1.2 or 2.5 g ergot sclerotia/kg feed (n = 24/group).
Parameters
Contamination of the Diet (g of Sclerotia/kg Feed)
0 1.2 2.5
Alkaline phosphatase (U/L) 275.7 ± 24.5 237.6 ± 16.7 228.6 ± 16.1
Alanine aminotransferase (U/L) 37.3 ± 1.9 31.74 ± 1.5 33.32 ± 1.6
Amylase (U/L) 1783 ± 123 1815 ± 99 2074 ± 122
Aspartate aminotransferase (U/L) 56.0 ± 6.8 42.6 ± 5.4 44.4 ± 3.94
Creatine kinase (U/L) 3377 ± 396 a 1924 ± 297 b 1300 ± 252 b
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Table 2. Cont.
Parameters
Contamination of the Diet (g of Sclerotia/kg Feed)
0 1.2 2.5
Lactate dehydrogenase (U/L) 962.8 ± 50.5 968.3 ± 57.7 1013.3 ± 72.5
Lipase (U/L) 6.45 ± 0.5 6.9 ± 0.3 5.9 ± 0.8
Albumin (μmol/L) 533.0 ± 9.7 530.4 ± 11.7 522.4 ± 13.3
T bilirubine (μmol/L) 11.2 ± 1.2 11.0 ± 1.2 7.4 ± 1.3
Cholesterol (mmol/L) 3.0 ± 0.1 a 2.6 ± 0.1 b 2.8 ± 0.1 a
Creatinine (μmol/L) 61.9 ± 6.2 63.3 ± 6.5 71.7 ± 6.4
Glucose PAP (mmol/L) 4.4 ± 0.2 a 4.7 ± 0.3 a 5.4 ± 0.3 b
Phosphorus (mmol/L) 3.1 ± 0.1 3.2 ± 0.1 3.0 ± 0.1
Total proteins (g/L) 63.5 ± 7.8 59.1 ± 7.4 62.5 ± 8.2
Urea (mmol/L) 4.7 ± 0.4 4.3 ± 0.3 3.5 ± 0.4
a, b mean values with different letters are statistically different (p < 0.05).
2.3. Alterations of Tissue Morphology Caused by Ergot Alkaloids
The effects of ergot on the liver and the intestine were investigated through histological analyses.
Exposure to ergot led to mild to moderate lesions of the liver (Figure 2) and the jejunum (Figure 3)
of pigs.
In the liver, tissue disorganization of hepatic cords, inflammation and vacuolation of hepatocytes,
megalocytosis and necrosis were the main morphological alterations (Figure 2B). Furthermore, animals
fed the contaminated diets presented a significant increase in the lesion liver score (Figure 2C).
(A) (B) (C) 
   
Contamination of the diet 
(g sclerotia/kg feed)  
Figure 2. Liver of piglets fed ergot diets. (A) Control piglet. Normal liver. HE. Objective 10×; (B) Piglet
fed 2.5 g ergot sclerotia/kg feed. Disorganization of hepatic cords and periportal hepatocyte vacuolation.
HE. Objective 10×. Insert: Hepatocyte vacuolation. HE. Objective 40×; (C) Liver lesion score. Values are
means with their standard errors of mean represented by vertical bars (n = 6 animals). Mean values with
different letters are significantly different (p < 0.05). Bar = 100 μm.
The main histological changes observed in the jejunum were villi atrophy, edema of lamina
propria and cytoplasmic vacuolation of enterocytes. As shown in Figure 3C, animals exposed to
the higher dose of ergot displayed a significant increase of the lesion score in the jejunum compared to
control animals (3.4 fold increase, p < 0.005). Morphometrical analysis revealed a significant decrease
in villi height (1.2 fold decrease at both doses) (Figure 3D). The number of goblet cells decreased
significantly in the jejunum (mean 1.6 fold decrease, p < 0. 001) of piglets exposed to ergot (Figure 3E).
Similar effects were observed in jejunum areas with Peyer’s patches (data not shown).
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(C) (D) (E) 
 
Contamination of the diet (g sclerotia/kg feed) 
Figure 3. Effect of ergot exposure on jejunum of pigs receiving a control diet or a diet contaminated with
1.2 or 2.5 g ergot sclerotia/kg feed for 28 days. Jejunal section with hematoxylin-eosin (HE), Objective 10×:
(A) Control piglet; (B) Piglet fed 2.5 g ergot sclerotia/kg feed; (C) Lesion score according to the occurrence
and severity of lesions observed on formalin-fixed tissue sections stained with HE; (D) Villi height
measured on formalin-fixed tissue sections stained with HE; (E) Number of goblet cells observed on
formalin-fixed tissue sections stained with Schiff’s periodic acid. Values are means of the score, villi height
and number of goblet cells/field respectively, with standard errors of the mean represented by vertical
bars (n = 6 animals). a,b mean values with different letters are statistically different (p < 0.05).
2.4. Effects of Ergot Alkaloids on mRNA Expression in the Jejunum
Given the lesions induced by ergot exposure in the jejunum and due to the lack of studies on
the toxicity of EAs in this organ, the expression of 34 genes coding for junctional proteins, inflammatory
and immunological mediators was evaluated by real-time-quantitative PCR (RT-qPCR) in the jejunum.
The expression profile of mRNA expression of different toll-like receptors (TLR) and cytokines
(TLR4, nuclear factor kappa B (NFkB), interleukin (IL)-6, IL-8, tumor necrosis factor-α (TNFA)) showed
a tendency to downregulation. In animals exposed to the higher dose of ergot, analysis of mRNA
expression of junctional proteins revealed a significant increase in claudin-3 (CLDN3), claudin-4 (CLDN4),
occludin (OCLN), zonula occludens-1 (ZO-1), junctional adhesion molecule (JAM-A) and E-cadherin
(ECAD) (Figure 4). The expression of genes coding for mucin-1 (MUC1), alkaline phosphatase (ALP) and
proliferating cell nuclear antigen (PCNA) was also significantly increased. Altogether, the overexpression
of the genes involved in maintaining the structure of the intestinal mucosa may reflect an attempt by
the tissue to reestablish its function.
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Figure 4. Expression of selected genes in the jejunum of pigs fed with a control diet or a diet
including ergot alkaloids for 28 days. mRNA levels were measured by RT-qPCR. The three panels
present different groups: TLR-encoding genes (A), junctional protein-encoding genes (B) and immune
mediator-encoding genes (C). The gene expression levels for the control group are shown in black
(mean value adjusted to 1 for this group) and those for the groups exposed to 1.2 and 2.5 g sclerotia/kg
feed ergot are shown in orange and red, respectively (n = 6 animals/group). * statistical difference in
gene expression between control animals and pigs exposed to the highest dose of ergot (p < 0.05).
3. Discussion
The aim of this study was to investigate the effects of ingestion of EA-contaminated feed on
the liver and intestine in pig. The levels of sclerotia in the feed were 1.2 g sclerotia or 2.4 mg total ergot
alkaloids/kg. Using these concentrations that were close to the regulatory limits for 28 days, we observed
not only effects on animal performances but also lesions in the liver and the intestine. This study shows
that the regulation of 1 g sclerotia/kg of feed materials is probably not protective enough for pigs and
deserves to be re-evaluated. In terms of human health, a LOAEL of 100 μg/kg bw per day could be
established from the present data. This is lower than the BMDL associated with a 10% response of
330 μg/kg bw per day, which is set by EFSA as the tolerable daily intake for human. The present
experiment thus provides evidence of the necessity to re-examine the current TDI for humans.
Considering the mean feed intake of these animals (1163 and 962 g/day after respectively, two and
four weeks of exposure) and their mean weight (17.5 and 27.8 kg after respectively, two and four weeks
of exposure), it represents an exposure to ergot alkaloids of 159 and 83 μg/kg bw per day after two and
four weeks of exposure, respectively. The lowest observed adverse effect level (LOAEL) is lower than
the benchmark dose limit (BMDL) associated with a 10% response of 330 μg/kg bw per day retained by
EFSA to set the tolerable daily intake (TDI) of 0.6 μg/kg bw per day [1], based on the vasoconstrictive
effects observed in a rat model exposed to ergotamine for 13 weeks [19]. Given the interspecies differences
in the observed effects, pig could be considered as a relevant species for ergot alkaloids risk assessments.
These data reinforce the need to increase the knowledge on the effects of EAs and suggest a revision of
the TDI for EAs.
As already reported in other studies, we observed that the ingestion of EAs damages
the zootechnical parameters as measured by feed intake and average daily gain [17,20]. Reduction of
weight gain appears to be caused by the reduction in feed intake, which in turn may be explained
by the action of the EAs on serotoninergic receptors in the gut, thereby affecting motility [2].
The composition and proportion of EAs in sclerotia can vary but the total EA content appears to
be more important than the composition of EA for the alteration of animal performances [21].
The consumption of ergot also affected intestinal integrity, as revealed by histological and
molecular analyses, and might have contributed to growth impairment of the animals. Histological and
morphometric evaluation of the intestinal tissue revealed a sensitive endpoint for the evaluation of
the effects of mycotoxin exposure. Modifications in villi height reflect changes in the balance between
enterocyte proliferation and apoptosis. The increase in the lesion score and villi flattening in the intestine
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of animals exposed to EAs could be explained by their action on serotoninergic receptors present in
epithelial intestinal cells, primary afferent neurons and secretor motor neurons of the intestine [22].
In addition to the action of EAs on the serotoninergic system, recent in vitro studies demonstrated that
EAs also cause cytotoxicity and apoptosis in intestinal HT-29 and liver HepG2 cell lines, providing
evidence for an intricate mode of action [23]. Additionally, the number of goblet cells was reduced in
animals exposed to EAs, revealing impairment in the intestinal barrier function [15,24]. Taken together,
these alterations could lead to a compensatory upregulation of mRNA levels of CLDN3, CLDN4,
OCLN, ZO-1, JAM-A, ECAD, ALP and PCNA, as already described in the intestine of mice [25]
or in intestinal epithelial cells exposed to deoxynivalenol [26]. Immunoregulatory mechanisms in
the intestine play a crucial role in the defense of the organism [27]. The pattern recognition receptors
(PRR) are membrane-bound receptors that specifically bind to pathogen-associated molecular patterns
(PAMPs) shared by various microorganisms. PRR are highly expressed in the jejunum and ileum of
pigs and trigger an inflammatory response, involving the activation of myeloid differentiation 88 and
NFkB [28]. In the present work, mRNA expression of TLR-1 2, 4, 5 and 6 as well as TNF-A, IL-1A, IL-8
and IFNG tended to be downregulated in the jejunum of animals exposed to EAs. This could reduce
tolerance to commensal microbiota and the organism’s ability to trigger inflammation response against
pathogens, thereby increasing susceptibility to infections [29].
Besides the action of EAs on the intestine, their effects were also studied on the liver where tissue
disorganization, inflammation and necrosis were observed and assessed by a significant increase of
the lesion liver score. We observed that the consumption of EA-contaminated feed affected the levels of
cholesterol, glucose and creatine kinase, parameters correlated with adiposity and muscle growth [30].
Hypocholesterolemia could correlate with the malabsorption of nutrients as well as with an altered lipid
metabolism that often accompanies hepatic disease [31]. Glucose levels were elevated in the group
that received the higher ergot content. In the post-absorptive phase, glucose is transported from
its site of uptake in the gut to the sites of glycogen storage, principally the liver and muscles [32].
The increase in glucose level indicates glycogen mobilization from the storage sites to provide energy
to the organism. In the present study, the morphological changes observed in hepatocytes could be
associated with functional alterations such as lipid metabolism and glycogen storage. The reduction
in creatine kinase may indicate hypoplasia, atrophy or the mild destruction of skeletal muscles [31,32].
EAs induce vasoconstriction through binding with serotoninergic receptors in the smooth muscle cells of
vessels walls [5]. Therefore, an association between a relative ischemia and changes in creatine kinase
could be hypothesized. In short, the biochemical alterations observed in animals exposed to ergot could
be correlated to liver and mild muscle lesions [30].
4. Conclusions
The contamination of cereals by EAs has recently been shown to be increasing in different
countries and is a source of concern for human and animal health. This study confirmed that EA
reduces the performances of pigs, and demonstrated that EAs provoke hepatotoxicity, as revealed
by deleterious effects on tissue morphology, and mild biochemical alterations. Moreover, EA alters
the intestinal epithelium, reduces the number of goblet cells and modulates the expression of genes
involved in immune response and barrier function. This suggests that ingestion of EA-contaminated
feed may alter the intestinal barrier function, predisposing animals to enteric infections and potentially
causing hepatotoxicity.
From the point of view of pig health, our data indicate that feed contaminated at the regulatory
limits induces deleterious effects in the liver and intestine in pigs, suggesting that the regulatory limit
is not adequately protective. From the point of view of human health, this study reveals the sensitivity
of pigs to EAs with a LOAEL lower than the BMDL obtained in rats, which is employed by EFSA to set
the tolerable daily intake for human. The present data should be considered in a further assessment of
human risk of exposure to EAs.
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5. Materials and Methods
5.1. Experimental Diets
Experimental diets, based on wheat, corn and soybean and formulated according to the CORPEN
(1996) norms are detailed in Table 3. Two batches of sclerotia obtained from contaminated wheat were
used to prepare the contaminated diets. Levels of sclerotia of 0 (control), 1.2 g/kg (dose 1) and 2.5 g/kg
(dose 2) were used, the first dose being close to the regulatory limit of 1 g/kg [13].
Table 3. Chemical composition of the diets (% of dry matter DM).
Parameters
Contamination of the Diet (g of Sclerotia/kg Feed)
0 1.2 2.5
Total nitrogen 20.1 20.2 20.3
Raw cellulose 2.6 2.7 2.8
Lipids 4.3 4.4 4.4
Minerals 6.0 6.1 6.0
5.2. Ergot Alkaloid Composition of the Diets
The quantities of EAs were determined by liquid chromatography coupled with a tandem mass
spectrometry (LC/MS/MS) (TSQ Quantum Ultra, ThermoFisher Scientific, Villebon sur Yvette, France)
at Qualtech laboratory (Vandœuvre, France).
After preparation, diets were analyzed four times and the mean EA concentrations were 2.36 and
5.05 mg/kg, for diets with ergot dose 1 and 2, respectively. The most abundant alkaloid was ergotamine,
followed by ergosine, ergocristine and their corresponding-inine epimers (Table 4). The amount of the-ine
isomers was approximately two-thirds of total alkaloids.
Contamination with other mycotoxins was investigated. Deoxynivalenol was naturally present in
the wheat (19 μg/kg) and corn (171 μg/kg) but at an insignificant rate. Other mycotoxins, including DON
acetylated, nivalenol, T2, HT-2, zearalenone and fumonisin were below the detection limit.
Table 4. Ergot alkaloid content in experimental feed (mg/kg).
Alkaloids (mg/kg Feed)














Total alkaloids 2.4 5.1
5.3. Animals
Animal experiments were carried out at ARVALIS—Institut du végétal facility (Villerable, France)
in accordance with the guidelines for protection of animals used for scientific purposes issued by
French Ministry of Higher Education and Research. Seventy-two castrated, 21 day-old crossbreed
(P76 X Naïma) piglets (mean weight 10.7 ± 0.9 kg) were housed in the facility with free access to control
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starter feed and water. When they were 34 days old, they were housed in individual pens and assigned to
three groups of 12 males and 12 females one group fed the control diet, another ergot dose 1 and the third
ergot dose 2 diet. At the end of the experiment (62 days old) their mean weight was 27.9 ± 3.8 kg,
27.8 ± 2.6 kg, 25.6 ± 3.1 kg in the control group, ergot dose 1 and ergot dose 2 diet groups, respectively.
5.4. Experimental Setting and Sample Collection
Animals received experimental diets for a period of 28 days. Weight and consumption were
measured on the first day of the experiment, 14 days later and on the last day of the experiment.
The animals were observed daily to detect possible signs of ergot intoxication such as balance disorders
or necrosis of the extremities.
At the end of the experiment, blood samples were taken from the external jugular vein of all
the animals for biochemical and hematological analyses. In addition, six male animals in each group were
euthanized and liver, jejunum and jejunum with Peyer’s patches were sampled in 10% buffered formalin
(Sigma, Saint-Quentin Fallavier, France) for histopathological analysis or immediately quick-frozen in
liquid nitrogen and stored at −80 ◦C until RNA extraction [33].
5.5. Hematology and Blood Chemistry
Hematological parameters (white and red blood cells, hemoglobin and platelets) were analyzed
at Medibiolab (Vendome, France), with a Sysmex XT2000i automated hematology analyzer
(Sysmex, Villepinte, France). Serum biochemistry was determined with a Pentra 400 Clinical Chemistry
benchtop analyzer (Horiba, Les Ulis, France) at GenoToul-Anexplo platform (Toulouse, France).
5.6. Histomorphometrical Analysis
Formalin-fixed tissue samples were dehydrated in ethanol and embedded in paraffin wax.
Sections (3 μm) were stained with hematoxylin-eosin (HE, Sigma) for histopathological analysis.
A lesion score per animal was established by taking into account the severity of the lesion and its extent
(intensity or observed frequency; scored from 0 to 3) as described previously [34]. Morphometry was
evaluated in the jejunum by measuring the height of 30 randomly chosen villi using a MOTIC Image
Plus 2.0 ML 1 image analysis system (Richmond, Canada, 2003), as described previously. In addition,
Schiff’s periodic acid stain was used to evaluate goblet cell density (five fields/slide, objective 20×) [35].
5.7. Expression of mRNA by Real-Time PCR
Intestinal tissue was processed in lysing matrix D tubes (MP Biomedicals, Illkirch, France) containing
Extract-All (Eurobio, Les Ulis, France) in a Fast-Prep FP120 instrument (MP Biomedicals) as described
previously [36,37]. The concentrations and purity of RNA were determined using a Nanodrop nd1000
instrument (Labtech International, Paris, France). Total RNA samples were reverse-transcribed using
a High Capacity cDNA-RT kit (Life Technologies, Saint Aubin, France). RT-qPCR was performed
in 384-well plates in a ViiA 7 thermocycler (Life Technologies, Saint Aubin, France) as described
previously [38]. All reactions were performed in duplicate and averages were used for further analysis.
Primers for the real-time quantitative PCR are presented in Table 5. Among the different internal reference
genes tested were Beta-2-microglobulin (B2M), peptidylprolyl isomerase A (PPIA—cyclophilin A) and
ribosomal protein L32 (RPL32); the latter were selected for their stability of expression assessed with
the NormFinder program [39]. Data from qPCR were analyzed with the LinRegPCR 2016. 2 program [40],
enabling the determination of the starting concentrations (N0).
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Table 5. Primer sequences of genes used for qRT-PCR analysis of the jejunum (F: forward; R: reverse).
Target Gene Primer Sequence (5′–3′) mRNA Reference
Alkaline phosphatase (ALP) F AAGCTCCGTTTTTGGCCTG ENSSSCT00000037252.1 [28]R GGAGGTATATGGCTTGAGATCCA
Beta-2-microglobulin (B2M) F TTCTACCTTCTGGTCCACACTGA NM_213978.1 [41]R TCATCCAACCCAGATGCA
C-C Motif Chemokine Ligand
20 (CCL20)
F GCTCCTGGCTGCTTTGATGTC
NM_001024589 Present studyR CATTGGCGAGCTGCTGTGTG
C-C Motif Chemokine Ligand
28 (CCL28)
F GGCTGCTGTCATCCTTCATGT
ENSSSCT00000018375 Present studyR TGAGGGCTGACACAGATTCTTCT
Claudin 3 (CLDN3)
F CTGCTCTGCTGCTCGTGCCC






NM_001163060.1 Present studyR TGGGAGCTGGGAAACGTG





















NM_214415 Present studyR GCAGCAATTCAGGGTCCAAG
Interleukin 23A (IL-23A)
F TTCTCTACACCCTGATGGCTCTG




NM_001128444.1 Present studyR CACAAGTGTAATCTCCAGCATCAGA
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Table 5. Cont.
Target Gene Primer Sequence (5′–3′) mRNA Reference
Toll-like receptor 1 (TLR1) F TGCTGGATGCTAACGGATGTC AB219564.1 [28]R AAGTGGTTTCAATGTTGTTCAAAGTC
Toll-like receptor 2 (TLR2) F TCACTTGTCTAACTTATCATCCTCTTG AB085935.1 [28]R TCAGCGAAGGTGTCATTATTGC
Toll-like receptor 4 (TLR4) F GCCATCGCTGCTAACATCATC AB188301.2 [28]R CTCATACTCAAAGATACACCATCGG
Toll-like receptor 5 (TLR5) F CCTTCCTGCTTCTTTGATGG NM_001348771 [28]R CTGTGACCGTCCTGATGTAG
Toll-like receptor 6 (TLR6) F AACCTACTGTCATAAGCCTTCATTC AB085936.1 [28]R GTCTACCACAAATTCACTTTCTTCAG




Zonula occludens 1 (ZO-1)
F ATAACATCAGCACAGTGCCTAAAGC
AJ318101.1 Present studyR GTTGCTGTTAAACACGCCTCG
5.8. Statistical Analysis
The zootechnical parameters (daily feed intake and average weight gain) were measured on
24 piglets per group, and the differences in variance analysis were assessed with the Newman et Keuls
post hoc test.
Histological data were measured on 6 animals per group and statistically analyzed by the free
software Action 2.3 (Estatcamp, Campinas, SP, Brazil, 2003) using normality (Shapiro-Wilk’s test) and
homogeneity (Bartlett) tests. When these two assumptions were met, the lesional score, the intestinal
morphometry and the number of goblet cells were analyzed by ANOVA followed by Tukey’s test.
For gene expression, quantification by qPCR and statistical analysis, the mRNA expression of target
genes was normalized to the expressed housekeeping genes using REST© 2009 software (Qiagen, Valencia,
CA, USA) which uses the pair-wise fixed reallocation randomization test as statistical model [44]. P values
below 0.05 (p ≤ 0.05) were considered significant.
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Abstract: Zearalenone is a toxic low-molecular-weight molecule that is naturally produced by moulds
on crops as a secondary metabolite. The aim of this study was to determine the genotoxicity of
caecal water collected successively from the caecal contents of gilts exposed to low doses (LOAEL,
NOAEL, and MABEL) of zearalenone. The experiment was performed on 60 clinically healthy
gilts with average BW of 14.5 ± 2 kg, divided into three experimental groups and a control group.
Group ZEN5 were orally administered ZEN at 5 μg/kg BW, group ZEN10—10 μg ZEN/kg BW
and group ZEN15—15 μg ZEN/kg BW. Five gilts from every group were euthanized on analytical
dates 1, 2, and 3. Caecal water samples for in vitro analysis were collected from the ileocaecal region.
The genotoxicity of caecal water was noted, particularly after date 1 in groups ZEN10 and ZEN15
with a decreasing trend. Electrophoresis revealed the presence of numerous comets without tails
in groups C and ZEN5 and fewer comets with clearly expressed tails in groups ZEN10 and ZEN15.
The distribution of LLC-PK1 cells ranged from 15% to 20% in groups C and ZEN5, and from 30% to
60% in groups ZEN10 and ZEN15. The analysis of caecal water genotoxicity during exposure to very
low doses of ZEN revealed the presence of a counter response and a compensatory effect in gilts.
Keywords: zearalenone; doses; caecal water; genotoxicity; pre-pubertal gilts
Key contribution: The extent of DNA damage was proportional to the ingested mycotoxin dose.
Therefore, the proposed MABEL dose could be considered as a preventive dose for pre-pubertal gilts.
1. Introduction
The symptoms and health (toxicological) consequences of exposure to high doses of most
mycotoxins, in particular, zearalenone (ZEN), are generally well known [1,2]. Research conducted in
the past decade demonstrated that exposure to low doses of the parent compound without modified
mycotoxins can also lead to health problems [3]. Similar findings had been reported previously
by members of the EFSA Panel on Contaminants in the Food Chain [4,5]. The above is confirmed
by the hormesis paradigm [6,7]. Doses below the lowest observed adverse effect level (LOAEL)
values [8,9] that produce subclinical symptoms of disease are referred to as no observed adverse
effect levels (NOAEL) doses [10]. The lowest measurable dose that enters positive interactions with
the host’s body in various stages of life is known as the minimal anticipated biological effect level
(MABEL) dose [11]. The dose-response paradigm has been undermined by the low dose hypothesis.
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The above applies particularly to hormonally active compounds [12], including mycosteroids such
as ZEN. The dose-response relationship is ambiguous, and it does not support direct and monotone
extrapolation or meta-analysis of the risks (clinical symptoms or laboratory results) associated with
the shift from a high to a low dose [13]. The concept of a minimal dose (MABEL) that induces a
counter-intuitive response is garnering increasing interest in biomedical sciences. The mechanisms
associated with the MABEL dose must be researched to quantify the relevant risks and final
outcomes [14] in the decision-making process.
Most Fusarium mycotoxins are absorbed primarily in the proximal segment of the small
intestine [15]. Intestinal fragments are characterized by high physiological variability. The duodenum
and the jejunum have the lowest content of mucus glycoproteins, which maximizes the availability of
digesta for intestinal walls [16] and, consequently, the body. Most carbohydrates are also absorbed
in the proximal segment of the small intestine [17], which promotes absorption, accumulation, and,
probably, biotransformation of mycotoxins in enterocytes [18,19].
The highest percentage content of ZEN was observed in the small intestine in early stages
of exposure. On successive days of exposure, ZEN was also accumulated in the duodenum and
the descending colon. During exposure to the parent compound (ZEN) only, biotransformation
processes were not observed or were significantly inhibited in the porcine gastrointestinal tract [20].
The accumulation of ZEN in intestinal tissues began already in the first week of exposure.
According to research into the changes that accompany exposure to small ZEN doses [21],
the mycotoxin can produce side effects that are difficult to predict. This uncertainty is associated
with both the dose and the duration of exposure. The exposure to small doses often produces
surprising effects: (i) The body fails to recognize the presence of undesirable substances, such as
mycotoxins [22], and the underlying principle is similar to the T-regs theory [23], postulating that these
cells do not respond to small amounts of infectious factors; (ii) Mycotoxin absorption increases during
prolonged per os exposure to ZEN [20]; (iii) The compensatory effect [24] inhibits the analysed factors,
and homeostasis is restored [13] despite ongoing exposure.
Minimal doses of undesirable substances such as ZEN can be used for preventive or even
therapeutic purposes. The genotoxicity of various (perhaps threshold) doses of the administered
compound should be studied to determine their mutagenic effects. Fleck et al. [25] and Pfeiffer et
al. [26] compared the genotoxicity of estradiol (E2), estrone (E1), ZEN, and α-zearalenol in a cell-free
system and found that these compounds had similar DNA-damaging potential to endogenous steroids,
and that they enhanced the carcinogenic effects of endogenous estrogens. These results are difficult
to apply to the results of in vivo studies, which investigate the correlations between the dose and
DNA-damaging potential.
De Ruyck et al. [27] observed that various substances, including carcinogenic compounds, are
accumulated in the bodily tissues of animals exposed to ZEN. The epithelium of the digestive tract
is exposed first to the ingested low doses of ZEN [28–31]. The intestinal mucosa prevents antigens,
including undesirable substances such as ZEN, commensal bacteria, and pathogens from penetrating
deeper tissues [32]. In a study by Nowak et al. [33], ZEN administered per os at 40 μg/kg BW increased
the genotoxicity of caecal water (CW), mainly in the sixth week of the experiment, in the proximal
and distal segments of the large intestine. Genotoxicity also increased in the proximal part of the
colon. The authors suggested that the slow transit of intestinal contents after exposure to ZEN [34]
increased the risk of adverse changes, including carcinogenic changes, in tissues containing estrogen
receptors [35].
Genotoxins such as ZEN can damage DNA [36]. In somatic cells, DNA damage can lead to somatic
mutations and, consequently, malignant transformations. There is a wide variety of in vitro and in vivo
genotoxicity tests supporting the detection of many terminal points of DNA damage or its biological
consequences for eukaryotic cells, including in mammals [37]. These tests should be used to evaluate
the safety of feedstuffs and detect the presence of undesirable substances, including mycotoxins, in
animal feed.
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The comet assay is one of the most popular techniques for detecting DNA damage. The test is
highly sensitive, and it can be performed on a small number of cells. Several modifications of the
comet assay have been proposed to detect various types of DNA damage. The alkaline comet assay
detects a combination of DNA changes, including single- and double-strand breaks, and alkali-labile
sites [37]. Several indicators are used in the comet test, but the percentage of DNA damage in the
comet tail (%DNAT) is regarded as the most reliable indicator, because it covers the broadest range
of DNA damage and is linearly correlated with the frequency of DNA breaks [37]. For this reason,
%DNAT was the indicator of choice in this study.
The above arguments indicate that prolonged oral administration of a natural parent compound
such as ZEN increases carry-over values in successive segments of the gastrointestinal tract and
increases the concentration of ZEN in digesta [20]. The degree of exposure can be evaluated by
analysing the contents of the distal fragment of the digestive tract. The results of such analyses
constitute valuable inputs for dietary intervention studies [33]. Biological markers are used to detect
the DNA-damaging potential and/or mutagenic effects in digesta sampled from different intestinal
segments. The aim of this study was to evaluate the genotoxicity of CW collected successively from
the caecal contents of gilts exposed to low (LOAEL, NOAEL, and MABEL) doses of ZEN.
2. Results
2.1. Experimental Feed
The analysed feed did not contain mycotoxins, or its mycotoxin content was below the sensitivity
of the method (VBS). The concentrations of modified and masked mycotoxins were not analysed.
2.2. Clinical Observations
Clinical signs of ZEN mycotoxicosis were not observed throughout the experiment. However,
changes in specific tissues or cells were frequently observed in analyses of selected biochemical
parameters in samples collected from the same animals and in those animals’ growth performance.
The results of these analyses were published in a different paper [38].
2.3. General Information
The percentage of DNA damage in the comet tail (%DNAT) of non-exposed cells (negative control,
LLC-PK1 cells in DMEM/Ham’s F12 medium) was determined at 4.1% ± 0.7%. In cells exposed to 25
μM hydrogen peroxide (positive control), %DNAT reached 86.3% ± 2.3%.
2.4. Single Cell Gel Electrophoreses (Comet Assay)
The genotoxicity of CW (Figure 1) obtained from gilts exposed to different ZEN doses was
determined on three analytical dates. On every date, CW genotoxicity was lowest in group C (control
group) with mean values of 19.5% to 22.0% and standard error of the mean (S.E.M.) of 2.7% and
1.9%, respectively.
No significant differences (Figure 1) were observed on analytical date 1 between groups C and
ZEN5 (5 μg ZEN/kg BW), whereas the differences between groups ZEN10 (10 μg ZEN/kg BW) and
ZEN15 (15 μg ZEN/kg BW) were significant. Similar differences were noted on date 2. On date 3,
significant differences were observed between group C and groups ZEN5 and ZEN15 and between
groups C and ZEN10 and groups ZEN5 and ZEN15.
Significant differences (Figure 1) between analytical dates were noted between groups ZEN10
and ZEN15 on date 1 vs. group ZEN10 on date 3 and group ZEN15 on date 2, and between group
ZEN5 values on analytical dates 2 and 3.
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Figure 1. DNA damage expressed by the mean number of DNA breaks in the LLC-PK1 porcine kidney
epithelial cell line of control gilts and gilts administered ZEN doses of 5, 10, and 15 μg ZEN/kg BW.
Samples were collected on analytical dates 1, 2, and 3. A total of 100 cells was scored for each individual.
Mean results differ significantly from: a control group, b ZEN5 group, c ZEN10 group, and d ZEN15
group values in a given week and e, f, g between the same concentrations of ZEN on different dates;
ANOVA (p ≤ 0.05).
Significant differences (p ≤ 0.05) are indicative of genotoxicity (Figure 2—clear comet tail).
On analytical date 1, an increase was observed in groups ZEN10 and ZEN15, in which mean values
reached 40.0% ± 7.5% and 45.6% ± 7.4%, respectively, relative to groups C and ZEN5 (Figure 1),
in which mean values were determined 19.8% ± 5.44% and 24.1% ± 6.26%, respectively.
On analytical date 2, %DNAT values were significantly less scattered across groups, but they
were significantly more scattered in groups ZEN10 and ZEN15 (30.2% ± 3.9% and 32.2% ± 4.7%,
respectively) relative to group C (21.8% ± 3.15%) and even more scattered relative in group ZEN5
(19.2% ± 4.25%) (p ≤ 0.05). These data indicate that genotoxic processes took place in groups ZEN10
and ZEN15, but not in groups C or ZEN5.
On analytical date 3, %DNAT was determined at 20.7% ± 3.67% in group C. In the LLC-PK1 cell
line, %DNAT values in group ZEN5 increased in the range of 26.5% ± 3.3% to 43.3% ± 3.3%, with a
mean value of 34.9% ± 6.2%. In group ZEN10, mean genotoxicity was determined at 22.6% ± 3.7%
%DNAT, and it was lower than on dates 1 and 2 (40.0% ± 7.5% and 30.2% ± 3.9%, respectively)
(p ≤ 0.05). In group ZEN15, %DNAT ranged from 27.0% ± 9.6% to 45.9% ± 9.34% (Figure 1), with a
mean value 36.6% ± 4.7%.
The values of correlation coefficients (Pearson’s r) (Table 1) were calculated based on the
relationship between the percentage of cells with damaged DNA and the percentage of DNA damage
in a cell on different analytical dates and in different groups.
Table 1. Correlation coefficients (Pearson’s r).
Analytical Date Group C Group ZEN5 Group ZEN10 Group ZEN15
1 0.29 0.29 0.52 0.61
2 0.45 0.16 0.41 0.08
3 0.26 0.07 0.44 0.46
Key: Ratio between the percentage of cells with damaged DNA and the percentage of DNA damage in a cell on
different analytical dates and in different groups: Group C—placebo; Group ZEN5—5 μg ZEN/kg BW, administered
once daily before morning feeding; Group ZEN10—10 μg ZEN/kg BW, administered once daily before morning
feeding; Group ZEN15—15 μg ZEN/kg BW, administered once daily before morning feeding. Samples were
collected immediately after euthanasia on three analytical dates (exposure days 7, 21, and 42).
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The results presented in Table 1 should be analysed in view of the strength of the observed
correlations [39]. The correlation is positive when r > 0. The strength of correlations is evaluated
on the following scale: r < 0.2—absence of a linear correlation; r = 0.2–0.4—weak correlation;
r = 0.4–0.7—moderate correlation; r = 0.7–0.9—relatively strong correlation; and r > 0.9—very strong
correlation. A weak correlation and a moderate correlation were noted in group C on two dates (very
low %DNAT, which is natural). In group ZEN5, a weak correlation was observed initially, followed by
an absence of linear correlations on two successive dates (very low %DNAT, which could suggest that
the analysed ZEN dose has protective effects). A moderate correlation was noted in group ZEN10
and in group ZEN15, but an absence of a linear correlation was noted on date 2 in group ZEN15.
Very low values of r in groups C and ZEN5 point to the presence of certain trends with some outliers.
Genotoxicity was confirmed when the values of r were closer to 1. The above was noted in group
ZEN15, but the observed trend was highly variable.
The electrophoresis of exposed cells revealed an absence of comet tails (even short tails) and
nearly symmetrical comets in groups C and ZEN5 (Figure 2A). Groups ZEN10 and ZEN15 were
characterized by comets with relatively long and long tails with damaged DNA, respectively
(Figure 2B). These comets had very long tails and small heads. Their density (number of comets
per slide) was considerably lower than in group C.
 
Figure 2. Typical images of DAPI-stained (4′,6-diamidino-2-phenylindole) comets: (A) group C; and (B)
group ZEN15 on analytical date 1.
2.5. Histograms of Endogenous DNA Damage
The distribution of LLC-PK1 cells based on the percentage of damaged DNA in the comet tail is
presented in Figure 3. In group C, maximum %DNAT values were distributed in columns 5% or 10%
on date 1 (Figure 3A), in columns 5% or 15% on date 2 (Figure 3E), and in columns 10% or 15% on date
3 (Figure 3I). The maximum percentage of cells with damaged DNA was relatively low (below 20%).
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Figure 3. Histograms illustrating the distribution of endogenous DNA damage, measured as the mean
%DNAT of porcine kidney epithelial cells (LLC-PK1 cell line) in: group C (A,E,I), CW of gilts fed with
group ZEN5 (B,F,J), group ZEN10 (C,G,K) and group ZN15 (D,H,L). Analytical dates—date 1 (A–D),
date 2 (E–H) and date 3 (I–L). A total of 100 cells were scored for each individual.
The distribution of cells with damaged DNA was similar in group ZEN5, in columns 5–15%
(Figure 3B,F,J). On the first two analytical dates, %DNAT values were distributed in columns 5% or
10% (Figure 3B,F), and on date 3–in columns 10% or 15% (Figure 3J). On date 2, the maximum number
of cells with damaged DNA exceeded 20% (Figure 3F), but it was noted in column 5%.
In groups ZEN10 and ZEN15, the maximum percentage of cells was very low (<10) on analytical
date 1 (Figure 3C,D), but maximum %DNAT was distributed in columns 35% or 40% in group
ZEN10 and in columns 30% or 35% in group ZEN15 (Figure 3C,D, respectively). In group ZEN10,
the maximum percentage of cells with damaged DNA increased to 14% on date 2 (Figure 3G) and
to nearly 20% on date 3 (Figure 3K). The maximum %DNAT values were distributed in columns
10% or 15% on date 2 (Figure 3G) and in columns 5% or 10% on date 3 (Figure 3K). In group ZEN15,
the maximum percentage of cells with damaged DNA was estimated at 10% on analytical dates 2 and
3 (Figure 3H,L, respectively). The maximum %DNAT values were distributed in columns 15% or 25%
on date 2 (Figure 3H) and in columns 5% or 10% on date 3 (Figure 3L).
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3. Discussion
Zearalenone ingested with feed can lead to endocrinological disorders in humans and animals.
Zearalenone is a macrocyclic β-resorcylic acid lactone with distinctive estrogen activity. Previous
studies into the metabolism of ZEN revealed the presence of reducing metabolites, in particular
α-zearalenol and its stereoisomer β-zearalenol. During the synthesis of these catechol metabolites, ZEN
activity becomes similar to that of endogenous estrogens E2 and E1. These promiscuous steroids [40]
and steroid-like substances are associated with the risk of bowel cancer [41], breast cancer [35],
uterine cancer [9], and malignant changes in other estrogen-sensitive organs [21]. There is evidence
to indicate that E2/E1 catechol metabolites are weak genotoxins that contribute to malignant
transformations by producing quinones that generate DNA adducts [42]. Catechol production is the
main metabolic pathway of ZEN and its metabolites in many mammals [43], including humans [44].
The above could suggest that even small doses of ZEN contribute to CW genotoxicity [25].
In this experiment, the tested ZEN doses confirmed that dose plays an important role during
exposure to undesirable compounds. The above is validated by the results of the statistical analysis,
which revealed a significant increase (p < 0.05) in CW genotoxicity on different analytical dates.
The only exception was date 1 (exposure day 7) when maximum %DNAT values reached 39.8% ± 4.0%
in group ZEN10 and 45.6% ± 4.8% in group ZEN15. The above results were among the highest
%DNAT values noted in the experiment. The distribution of LLC-PK1 cells in groups C and ZEN5
based on their %DNAT values in comet tails ranged from 15% to 20%, which is a very low result when
negative control values are subtracted (4.1%). These findings could point to the absence of genotoxicity
in group ZEN5.
Similar observations were made in an analysis of the correlations between the percentage of cells
with damaged DNA to the percentage of DNA damage in a cell (Pearson’s r) (Table 1). On analytical
date 1, r values were equally low in group ZEN5 and in group C, which could validate the hypothesis
that small amounts of undesirable substances are not detected by the body (similarly to the T-regs
theory, which postulates that T-regs do not respond to small amounts of infectious factors) [23].
Zearalenone was recognised by the body only on analytical date 3, as in group C. The proposed MABEL
dose probably approximated threshold values [25,26]. It should also be noted that pre-pubertal gilts
are characterised by physiological hypoestrogenism [21] when the demand for estrogens exceeds
supply. As an exogenous estrogen, ZEN (mycoestrogen) can be utilized by the body to exert protective
effects. Interestingly, r values in group ZEN5 continued to decrease on successive analytical dates
(Table 1), which could indicate that the MABEL dose (5 μg ZEN/kg BW) exerted a protective effect on
gilts throughout the experiment.
In contrast, the values of r observed in groups ZEN10 (10 μg/kg BW—NOAEL) and ZEN15
(15 μg/kg BW—LOAEL) on date 1 point to hyperestrogenism, namely, the presence of “free” ZEN
in the body. Hyperestrogenism increases %DNAT values, namely, the percentage of comets with
much longer tails and small heads (Figure 2B) whose density was significantly lower than in group
C (Figure 2A). The above suggests that CW genotoxicity, preceded by oxidative damage and mitotic
spindle dysfunction, is induced already by the NOAEL dose (10 μg ZEN/kg BW) [42]. The above
is generally accompanied by a host of genotoxic effects in CW, including intensified Ca2+ transfer
to cells [45] and changes in the activity of selected hydroxysteroid dehydrogenase enzymes [46],
which can lead to steroidogenesis disorders [19].
The ZEN doses administered to groups ZEN10 and ZEN15 induced CW genotoxicity, but the
observed correlations were moderate (r = 0.4 to 0.7, Table 1) with a decreasing trend (Figure 3).
According to Błasiak et al. [47], the results of the comet assay should be analysed based on the
distribution of cells based on damage to their DNA (histograms) to determine the susceptibility of
individual cells to DNA damage. The histograms illustrating the distribution of damage to endogenous
DNA (Figure 3G,H,K,L) in the experimental cells differ significantly between groups. On analytical
date 1, the histograms for groups ZEN10 and ZEN15 (Figure 3C,D) were very strongly shifted toward
higher values (from 20% to 65%). On date 2, the extent of DNA damage decreased 1.3- to 1.4-fold
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relative to date 1. On the last two analytical dates, the histograms for groups ZEN10 and ZEN15
were significantly flattened and shifted toward higher values in comparison with the histograms
for groups C and ZEN5 (Figure 3H,L). This could imply that under exposure to higher ZEN doses,
genotoxic processes in CW are initially more expressed and can provoke clinical symptoms. On
successive days of exposure, genotoxic processes in CW were still more pronounced than in groups C
and ZEN5. The above could be attributed to the fact that in gilts exposed to ZEN, the carry-over of
ZEN to tissues other than the intestines [20], the initiation of biotransformation processes in the liver,
the detoxifying activity of gut microbiota [48], and the conversion of modified mycotoxins to a free
form in the colon [3] proceeded at a faster rate than the destruction of DNA in the caecal epithelium.
The results of this study suggest that ZEN has a damaging effect on cells cultured in vitro and,
most importantly, on cells on the organism of gilts. The values corresponding to the percentage of DNA
breaks in cells were highly scattered. On successive days of exposure to ZEN, damage histograms
were flattened and shifted toward lower values in groups C and ZEN5 and were shifted toward higher
values in groups ZEN10 and ZEN15, which indicates that the counter response in the porcine model is
influenced by the amount of ZEN ingested with feed.
The present results support the formulation of two hypotheses. The first hypothesis postulates the
presence of a compensatory effect based on the values of r in groups ZEN10 and ZEN15, which were
higher on analytical date 1 than on successive days of exposure. The second hypothesis states that the
proposed MABEL dose is not genotoxic, but further research is needed to confirm this observation.
4. Conclusions
The results of this study, which investigated CW genotoxicity, indicate that very small doses of
ZEN (LOAEL, NOAEL, and MABEL) induce a counter response and a compensatory effect in the
porcine model. The extent of DNA damage was proportional to the administered mycotoxin dose.
Our findings suggest that the MABEL dose could be used for preventive purposes in pre-pubertal gilts.
5. Materials and Methods
5.1. In Vivo Study
5.1.1. General Information
All experimental procedures involving animals were carried out in compliance with Polish
regulations setting forth the terms and conditions of animal experimentation (Opinions No. 12/2016
and 45/2016/DLZ of the Local Ethics Committee for Animal Experimentation of 27 April 2016 and
30 November 2016).
5.1.2. Experimental Animals and Feed
The in vivo experiment was performed at the Department of Veterinary Prevention and Feed
Hygiene of the Faculty of Veterinary Medicine at the University of Warmia and Mazury in Olsztyn
on 60 clinically healthy pre-pubertal gilts with initial BW of 14.5 ± 2 kg. The animals were housed in
pens with free access to water. All groups of gilts received the same feed throughout the experiment.
They were randomly assigned to three experimental groups (group ZEN5, group ZEN10, and group
ZEN15; n = 15) and a control group (group C; n = 15) [49,50]. Group ZEN5 gilts were orally
administered ZEN (Z2125-26MG, Sigma-Aldrich, St. Louis, MO, USA) at 5 μg ZEN/kg BW, group
ZEN10 pigs–10 μg ZEN/kg BW, and group ZEN15 pigs–15 μg ZEN/kg BW. Analytical samples of
ZEN were dissolved in 96 μL of 96% ethanol (SWW 2442-90, Polskie Odczynniki SA, Poland) in
weight-appropriate doses. Feed containing different doses of ZEN in an alcohol solution was placed
in gel capsules. The capsules were stored at room temperature before administration to evaporate
the alcohol. In the experimental groups, ZEN was administered daily in gel capsules before morning
feeding. The animals were weighed at weekly intervals, and the results were used to adjust individual
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mycotoxin doses. Feed was the carrier, and group C pigs were administered the same gel capsules but
without mycotoxins.
The feed administered to all experimental animals was supplied by the same producer.
Friable feed was provided ad libitum twice daily, at 8:00 a.m. and 5:00 p.m., throughout the experiment.
The composition of the complete diet, as declared by the manufacturer, is presented in Table 2.
Table 2. Declared composition of the complete diet.







Vitamin-mineral premix 1 2.5
1 Composition of the vitamin-mineral premix per kg: vitamin A–500.000 IU; iron–5000 mg; vitamin D3–100.000
IU; zinc–5000 mg; vitamin E (alpha-tocopherol)–2000 mg; manganese–3000 mg; vitamin K–150 mg; copper
(CuSO4·5H2O)–500 mg; vitamin B1–100 mg; cobalt–20 mg; vitamin B2–300 mg; iodine–40 mg; vitamin B6–150 mg;
selenium–15 mg; vitamin B12–1500 μg; L-lysine–9.4 g; niacin–1200 mg; DL-methionine+cystine–3.7 g; pantothenic
acid–600 mg; L-threonine–2.3 g; folic acid–50 mg; tryptophan–1.1 g; biotin–7500 μg; phytase+choline–10 g;
ToyoCerin probiotic+calcium–250 g; antioxidant + mineral phosphorus and released phosphorus–60 g; magnesium–5
g; sodium; calcium–51 g.
The proximate chemical composition of diets fed to pigs in groups C, ZEN5, ZEN10,
and ZEN15 was determined using the NIRS™ DS2500 F feed analyser (FOSS, Hillerød, Denmark),
a monochromator-based NIR reflectance and transflectance analyser with a scanning range of
850–2500 nm.
5.1.3. Toxicological Analysis
Feed was analysed for the presence of ZEN and DON by high-performance liquid chromatography
with UV–vis detection (HPLC-UV). The obtained values did not exceed the limits of quantitation
(LOQ) of 2 ng/g for ZEN and 5 ng/g for DON based on the validation of chromatographic methods
for the determination of ZEN and DON levels in feed materials and feeds, which was performed at the
Department [51].
5.1.4. Sampling for In Vitro Tests
Five gilts from every group were euthanized on analytical date 1 (exposure day 7), date 2 (exposure
day 21), and date 3 (exposure day 42) by intravenous administration of pentobarbital sodium (Fatro,
Ozzano Emilia BO, Italy) and bleeding. Sections of intestinal tissues were collected immediately
after cardiac arrest and were prepared for analyses. Caecal water samples for in vitro analysis were
collected from a 10-cm-long intestinal fragment resected from the ileocecal region and the colon.
Intestinal segments were tied at both ends before resection to avoid tissue damage. The resected
fragments were transported to the laboratory, and CW samples were analysed.
5.2. In Vitro Study
The in vitro experiment was performed at the Institute of Fermentation Technology and
Microbiology, Lodz University of Technology in Lodz.
5.2.1. Caecal Water Preparation
Caecal water samples were collected in plastic containers. Freshly obtained caecal contents
(20%) were mixed with sterile phosphate-buffered saline (PBS, pH 7.2) (80%), homogenised for 2 min,
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and centrifuged (10,700× g, 40 min, 4 ◦C). The supernatant fractions were filtered (0.45 μm pore size,
Merck–Millipore, Darmstadt, Germany) and stored at −20 ◦C until analysis.
5.2.2. Cell Culture and Treatment
The LLC-PK1 porcine kidney epithelial cell line (Cell Lines Service, Eppelheim, Germany) from
38 passage was used in the research. This cell line is often used to test the genotoxicity and cytotoxicity
of mycotoxins [36,52].
The cells were cultured in T75 flasks (Roux type) (Becton, Dickinson and Co., Franklin Lakes,
NJ, USA) as a monolayer in Dulbecco’s Modified Eagle’s Medium/Ham’s F12 (DMEM/Ham’s
F12, 1:1; Cell Lines Service, Eppelheim, Germany) with 5% foetal bovine serum (FBS, Cell Lines
Service, Eppelheim, Germany), supplemented with 2 mM L-glutamine (Cell Lines Service, Eppelheim,
Germany) and HEPES (Cell Lines Service, Eppelheim, Germany). The cells were incubated in a
CO2 incubator (Galaxy 48S, New Brunswick, UK) at 37 ◦C under 5% CO2 atmosphere for 7 days,
until confluence. The cells were sub-cultivated, and the medium was changed every 2–3 days.
LLC-PK1 cells were detached with TrypLETM Express (Gibco, Thermo Fisher Scientific, Waltham,
MA, USA) for 20 min and gently shaken off the plastic flask. According to the manufacturer’s
instructions, neutralisation with FBS is not required for reagents of the plant origin. After detaching,
the cell suspension in PBS (Sigma-Aldrich, St. Louis, MO, USA) was transferred to a Falcon tube,
centrifuged (182× g, 5 min), decanted, and resuspended in fresh medium. Cell counts and viability
were determined by trypan blue exclusion assay (min. 90%), and the cells were ready to use.
5.2.3. Comet Assay—Single Cell Gel Electrophoresis Assay (SCGE)
The final concentration of LLC-PK1 cells in each sample was adjusted to 105 cells/mL. The cells
were incubated with CW (20%, v/v) at 37 ◦C for 1 h. The cells were incubated in a medium without
FBS to avoid interactions between FBS and the mycotoxin.
The comet assay was performed under alkaline conditions (pH > 13) according to Błasiak and
Kowalik [53], as described previously [33]. After incubation, the cells were centrifuged (182× g, 15 min,
4 ◦C), decanted, suspended in 0.75% low melting point (LMP) agarose (Sigma-Aldrich, St. Louis,
MO, USA), layered onto slides precoated with 0.5% normal melting (NMP) agarose (Sigma-Aldrich,
St. Louis, MO, USA), and lysed at 4 ◦C for 1 h in a buffer consisting of: 2.5 M NaCl, 1% Triton X-100,
100 mM EDTA and 10 mM Tris, pH 10. Next, the slides were placed in an electrophoresis unit, and DNA
was allowed to unwind for 20 min in an unwinding buffer containing 300 mM NaOH and 1 mM
EDTA. Electrophoresis was conducted at 4 ◦C for 20 min at field strength of 0.73 V/cm (300 mA) in
electrophoretic buffer containing 30 mM NaOH and 1 mM EDTA. Then, the slides were neutralised
(0.4 mol/L Tris), stained with 1 μg/mL 4′,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich, St. Louis,
MO, USA), and covered with cover slips. The slides were analysed at 200× magnification under a
fluorescence microscope (Nikon, Tokyo, Japan) connected to a digital camera (Nikon Digital Sight
DS-U3, Tokyo, Japan) and the Lucia-Comet v. 7.0 digital image analysis system (Laboratory Imaging,
Prague, Czech Republic). One hundred images were randomly selected from each sample, and %DNAT
was determined as a measure of DNA damage.
5.2.4. Statistical Analysis
Comet assay data were analysed by two-way analysis of variance (ANOVA), and mode of
interaction × time was used to compare the effects induced by the chemicals in the analysed mode
of interaction. Differences between samples with normal distribution were evaluated. ANOVA
was performed using OriginPro 6.1 software (OriginLab Corporation, Northampton, MA, USA).
Dose–response relationships were determined by Pearson’s correlation. Differences were regarded as
significant at p ≤ 0.05. The results were presented as means ± standard error of the mean (S.E.M.).
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proliferative activity of immunocompetent cells in the jejunal and iliac lymph nodes of prepubertal female
wild boars diagnosed with mixed mycotoxicosis. B. Vet. I. Pulawy 2015, 59, 197–203. [CrossRef]
12. Vandenberg, L.N.; Colborn, T.; Hayes, T.B.; Heindel, J.J.; Jacobs, D.R.; Lee, D.-H.; Shioda, T.; Soto, A.M.;
vom Saal, F.S.; Welshons, W.V.; et al. Hormones and endocrine-disrupting chemicals: Low-dose effects and
nonmonotonic dose responses. Endocr. Rev. 2012, 33, 378–455. [CrossRef] [PubMed]
13. Grenier, B.; Applegate, T.J. Modulation of intestinal functions following mycotoxin ingestion: Meta-analysis
of published experiments in animals. Toxins 2013, 5, 396–430. [CrossRef] [PubMed]
14. Hickey, G.L.; Craig, P.S.; Luttik, R.; de Zwart, D. On the quantification of intertest variability in ecotoxicity
data with application to species sensitivity distributions. Environ. Toxicol. Chem. 2012, 31, 1903–1910.
[CrossRef] [PubMed]
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Abstract: Type B trichothecene mycotoxin deoxynivalenol (DON) is one of the most frequently
occurring food contaminants. By inducing trans-activation of a number of pro-inflammatory cytokines
and increasing the stability of their mRNA, trichothecene can impair intestinal health. Several yeast
products, especially Saccharomyces cerevisiae, have the potential for improving the enteric health of
piglets, but little is known about the mechanisms by which the administration of yeast counteracts
the DON-induced intestinal alterations. Using a pig jejunum explant model, a whole-transcriptome
analysis was performed to decipher the early response of the small intestine to the deleterious
effects of DON after administration of S. cerevisiae boulardii strain CNCM I-1079. Compared to the
control condition, no differentially expressed gene (DE) was observed after treatment by yeast only.
By contrast, 3619 probes—corresponding to 2771 genes—were differentially expressed following
exposure to DON, and 32 signaling pathways were identified from the IPA software functional
analysis of the set of DE genes. When the intestinal explants were treated with S. cerevisiae boulardii
prior to DON exposure, the number of DE genes decreased by half (1718 probes corresponding to
1384 genes). Prototypical inflammation signaling pathways triggered by DON, including NF-κB
and p38 MAPK, were reversed, although the yeast demonstrated limited efficacy toward some
other pathways. S. cerevisiae boulardii also restored the lipid metabolism signaling pathway, and
reversed the down-regulation of the antioxidant action of vitamin C signaling pathway. The latter
effect could reduce the burden of DON-induced oxidative stress. Altogether, the results show that S.
cerevisiae boulardii reduces the DON-induced alteration of intestinal transcriptome, and point to new
mechanisms for the healing of tissue injury by yeast.
Keywords: deoxynivalenol; Saccharomyces cerevisiae boulardii CNCM I-1079; intestine; transcriptome;
inflammation; oxidative stress; lipid metabolism
Key contribution: Saccharomyces cerevisiae boulardii reduces the transcriptional impact of
deoxynivalenol on the intestine. The yeast strain is particularly effective in signaling pathways
associated with (i) inflammation; (ii) oxidative stress; and (iii) lipid metabolism.
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1. Introduction
The intestine has been identified as one of the critical targets of the food-borne mycotoxins [1,2].
Trichothecene (TCT) mycotoxin deoxynivalenol (DON) causes intestinal immune alterations which
mimick inflammatory bowel diseases [3–5]. At the molecular level, the binding of DON or other
TCTs to the ribosome activates mitogen-activated kinases (MAPKs), and also induces trans-activation
of a number of pro-inflammatory cytokines, and an increase of the stability of their mRNA [6,7].
We showed that the frequently reported co-exposure to DON and other TCT could result in a synergistic
inflammatory response of the intestinal tissue [8–10].
Among the ways to tackle the variety of factors threatening intestinal health, probiotics are
considered good candidates, since they not only suppress the growth and binding of pathogenic
bacteria, as well as improving the barrier function of the intestinal epithelium, but also tune the immune
activity of the host [11,12]. Several yeast products are listed under the EC Regulation N.1831/2003 as
feed additives for pigs in the EU; Saccharomyces cerevisiae in particular has demonstrated its potential
for improving enteric health of piglets [13,14]. It was also recently shown that the yeast culture additive
reduces immune and liver damage in pigs induced by a DON and aflatoxin contaminated diet [15].
Little is known about the mechanisms by which S. cerevisiae improves intestinal health.
Preliminary in vitro data obtained in human monocytic, colonic, and gastric epithelial cells suggest that
S. cerevisiae boulardii decreases inflammation by inhibiting NF-κB-mediated IL-8 gene expression [16].
Regarding DON-induced alterations, S. cerevisiae boulardii decreases the activation of p38 MAPK
pathway, and reduces the expression of downstream inflammatory cytokines; this yeast also promotes
the expression of anti-apoptotic genes, and inhibits apoptosis in porcine alveolar macrophage cells [17].
In order to understand the early response of the small intestine to the administration of
S. cerevisiae boulardii in response to the deleterious effects of DON, a whole transcriptome analysis
of intestinal tissue was performed. Pre-treatment of the intestinal tissue with the yeast significantly
reduced the global impact of DON on the transcriptome, and reversed prototypical inflammation
signaling pathways including NF-κB and p38 MAPK. The yeast also restored the lipid metabolism
signaling pathway and reverted the down-regulation of the antioxidant action of the vitamin C
signaling pathway.
2. Results and Discussion
2.1. S. cerevisiae boulardii Reduces the Transcriptomic Impact of DON on the Intestine
To analyze the ability of S. cerevisiae boulardii to counteract the intestinal effect of DON, a pan
genomic analysis of the transcriptomic fingerprint was conducted in control jejunal explants, explants
treated with the yeast, and explants challenged with 10 μM DON in the presence, or absence,
of S. cerevisiae boulardii. In human gut, concentrations of 0.16–2 μg DON/mL (0.5–7 μM) are
considered realistic [8]. The lowest concentration value corresponds to the mean estimated daily intake
of French adult consumers on a chronic basis. The highest concentration value simulates levels that can
be reached after the consumption of heavily contaminated food, as can be occasionally encountered.
Animals, especially pigs, can be exposed to higher concentrations of DON. Assuming that DON is
ingested in one meal, diluted in 1 L of gastrointestinal fluid, and is totally bio accessible, the in vitro
concentration of 10 μM used in this study corresponds to feed contaminated with 3 mg DON/Kg [18].
In a recent scientific opinion, EFSA reported levels of DON in feed grains of up to 9.5 mg/kg [19].
Regarding the use of S. cerevisiae boulardii, the EFSA expert panel concluded that the additive has
the potential to be efficacious in weaned piglets at a dose of 2 × 109 CFU/kg feed [20]. The yeast
concentration used in this study was chosen to reflect the recommended dose.
A total of 4398 transcripts, out of the 40,726 tested, were differentially expressed in at least one
of the treatments when compared to control samples (adjusted p value < 0.05). As expected, and as
shown on the heatmap (Figure 1), exposure of the intestinal tissue to DON resulted in clear alteration
of the transcriptome. Hierarchical clustering indicated that control and S. cerevisiae boulardii-treated
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intestinal tissue samples separated from DON and DON + yeast treated groups. In comparison with
the control, 3619 probes—corresponding to 2771 genes—were differentially expressed (DEG) (adjusted
p value < 0.05) following exposure to DON, with fold-change values ranging from −3.43 to 11.44.
No DEG was observed for the yeast condition (Figure 2A).
The top-regulated genes are listed in Table 1. As previously reported, the top-up regulated genes
in intestinal explants exposed to DON were mainly related to inflammation [10,21,22]. The most
up-regulated genes include interleukin 1 alpha and beta (IL-1α and IL-1β) and interleukin 22 (IL-22),
the macrophage inflammatory proteins genes MIP-2 alpha and MIP-3 alpha (also known as CXCL2
and CCL20), the receptor for MIP-3 beta chemokine gene (CCR7), the positive regulatory domain
I-binding factor 1 gene (PRDM1) which drives the maturation of B-lymphocytes into Ig secreting cells,
and the A disintegrin and metalloproteinase with thrombospondin motifs gene (ADAMTS) which
may be associated with various inflammatory process. The amphiregulin gene (AREG), which can be
expressed by multiple populations of activated immune cells under inflammatory conditions, was also
up-regulated. Other genes in the top up-regulated category included FOSL-1, which regulates cell
proliferation, differentiation, or transformation, PLK-2, which may play an important role in cells
undergoing rapid cell division, and the transcriptional co-activator/repressor IFRD1, which controls
the growth and differentiation of specific cell types.
Figure 1. Gene expression profiles of intestinal explants exposed to DON or FX. Heatmap representing
differentially expressed probes between the control, DON, S. cerevisiae boulardii and DON + S. cerevisiae
boulardii conditions. Jejunal explants from six different animals were exposed for four hours to
DMSO (vehicle), or treated with a S. cerevisiae boulardii suspension, or exposed to 10 μM DON.
Gene expression was analyzed with a 60 K microarray. Red and green indicate values above and below
the mean (average Z-score), respectively. Black indicates values close to the mean.
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Figure 2. (A) Differentially expressed probes on the microarray for the yeast, mycotoxin, and yeast
administration followed by mycotoxin exposure conditions; (B) Venn diagram of differentially expressed
genes in the intestinal tissue after DON exposure or S. cerevisiae boulardii administration followed by
DON exposure. CTRL represents DMSO control.
Table 1. Top-20 up- and down-regulated genes in the DON and the DON + S. cerevisiae boulardii
conditions of the microarray experiment.














IL-1β 11.37 6.27 × 10−13 IL-1β 9.56 6.01 × 10−12
IL-22 5.62 3.24 × 10−8 IL-22 5.56 7.73 × 10−8
NOR-1 5.09 1.07 × 10−9 PTGS2 3.96 1.32 × 10−6
PTGS2 5.01 3.63 × 10−8 IL-1α 3.96 2.90 × 10−8
CXCL2 4.65 0.00045897 CCL20 3.96 3.85 × 10−7
IL-1α 4.17 5.78 × 10−9 NOR-1 3.88 7.73 × 10−8
CCL20 4.17 8.96 × 10−8 CXCL2 3.22 0.01419023
CCR7 3.36 1.36 × 10−7 IL8 2.95 0.0004445
HAMP 3.34 2.46 × 10−5 ARX 10G 2.87 7.48 × 10−7
PLK2 3.28 1.02 × 10−11 PRDM1 2.86 8.79 × 10−12
AREG 3.26 7.49 × 10−8 FOSL1 2.82 0.00026329
PRDM1 3.17 6.27 × 10−13 GADD45G 2.7 9.54 × 10−6
FOSL1 3.11 4.71 × 10−5 CCR7 2.63 1.35 × 10−5
CSF2 2.93 4.60 × 10−5 PLK2 2.6 2.32 × 10−9
ADAMTS1 2.92 9.33 × 10−10 GADD45A 2.6 2.12 × 10−6
CRSP-2 2.9 1.31 × 10−5 PRDM1 2.59 9.84 × 10−10
CD274 2.74 3.47 × 10−7 ATF3 2.57 4.04 × 10−6
RRAD 2.73 0.00150172 PLK2 2.5 3.89 × 10−9
IFRD1 2.66 1.47 × 10−8 RND1 2.48 3.07 × 10−6
GADD45G 2.64 7.57 × 10−6 HAMP 1.31 0.001954
170
Toxins 2018, 10, 199
Table 1. Cont.














CTBS −3.43 0.0323898 ACTN2 −4.83 0.03632277
C1QTNF3 −2.38 0.02819327 ACTA1 −4.28 0.03241036
PDLIM3 −2.2 0.04545171 TPM2 −2.88 0.04875964
BTC −2 0.04718046 TPM1 −2.81 0.04897366
TMEFF2 −1.97 0.02364126 MYL9 −2.66 0.04636262
HAND1 −1.89 0.04906228 LIMS2 −2.57 0.04897366
SMPX −1.82 0.01890697 MYLK −2.53 0.04955867
BPI −1.76 0.03066332 C1QTNF3 −2.49 0.03403947
LYZ −1.72 0.02546107 SPOCK3 −2.41 0.02910998
LECT1 −1.7 0.04314249 BTC −2.26 0.04788811
ASPN −1.67 0.04519455 TPM1 −2.23 0.04179965
OGN −1.66 0.03041459 HAND1 −2.2 0.02447994
RYR2 −1.64 0.03593429 FLNA −2.1 0.03855459
DSTN −1.64 0.00936255 TMX 10FF2 −2.03 0.02907563
FHL1C −1.63 0.0438132 CPXM2 −2.02 0.02989774
CXCL12 −1.63 0.01364805 DNAJA4 −1.94 0.01272008
CYP4F2 −1.59 0.04673074 PRUNX 102 −1.86 0.0392422
ITGB1BP2 −1.59 0.0354242 SMARCD3 −1.83 0.04490504
ACTB −1.59 0.02928137 FHL1C −1.81 0.02399939
MATN2 −1.59 0.0065206 ATP2B4 −1.81 0.04252773
* Fold change compared to DMSO control.
The treatment of the intestinal explants with S. cerevisiae boulardii prior to DON exposure
decreased the number of DEGs by 50%, as only 1384 genes (1718 probes) were differentially expressed
in DON + yeast treated explants (Figure 2A). Nevertheless, the top up-regulated genes in the jejunal
tissue treated with either DON alone, or S. cerevisiae boulardii prior to DON exposure, were very
similar, and inflammation remained the hallmark of the intestinal transcriptome. It is worthy of note
that, except for growth arrest and DNA damage-inducible protein gamma gene (GADD45G), the 15
other genes expressed in both experimental conditions were slightly less expressed in the DON + yeast
condition (Table 1).
Microarray data validation was performed by quantitative real-time polymerase chain reaction
(qPCR) on a set of 12 DE genes in DON and DON + yeast conditions. A significant Spearman correlation
coefficient (r = 0.896) was observed between the two techniques (Supplementary Figure S1), confirming
the reliability of the transcriptome analyses.
2.2. Functional Analysis of the Intestinal Transcriptome Modulation by DON and/or S. cerevisiae boulardii
To further investigate the protective effect of S. cerevisiae boulardii, a comparative functional
analysis of DEGs in DON and DON + yeast conditions was performed using the core analysis
comparative function of Ingenuity Pathway Analysis (IPA) software.
Figure 3 shows that 32 canonical pathways were significantly affected in the jejunal tissue exposed
to DON (p-value < 0.05, −2 > IPA Z-score > +2). As previously described, the foremost up-regulated
signaling pathways in the DON condition, including HMGB1 signaling, IL-6, IL1, TNFR1, p38 MAPK,
and TREM1 signaling, were related to immunity/inflammation [21]. The B-cell activating factor, B-cell
receptor signaling, and the NF-κB signaling pathway, which not only regulates inflammation and
immunity, but also cell survival and cell proliferation, were also up-regulated by DON. Likewise,
intestinal exposure to DON resulted in the down regulation of the PPAR and the LXR/RXR activation
signaling pathways, which control diverse aspects of cholesterol and fatty acid homeostasis [21,23].
Lastly, a DON-induced oxidative stress in the intestinal tissue was reflected by down-regulation of the
antioxidant action of the vitamin C signaling pathway.
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Applying S. cerevisiae boulardii to the jejunal tissue prior to DON exposure reduced the number
of activated canonical pathways from 32 to 13 (Figure 3). In fact, only eight out of the 32 canonical
pathways triggered by DON really withstood the protective effects of S. cerevisiae boulardii, and five
new signaling pathways emerged from a set of DEGs specific to the interaction between DON and yeast
on the treated explants (Figures 2B and 3). The pathways expressed in both DON and yeast + DON
conditions were the hypoxia signaling, IL-1 signaling, TREM1 signaling, STAT3, the VDR/RXR
activation, the LPS/IL-1 mediated inhibition of RXR function, the coagulation system pathway,
and the IL-17F pathway in allergic inflammatory diseases. The interaction between DON and
S. cerevisiae boulardii resulted in the down-regulation of integrin signaling, IGF-1 signaling, glioma
signaling, and the PPARa/RXRa activation pathway, as well as the up-regulation of insulin receptor
signaling; in contrast, none of these pathways was affected when individually exposed to DON or
S. cerevisiae boulardii.
Aside from these few cases, the shutdown of the 24 other DON-triggered signaling pathways is
evidence that the yeast administration significantly restrained the detrimental effects of this mycotoxin
on the intestine. The application of S. cerevisiae boulardii was particularly effective on signaling
pathways associated with (i) inflammation, (ii) oxidative stress, and (iii) lipid metabolism.
2.3. S. cerevisiae boulardii Reduces the Pro-Inflammatory Effects of DON
Only four out of 19 inflammation/immunity signaling pathways triggered by DON were still
observed in explants treated with S. cerevisiae boulardii prior to DON exposure. These four signaling
pathways were IL-1 and TREM signaling, the LPS/IL-1 mediated inhibition of RXR function, as well as
the role of IL-17 in allergic inflammatory disease pathway. Treatment with S. cerevisiae boulardii
prevented the triggering of other inflammation pathways including HMGB1 signaling, TNFR1
signaling, and the IL-6 signaling pathway, as well as the pivotal NF-kB signaling and p38 MAPK
signaling pathways.
HMGB1 belongs to a family of endogenous compounds termed “alarmins”, which can be
released in the extracellular milieu during states of cellular stress or injury leading to infectious
or non-infectious conditions [24]. IL-6 is generated upon activation of the pattern recognition receptors
(PRRs) by pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns
(DAMPs), in the case of infectious lesion or tissue damage [25]. The DON-induced ribotoxic stress
has been previously linked with ribosomal RNA cleavage, which could be the starting point of a
DAMP-mediated PRR activation of the IL-6 and HMGB1 signaling pathways in the intestine [26].
The hypothesis of cytosolic sensing of cleaved RNA is also supported by the triggering of both a
signaling pathway linked with the role of pattern recognition receptors in the recognition of bacteria
and viruses, and even more, by another pathway associated with the role of RIG1-like receptors in
antiviral innate immunity in presence of DON (Figure 3).
The p38 MAPK pathway is a key regulator of pro-inflammatory cytokines biosynthesis at the
transcriptional and translational levels, which makes it critical for normal immune and inflammatory
response [27]. In isolated porcine alveolar macrophage cells, S. cerevisiae boulardii was shown to
attenuate p38 MAPK signaling by alleviating DON-induced phosphorylation and mRNA expression of
p38 MAPK protein [17]. A comparison of the activation patterns of the different genes involved in the
p38 MAPK in both DON-exposed tissue and S. cerevisiae boulardii treated tissue before DON exposure
(Figure 4) shows that the remediation action of S. cerevisiae boulardii involves many more mechanisms
in all the cellular compartments. First, the yeast counteracts the DON-induced upregulation of
the transmembrane receptors IL-1R and TNFR/Fas, as well as its adaptor molecule FADD, both of
which transduce the triggering signals delivered by IL-1 cytokine and Fas ligand. In the cytosolic
compartment, pre-treatment with S. cerevisiae boulardii before DON exposure also leads to restoration
of the DON-induced downregulation of apoptosis signal-regulating kinase 1 (ASK1) and a member
of the cytosolic phospholipase A2 family (cPLA2), and up-regulation of the TNF receptor associated
factor 6 (TRAF6). Recent studies revealed the involvement of ASK1 in ROS- or ER stress related
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diseases, suggesting that ASK1 could be a therapeutic target [28]. The members of the cPLA2 family
catalyze the hydrolysis of phospholipids to yield fatty acids and lysophospholipids, and are involved in
inflammation by driving arachidonic acid metabolism [29]. Finally, in the intestinal tissue, S. cerevisiae
boulardii was also seen to downscale the DON-induced activation of the signal transducer and activator
of transcription 1 (STAT1), which translocates to the nucleus to promote expression of cytokine response
genes [30].
Figure 5 summarizes the effect of DON in the presence, or absence, of S. cerevisiae boulardii on
the NF-κB signaling pathway. Activation of NF-κB signaling via canonical or alternative pathways
regulates various biological processes, including immune response, inflammation, cell growth and
survival, and development [31]. We observed that upon intestinal exposure to DON, both canonical
and alternative NF-κB signaling pathways were activated. IL-1, TNF-α and bone morphogenetic
protein 2 (BMP2) primary signals converged to the nuclear translocation of the heterodimeric NF-κB
complex p50/RelA via activation of the catalytic IκB kinase subunits IKKα and IKKβ, while the
B-cell activating factor (BAFF) signal led to upregulation and subsequent nuclear translocation of
p52/RelB dimer. By contrast, neither p50/RelA, nor p52/RelB complexes showed up-regulation of gene
expression when the intestinal explants were treated with S. cerevisiae boulardii prior to DON exposure
(supplementary Table S1). Interestingly, administration of S. cerevisiae boulardii counteracts upstream,
the DON-induced upregulation of transmembrane receptors IL-1R/TLR, TNFR and CD40 and adaptor
molecules FADD, TRADD and TRAF, on the one hand, and on the other hand, the DON-induced
upregulation of BAFF. This suggests that S. cerevisiae boulardii may prevent the activation of the
canonical pathway of NF-κB signaling by altering the transduction of IL-1 and TNF-α primary signals,
and the activation of the alternative pathway by suppressing the initial BAFF signal.
To summarize, the administration of S. cerevisiae boulardii prevented the intestinal tissue from
the onset of several signaling pathways driving inflammation that is the hallmark of the low-dose
exposure to DON and other trichothecene mycotoxins.
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2.4. S. cerevisiae boulardii Reverses the Effect of DON on the Antioxidant Action of Vitamin C
The antioxidant action of the vitamin C signaling pathway was down-regulated in the intestinal
tissue following exposure to DON (Figure 6). Feeding a DON–contaminated feed to broiler chickens
has previously been shown to significantly up-regulate the expression of two sensitive markers of
oxidative injury, hypoxia inducible factor 1 subunit alpha (HIF-1α), and heme-oxygenase (HMOX),
in intestinal tissue [32]. Oxidative stress is one of the most important underlying mechanisms of the
toxicity of DON in eukaryotic cells, and two mechanisms (generation of reactive oxygen species (ROS)
and alteration in antioxidant status) have been reported for this mycotoxin [33,34]. Both mechanisms
are represented in Figure 6. The DON-induced cytokine signal transduction in the intestinal tissue
could generate ROS, while the antioxidant action of vitamin C is repressed. The protective effect of
vitamin C as a free radical scavenger warrants its use in the prevention of DON-mediated oxidative
stress [35]. Vitamin C can enter the cell directly via sodium-dependent ascorbate co-transporters
(SVCT); alternatively, GLUT transporters can carry dehydroascorbic acid that will be reduced to
vitamin C by enzymes such as thioredoxin reductase (TXN) and dehydroascorbic acid reductase
(DHA), once inside the cell [36]. Hence, by downregulating the TXN gene (Figure 6), DON could
impair the conversion of dehydroascorbic acid, and limit intracellular levels of vitamin C, leading to
lowered capacity for the inhibition of ROS-mediated events.
As shown by the microarray data in Table 1, and confirmed by the qRT-PCR data in Table 2 and
supplementary Table S2, the pre-treatment of the intestinal tissue with S. cerevisiae boulardii had a
limited effect on the DON induced up-regulation of cytokine expression, which means that the ROS
generation was preserved. Nonetheless, comparison of gene activation patterns in the antioxidant
action of vitamin C signaling pathway in the DON and DON + S. cerevisiae boulardii conditions
indicates that the yeast treatment counteracted the DON-induced down-regulation of TXN (Figure 6).
This highlights the fact that, although S. cerevisiae boulardii could not protect the intestinal tissue from
ROS generation, the probiotic helps restore intracellular vitamin C, and could downscale the burden
of the DON-induced oxidative stress via ROS generation.
Table 2. Expression of key inflammatory genes in the DON and the DON + S. cerevisiae boulardii
conditions in microarray and qRT-PCR experiments.

















IL-1β 11.37 6.27 × 10−13 6.08 9 × 10−4 9.56 6.01 × 10−12 4.96 0.0089
IL-22 5.62 3.24 × 10−8 5.88 0.0791 5.56 7.73 × 10−8 3.65 0.0964
IL8 2.22 0.0081 3.13 1.8 × 10−4 2.95 4.45 × 10−4 2.91 0.0025
IL17A 2.28 2.4 × 10−4 7.62 0.0022 1.81 0.0025 1.75 0.018
TNF-α 2.07 1.82 × 10−7 2.99 0.0085 1.71 6.14 × 10−5 1.61 0.01
* Fold change compared to DMSO control in the microarray experiment. ** Fold change compared to DMSO control
in the qRT-PCR experiment.
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2.5. S. cerevisiae boulardii Restores the Lipid Metabolism Altered by DON
The functional analysis of the intestinal transcriptome upon exposure to DON revealed repression
of both PPAR signaling and the LXR/RXR activation which control lipid metabolism (Figure 7).
The PPAR/RXR and LXR/RXR heterodimers act as sensors of intracellular lipid metabolism,
and thereby, regulate diverse aspects of cholesterol and fatty acid homeostasis [23]. PPARγ is a highly
expressed nuclear receptor in macrophages, and its activation increases LXRα expression, which in turn
transactivates target genes and reduces cell cholesterol levels. As a consequence, deficiency in PPAR
signaling is pivotal for the establishment of the foam cells of atherosclerotic lesions [37]. As shown in
Figure 7, on the one hand, intestinal exposure to DON repressed PPARγ via NF-κB signaling, and on
the other hand, down-regulated the expression of LXRα gene. By contrast, the DON-induced down
regulation of LXRα was prevented by the pre-treatment of intestinal tissue with S. cerevisiae boulardii
along with the canceling of signal transduction at an early-stage of the NF-κB pathway.
Interestingly, expression of the insulin receptor gene and of the platelet-derived growth factor
receptor gene (PDGF) was also down-regulated. As a phosphoprotein, the transcriptional activity of
PPARγ is affected by the extracellular receptor kinase-mitogen activated protein kinase (ERK-MAPK),
and thereby its constitutive activators insulin and PDGF [38]. Phosphorylation by ERK has been shown
to decrease the transcriptional activity of PPARγ [39,40]. Hence, the down-regulation of the insulin
and PDGF receptors observed in tissue treated with yeast prior to exposure to DON could limit the
basal inactivation of PPARγ, and function as a potentiating factor for recovery from DON-suppressed
PPAR functions.
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3. Conclusions
The aim of the present study was to investigate the effects of S. cerevisiae boulardii as a strategy
to alleviate the effect of DON. To this end, a transcriptional analysis of intestinal explant was
performed. On its own, S. cerevisiae boulardii induced no differential gene expression in the intestine.
However, application of the yeast significantly reduced the global impact of DON on the transcriptome.
Prototypical signaling pathways linked to inflammation and immunity, including the NF-κB and the
p38 MAPK, triggered by DON were reversed by the S. cerevisiae boulardii treatment, although the yeast
showed limited efficacy toward some other signaling pathways. Transcriptomic data also suggest that
S. cerevisiae boulardii reduces the burden of the global DON-induced oxidative stress and restores the
PPAR signaling functions which control lipid homeostasis. How these striking observations, made in
an oversimplified explant model, apply at a functional level in vivo still remains to be investigated.
4. Materials and Methods
4.1. Toxin
Purified deoxynivalenol (DON) purchased from Sigma (Saint Quentin Fallavier, France) was
dissolved to 10 mM in dimethylsulfoxide (DMSO), and stored at −20 ◦C before dilution in complete
culture media.
4.2. Yeast Strain and Culture
Industrial dry yeast Levucell SB20 (Saccharomyces cerevisiae boulardii CNCM I-1079) from
Lallemand Animal Nutrition (Blagnac, France) was rehydrated (10 g/100 g) in a suspension medium
(NaCl, K2HPO4, KH2PO4, casein peptone and Tween 80) and allowed to rehydrate for 20 min with
gentle agitation (120 rpm) in a shaking water bath at 37 ◦C. Serial dilutions were performed in peptone
saline water (NaCl, casein peptone), and a 1/1000 dilution containing 4 × 106 CFU/mL of live cells
was used. The yeast solutions were prepared just before use. Whole culture material was used in
this experiment, since it is established that the effects of S. cerevisiae boulardii on the host result from
cell to cell interactions, as well as from interactions between yeast secreted molecules and epithelial
cells [41,42].
4.3. Culture of Jejunum Explants
Jejunal explants were obtained from 5-week old crossbred castrated male piglets, as described
previously [7,43,44]. Briefly, 5 cm middle jejunum segments were collected in complete William’s
Medium E (Sigma, Saint Quentin Fallavier, France). Four to six washes were performed with William’s
Medium E. After removing external tunica muscularis, each jejunum segment was opened longitudinally,
and pieces of 6 mm diameter were obtained with biopsy punches (Kruuse, Centravet, Dinan, France).
Two explants/wells were deposited villi upward on 1-cm2 biopsy sponges (Medtronic, Minneapolis,
MN, USA) in six well plates (Cellstar, Greiner Bio-One, Frickenhausen, Germany) containing the
control medium, supplemented or not with S. cerevisiae boulardii containing medium. The culture
medium contained 100 U/mL penicillin, 100 μg/mL streptomycin, and 50 μg/mL gentamycin (Eurobio,
Courtaboeuf, France). All these operations were achieved in less than one hour after the piglets
were euthanized.
The experiment was conducted according to the guidelines of the French Ministry of Agriculture
for animal research. All animal experimentation procedures were approved by the Ethics committee of
Pharmacology-Toxicology of Toulouse-Midi-Pyrénées in animal experimentation (Toxcométhique),
N◦ TOXCOM/0017/IO PP, in accordance with the European Directive on the protection of animals used
for scientific purposes (Directive 2010/63/EU). The date of approval is 1 September 2017. The three
authors (I.A.K, I.P.O. and P.P) have an official agreement with the French Veterinary Services allowing
animal experimentation. The explants were pre-treated, or not, with 75 μL of the S. cerevisiae boulardii.
I-1079 (which corresponds to 3 × 105 colony forming units) for 30 min, and then challenged with
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10 μM DON for 4 h at 39 ◦C. The dose of DON and S. cerevisiae boulardii I-1079 were chosen to reflect
doses in feed equivalent to 3 ppm of DON and 2 × 109 CFU/kg of feed of S. cerevisiae boulardii I-1079,
respectively. A toxin vehicle (DMSO) condition, and an S. cerevisiae boulardii I-1079 condition, were
used as controls. After incubation, treated explants were stored at −80 ◦C before RNA extraction.
4.4. RNA Extraction
Jejunal explants were lysed in 1 mL of Extract All reagent (Eurobio, Les Ulis, France) with ceramic
beads (Bertin Technologies, Saint Quentin en Yvelines, France). Total RNA was extracted according
to the manufacturer’s recommendations, as previously described [45,46]. The RNA concentration
was determined by measuring the optical density at 260 nm, and the RNA integrity was assessed
using both NanoDrop spectrophotometric analysis (Labtech International, Paris, France) and Agilent
capillary electrophoresis (Agilent 2100 Bioanalyzer, Agilent Technologies Inc., Santa Clara, CA, USA).
The mean (±SD) RNA integrity number (RIN) of these mRNA preparations was 6.85 (±0.8).
4.5. Microarray Processing and Functional Analysis of Expressed Genes
The microarray GPL16524 (Agilent technology, Santa Clara, CA, USA, 8 × 60 K) used in this
experiment consisted of 43,603 spots derived from the 44 K (V2:026440 design) Agilent porcine-specific
microarray [21]. This microarray was enhanced with 9532 genes from adipose tissue, 3776 genes from
the immune system, and 3768 genes from skeletal muscle. A total of 24 samples (6 replicates per
treatment group) were processed. For each sample, cyanine-3 (Cy3)-labeled cRNA was prepared from
200 ng of total RNA using the One-Color Quick Amp Labeling kit (Agilent, Santa Clara, CA, USA),
according to the manufacturer’s instructions, followed by the Agencourt RNAClean XP (Agencourt
Bioscience Corporation, Beverly, MA, USA). Approximately 600 ng of Cy3-labeled cRNA was hybridized
onto the SurePrint G3 Porcine GE microarray (8 × 60 K), following the manufacturer’s instructions.
Immediately after washing, the slides were scanned on an Agilent G2505C Microarray Scanner using
Agilent Scan Control A.8.5.1 software, and the fluorescence signals were extracted using the Agilent
Feature Extraction software v10.10.1.1 with the default parameters. The microarray data were analyzed
using R (www.r-project.org, R v. 3.1.2) and the Bioconductor packages (www.bioconductor.org, v 3.0),
as described in GEO entry GSE97821, which also contains all the details of the experiments.
Network analysis and functional analysis of the DE genes were performed using the Ingenuity
Pathway Analysis tool (IPA, http://www.ingenuity.com) to identify gene networks and signaling
pathways affected by each treatment. The IPA output included statistical assessment of the significance
of gene networks and signaling pathways based on Fisher’s exact test; only networks and pathways
that presented a p value < 0.05 or a −log p value exceeding 1.30 (FDR q-values < 0.05) and a Z-score
with an absolute value ≥ 2 were retained.
4.6. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) Analysis
The reverse transcription and real-time qPCR steps were performed on total RNA samples
(n = 6 per treatment group), as previously described [47]. The primers for selected differentially
expressed genes on the microarray (Supplementary Table S3) were designed using Primer Express
Software, and purchased from Invitrogen (Invitrogen, Life Technologies Corporation, Paisley, UK).
Non-reverse transcribed RNA was used as the non-template control for verification of the genomic
DNA amplification signal. The specificity of the qPCR products was assessed at the end of the reactions
by analyzing the dissociation curves. The expression stability of five candidate reference genes,
(Cyclophylin A (CycloA), β-actin, β2-microglobulin, Ribosomal Protein L32 (RPL32), and Hypoxanthine
Phosphoribosyl transferase 1 (HPRT-1)) across different experimental samples has been investigated;
it was demonstrated that RPL32 showed the highest stability (SD = 0.82; r = 0.971) [21]. RPL32 and
CycloA were chosen as housekeeping genes, and the 2-ΔΔCt method was used to calculate the fold
change in gene expression. For comparison with microarray data, the Spearman correlation between
the microarray Log2 (FC) and qPCR Log2 (2-ΔΔCt) values was calculated.
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4.7. Statistical Analysis
The microarray data were analyzed using the R Bioconductor packages and the limma lmFit
function, as previously described [21]. Probes with adjusted p values ≤ 0.05 (FDR correction using
the Benjamini Hochberg procedure) were differentially expressed between the treated and control
conditions. Hierarchical clustering was applied to the samples and the probes, using the 1-Pearson
correlation coefficient as the distance and Ward’s criterion for agglomeration, and was then illustrated
as a heatmap presenting gene expression profiles of selected regulated genes.
For gene expression quantification by qRT-PCR, the mRNA expression of the target genes was
normalized to the expressed housekeeping genes using REST© 2009 software (Qiagen, Valencia,
CA, USA), which uses the pair-wise fixed reallocation randomization test as the statistical model [10].
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/10/5/199/s1,
Table S1: Expression of the genes involved in the NF-κB signalling pathway, Table S2: List of probes with a fold
change >2 in the DON and DON+S.c. boulardii conditions, Table S3: Primer sequences used for qRT-PCR analysis
(F: Forward; R: Reverse), Figure S1: Comparison between microarray-based Log2 (FC) and qRT-PCR-based results
Log2 (2-ΔΔCt) by Spearman correlation scattered plots.
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Abstract: Zearalenone (ZEN), a nonsteroidal estrogen mycotoxin, is widely found in feed and
foodstuffs. Intestinal cells may become the primary target of toxin attack after ingesting food
containing ZEN. Porcine small intestinal epithelial (SIEC02) cells were selected to assess the effect of
ZEN exposure on the intestine. Cells were exposed to ZEN (20 μg/mL) or pretreated with (81, 162,
and 324 μg/mL) N-acetylcysteine (NAC) prior to ZEN treatment. Results indicated that the activities
of glutathione peroxidase (Gpx) and glutathione reductase (GR) were reduced by ZEN, which induced
reactive oxygen species (ROS) and malondialdehyde (MDA) production. Moreover, these activities
increased apoptosis and mitochondrial membrane potential (ΔΨm), and regulated the messenger
RNA (mRNA) expression of Bax, Bcl-2, caspase-3, caspase-9, and cytochrome c (cyto c). Additionally,
NAC pretreatment reduced the oxidative damage and inhibited the apoptosis induced by ZEN. It can
be concluded that ZEN-induced oxidative stress and damage may further induce mitochondrial
apoptosis, and pretreatment of NAC can degrade this damage to some extent.
Keywords: Zearalenone; N-acetylcysteine; SIEC02 cells; Mitochondrial apoptosis
Key contribution: The gastrointestinal tract is the primary target of mycotoxin attack, and ZEN
produced cytotoxic effects on SIEC02 cells. Oxidative stress and mitochondrial apoptosis of SIEC02
cells, produced after exposure to ZEN and NAC pretreatment, can alleviate the negative effect of
ZEN on SIEC02 cells.
1. Introduction
Zearalenone (ZEN), a secondary metabolite produced by fungi of the genus Fusarium,
can seriously affect animal growth, reproduction, and immune function [1–3]. Studies estimate that
one-fourth of the global food and feed output is contaminated by mycotoxins, and the number is likely
to be closer to 50% if new fungal toxins are considered for limited data [4,5]. ZEN is being increasingly
recognized as a frequent contaminant in animal feeding, which has a significant effect on human and
animal health [6,7]. According to a recent report, the United States Department of Agriculture (USDA),
the European Food Safety Authority (EFSA), and China are concerned about mycotoxin contamination
in cereals, and they have renewed the maximum residue limits (MRLs) in food and feeds [8]. The MRLs
in food is 350 μg/kg, 350 μg/kg, and 60 μg/kg, respectively. EFSA and China also reiterated that the
MRLs in feed is 2000 μg/kg and 500 μg/kg [8].
It is shown that most animals have a certain sensitivity to ZEN, and the pig is the most sensitive
animal [9]. The primary attack target of toxins from ingested food or feed is the gastrointestinal
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tract, and thus it affects intestinal function [10,11]. The main metabolites of ZEN are α-zearalenol
(α-ZOL) and β-zearalenol (β-ZOL) [12]. Establishing a barrier model (IPEC-1) in vitro, study has
shown that ZEN and its metabolites damage barrier function by reducing the immune response [13].
It has been reported that ZEN affects the villous structures and reduces the expression of junction
proteins in a dose-dependent manner in pregnant rats [14]. The estrogen-like effects of ZEN and its
derivatives have been determined in vivo and in vitro [13,15]. A further experiment has demonstrated
that oxidative damage is likely to be evoked as one of the main pathways of ZEN toxicity [16].
Moreover, data suggested that ZEN induced apoptosis in a dose-dependent manner in many cell lines
(HepG2, porcine granulosa, and SHSY-5Y cells) [6,17,18]. Therefore, it is necessary to analyze the effect
of ZEN on the intestinal tract.
N-acetylcysteine (NAC), the precursor of glutathione, is a water-soluble molecule that has
antioxidant, anti-inflammatory, and tumor-inhibitory properties [19,20]. A previous study has shown
that NAC can exert antioxidant effects both in vitro and in vivo [21]. It is generally assumed that the
action of NAC is to scavenge free radicals by increasing the intracellular glutathione (GSH) level [22].
More recently, studies have found that NAC can directly inhibit the production of reactive oxygen
species (ROS), and thus inhibit apoptosis [23,24]. Similarly, NAC pretreatment can reduce lipid
peroxidation and inhibit apoptosis [25]. In addition, NAC also plays an important role in protecting
renal function by reducing oxidative stress [26,27].
Cells were poisoned by ZEN, cells may undergo complex and different pathways of damage,
including apoptosis [16,18]. The SIEC02 cells retained the morphological and functional characteristics
that were typical of primary swine intestinal epithelial cells by introducing the human telomerase
reverse transcriptase, and thus they provide a cell model in vitro [28]. However, the mechanism
underlying the apoptosis of intestinal cells after exposure to ZEN is still not totally understood.
Therefore, the purpose of this study was to evaluate whether ZEN-induced oxidative damage could
further lead to apoptosis, and whether the addition of NAC could alleviate this negative effect on
SIEC02 cells.
2. Results
2.1. Effects of ZEN and NAC on Cell Viability
To examine the cytotoxic effects of ZEN, SIEC02 cells were incubated with ZEN (5, 10, 15, 20, 25
and 30 μg/mL) for 24 h. After incubation, ZEN treatment inhibited the cell viability markedly in a
dose-dependent manner (Figure 1A). Cell viability was only 36.30% at a ZEN concentration of 30 μg/mL,
and the inhibitory concentration of IC50 (50% inhibitory concentration) was 22.68 ± 0.80 μg/mL. Hence,
a cytotoxic concentration of ZEN (20 μg/mL) was selected for subsequent experiments. In addition,
NAC alone did not show any cytotoxicity at concentrations (81, 162, and 324 μg/mL) of incubation
for 6 h. However, compared with the control group, cell viability was significantly reduced when
cells were treated by NAC (162 and 324 μg/mL) for 12 h (P < 0.05). All three concentrations of NAC
significantly reduced cell viability for 24 h (P < 0.01) (Figure 1B). Based on the additions shown in
Figure 1B, NAC concentrations (81, 162 and 324 μg/mL) were selected for pretreating the cells for 6 h
prior to the ZEN treatment.
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Figure 1. Effects of zearalenone (ZEN) and N-acetylcysteine (NAC) on SIEC02 cells viability. Cells were
treated without or with different concentrations of ZEN (0, 5, 10, 15, 20, 25 and 30 μg/mL) for 24 h (A).
Cells were pretreated without or with different concentrations of NAC (81, 162 and 324 μg/mL) for 6
h, 12 h, and 24 h (B). Cells survival was measured by Cell Counting Kit-8 (CCK-8) assay. The values
are mean ± SD of three independent experiments. *** indicates a significant difference between ZEN
and control at P < 0.001. #, ## indicates a significant difference of 12 h between NAC and control,
with significant differences at P < 0.05 and P < 0.01. $$, $$$ indicates a significant difference of 24 h
between NAC and the control at P < 0.01 and P < 0.001.
2.2. Effects of ZEN and NAC on Oxidative Stress
2.2.1. Glutathione peroxidase (Gpx) Activity
Data on the activity of antioxidative enzymes and related products in SIEC02 cells is summarized
in Figure 2. As shown in Figure 2A, Gpx activity was significantly reduced after ZEN treatment on
0.227 μmol/mg of protein, compared with the control group (0.325 μmol/mg) (P < 0.001). The Gpx
activity was restored to a certain extend by the pretreatment of cells with NAC (81, 162 and 324 μg/mL)
(P < 0.001) and increased to 0.247, 0.248 and 0.254 μmol/mg of protein, respectively. Based on these
data, NAC pretreatment could significantly increase the reduction in Gpx activity induced by ZEN,
and the optimal concentration of NAC was 324 μg/mL (P < 0.05).
2.2.2. Glutathione reductase (GR) Activity
According to Figure 2B, compared with the control group (11.307 U/mg), the GR activity of ZEN
treatment was significantly reduced to 0.857 U/mg of protein (P < 0.001). The reduction in GR activity
induced by ZEN was restored to a certain extend by the treatment of cells with NAC (81, 162 and
324 μg/mL) (P < 0.05) and increased to 3.859, 3.537 and 3.269 U/mg of protein, respectively. Based on
these data, NAC pretreatment could significantly increase the activity of GR. Three concentrations of
NAC did not reach a significant level.
2.2.3. Malondialdehyde (MDA) Level
As shown in Figure 2C, the MDA level of ZEN treatment was significantly higher (151.9 nmol/mg
of protein) than the control group (32.2 nmol/mg) (P < 0.001). Pretreatment with NAC (81, 162 and
324 μg/mL) significantly reduced the increase in the MDA level as induced by ZEN (P < 0.001),
and decreased to 132.2, 130.2 and 132.5 nmol/mg of protein, respectively. Three concentrations of
NAC did not reach a significant level.
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Figure 2. Effect of ZEN (20 μg/mL) and NAC (81, 162 and 324 μg/mL) on intracellular glutathione
peroxidase (Gpx), glutathione reductase (GR) activity, and malondialdehyde (MDA) levels. Cells were
exposed to ZEN for 24 h, including NAC pretreatment for 6 h. The results of Gpx, GR, and MDA
were μmol/mg, U/mg, nmol/mg of protein, respectively. Each set of data shows the mean ± SD
of three independent experiments. *** indicates a significant difference between ZEN and control
P < 0.001. #, ###, indicates a significant difference between ZEN and NAC in mutual treatment at
P < 0.05 and P < 0.001. $ indicates a significant difference between three concentrations of NAC at
P < 0.05 (A–C).
2.3. Effects of ZEN and NAC on Intracellular ROS Generation
ROS was generated as by-products of cellular metabolism, which could trigger oxidative stress at
high concentrations [29] . ROS production was monitored by measuring the fluorescence intensity of
DCFH-DA (2',7'-dichlorodihydrofluorescein diacetate dye). DCFH-DA is a fluorescent probe of ROS.
The non-fluorescent fluorescin DCFH-DA derivatives will emit fluorescence after being oxidized by the
radicals generated by the toxins. In the presence of ROS, H2-DCF is rapidly oxidized to become highly
fluorescent DCF [30,31]. The result indicated that ZEN could significantly induce ROS accumulation in
SIEC02 cells (P < 0.001) (Figure 3) and the ROS content in the ZEN group was significantly higher than
that in control group. As observed in Figure 3, NAC pretreatment significantly reduced ZEN-induced
ROS production (P < 0.01), and the optimal concentration of NAC was 162 μg/mL (P < 0.05).
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Figure 3. Effect of ZEN (20 μg/mL) and NAC (81, 162 and 324 μg/mL) on intracellular reactive oxygen
species (ROS) production. Cells were exposed to ZEN for 24 h, including NAC pretreatment for 6 h.
The results are expressed as mean fluorescent intensity (MFI). Each set of data shows the mean ± SD
of the three independent experiments. *** indicates a significant difference between ZEN and control
at P < 0.001. ##, ### indicates a significant difference between ZEN and NAC in mutual treatment at
P < 0.01 and P < 0.001. $ indicates a significant difference between three concentrations of NAC at
P < 0.05.
2.4. Effects of ZEN and NAC on Apoptosis
Cells were stained with Annexin V-FITC/PI to determine whether ZEN induced cell apoptosis
and its consequences following alleviation with NAC were evaluated. Compared with the control
group (Figure 4A), the number of living cells were decreased and the early apoptosis of ZEN treatment,
and the late apoptotic cells were significantly increased (P < 0.05) (Figure 4B and 4F). As seen in
Figure 4C,D,E and F, the apoptotic cells of Q2 and Q4 were reduced compared with Figure 4B,
and the apoptotic rate was also significantly reduced (P < 0.01) by NAC pretreatment. The optimal
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Figure 4. Annexin V-FITC/PI flow cytometry was used to detect SIEC02 cells treated with ZEN
(20 μg/mL) and NAC (81, 162 and 324 μg/mL). The Q1, Q2, Q3, and Q4 gates, respectively, represented
dead cells, the late stage of cell apoptosis, normal cells, and the early stage of cell apoptosis (A, B,
C, D and E are control, ZEN 20 μg/mL, ZEN 20 μg/mL + NAC 81 μg/mL, ZEN 20 μg/mL + NAC
162 μg/mL, and ZEN 20 μg/mL + NAC 324 μg/mL, respectively). Apoptosis results are expressed as
the rate of apoptosis. Each set of data shows the mean ± SD of the three independent experiments.
*** indicates a significant difference between ZEN and control at P < 0.001. ## indicates a significant
difference between ZEN and NAC in mutual treatment at P < 0.01. $ indicates a significant difference
between three concentrations of NAC at P < 0.05 (F).
2.5. Effects of ZEN and NAC on the Change of ΔΨm
JC-1 (mitochondrial probe) formed J-aggregates in the mitochondrial matrix (red) at high ΔΨm
in nonapoptotic cells, and formed monomeric (green) at low ΔΨm in apoptotic cells (Figure 5).
Therefore, the change of ΔΨm was reflected by decreasing the red and green fluorescence ratio.
The effects of different treatments on mitochondrial membrane potential in SIEC02 cells are shown in
Figure 5A–E. As shown in Figure 5B, the green aggregates were increased compared with the control
group (Figure 5A), indicating that the ΔΨm was decreased, the cell membrane was severely damaged,
and the apoptosis rate was significantly increased (P < 0.001) (Figure 5F). After NAC pretreatment,
green aggregates showed signs of weakening (Figure 5C,D and E) compared with the ZEN group
(Figure 5B). The apoptosis rate of the cells was significantly decreased by NAC pretreatment (P < 0.01)
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Figure 5. A laser scanning confocal microscope was used to observe the changes of mitochondrial
membrane potential (ΔΨm) in SIEC02 cells treated with ZEN and NAC. The scanning pictures were
as shown in the figure (A–E are control, ZEN 20 μg/mL, ZEN 20 μg/mL + NAC 81 μg/mL, ZEN 20
μg/mL + NAC 162 μg/mL and ZEN 20 μg/mL + NAC 324 μg/mL, respectively). Scale bar: 10 μm.
The results are expressed as apoptosis rate (F); each set of data shows the mean ± SD of the three
independent experiments. *** indicates a significant difference between ZEN and control at P < 0.001.
##, ### indicates a significant difference between ZEN and NAC in mutual treatment at P < 0.01 and
P < 0.001 (F).
2.6. Effects of ZEN and NAC on Apoptosis-Related mRNA Expression
2.6.1. Bax
The effects of ZEN and NAC protection apoptosis-related mRNA levels via caspase pathways
are shown in Figure 6. As shown in Figure 6A, the mRNA expression levels of Bax were significantly
increased by ZEN, compared with the control group (P < 0.001). Compared with the ZEN treatment,
the NAC-pretreated significantly reduced the mRNA expression of Bax (P < 0.001). Three concentrations
of NAC did not reach a significant level.
2.6.2. Bcl-2
The expression of Bcl-2 mRNA was opposite to that of Bax. As shown in Figure 6B, the mRNA
expression levels of Bax were significantly decreased in the ZEN group (P < 0.01). Compared with
ZEN treatment, the production of Bcl-2 could not be significantly decreased at a NAC concentration of
324 μg/mL. When the concentration of NAC were 81 and 162 μg/mL, the mRNA expression of Bcl-2
significantly increased (P < 0.001), and the optimal concentration of NAC was 162 μg/mL (P < 0.01).
2.6.3. Cytochrome c (Cyto c)
As shown in Figure 6C, the mRNA expression levels of cyto c were significantly increased by
ZEN (P < 0.01). Compared with ZEN treatment, the production of cyto c could not be significantly
decreased at a NAC concentration of 81 μg/mL. When the NAC concentration of NAC were 162 and
324 μg/mL, cyto-c production was significantly decreased (P < 0.01).
2.6.4. Caspase-9 and Caspase-3
Similar to cyto c mRNA expression, caspase-9 and caspase-3 mRNA levels were significantly
increased by ZEN (P < 0.05) (Figure 6D,E). Compared with ZEN treatment, the mRNA expression of
caspase-9 was significantly reduced at the NAC concentrations of 81 and 162 μg/mL (P < 0.05). At the
same time, when the NAC concentration of NAC were 162 and 324 μg/mL, the mRNA expression of
caspase-3 was significantly increased (P < 0.001).
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Figure 6. The results of the ZEN (20 μg/mL) and NAC (81, 162 and 324 μg/mL) expression levels of each
apoptotic gene (Bcl-2, Bax, cytochrome c, caspase-9, caspase-3) in the SIEC02 cells. Cells were exposed to
ZEN for 24 h, including NAC pretreatment for 6 h. The results are expressed relative to the expression of
actin; each set of data shows the mean ± SD of the three independent experiments. *, **, *** indicates a
significant difference between ZEN and control at P < 0.05, P < 0.01, and P < 0.001. #, ##, ### indicates
a significant difference between ZEN and NAC in mutual treatment at P < 0.05, P < 0.01, and P < 0.001.
$$ indicates a significant difference between three concentrations of NAC at P < 0.01 (A–E).
3. Discussion
ZEN and its major metabolites are secondary metabolites of Fusarium fungi that produce
cell damage [12,32]. A number of studies have found that ZEN has an inhibitory effect on cell
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proliferation [15,16]. The most direct indicator is the number of living cells due to toxic changes.
The IC50 is an important indicator of the cellular response to chemical effects. In human hepatoma
cells (HepG2) and colorectal cancer cells (HCT116), the IC50 is 100 μM and 60 μM, respectively, and cell
proliferation undergoes a dose-dependent reduction after ZEN treatment [18,33]. In this experiment,
Cell Counting Kit-8 (CCK-8) method was used to detect the effect of ZEN on the activity of SIEC02
cells cultured in vitro. The results showed that after treatment with ZEN for 24 h, the IC50 range was
22.68 ± 0.80 μg/mL (62.89 μM). This value might differ slightly from that just mentioned, because of
differences in cell lines. With the increase in ZEN concentration, the cell activity gradually decreased
and showed a dose-response relationship.
The gastrointestinal tract is the primary site of toxin interaction, and intestinal epithelial cells
are an important first target site for mycotoxin [34,35]. Most studies of toxicity have shown that
the cytotoxicity of ZEN is determined by the production of ROS, DNA damage, and an increased
formation of lipid peroxidation [36,37]. In normal physiological processes, small amounts of ROS are
generated as by-products of cellular metabolism, primarily in the mitochondria [29,32]. ROS are highly
reactive molecules, among which oxygen-free radicals can destroy cell structures, and increase lipid
peroxidation of biofilms [38,39]. MDA, as the final product of lipid peroxidation, which can cause cell
serious injuries in membrane structure, changes the permeability of cell membranes, leading to cell
apoptosis, and necrosis [40]. Therefore, the measurement of MDA content can indirectly reflect the
degree of lipid peroxidation. In this experiment, our results showed that 20 μg/mL of ZEN significantly
increased ROS and MDA contents in SIEC02 cells. Previous studies have found similar effects in
different cell types that are exposed to ZEN. These results were consistent with the findings that ZEN
can significantly increase ROS in CHO-K1 and IPEC-J2 cells and MDA in Caco-2 cells [36,41,42].
NAC, a precursor of GSH that is a free radical scavenger, which plays an important role as
an antagonistic foreign chemical to the oxidative damage caused by biological organisms [22,43].
The antioxidant activity of NAC is evaluated by the enzymatic system. The antioxidant enzymes and
other regulatory enzymes can be used as the first line of defense, and they play a role in scavenging
free radical damage intracellularly and extracellularly [38]. GR and Gpx are the intrinsic anti-oxidative
enzymes of cells [44]. Gpx catalyzes GSH to decompose H2O2 into water, and to form Glutathione
oxidized (GSSG), and the GR enzyme can reduce GSSG to GSH, to scavenge excess H2O2 [45,46].
NAC could increase intracellular glutathione and produce sulfhydryl groups that directly eliminate
ROS, such as hypochlorous acid, hydrogen peroxide, superoxide, and hydroxyl radicals [47,48].
Consequently, NAC increases the activity of the antioxidant enzymes Gpx and GR by restoring
intracellular GSH content, thereby eliminating ROS. In this experiment, our data clearly demonstrated
that the activities of Gpx and GR were significantly increased after NAC pretreatment, and that ROS
was significantly reduced. Our study showed that NAC preconditioning could alleviate the activity of
antioxidant enzymes in SIEC02 cells, and this result is also consistent with another team's results on
the pig kidney PK15 cells [49]. In addition, pretreatment with NAC positively reduced ROS generation,
suggesting a potential antioxidant for NAC, which is conformed to reduce cellular ROS by adding
NAC in Jurkat T cells [50].
Apoptosis, a form of programmed cell death, is an essential process in cell growth, reproduction,
and self-adjustment and it is characterized by morphological changes such as nucleosome fracture
and the formation of apoptotic bodies [51,52]. In apoptosis caused by exposure to mycotoxins,
mitochondrial-mediated apoptosis is the main pathway, which is activated programmed cell death
by ROS via mediated by mycotoxins [53]. The mitochondria are an important source of ROS within
most mammalian cells [54]. In response to apoptotic stimuli, DNA damage and oxidative stress occur,
and eventually the mitochondrial pathway is triggered [30]. The mitochondrial outer membrane is
highly permeability in mitochondria [31,55]. Indeed, a previous study reported that when cells are
poisoned or subjected to other stimuli, the ΔΨm decreases [56]. The ΔΨm disruption is an important
trigger in managing apoptosis [57]. Studies have found that ZEN may cause mitochondrial membrane
hyperpolarization over a short period of time, followed by loss of the ΔΨm [58,59]. Previous in vitro
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experiments demonstrate that ZEN directly causes apoptosis through the mitochondrial pathway at
low concentrations. Subsequently, numerous studies show that ZEN causes intracellular ROS and
MDA levels to rise and ΔΨm decreases, leading to cell apoptosis [32,60,61]. Based on these findings,
to reveal whether ZEN-induced apoptosis involves ΔΨm, our study focused on detecting ΔΨm in
SIEC02 cells by JC-1 fluorescence to detect changes in membrane potential. Green fluorescence is
indicative of the ΔΨm decline by JC-1 staining [62,63]. Our results showed that treatment with ZEN
caused an increase in ROS and loss of ΔΨm, suggesting that ZEN passed the mitochondrial-mediated
pathway. In this study, the percentage of ZEN cells with green fluorescence increased by NAC.
This may be because NAC is deacetylated to cysteine, rapidly oxidized, and then transported to cells,
which is reduced to GSH, thereby restoring the cell state [6]. The results showed that after addition of
NAC pretreatment, ΔΨm increased, inhibiting apoptosis in SIEC02 cells. This result is consistent with
recent studies that have promoted apoptosis of the mitochondria-mediated pathway through ZEN [64].
When mitochondrial membrane permeability changes, cyto c is first released from the
mitochondrial membrane space into the cytoplasm, resulting in subsequent activation of capase-9 [65,66].
Next, activation of caspase-9 activates the downstream performer (caspase-3), thereby triggering
apoptosis in the cascade [67]. In the mitochondrial apoptosis pathway, caspase-9 is a key activator of
the caspase cascade; caspase-3 is located downstream of the apoptotic ordered cascade reaction and it
is the key executor of the transfer, and its activation marks the process of apoptosis [68,69]. Previous
studies have found that the production of ROS can proceed from the release of cyto c [70]. Furthermore,
a study has shown that ROS can further release cyto c from the mitochondria into the cytoplasm [64].
In this experiment, after ZEN exposure, both intracellular ROS and cyto c increased significantly
consistent with previous studies. The Bcl-2 protein family may regulate mitochondrial permeability
through both permeabilization of the mitochondrial membrane or translocation of cyto c [28]. Bax is
the representative of apoptosis-promoting proteins, and Bcl-2 is a gene that inhibits apoptosis [71].
When the cell damage is serious, Bcl-2 protein expression decreases and Bax protein expression
increases [72]. The current study showed that ZEN downregulated Bcl-2 and upregulated Bax mRNA
expression, which triggered apoptosis in SIEC02 cells. In the current study, our results showed that
after treatment with ZEN toxins, a significant increase in apoptosis was observed. ZEN treatment
upregulated mRNA expression of cyto c, caspase-3, and caspase-9. According to the results of this
experiment, pretreatment with NAC could inhibit the expression of proapoptotic genes in cells, increase
the expression of antiapoptotic genes, and reduce the cell damage induced by ZEN.
4. Conclusions
In conclusion, the results of this study suggested that ZEN induced oxidative stress in SIEC02 cells
and sequentially promoted apoptosis through the mitochondrial pathway. ZEN produced substantial
cytotoxicity to SIEC02 cells because of elevated ROS levels, which in turn led to increased caspase-3
activation and apoptosis. In addition, NAC pretreatment increased antioxidant enzyme activity,
elevated ΔΨm, and inhibited ZEN-induced apoptosis through the mitochondrial pathway. Based on
these results, this study provides new insights into the mechanism of action of ZEN on intestinal cells
in vitro, and the mitigation of this effect by pretreatment with NAC. However, all of the effects of ZEN
and its protective mechanisms for the intestine are still not fully understood, and further research
is needed.
5. Materials and Methods
5.1. Chemicals and Reagents
ZEN and NAC were supplied by Sigma-Aldrich (St. Louis, MO, USA). Dulbecco modified Eagle
medium (DMEM)-F:12 cell culture medium was purchased from Thermo Fisher (Hyclone, Shanghai,
China). Fetal bovine serum (FBS) was supplied by Gibco (Invitrogen Corporation, Grand Island,
NY, USA). CCK-8 was supplied by Dojindo (Kumamoto, Japan). ROS assay kit, MDA, Gpx, and GR
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antioxidant kits, and ΔΨm assay kit with JC-1 were supplied by Beyotime Biotechnology (Nantong,
China). Phosphate buffered saline (PBS) was purchased from Biotopped (Beijing, China). Ethanol at
a concentration of 0.25% was chosen as an organic solvent for the dilution of ZEN pure product for
subsequent testing.
5.2. Cell Culture and Conditions
SIEC02 cells were donated by Northwest A&F University. The SIEC02 cell line was derived
from the mid-jejunum of neonatal, un-suckled, and 1-day-old Landrace piglets [73]. Cells (passages
15–30) were grown in DMEM-F:12 supplemented with 10% fetal calf serum, and 1% penicillin and
streptomycin, and cultured at 37 ◦C in an atmosphere of 5% CO2 in a cell incubator. The cells were
inoculated in a 25 cm2 cell culture flask (Nest, Eimer Biotechnology Company, Wuxi, China), and the
culture medium was changed after 24 h. When the cells were confluent to approximately 80%–90%,
the cell monolayer was washed with PBS and digested with 1× trypsin/EDTA (Beyotime Institute of
Biotechnology, Nantong, China) for subsequent testing.
5.3. Cell Viability Assay
The cytotoxicity of ZEN on SIEC02 cells was measured by CCK-8. Cells (0.5–0.8 × 106/mL) were
seeded in 96-well culture plates for 24 h (Nest, Eimer Biotechnology Company, Wuxi, China) and then
treated with ZEN (0, 5, 10, 15, 20, 25 and 30 μg/mL). Similarly, cells were seeded in the same culture
plates (6, 12, and 24 h) and then treated with NAC (81, 162, and 324 μg/mL). After all treatments
were completed, cells were washed twice with PBS. CCK-8 was then added to a final concentration
of 10% in a serum-free medium and cultured at 37 ◦C for 3 h. The viability rate was measured by
measuring the absorbance on a microplate reader with an emission wavelength of 450 nm (SpectraMax
M5, Molecular Devices, Sunnyvale, CA, USA).
5.4. Experiment Design
For all experiments, cells were used at 80%–90% confluence and assigned into five treatment
groups: control group (cells were incubated with FBS-DMEM-F:12 culture medium for 24 h);
ZEN group (cells were incubated with 20 μg/mL ZEN for 24 h); NAC+ZEN group after cells were
pretreated with NAC (81, 162 and 324 μg/mL) for 6 h, then placed with fresh culture medium
containing 20 μg/mL ZEN for 24 h. The cells of the subsequent experiments (0.5–0.8 × 106/mL) were
seeded in 6-well culture plates (Nest, Eimer Biotechnology Company, Wuxi, China) and treated with
drugs as described in this section.
5.5. Determination of Antioxidant Enzyme Activity and Oxidative Products
SIEC02 cells were used for the analysis of antioxidative enzyme and related products. Briefly,
cells were washed with 4 ◦C precooled PBS and resuspended, then lysed on ice. Antioxidant enzyme
activities such as Gpx and GR were measured using the assay kit according to the manufacturer’s
instructions. The results were expressed as μmol/mg or U/mg of protein, respectively. The level of
MDA was measured according to the kit instructions, and the results were expressed as nmol/mg
of protein. The density of each protein was detected by Enhanced BCA Protein Assay Kit (Beyotime
Institute of Biotechnology, Nantong, China).
5.6. Detection of ROS Generation
The balance between the generation and clearance of ROS is important to maintain intracellular
redox states. A flow cytometry technique was used to assess the intracellular amounts of ROS with
dichlorofluorescein diacetate (DCFH-DA). Briefly, cells were washed with PBS and incubated with
10 μM DCFH-DA at 37 ◦C for 20 min. After incubated, cells were washed thrice with serum-free
cell culture medium. Intracellular production of ROS was measured by a FACS flow cytometry
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(Becton-Dickinson, San Jose, CA, USA) with an excitation wavelength of 488 nm and an emission
wavelength of 525 nm. The DCF fluorescence intensity indicates the amount of intracellular ROS and
the results were analyzed by mean fluorescent intensity (MFI).
5.7. Apoptosis Detection
5.7.1. Annexin V-FITC/PI Double Staining
The apoptosis of SIEC02 cells was measured by the Annexin V-FITC/PI apoptosis detection kit
(Biosea Biochemicals, Shanghai, China). Briefly, cells were trypsinized and harvested via centrifugation
at 2000×g and 4 ◦C for 5 min, then re-suspended in 500 μL binding buffer. Annexin-FITC (10 μL) was
injected into the solutions and incubated for 40 min at 37 ◦C in the dark. Finally, 5 μL PI (10 μg/mL) was
added. Scattering signals were detected by FACS flow cytometry as described in the previous section.
5.7.2. ΔΨm Assay
In this experiment, ΔΨm was monitored by the cationic dye JC-1. Briefly, after treatment and
washing three times with PBS, culture medium (1 mL) and JC-1 staining solution (1 mL) are added;
after being fully mixed, the cells are incubated at 37 ◦C for 20 minutes. During incubation, according to
1 mL JC-1 staining buffer (5×) with 4 mL distilled water, JC-1 staining is mixed with JC-1 staining buffer
(1×). An increase in the green/red fluorescence intensity ratio indicates mitochondrial membrane
depolarization. To each well, 0.5 mL culture medium was added, and the results were detected using a
laser scanning confocal microscope (LEICA, Hesse, Germany).
5.7.3. RNA Extraction and Quantitative real time polymerase chain reaction (qRT-PCR)
Total RNA was extracted using RNA fast 200 (Fastagen, Shanghai, China), according to the
manufacturer's instruction. The A260/A280 ratio was measured by using a using a Nano Photometer
P-Class (Implen GmbH, Munich, Germany) to ensure the purity of the RNA sample, and agarose gel
electrophoresis was used to ensure the integrity of the total RNA sample. The complementary DNA
(cDNA) was amplified by qRT-PCR using a SYBR Premix Ex Taq RT-PCR kit (Takara, Dalian, China)
and used for RT-PCR. SYBR Green I RT-PCR kit (Takara, Dalian, China) was used to measure the
mRNA expression of apoptosis-related genes (Bcl-2, Bax, cyto c, caspase-9, caspase-3), and β-actin was
used as the internal control gene to correct for differences. The sequences of the specific primers used
were as follows in Table 1 [49]. The sequences of the specific primers in this study used were designed
from published GenBank sequences, and they were synthesized by Sangon (Shanghai, China).
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RT-PCR was performed by an ABI PRISM 7500 SDS thermal cycler (Applied Biosystems, Foster
City, CA, USA). The reaction was carried out using a 10 μL system of PCR, including 1.0 μL of cDNA
and 0.2 μL of each primer. The cycle numbers and annealing temperature were optimized for each
primer pair. The PCR cycling conditions were as follows: a denaturation step at 95 ◦C for 30 s, followed
by 40 cycles of denaturing at 95 ◦C for 5 s and annealing at 60 ◦C for 34 s. The relative expression of
the apoptosis cytokine mRNA was measured by the 2−ΔΔCt method [74].
5.8. Statistical Analysis
Data were analyzed using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA, 2008), and the
data of three independent experiments were expressed as mean ± standard deviation (SD). All the
experimental data were analyzed for variance uniformity. When the variance was uniform, data were
analyzed by a one-way ANOVA followed by Least-Significant Difference (LSD). When the variance
was uneven, data were converted into logarithms, and then analyzed by one-way ANOVA followed
by LSD. The significance was considered to be at the probability level of P < 0.05.
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Abstract: Deoxynivalenol (DON) is commonly detected in cereals, and is a threat to human and
animal health. The effects of microbiological detoxification are now being widely studied. A total
of 24 pigs (over four months) were randomly divided into three treatments. Treatment A was fed
with a basal diet as the control group. Treatment B was fed with naturally DON-contaminated
wheat as a negative control group. Treatment C was fed with a contaminated diet that also had
Clostridium sp. WJ06, which was used as a detoxicant. Growth performance, relative organ weight,
intestinal morphology, and the intestinal flora of bacteria and fungi were examined. The results
showed that after consuming a DON-contaminated diet, the growth performance of the pigs
decreased significantly (p < 0.05), the relative organ weight of the liver and kidney increased
significantly (p < 0.05), and the integrity of the intestinal barrier was also impaired, though the toxic
effects of the contaminated diets on growing pigs were relieved after adding Clostridium sp. WJ06.
The data from MiSeq sequencing of the 16S ribosomal ribonucleic acid (rRNA) gene and internal
transcribed spacer 1 (ITS1) gene suggested that the abundance of intestinal flora was significantly
different across the three treatments. In conclusion, the application of Clostridium sp. WJ06 can reduce
the toxic effects of DON and adjust the intestinal microecosystem of growing pigs.
Keywords: Clostridium sp. WJ06; deoxynivalenol; pig; intestinal morphology; microbial diversity
1. Introduction
Deoxynivalenol (DON), also known as vomitoxin, is synthesized mainly by the toxigenic fungi of
the Fusarium genus, which is commonly detected in cereals, particularly wheat, barley, maize, and their
by-products all over the world [1]. This mycotoxin remains stable for many years when stored at room
temperature, or even when heated at 135 ◦C. Its deactivation occurs through the destruction of the
epoxide ring under drastic acid or alkaline conditions, reactions with aluminum and lithium hydrates
or peroxides, and hydration in autoclave [2]. Therefore, DON readily enters the human and animal
food chains [3–5]. DON causes toxic effects in humans as well as in all animal species investigated
to date. Among animal species, pigs show a relatively high sensitivity to DON because of the high
percentage of cereals in their diet and the lack of microorganisms in the front of their small intestine,
which are able to degrade mycotoxins before DON is absorbed by the small intestine [6,7].
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The intestinal tract is the first target for mycotoxins following ingestion of contaminated feed.
Consumption of DON-contaminated feed in pigs impacts the gastrointestinal tract, causing epithelial
injuries of the stomach and the intestine, and leading to intestinal inflammatory response [8,9].
In vitro and in vivo studies have also demonstrated that DON inhibits intestinal nutrient absorption,
alters intestinal cell functions, and compromises the intestinal barrier [10]. Additionally, stability of
the intestinal flora appeared to be an important factor in animal health. Surprisingly, the effect of
DON on intestinal microflora has been poorly investigated [11]. Direct impact of DON on intestinal
microflora composition has never been reported, and only few data are available for other members of
the trichothecene toxin group [12,13].
Due to the detrimental effects of mycotoxins, some strategies have been developed to prevent
the growth of mycotoxigenic fungi and also to decontaminate and detoxify foods and feeds [14].
These strategies include: (1) the prevention of mycotoxin contamination; (2) the detoxification
of mycotoxins present in foods and feeds; and (3) the inhibition of mycotoxin absorption in the
gastrointestinal tract. Although numerous physical and chemical detoxification methods have been
tested, none really provide the necessary efficacy and safety [15]. Since cost-effective methods to
detoxify mycotoxin-contaminated grains and foods are urgently needed to minimize potential losses
to the farmer and toxicological hazards to the consumer, it is a necessity to find new suitable methods
for the decontamination of mycotoxins. Therefore, the development of microbiological detoxification
measures is essential for improving the safety of these foods for human consumption. Microbes or
their enzymes could be used for mycotoxin detoxification, and such biological approaches are now
being widely studied [16,17]. DON, as well as other trichothecenes, may have its chemical structure
altered by bacteria or fungi, which utilize their enzymatic systems as a carbon source.
Therefore, the present study aims to: (i) investigate the influence of naturally DON-contaminated
wheat on the intestinal morphology and intestinal microflora of growing pigs; and (ii) evaluate the
effect of Clostridium sp. WJ06 on the intestinal morphology and intestinal microflora of growing pigs
as a detoxicant.
2. Results
2.1. Effect of Clostridium sp. WJ06 on Growth Performance and Relative Organ Weight of Growing Pigs
The effect of Clostridium sp. WJ06 and DON-contaminated wheat on the growth performance
of growing pigs is shown in Table 1. In this study, average daily body weight gain (ADG) and
average daily feed issue (ADFI) decreased significantly more than in the control group after feeding
DON-contaminated wheat (p < 0.05), while the ratio of feed intake to body weight gain (F/G) increased
significantly (p < 0.05). There were no significant differences (p ≥ 0.05) from the control group after
adding Clostridium sp. WJ06.
Table 1. Effect of Clostridium sp. WJ06 on the growth performance of pigs.
Treatment * Initial Weight (kg) Final Weight (kg) ADG (g) # ADFI (kg) # F/G #
A 54.38 ± 1.21 78.3 ± 1.78 885.93±72 2.14±0.38 2.41 ± 0.32
B 56.44 ± 1.63 71.33 ± 2.98 a 551.48±46 a 1.66±0.33 a 3.01 ± 0.41 a
C 56.06 ± 1.78 76.07 ± 3.15 741.16 ± 62 1.98 ± 0.27 2.68 ± 0.36
Values are presented as Mean ± SD, n = 8. The values with different small letters (a) in the same column differ
significantly (p < 0.05). # ADG, average daily body weight gain; ADFI, average daily feed intake; F/G, the
ratio of feed intake to body weight gain, indicating feeding efficiency. Feed was calculated based on dry weight.
* Treatment A refers to the control diet; Treatment B refers to the contaminated diet; Treatment C refers to the
contaminated diet with Clostridium sp. WJ06 added.
The effect of Clostridium sp. WJ06 on the relative organ weight of growing pigs is shown in
Figure 1. The results showed that the relative weights of the liver, kidney, and spleen of growing
pigs increased significantly more than in the control group after feeding DON-contaminated wheat
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(p < 0.05), while there were no significant differences (p ≥ 0.05) for the relative weights of the heart
and lungs. After adding Clostridium sp. WJ06, the relative weight of the liver and kidney were not
significantly different (p ≥ 0.05) to the control group, while the spleen increased significantly (p < 0.05).
 
Figure 1. Effect of Clostridium sp. WJ06 on relative organ weight 1 of growing pigs. 1 Relative organ
weight (kg/kg) = organ weight (kg)/live weight (kg). A, B, and C represent the samples of different
treatments. Bars are presented as mean ± SD, n = 3. ** Indicates that results differ significantly between
treatments (p < 0.05).
2.2. Effects of Clostridium sp. WJ06 on Intestinal Morphology of Growing Pigs
Representative morphologies of the ileum, caecum and colon are illustrated in Figure 2.
Scanning electron microscope observations revealed that the mucosa of ileum, caecum and colon were
severely damaged after pigs were fed with DON-contaminated wheat compared with the control
group, especially for ileum. Additionally, epithelial cells on the surface of the intestinal villus were
not integrated and exhibited histological lesions. In contrast, the damage to the villus barriers of the
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Figure 2. The effect of Clostridium sp. WJ06 on the morphology of different intestine regions of growing
pigs via scanning electron microscopy (n = 3). (a–c) refer to samples of the ileum, caecum, and colon,
respectively. A, B, and C refer to the samples of different treatments. 1000×, 5000×, and 15,000×
represent the magnification of electron microscopy at transverse sections. V represents the photo of a
vertical section magnified 15,000×.
2.3. Analysis of Operational Taxonomic Units (OTUs) and the Alpha Diversity of Bacteria Flora and Fungal
Flora in all Samples
Alpha diversity was applied in analyzing the complexity of species diversity for one sample,
and two indices (rarefaction curves and rank-abundance curves) were selected to identify community
richness and diversity (Figure 3). Rarefaction curves reflect the reasonability of the number of
sequencing reads used for analysis, and can be used to infer species richness in the sample. A flat
curve means that the number of sequencing reads is reasonable, and less new species can be detected
with increasing sequencing reads. Rank abundance curves directly reflect the richness and evenness
of species in the sample. Species richness can be viewed as the range of the curve in the horizontal
direction. The results demonstrated that the curves of all of the samples have almost approached
the saturation plateau, which indicates that the 16s ribosomal ribonucleic acid (rRNA) gene and the
internal transcribed spacer 1 (ITS1) gene sequence database was very abundant, and the current
analysis had adequate depth to capture most microbial diversity information.
In the present study, a total number of 253,708 qualified sequence reads were obtained from nine
samples via V3–V4 16S rRNA sequencing, with an average of 43,177 effective sequence reads for each
sample (the minimum sample was 34,392, and the maximum was 47,673), and the average length of the
effective bacterial sequence reads was 389 bp (Table 2). At the same time, the data of the operational
taxonomic units (OTUs) and the richness estimator by ITS1 sequencing are listed in Table 3. A total
number of 605,933 qualified sequence reads were obtained from nine samples, with an average of
67,326 effective sequence reads for each sample (the minimum sample was 46,157, and the maximum
was 102,600), and the average length of the effective fungal sequence reads was 227 bp (Table 3).
In order to analyze the species diversity within samples, we clustered all of the effective tags
to operational taxonomic units (OTUs) at 97% similarity. Then, we performed species annotation
based on the OTUs’ representative tags. According to the results of species annotation, the statistics
of the sequence numbers in different classification levels (kingdom, phylum, class, order, family,
genus, and species) are calculated and displayed in Figure 4. The composition of each sample and
differences among samples can be understood through Figure 4. The results in our study showed that
the sequence number of fungi flora varied significantly in the three treatments at several classification
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levels, while that of bacteria flora were not shifted significantly; that is, the structure of intestinal




Figure 3. Rarefaction curve and rank abundance curve in nine libraries. (A1,A2) represented the
data from 16S ribosomal ribonucleic acid (rRNA) gene sequencing. (B1,B2) represented the data from
internal transcribed spacer 1 (ITS1) gene sequencing. In the rarefaction curves plot (A1 & B1), the x-axis
is number sequencing reads randomly chosen from a certain sample to obtain operational taxonomic
units (OTUs). The y-axis is corresponding OTUs. In the rank-abundance curves plot (A2 & B2),
the x-axis is the abundance rank, and the y-axis is the relative abundance. The higher the abundance,
the smaller the rank. Curves for different samples are represented by different colors.
Table 2. OTUs 1 data and richness estimator of nine libraries via 16S rRNA gene sequencing.
Sample Name * Raw PE # Qualified # Base (nt) # AvgLen (nt) # Effective% # Chao Ave 2 Observed Species Shannon Ave 2
A1 64,782 34,392 10,231,113 390 40.5 564.27 426 4.93
B1 69,691 41,156 14,360,310 388 53.05 496.63 380 4.66
C1 68,531 40,201 13,531,583 384 51.41 538.44 443 5.44
A2 72,117 47,250 15,233,409 389 54.37 434.19 365 5.21
B2 64,769 45,377 14,399,002 389 57.1 436.26 389 5.90
C2 69,357 45,332 14,537,019 385 54.4 379.02 329 5.53
A3 75,203 47,673 14,834,644 392 50.28 489.40 406 4.85
B3 68,288 41,553 14,224,802 396 52.59 468.35 382 5.05
C3 70,715 45,665 14,628,909 386 53.59 586.57 485 6.00
Total 409,247 253,708 82,292,436 2325 311 4393 3605 48
Average 69,272 43,177 13,997,865 389 51.92 488.13 401 5.29
* A1, B1, and C1 represent the sequences of ileum from different treatments. A2, B2, and C2 represent the sequences
of caecum from different treatments. A3, B3, and C3 represent the sequences of colon from different treatments.
1 The operational taxonomic units (OTUs) were defined at 3% dissimilarity level. 2 The richness estimators (Chao)
and diversity indices (Shannon) were calculated using the program QIIME. # Raw PE means original PE reads tested
by the Illumina MiSeq platform. Qualified means the raw reads with chimeric sequences and low quality sequences
removed. Base refers to the final effective data of the basic group. AveLen refers to the average length of effective
tags. Effective means Effective Tags/Raw PE × 100%.
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Table 3. OTUs 1 data and richness estimator of nine libraries via ITS1 gene sequencing.
Sample Name * Raw PE # Qualified # Base (nt) # AvgLen (nt)# Effective% # Chao Ave 2 Observed Species Shannon Ave 2
A1 123,899 72,335 18,813,512 267 56.92 798.77 611 5.18
B1 70,194 54,056 12,893,920 246 74.80 389.73 287 2.92
C1 121,183 102,600 22,150,221 218 83.97 656.80 447 3.46
A2 103,737 79,891 17,630,954 221 76.95 843.35 570 5.07
B2 72,542 46,157 10,630,776 234 62.49 992.45 667 5.71
C2 95,418 78,657 16,739,208 213 82.33 656.80 665 3.46
A3 78,988 64,817 12,797,508 198 81.95 959.79 748 6.87
B3 83,591 62,692 13,180,068 211 74.72 1195.65 918 6.52
C3 72,307 44,728 10,577,687 238 61.34 886.02 769 5.96
Total 821,859 605,933 135,413,854 2046 655.47 7379.36 5681 45.14
Average 91,318 67,326 15,045,984 227 72.83 819.93 631 5.02
* A1, B1, and C1 represent the sequences of ileum from different treatments. A2, B2, and C2 represent the sequences
of caecum from different treatments. A3, B3, and C3 represent the sequences of colon from different treatments.
1 The operational taxonomic units (OTUs) were defined at 3% dissimilarity level. 2 The richness estimators (Chao)
and diversity indices (Shannon) were calculated using the program QIIME. # Raw PE means original PE reads tested
by the Illumina MiSeq platform. Qualified means the raw reads with chimeric sequences and low quality sequences
removed. Base refers to the final effective data of the basic group. AveLen refers to the average length of effective
tags. Effective means Effective Tags/Raw PE × 100%.
(A) (B)
Figure 4. Tag abundance of each sample at different classification levels. Sequence number indicates the
number of sequences annotated to that level, which are expressed in different colors. Bars are presented
as means, n = 3. (A) The sequence number of bacteria flora in different treatments. (B) The sequence
number of fungi flora.
2.4. Effects of Clostridium sp. WJ06 on Intestinal Bacterial Flora of Pigs via 16S rRNA Gene Sequencing
In this paper, the top 10 species of bacteria flora with the highest relative abundance at the
phylum and genus levels are shown in Figures 5 and 6, respectively. Based on relative abundance,
Firmicutes, Spirochaetes, Bacteroidetes, and Proteobacteria were identified as the major bacterial taxa
of the pig bacterial community in all of the samples. For Firmicutes in particular, the average
relative abundance was over 86% in different treatments. As shown in Figure 5, the abundance
of Firmicutes in the ileum and colon decreased significantly after being fed with contaminated
diets, while that of Spirochaetes and Bacteroidetes in the ileum and colon were significantly increased.
However, the abundance of these bacteria was not affected after adding Clostridium sp. WJ06. The result
also showed that the dominant bacteria of caecum were not significantly affected by contaminated diets.
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Figure 5. Relative abundance of the dominant bacterial phyla level in nine libraries. Each bar
represents the relative abundance of each sample. Each color represents a particular bacterial family.
Sequences that could not be classified into the top 10 were classified as ‘others’. A, B, and C represent
the samples from three treatments, and 1, 2, and 3 represent the samples of the ileum, caecum and
colon, respectively.
 
(a) (b) (c) 
Figure 6. Relative abundance of the dominant bacteria at the same gut region at the genus level.
Each bar represents the relative abundance of each sample. Each color represents a particular bacterial
family. (a) A1, B1, and C1 represent the samples of the ileum in different treatments. (b) A2, B2, and C2
represent the samples of the caecum in different treatments. (c) A3, B3, and C3 represent the samples of
the colon in different treatments.
Lactobacillus represented the largest number of bacteria in the ileum (47%), ceacum (13%), and colon
(14%) at the genus level, especially for ileum. The abundance of Lactobacillus was significantly decreased
in the ileum (11%), ceacum (2%) and colon (9%) after being fed with contaminated diets, while that
of Lactobacillus was higher than the control group in the ceacum (10%) and colon (12%), but not in the
ileum (13%) after adding Clostridium sp. WJ06 (Figure 6). Meanwhile, the abundance of Clostridium
increased significantly after the use of Clostridium sp. WJ06. The abundance of Clostridium in the ileum and
colon of the control treatment were all 7%, while that of Clostridium in the ileum and colon increased to
28% and 27%, respectively, after adding Clostridium sp. WJ06. The abundance of Clostridium in the ceacum
of the control treatment was 19%, but fell to 6% after adding Clostridium sp. WJ06. However, the abundance
of Clostridium was not affected by contaminated diets, which may be connected with the reproductive
ability of Clostridium sp. WJ06 and was different in the ileum, caecum, and colon, respectively.
In our study, the result showed that the structure of porcine cecal flora was quite different from
that of the flora of the ileum and colon. Christensenellaceae, Eubacterium, and Subdoligranulum belong to
the dominant flora in the ceacum, but not in the colon and ileum. At the same time, Sulfurovum, Leeia,
and Treponema formed dominant populations in the ileum and colon, but not in the ceacum. The shifts
of the bacterial community compositions were further corroborated by a clear clustering of the
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dominant bacterial genus corresponding to different treatment in the heat map, as shown in Figure 7.
The result revealed that the bacterial composition in the ileum, ceacum, and colon of growing pigs
varied significantly in different diets, but the structure of bacteria was relatively stable and simple.
 
Figure 7. Hierarchically clustered heat map of the highly represented fungal taxa (at the genus level)
in nine libraries. The relative percentages (%) of the bacterial families are indicated by varying color
intensities, according to the legend at the top of the figure. The darker the color of samples, the higher
the relative abundance shown in the picture.
2.5. Effects of Clostridium sp. WJ06 on Intestinal Bacterial Flora of Pigs via ITS1 Gene Sequence
In this paper, the top 10 species of fungal flora with the highest relative abundance at the phylum
and genus levels are shown in Figures 8 and 9, respectively. It can be seen from Figure 8 that the
number of dominant fungi species varied significantly in the ileum, caecum, and colon in different
diets, especially in regard to the abundance of Basidiomycota and Ascomycota.
 
Figure 8. Dominant fungi composition of the different communities at the phyla level. Each bar
represents the relative abundance of each sample. Each color represents a particular bacterial family.
Sequences that could not be classified into top 10 were assigned as ‘others’. A, B, and C represent
the samples from three treatments, and 1, 2, and 3 represent the samples of the ileum, caecum,
and colon, respectively.
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(a) (b) (c) 
Figure 9. Relative abundance of the dominant fungi at the same gut region at the genus level. Each bar
represents the relative abundance of each sample. Each color represents a particular bacterial family.
(a) A1, B1, and C1 represent the samples of ileum in different treatments. (b) A2, B2, and C2 represent
the samples of caecum in different treatments. (c) A3, B3, and C3 represent the samples of the colon in
different treatments.
As shown in Figure 9, the results revealed that the abundance of Lysurus, Kazachstania,
and Fusarium were significantly increased in the ileum and colon at the genus level after being
fed with contaminated diets, and that these bacteria had not significantly increased after adding
Clostridium sp. WJ06. The result indicated that the species structure of the caecum was significantly
different from that of the ileum and colon.
The shifts of the fungal community compositions were further corroborated by clear clustering
of the dominant bacterial genus corresponding to different treatments in the heat map, as shown in
Figure 10. The results suggested that the number of fungi in the treatment groups varied greatly.
 
Figure 10. Hierarchically clustered heat map of the highly represented fungal taxa (at the genus level)
in nine samples. The relative percentages (%) of the bacterial families are indicated by varying color
intensities according to the legend at the top of the figure. The more brunette the samples’ color,
the higher relative abundance shown in the picture.
2.6. Analysis of Beta Diversity of all Samples
Beta diversity analysis was used to evaluate the differences of samples in species complexity,
and principal component analysis (PCA) was carried out for this paper [18]. The PCA plot based on
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the relative abundance of bacterial OTUs revealed a separation between the different treatments and
different intestinal regions on the basis of the first two PC scores, which accounted for 11.72% and
18.16% of the total variation, respectively (Figure 11A). The more similar the composition of samples,
the closer the distance shown in the PCA picture. Our data showed that the bacterial flora diversity




Figure 11. Principal component analysis (PCA) in nine libraries. Scatterplot of PCA score depicting the
variance in fingerprints derived from different bacterial communities. The more similar the composition
of samples, the closer the distance shown in the PCA picture. (A) The sequence number of bacteria
flora. (B) The sequence number of fungi flora.
At the same time, the fungal diversity was analyzed by PCA, and the two PC scores accounted for
18.74% and 21.68% of the total variation, respectively (Figure 11B). Our data showed that the fungal
flora diversity varied significantly more in the colon than in the ileum and caecum in different diets.
2.7. Analysis of the Concentration of DON and De-Epoxy-DON (DOM-1) in Urine and Feces
De-epoxydeoxynivalenol (DOM-1) had not been found in porcine urine in any experimental
group. The concentration of DON in urine at different trail periods is displayed in Figure 12. The result
indicated that on the 14th, 21st, and 35th day of the experiment, the DON value in group B was
significantly higher (p < 0.05) when compared with the other groups. Meanwhile, the DON value
in group C was significantly lower when compared to group B (p < 0.05), but significantly higher
than the control group (p < 0.05). No significant differences were found in each group on different
exposure days.
Figure 12. Concentration of deoxynivalenol (DON) in porcine urine at different exposure days.
A, B, and C represent the samples of different treatments. Bars are presented as mean ± SD, n = 5.
The values with different asterisks (* or **) differed significantly on the same exposure day (p < 0.05).
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The concentration of DON and DOM-1 in porcine feces is displayed in Figure 13. The result
showed that the DON value in group B increased significantly compared with the other groups
(p < 0.05), and a gradual increasing trend of the DON value from day 14 to day 35 appeared in groups
B and C. The concentration of DOM-1 had not been found in group A in our study. The DOM-1 value of
group B decreased significantly more than that of group C (p < 0.05), while the values at days 21 and 35
were significantly higher than the value at day 14 (p < 0.05). This result indicated that DOM-1 was
mainly converted in the intestinal tract by Clostridium sp. WJ06.
(a) (b) 
 
Figure 13. Concentration of DON and de-epoxy-DON (DOM-1) in porcine feces at different exposure
days. (a) The concentration of DON. (b) The concentration of DOM-1. A, B, and C represent the
samples of different treatments. Bars are presented as mean ± SD, n = 5. The values with different
asterisks (* or **) in the same exposure day differ significantly (p < 0.05).
3. Discussion
3.1. DON Metabolism and the Toxic Effects of DON
Since the discrepancy existed in the absorption, metabolism and clearance procedures,
the tolerance for the toxicity and pathogenic dose of DON were different for different animal
species in vivo [19,20]. DON was degraded by microorganisms into a variety of products (such as
de-epoxy-DON) in the digestive tract or in the intestinal mucosa, liver, kidney, and other organs.
Chemical structure of DON and DOM-1 was listed in Figure 14. Residual DON and DOM-1 were
the highest in the pig kidney, followed by the liver, and the high DON residue in the kidney may be
associated with urine enrichment [21–23].
 
Figure 14. Chemical structure of DON and DOM-1 was cited by Maresca [24]. DON and DOM-1 were
drawn using Marvin software. Images on the right show an electrostatic map of the molecules, with the
blue color indicating a positive region, the red color indicating a negative region, and the gray color
indicating a neutral region. The purple circles on the left images and the yellow arrows on the right
images indicate the position of the epoxide or de-epoxide functions in DON and DOM-1, respectively.
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In this study, the relative weight of the liver and kidney of growing pigs increased significantly
after being fed with DON-contaminated wheat, indicating that the toxicity of DON was related to
its metabolism and residual presence in the liver and kidney, which was consistent with the result
reported before [21–23]. Meanwhile, the toxin effects on the liver and kidney of growing pigs were
relieved after adding Clostridium sp. WJ06. These results come from the analysis of DON and DOM-1
in porcine feces and urine, and revealed that DOM-1 was mainly converted in the intestinal tract
by Clostridium sp. WJ06. This indicated that the detoxified effect of Clostridium sp. WJ06 may be
because it can convert DON to DOM-1 in the intestinal tract, and then reduce the absorption of DON
in the intestine.
The results of this study also showed that DON-contaminated wheat can also cause a significant
increase in the relative weight of the spleen, which was inconsistent with previous results [21,22].
Clostridium sp. WJ06 had no protective effect on the spleen of pigs, which may be due to the coexistence
of other mycotoxins in the naturally contaminated wheat. The special metabolic pathways may exist
in the spleen, so that Clostridium sp. WJ06 cannot decompose the toxicity of a variety of mycotoxins on
the spleen of pigs.
3.2. Intestinal Morphological Structural Integrity and Toxic Effects of DON
The integrity of the intestinal barrier can effectively prevent intestinal bacteria,
toxins, inflammatory mediators, and other harmful substances from passing through the intestinal
mucosa into the blood [12,25]. DON is mainly absorbed in the small intestine, and it can pass through
the intestinal barrier, enter the blood circulation and distribution system, and travel to the peripheral
organs, thereby affecting the activity and function of the cells [26–28]. The absorption rate of DON
exhibited the great difference between animal species; for example, the absorption rates of pigs,
chickens, sheep, and cows were 82%, 19%, 9.9%, and 1%, respectively [29,30]. These differences
are mainly related to the distribution of parasitic flora before or after the small intestine [31].
Before entering the small intestine of ruminants and poultry, DON is exposed to higher concentrations
of microorganisms, which can convert DON to DOM-1 [32]. For humans and monogastric animals,
there are a lack of microorganisms in the front of the small intestine, so humans and pigs are more
sensitive to DON than poultry and ruminants [33,34].
In this study, the results suggested the microstructure of the ileum, caecum, and colon were
destroyed by DON, especially ileum, which may be due to fewer microorganisms in the ileum of
pigs than the caecum and colon. After adding Clostridium sp. WJ06, the damage to the intestinal
barrier were alleviated significantly. The results indicated that DON may induce intestinal lesions
by disrupting the integrity of the intestinal barrier, which is consistent with previous findings [35].
Clostridium sp. WJ06’s protection of the intestine is probably because it can convert DON to DOM-1 in
the intestine, thereby reducing its absorption and protecting the intestinal barrier of growing pigs. In
the future, a study concerning the mechanism of Clostridium sp. WJ06 on degrading DON needs to be
carried out.
3.3. Effects of Clostridium sp. WJ06 on Intestinal Microflora Diversity
The animal digestive tract, especially that of mammals, is very suitable for microbial mass
reproduction. The complex microbial communities that survive in the intestine are called microbial
flora [36]. Intestinal microflora planted in the small intestine and large intestine play an important role
in maintaining the host’s functions, including the energy intake of food, generation of the host’s key
metabolites, development of the immune system, response to gastrointestinal diseases, and so on [37].
In this research, the effects of Clostridium sp. and DON on the diversity of bacteria and fungi in the pig
intestine were studied by MiSeq sequencing of the 16S rRNA gene and the ITS1 gene.
At the phylum level, Firmicutes is the predominant group of bacteria in the intestinal tract
of mammals, with a proportion of more than 80%. Bacteroidetes is in the intestinal tract of second
heterotic groups, which are connected with fermentation of carbohydrates, glucose metabolism,
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and bile acid metabolism. In the analysis of the genus level, Lactobacillus was the largest number
of bacteria in the ileum, caecum and colon, especially in the ileum. The abundance of Lactobacillus
was significantly decreased in all of the intestinal regions. A number of physiological influences
of Lactobacillus on their hosts have been examined, including antimicrobial effects, microbial
interference, supplementary effects on nutrition, antitumor effects, the reduction of cholesterol in
serum, and immunomodulatory effects, and so on [38,39]. The analysis concerning the diversity of
fungal flora of growing pigs in different diets was listed in this paper.
In conclusion, the results indicated that the bacterial and fungal composition in the ileum, caecum
and colon of growing pigs varied significantly in different diets, but the structure of bacteria was
relatively stable and simple. The effect of detoxification of Clostridium sp. WJ06 may be connected with
the adjustment effect on the composition and diversity of intestinal microflora. Meanwhile, our results
suggested that the composition and structure of the caecum of pigs was different significantly compared
with that of the ileum and colon.
4. Materials and Methods
4.1. Ethics Statement
All procedures were carried out in accordance with the Guidelines for Experimental Animals of
the Ministry of Science and Technology (Beijing, China) for the ethical use of experimental animals.
The protocol were reviewed and approved by the Animal Care and Use Committee in the Shandong
Agricultural University of China. (Permit Number ACSA-2016-036, 15 September 2016).
4.2. Bacteria Culture
Clostridium sp. WJ06 (Patent No: CN102485883.B) was separated from the intestinal tract of adult
chickens, provided by Dr. Wang Jinquan of the Chinese Academy of Agricultural Sciences. L10 broth
or agar was used to culture Clostridium sp. WJ06 at 37 ◦C for 48–72 h in an anaerobic chamber with
an atmosphere of 85% N2, 10% CO2, and 5% H2. At the same time, the conversion of DON was
determined by high performance liquid chromatography (HPLC), and the results showed that the
DON can be converted into DOM-1 with a degradation rate of over 90% by Clostridium sp. WJ06
(Figure 15) and has good stability.
Figure 15. The effect of Clostridium sp. WJ06 culture on degrading DON in vitro via high
performance liquid chromatography (HPLC). (A) The chromatogram of standard DON and DOM-1.
(B) The chromatogram of the co-culture of DON (20 ppm) and L10. (C) The chromatogram of the
co-culture of DON (20 ppm), L10, and Clostridium sp. WJ06.
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4.3. Diets, Animals, and Experimental Design
The basal diet on the basis of de Blas and Wiseman (1998) and the addition of DON-contaminated
wheat diets (33.3%) were completed before the trial of the seventh day, and the diet composition and
nutrition level are shown in Table 4. DON, Aflatoxin B1 (AFB1), Fumonisin B1 (FB1) and Zearalenone
(ZEA) were all examined by LC-MS/MS in the Institute of Quality Standards and Detection Technology,
Chinese Academy of Agricultural Sciences (Beijing, China).
Table 4. Composition of the experimental diets.
Basal Diet Contaminated Diet
Ingredients (%)
Corn 60.0 32.7
Soybean Meal 23.0 18.0
Extruded soybean 2.0 1.0
Contaminated wheat 0 33.3
Concentrate feed # 15 15
Total 100 100
Calculated composition (%)
Dry matter 85.4 86.62
Crude ash 4.79 4.88
Calcium 0.63 0.58
Available phosphorus 0.57 0.62
Crude fibre 53.75 52.55
Crude protein 16.67 16.70
Crude fat 3.78 2.72
Digestible energy (MJ/kg) 17.17 16.69
Content of mycotoxin (ug/kg) 2
DON 371.2 1904.44
Aflatoxin B1 (AFB1) 1.56 1.59
Fumonisin B1 (FB1) 256.3 325.7
Zearalenone (ZEA) 145.16 96.08
# Concentrate feed provided per kg diet: Ca 2.1 g; P 1.2 g; Mn 6 mg; Fe 150 mg; Zn 150 mg; Cu 9 mg; I 0.21
mg; Se 0.45 mg; vitamin A 3300 IU; vitamin D 290 IU; vitamin E 24 IU; vitamin K 30.75 mg; vitamin B1 1.50 mg;
vitamin B2 5.25 mg; vitamin B6 2.25 mg; vitamin B 120.026 mg; pantothenic acid 15 mg; nicotinic acid 22.50 mg.
2 Measured by HPLC methods.
Twenty-four commodity generation PIC pigs (quinary crossbred Pig improve Co. England,
four months of age) of both sexes (equal male to female ratio per treatment and 55.58 ± 1.83 kg in
mass) were used for experiments after an adaptation period of seven days. The pigs were divided into
eight healthy pigs per treatment group and assigned to the three experimental diets by average liver
mass, which was monitored every day. Treatment A was only fed with basal diet as a control group.
Treatment B was fed with the basal diet with the addition of DON-contaminated wheat as the negative
control group. Treatment C was fed with the basal diet with the addition of DON-contaminated wheat,
but using Clostridium sp. WJ06 as a detoxicant every day. The addition amount of Clostridium sp. was
30 mL per pig every day, and the culture solution of Clostridium sp. WJ06 was poured into the feed
and mixed completely before feeding in the morning. The feeding experiment was carried out at a
Kongjiazhuang farm in Shandong province.
The experiment lasted for 35 days, including a seven-day adaptation period and a 28-day
experimental period. Feeds and water were provided ad libitum and offered at 8:30 am and 5:30 pm
daily. The residual feed was collected daily. Pigs were weighed individually at the beginning and the
end of the experiment, and the average daily weight gain (ADG) was calculated. The average daily
feed intake (ADFI) was recorded, and the feed intake to body weight gain (F/G) ratio was calculated.
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On days 14, 21, and 35 of the experiment, the urine and feces of 20 pigs (five pigs per treatment)
were collected and stored at −20 ◦C for further analysis. On the 35th day of the experiment,
three healthy pigs randomly selected from each treatment group were euthanized by electric shock at
the same time (8:00 am). The liver, kidney, heart, and other organs were separated and weighed.
The relative weight of the organ (kg/kg) = organ weight (kg)/live weight (kg) was calculated.
Meanwhile, their digestive tracts had been removed within less than 15 min. The content of the
intestines (including the ileum, caecum, and colon) were collected and frozen immediately in liquid
nitrogen, and subsequently stored at −70 ◦C until analyzed. Then, the approximately two-centimeter
segment of the middle portion of the ileum, caecum, and colon was fixed in 2.5% glutaraldehyde at
room temperature for observation under a scanning electron microscope.
4.4. DNA Extraction
Twenty-seven samples (200 mg of the intestinal content of the ileum, caecum, and colon)
were suspended in 1.4 mL of ASL buffer (stool lysis buffer, Qiagen, Hilden, Germany), and DNA
was extracted using a QIAamp DNA Stool Mini kit (Qiagen, Hilden, Germany), following the
manufacturer’s instructions. The bacterial cells were disrupted by a bead beater with sterile zirconia
beads added to the samples, which improved extraction yield and the quality of the community
DNA [40]. For each sample, DNA was extracted in duplicate to avoid bias [41], and the extracts
from the same sample were pooled for 16S rRNA sequencing. To assess the DNA quality, A 260/280
measurements were performed using a DU640 Nucleic Acids and Protein Analyzer (Beckman Coulter,
Brea, CA, USA). The DNA samples were diluted to 20 ng/uL using sterile ultrapure water. After the
extracted DNA was detected and quantified strictly, equal moles of three DNA samples of the same
treatment and the intestinal regions were mixed [42]. Therefore, the total number of mixed DNA
samples was nine, and then nine libraries were coded as A1, A2, A3, B1, B2, B3, C1, C2, and C3; that is,
A, B, and C represented the samples from three treatments, and 1, 2, and 3 represented the samples of
the ileum, caecum, and colon, respectively. Then, all of the samples were stored at −20 ◦C until use.
4.5. MiSeq Sequencing of 16S rRNA Gene and ITS1 Gene
For all of the samples collected, we used a barcoded high-throughput sequencing approach similar
to that described in Jia et al. [43] and McGuire et al. [44] to survey the diversity and composition
of the bacterial and fungal species in each of these samples. PCR amplifications were conducted
with the barcoded primer pair 341F/806R set that amplifies the V3–V4 fragments of the 16S rRNA
gene (341F: CCTAYGGGRBGCASCAG, 806: GGACTACNNGGGTATCTAAT). Meanwhile, the first
internal transcribed spacer region (ITS1) of the fungal rRNA gene was amplified using the ITS5-1737F
(GGAAGTAAAAGTCGTAACAAGG) and ITS2-2043R (GCTGCGTTCTTCATCGATGC) as the primer
pair. All of the amplicon sequencing samples were accomplished using the Illumina MiSeq platform at
the Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
At first, all of the initial template DNA concentrations were normalized between samples. PCR
reactions were performed according to protocols described by Caporaso et al. [45]. All of the PCR
reactions were carried out with Phusion® High-Fidelity PCR Master Mix (NEB, Beijing, China).
We mixed the same volume of 1× loading buffer (contained SYB green) with PCR products
and operate electrophoresis on 2% agarose gel for detection. Samples with a bright main strip
between 400–450 bp were chosen for further experiments. PCR products were mixed in equidensity
ratios. Then, the mixture of PCR products was purified with a Qiagen Gel Extraction Kit
(Qiagen, Hilden, Germany). Sequencing libraries were generated using a TruSeq® DNA PCR-Free Sample
Preparation Kit (Illumina, San Diego, CA, USA) following the manufacturer’s recommendations, and index
codes were added. The library quality was assessed on the Qubit® 2.0 Fluorometer (Thermo Scientific,
Waltham, MA, USA) and Agilent Bioanalyzer 2100 system (Agilent, Waldbronn, Germany). At last,
the library was sequenced on an IlluminaHiSeq2500 platform and 250 bp paired-end reads were generated.
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4.6. Bioinformatics Analysis
Paired-end reads were assigned to each sample based on their unique barcode and truncated
by cutting off the barcode and primer sequence. The high-quality clean tags were obtained,
which complied with the method reported by Jia et al. [43]. These sequences were classified into
the same OTUs (operational taxonomic units) at an identity threshold of 97% similarity using UPARSE
software (UPARSE v7.0.1001, Edgar, Tiburon, California, USA, http://drive5.com/uparse/) [46].
For each representative sequence, the GreenGene Database (http://greengenes.lbl.gov/cgi-bin/nph-
index.cgi) was used based on the Ribosomal Database Project (RDP) classifier (Version 2.2, http:
//sourceforge.net/projects/rdp-classifier/) algorithm to annotate taxonomic information. The taxon
abundance of each sample was generated into phylum, class, order, family, and genera levels. In order
to study the phylogenetic relationship of different OTUs, and the difference of the dominant species in
different samples (groups), multiple sequence alignments were conducted using the MUSCLE software
(Version 3.8.31, http://www.drive5.com/muscle/) [47].
We processed the ITS1 fungal amplicon data following methods outlined in McGuire et al. [47].
We used the QIIME pipeline in a similar way as for the 16S rRNA data, except the Unite Database
(https://unite.ut.ee/) was used based on the Blast algorithm, which was calculated by QIIME software
(Version 1.9.1, http://qiime.org/scripts/assign_taxonomy.html) to annotate taxonomic information.
All of the analyses from clustering to alpha diversity (within each sample) and beta diversity
(between samples) were performed with QIIME (Version 1.9.10,) and displayed with R software
(Version 2.15.3) [48].
4.7. Analysis of the Concentration of DON and DOM-1 in Urine and Feces
The concentrations of DON and de-epoxy-DON (DOM-1) in urine and feces were analyzed by
LC-MS/MS (liquid chromatography-tandem mass spectrometry). The sample preparation methods
were described in detail earlier [49]. LC-MS/MS analysis was performed using an Agilent 1200
liquid chromatograph (Agilent Technologies, Palo Alto, CA, USA) coupled to a 3200 QTrap® mass
spectrometry system (Applied Biosystems, Foster City, CA, USA) equipped with a Turbo electrospray
ionization (ESI) interface. All investigations concerning the concentration of DON and DOM-1 were
carried out in the Institute of Quality Standards and Detection Technology, Chinese Academy of
Agricultural Sciences.
4.8. Statistical Analysis
The data analyses for growth performance and the relative weight of organs were performed using
one-way analysis with SPSS for Windows, version 14.0, and differences between means were compared
by Duncan’s least significant difference. p value < 0.05 was considered a significant difference, and the
analysis result was noted with mean ± standard deviation (mean ± SD).
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Abstract: The objective of the current experiment was to explore the intestinal microbiota ecological
response to oral administrations of hydrogen-rich water (HRW) and lactulose (LAC) in female
piglets fed a Fusarium mycotoxin-contaminated diet. A total of 24 individually-housed female piglets
(Landrace × large × white; initial average body weight, 7.25 ± 1.02 kg) were randomly assigned
to receive four treatments (six pigs/treatment): uncontaminated basal diet (negative control, NC),
mycotoxin-contaminated diet (MC), MC diet + HRW (MC + HRW), and MC diet + LAC (MC + LAC)
for 25 days. Hydrogen levels in the mucosa of different intestine segments were measured at the
end of the experiment. Fecal scoring and diarrhea rate were recorded every day during the whole
period of the experiment. Short-chain fatty acids (SCFAs) profiles in the digesta of the foregut and
hindgut samples were assayed. The populations of selected bacteria and denaturing gradient gel
electrophoresis (DGGE) profiles of total bacteria and methanogenic Archaea were also evaluated.
Results showed that Fusarium mycotoxins not only reduced the hydrogen levels in the caecum but
also shifted the SCFAs production, and populations and communities of microbiota. HRW treatment
increased the hydrogen levels of the stomach and duodenum. HRW and LAC groups also had
higher colon and caecum hydrogen levels than the MC group. Both HRW and LAC protected
against the mycotoxin-contaminated diet-induced higher diarrhea rate and lower SCFA production
in the digesta of the colon and caecum. In addition, the DGGE profile results indicated that HRW
and LAC might shift the pathways of hydrogen-utilization bacteria, and change the diversity of
intestine microbiota. Moreover, HRW and LAC administrations reversed the mycotoxin-contaminated
diet-induced changing of the populations of Escherichia coli (E. coli) and Bifidobacterium in ileum digesta
and hydrogen-utilizing bacteria in colon digesta.
Keywords: intestinal microbiota; hydrogen-rich water; lactulose; Fusarium mycotoxins; piglets
Key contribution: Our results showed that both hydrogen-rich water and lactulose administrations
protected against the imbalance of intestinal microbiota, reduction of SCFAs production and
higher diarrhea rate induced by a Fusarium mycotoxin diet, partly through affecting the
communities/populations of microbiota and the evaluation of hydrogen gas.
1. Introduction
Fusarium mycotoxins are secondary metabolites of fungi, produced by several kinds of Fusarium
species that occur naturally worldwide in cereal grains and animal feed [1]. Among the Fusarium
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mycotoxins, deoxynivalenol (DON) and zearalenone (ZEN) are of special importance as they are formed
under predisposing environmental conditions in the field prior to harvest and cannot be completely
avoided by strategies [2]. Consumption of Fusarium mycotoxins is widely considered as a serious health
hazard issue for both animals and human beings, due to their potent toxicity on the gastrointestinal (GI)
tract, with symptoms including nausea, vomiting, diarrhea, and oxidative damage [3]. The GI tract
is the place where mycotoxin absorption and metabolism occur. Therefore, interactions between the
mycotoxins and intestinal microbiota play a major role in the toxicology of mycotoxins [4]. It has been
shown that intestinal bacteria are able to bind, transform, degrade, and transfer mycotoxins in vivo and
in vitro [5]. Increasingly attention has been paid on how mycotoxin exposure impacts the intestinal
microbiota. Previous studies have shown that the profiles and biodiversity of intestinal microbiota
were rapidly and clearly modified in pig exposure to a mycotoxin-contaminated diet [6,7]. Considering
the functional effects of microbiota, many methods have been attempted to balance gut microbiota to
normalize microbiota in intestinal tracts and keep the host healthy. For example, supplementation of
nutritional elements, probiotics, and prebiotics or symbiotic, etc.
Hydrogen gas is one of the metabolites of bacterial fermentation in the gut, which has been
proven to act as a novel antioxidant [8]. It has been demonstrated that H2 could penetrate cytoplasmic
membranes, targets intracellular organelles, and selectively neutralizes cytotoxic reactive oxygen
species (ROS) [9]. As a result, hydrogen gas has been applied in many disease models, such as dextran
sodium sulfate (DSS)-induced colon inflammatory [10] and intestinal ischemia-reperfusion injuries [11].
A recent report described that 70% of GI microbial species that encoded genetic capacity to metabolize
H2 [12], indicating that H2 levels might affect the gut microbial activity, population, or community.
Interestingly, one recent study reported that molecular hydrogen-dissolved alkaline electrolyzed water
(AEW) had a strong antimicrobial effect and significantly reduced populations of pathogenic bacteria,
such as Escherichia coli O157 and Salmonella [13]. Xiao et al. also reported that HRW oral gavage
resulted in retention of the total abdominal irradiation (TAI)-shifted intestinal bacterial composition
in mice [14]. As we know, H2 is produced continuously under a normal physiological condition in
mammalian animals, primarily during the fermentation of non-digestible carbohydrates by bacteria in
the large intestine. Therefore, administration of hydrogen-producing prebiotics might also be a viable
method to provide functional H2 to animals and humans. Lactulose is a synthetic non-absorbable
disaccharide consisting of fructose and galactose [15]. It has been reported that microbial fermentation
of lactulose in the hindgut could induce dramatic amounts of endogenous H2, providing beneficial
effects on liver regeneration [16] and cerebral ischemia-reperfusion injury [17] in rats. In addition,
lactulose administration could also lead to the production of short-chain fatty acids (SCFAs) and
methane, increasing the diversity and creating a distinct microbiota community in piglets [18,19].
Although HRW and LAC have shown the modifications of microbiota, the effects of HRW or LAC
on mycotoxin-induced microbiota imbalance in piglets have not ever been studied. Here, the rationale
underlying this study is that HRW or LAC might maintain the intestinal microbiota communities and
bacteria populations, thus affecting SCFAs production and eventually improving the health status
of female weaning piglets. Therefore, the impacts of HRW and LAC on fecal scoring, diarrhea rate,
SCFAs production, intestinal microbiota communities, and populations in piglets fed a Fusarium
mycotoxin-contaminated diet were explored in this study.
2. Results
2.1. Hydrogen Levels in Intestinal Segments
At the end of the experiment, that is, day 25 of the experiment, hydrogen concentrations in
the mucosa of stomach, duodenum, jejunum, ileum, colon, and caecum are presented in Figure 1.
Results showed that stomach and duodenum in the MC + HRW group had the highest hydrogen
levels among the four groups (p < 0.05), while no difference was found among the other three groups
(p > 0.05). No difference was found in the jejunum and ileum hydrogen concentrations among the four
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groups (p > 0.05). Fusarium mycotoxin-contaminated diet was found to reduce the hydrogen levels in
the caecum (p < 0.05), but have no impact on the hydrogen levels in the colon (p > 0.05). Interestingly,
both LAC and HRW treatments significantly increased the hydrogen levels either in the colon or
caecum when they compared with the MC group (p < 0.05). Furthermore, the MC + LAC group had
higher hydrogen levels than the MC + HRW group in the colon and caecum samples (p < 0.05).
Figure 1. Effects of hydrogen-rich water and lactulose on hydrogen concentrations in different intestinal
segments of female piglets fed a Fusarium mycotoxin-contaminated diet. Each column represents
the mean hydrogen levels with five independent replications, mean ± SD. Letters a–c above the
bars indicate statistical significance (p < 0.05) among the four treatments. NC (negative control),
basal diet; MC, Fusarium mycotoxin-contaminated diet; MC + LAC, MC diet + lactulose treatment;
and MC + HRW, MC diet + hydrogen-rich water treatment.
2.2. Fecal Scoring and Diarrhea Rate
The effects of HRW and LAC on fecal scoring and diarrhea rate in piglets fed a Fusarium
mycotoxin-contaminated diet are shown in Table 1. From days 0 to 7 and days 7 to 14, the Fusarium
mycotoxin diet was found to significantly increase the fecal score (p < 0.05), while HRW and LAC
treatments lowered the fecal score from days 0 to 7 and days 7 to 14, respectively (p < 0.05). From days
14 to 21, days 21 to 25, and days 0 to 25, no significant difference was found on fecal scoring among the
four groups (p > 0.05). No difference was found on the diarrhea rate from different time periods except
from days 0 to 7 (p > 0.05). Compared with the NC group, the diarrhea rate was significantly increased
in both MC and MC + LAC from days 0 to 7 (p < 0.05), while HRW treatment decreased the diarrhea
rate compared with the MC group (p < 0.05). Additionally, there was no difference between the MC
and MC + LAC groups (p > 0.05).
Table 1. Effects of hydrogen-rich water and lactulose on fecal scoring and diarrhea rate of female
piglets fed a Fusarium mycotoxin-contaminated diet 1,2.
Item NC MC MC + LAC MC + HRW SEM p-Value
Fecal score
Days 0–7 2.64 c 3.60 a 3.17 b 2.64 c 0.10 <0.001
Days 7–14 2.84 b 3.74 a 3.12 b 3.02 b 0.12 0.037
Days 14–21 2.78 3.00 2.82 2.95 0.11 0.909
Days 21–25 2.79 2.53 2.82 3.00 0.15 0.758
Days 0–25 2.76 3.30 3.02 2.91 0.09 0.163
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Table 1. Cont.
Item NC MC MC + LAC MC + HRW SEM p-Value
Diarrhea rate %
Days 0–7 5.00 b 30.00 a 25.00 a 5.00 b 3.64 0.008
Days 7–14 5.00 30.00 22.50 15.00 5.00 0.353
Days 14–21 7.50 17.50 15.00 12.50 5.09 0.927
Days 21–25 12.00 0.00 12.00 16.00 5.53 0.788
Days 0–25 6.92 22.31 20.00 12.31 3.65 0.449
a,b,c Values with different letters within the same row are different (p < 0.05).1 NC (negative control), basal diet;
MC, Fusarium mycotoxin-contaminated diet; MC + LAC, MC diet + lactulose treatment; and MC + HRW, MC diet +
hydrogen-rich water treatment. 2 n = 5.
2.3. Short-Chain Fatty Acids (SCFAs) Levels in the Digesta of Jejumun, Ileum, Colon, and Caecum
There was no difference (p > 0.05) in the pH value of different intestine segments among the
four groups (Table S1). The concentrations of SCFAs levels in different intestinal segments among the
treatments are shown in Table 2. In the jejunum and ileum, the levels of acetate, propionate, butyrate,
and total SCFAs were found to be no different among the four groups (p > 0.05). In the colon, the acetate
levels were not influenced by treatments (p > 0.05), but the propionate, butyrate, valeric acid, and total
SCFAs concentrations in the MC group were lower than the NC group (p < 0.05). Compared with the
MC group, HRW treatment had higher levels of butyrate (p < 0.05) and no effects on colon propionate,
valeric acid, and total SCFAs status (p > 0.05). However, LAC administration significantly increased
the levels of propionate, butyrate, valeric acid, and total SCFAs (p < 0.05) when they compared with
the MC group. In the caecum, the Fusarium mycotoxin-contaminated diet significantly reduced the
concentrations of acetate, propionate, butyrate, valeric acid, and total SCFAs (p < 0.05). Compared with
the MC group, the LAC group had higher concentrations of acetate, propionate, butyrate, and total
SCFAs (p < 0.05), and the HRW group had higher levels of acetate, butyrate, and total SCFAs (p < 0.05).
Table 2. Effects of hydrogen-rich water and lactulose on short-chain fatty acids (SCFAs) profiles in the
jejunum, ileum, colon, and caecum digesta of female piglets fed a Fusarium mycotoxin-contaminated
diet 1,2.
Item NC MC MC + LAC MC + HRW SEM p-Value
Jejunum (μmol/g wt digesta)
Acetate 4.30 3.80 4.48 4.14 0.27 0.819
Propionate 2.08 1.58 1.83 1.99 0.12 0.486
Butyrate 0.94 0.72 0.84 1.00 0.06 0.425
Total SCFAs 7.45 6.10 7.15 7.13 0.43 0.737
Ileum (μmol/g wt digesta)
Acetate 10.50 10.64 10.58 10.29 0.41 0.993
Propionate 5.09 5.56 5.65 5.16 0.27 0.660
Butyrate 0.49 0.50 0.52 0.54 0.03 0.932
Total SCFAs 16.08 16.69 16.75 15.99 0.66 0.971
Colon (μmol/g wt digesta)
Acetate 44.28 39.83 49.94 43.78 1.48 0.102
Propionate 19.13 a 11.19 b 20.13 a 14.62 ab 1.17 0.010
Butyrate 8.25 a 4.00 b 7.55 a 7.35 a 0.53 0.008
Valeric acid 4.40 a 1.00 c 2.55 b 0.91 c 0.40 <0.001
Total SCFAs 76.06 a 56.02 b 80.18 a 66.66 ab 2.99 0.008
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Table 2. Cont.
Item NC MC MC + LAC MC + HRW SEM p-Value
Caecum (μmol/g wt digesta)
Acetate 57.29 a 51.47 b 60.45 a 60.91 a 1.14 0.003
Propionate 26.20 a 19.12 b 25.97 a 22.50 ab 0.99 0.020
Butyrate 12.43 a 6.02 c 9.89 b 10.04 b 0.59 <0.001
Valeric acid 9.84 a 2.49 b 2.22 b 3.01 b 0.77 <0.001
Total SCFAs 105.76 a 79.10 c 98.53 ab 96.46 b 2.60 <0.001
a,b,c Values with different letters within the same row are different (p < 0.05). 1 NC (negative control), basal diet;
MC, Fusarium mycotoxin-contaminated diet; MC + LAC, MC diet + lactulose treatment; and MC + HRW, MC diet +
hydrogen-rich water treatment. 2 n = 5.
2.4. Microbiota Communities of Total Bacteria and Methanogenic Archaea in the Digesta of
Intestinal Segments
Representative DGGE analysis of total bacteria in foregut (jejunum and ileum) and hindgut (colon
and caecum) are shown in Figure 2A,C and Figure 3A,C, respectively. DGGE profiles of PCR products
in the V6–V8 regions of the 16S rRNA gene from the four groups revealed some difference among
different treatments at the foregut and hindgut. It is shown that jejunum (Figure 2A), ileum (Figure 2C),
and colon (Figure 3A) amplicons migrating to the top of the gel were predominant in the samples of
all groups, and caecum amplicons (Figure 3C) migrating to the middle of the gel were predominant in
the samples of all treatment.
Figure 2. Effects of hydrogen-rich water and lactulose on jejunum and ileum digesta
PCR-DGGE profiles of V6–V8 amplicons and similarities index of female piglets fed a Fusarium
mycotoxin-contaminated diet. (A) DGGE profile of bacteria community in the jejunum digesta
of four groups; (B) Similarity index of bacteria DGGE profile obtained from jejunum digesta of
four groups; (C) DGGE profile of bacteria community in the ileum digesta of four groups; (D) Similarity
index of bacteria DGGE profile obtained from ileum digesta of four groups. NC (negative control),
basal diet; MC, Fusarium mycotoxin-contaminated diet; MC + LAC, MC diet + lactulose treatment;
and MC + HRW, MC diet + hydrogen-rich water treatment.
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Figure 3. Effects of hydrogen-rich water and lactulose on colon and caecum digesta PCR-DGGE profiles
of V6–V8 amplicons and similarities index of female piglets fed a Fusarium mycotoxin-contaminated
diet. (A) DGGE profile of bacteria community in the colon digesta of four groups; (B) Similarity
index of bacteria DGGE profile obtained from colon digesta of four groups; (C) DGGE profile of
bacteria community in the caecum digesta of four groups; (D) Similarity index of bacteria DGGE
profile obtained from caecum digesta of four groups. NC (negative control), basal diet; MC, Fusarium
mycotoxins-contaminations diet; MC + LAC, MC diet + lactulose treatment; and MC + HRW, MC diet
+ hydrogen-rich water treatment.
Cluster analysis revealed that the overall similarity of total bacteria DGGE patterns in the jejunum,
ileum, colon, and caecum were 64.3%, 83.2%, 83.7%, and 66.3%, respectively (Figure 2B,D, Figure 3B,D,
respectively). In the jejunum and ileum, the NC group samples formed in one cluster with a similarity
of 67.8% and 86.6%, while MC, MC + LAC, and MC + HRW groups were in another cluster with a
similarity of 66.0% and 87.8%, respectively. In the colon, NC and MC + HRW groups formed in one
cluster with 84.2% similarity, and MC formed another cluster with the MC + LAC group. However,
the cluster pattern in the caecum was quite different, in which NC and MC groups were found in one
coherent cluster with 68.3% similarity, and MC + LAC with MC + HRW groups formed another cluster
with 67.1% similarity.
For the methanogenic Archaea compositions, the ileum (Figure 4A), colon (Figure 4C), and caecum
(Figure 4E) amplicons migrating to the top of gels were predominant in the samples of all groups.
DGGE cluster analysis showed that the overall similarity in the ileum, colon, and caecum were 39.7%,
83.7%, and 43.0%, respectively. In the ileum (Figure 4B), the NC group formed one cluster with a
similarity of 44.1%, while MC, MC + LAC, and MC + HRW groups formed another cluster with a
similarity of 43.6%. In the colon (Figure 4D), the methanogenic Archaea pattern is different than the
ileum, in which NC and MC + LAC treatments formed one cluster with 84.2% similarity, while MC and
MC + HRW groups formed another cluster with 87.2% similarity. In the caecum (Figure 4F), the NC
group formed one cluster with 58.3% similarity. Except for one sample from the MC + LAC group,
the MC, MC + HRW, and MC + LAC groups formed another cluster with 55.1% similarity.
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Figure 4. Effects of hydrogen-rich water and lactulose on the ileum, colon and caecum digesta
PCR-DGGE profiles of methanogenic Archaea and the similarities index of female piglets fed a Fusarium
mycotoxin-contaminated diet. (A) DGGE profile of methanogenic Archaea community in the ileum
digesta of four groups; (B) Similarity index of methanogenic Archaea DGGE profile obtained from ileum
digesta of four groups; (C) DGGE profile of methanogenic Archaea community in the colon digesta of
four groups; (D) Similarity index of methanogenic Archaea DGGE profile obtained from colon digesta
of four groups; (E) DGGE profile of methanogenic Archaea community in the caecum digesta of four
groups; (F) Similarity index of methanogenic Archaea DGGE profile obtained from caecum digesta
of four groups. NC (negative control), basal diet; MC, Fusarium mycotoxins-contaminations diet;
MC + LAC, MC diet + lactulose treatment; and MC + HRW, MC diet + hydrogen-rich water treatment.
The band number and Shannon diversity index of total bacteria and methanogenic Archaea were
also analyzed and are shown in Table 3. For total bacteria, the band numbers and Shannon diversity
in the jejunum were not affected by treatments (p > 0.05). In the ileum, Fusarium mycotoxins did
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not affect the band numbers (p > 0.05), but MC + LAC group had more band numbers than the
MC group (p < 0.05). The Shannon diversity was found to be significantly increased by Fusarium
mycotoxin treatment, while neither LAC nor HRW influenced the Shannon diversity (p > 0.05). In the
colon, Shannon diversity found no differences among the treatments (p > 0.05). MC and MC + LAC
groups were found to have higher band numbers than the NC and MC + HRW groups (p < 0.05),
and no difference was found neither between the MC and MC + LAC groups nor between the NC and
MC + HRW groups (p > 0.05). In the caecum, Shannon diversity did not find any differences among
the four groups. Band numbers in the MC, MC + LAC, and MC + HRW groups were significantly
higher than the NC group (p > 0.05), while no difference was found among the MC, MC + LAC,
and MC + HRW groups (p < 0.05).
Table 3. Effects of hydrogen-rich water and lactulose on the number of DGGE bands and Shannon
diversity of the jejunum, ileum, colon, and caecum digesta of female piglets fed a Fusarium
mycotoxin-contaminated diet 1,2.
Target Group DNA Sample Item NC MC MC + LAC MC + HRW SEM p-Value
Total bacteria
Jejunum Band number 59.20 60.60 64.60 59.60 1.34 0.498
Shannon diversity 3.40 3.64 3.68 3.60 0.05 0.278
Ileum Band number 34.40 c 37.70 bc 44.40 a 38.40 b 1.00 <0.001
Shannon diversity 3.00 b 3.27 a 3.49 a 3.34 a 0.06 0.006
Colon Band number 40.00 b 50.40 a 52.00 a 40.00 b 1.60 0.001
Shannon diversity 3.14 3.15 3.14 3.19 0.04 0.948
Caecum Band number 61.60 b 72.60 a 72.80 a 71.60 a 4.23 0.036
Shannon diversity 3.55 3.76 3.75 3.81 0.04 0.070
Methanogens
Ileum Band number 15.20 b 26.80 a 17.20 b 18.40 b 1.14 <0.001
Shannon diversity 2.27 b 2.91 a 2.27 b 2.28 b 0.09 0.015
Colon Band number 29.80 bc 36.20 a 32.20 b 27.40 c 0.89 <0.001
Shannon diversity 2.99 3.23 2.87 2.89 0.07 0.208
Caecum Band number 31.40 b 41.00 a 32.80 b 34.60 b 1.27 0.023
Shannon diversity 3.06 3.34 2.92 3.22 0.08 0.234
a,b,c Values with different letters within the same row are different (p < 0.05). 1 NC (negative control), basal diet;
MC, Fusarium mycotoxin-contaminated diet; MC + LAC, MC diet + lactulose treatment; and MC + HRW, MC diet +
hydrogen-rich water treatment. 2 n = 5.
For methanogenic Archaea, the band number from the ileum, colon, and caecum digesta in the MC
group were significantly higher than the NC group (p < 0.05), and both LAC and HRW were found
to reduce those band number compared with MC group (p < 0.05). The Shannon diversity of ileum
digesta in the MC group was significantly higher than the NC group (p < 0.05), and MC + LAC and
MC + HRW were found to have lower Shannon diversity than the MC group (p < 0.05). The Shannon
diversity of colon and caecum digesta showed no significant differences among the four groups
(p > 0.05).
2.5. Populations of Selected Bacteria in the Digesta of Different Intestinal Segments
Table 4 shows the populations of selected microbiota in the digesta of the jejunum, ileum, colon,
and caecum in piglets fed a Fusarium mycotoxin-contaminated diet. In the jejunum and caecum,
no difference was found on the abundance of selected bacteria among the four treatments (p > 0.05).
In the ileum, the populations of total bacteria, Lactobacillus, and Enterococcus were not impacted by
treatments, but the abundance of E. coli in the MC group was higher than NC, MC + LAC, and MC
+ HRW groups (p < 0.05). The MC group also had a lower (p < 0.05) Bifidobacterium abundance than
the NC, MC + LAC, and MC + HRW groups, while no difference was found among the latter three
groups (p > 0.05). In the colon, the populations of total bacteria and acetogenic bacteria showed no
significant difference among the four groups (p > 0.05). However, the abundance of methanogenic
Archaea and sulfate-reducing bacteria (SRB) was lower in the MC group than the NC group (p < 0.05).
In addition, MC + HRW and MC + LAC groups were found to have higher populations of these two
selected species than the MC group (p < 0.05).
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Table 4. Effects of hydrogen-rich water and lactulose on the populations (log copies number/g) of
selected bacteria in the digesta of the jejunum, ileum, colon and caecum of female piglets fed a Fusarium
mycotoxin-contaminated diet 1,2.
Sample Item NC MC MC + LAC MC + HRW SEM p-Value
Jejunum All bacteria 8.75 8.66 8.67 8.20 0.13 0.486
Lactobacillus 7.96 7.43 7.25 7.28 0.19 0.552
Bifidobacterium 4.90 4.76 5.26 5.14 0.08 0.124
Escherichia coli 4.87 5.78 5.53 5.31 0.14 0.127
Enterococcus 3.30 3.45 3.21 3.06 0.11 0.685
Ileum All bacteria 9.04 9.64 9.43 9.53 0.14 0.221
Lactobacillus 8.85 8.60 8.75 8.86 0.25 0.906
Bifidobacterium 5.07 a 4.23 b 5.26 a 5.13 a 0.13 0.009
Escherichia coli 5.67 b 7.25 a 6.14 b 6.21 b 0.16 0.005
Enterococcus 3.08 3.66 3.39 3.32 0.58 0.488
Colon All bacteria 11.04 11.09 11.17 10.93 0.07 0.704
Methanogens 4.49 a 3.47 c 5.52 a 4.58 b 0.20 0.001
SRB 3 4.54 a 3.27 b 4.68 a 4.12 a 0.18 0.011
Acetogenic bacteria 6.87 6.85 7.17 6.54 0.11 0.297
Caecum All bacteria 11.57 11.34 11.69 11.60 0.05 0.119
Methanogens 5.14 5.55 5.44 5.36 0.28 0.969
SRB 3 2.89 3.39 3.02 2.88 0.12 0.470
Acetogenic bacteria 6.21 6.31 6.32 6.19 0.16 0.992
a,b,c Values with different letters within the same row are different (p < 0.05).1 NC (negative control), basal diet;
MC, Fusarium mycotoxin-contaminated diet; MC + LAC, MC diet + lactulose treatment; and MC + HRW, MC diet +
hydrogen-rich water treatment. 2 n = 5. 3 SRB = Sulfate-reducing bacteria.
3. Discussion
The gut microbiota ecological system represents an abundant community of organisms, including
bacteria, archaea, fungi, and viruses, that colonized within the GI tract [20]. The complex and
large diverse communities of the microbiota play important roles in nutrition decomposition and
transformation, immunity intrusion, and gut villous structure development through a symbiotic
relationship with the host [20]. Diet is a major factor that influences the makeup and activity of
colonized microbes in the intestinal gut, and we had hypothesized that Fusarium mycotoxins could
induce compositions and/or metabolites changes in the gut microbiota, and eventually affect the
health of female piglets. In addition, oral HRW or lactulose administrations may partly spare the
harmful activity of Fusarium mycotoxins on the intestinal microbiota ecosystem of female weaning
piglets. These results partly support our hypothesis.
3.1. Hydrogen Levels in Intestinal Segments
One major function of microbiota in the gut lumen is the fermentation of indigestible
polysaccharides, dietary fiber, and resistant starch, which generates large quantities of H2 [21]. In this
study, our data showed that administration of HRW increased concentrations of H2 in the stomach,
duodenum, colon, and caecum. However, lactulose treatment was found to have no impact on the
H2 levels in the foregut, but significantly increased the concentrations of H2 in the hindgut (colon
and caecum). The communities, species, and population of microbiota in the hindgut were more
complex than the foregut and might contribute to this difference [22]. In fact, these observed H2
concentrations in the intestine were similar to those in a study reported by Liu et al. [23], who recently
developed a conventional gas chromatography method to measure the hydrogen levels in the tissue
following administration of HRW, hydrogen-rich saline and inhalation of hydrogen gas at different
time points. Their data indicated that after 30 min of administration, hydrogen gas could also be
detected at around 10–20 ppb/g intestine tissue. Moreover, oral administration of HRW had the highest
Cmax compared with other methods [23]. Watanabe et al. found that inhalation of hydrogen gas
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resulted in slower elevation than that achieved with intraperitoneal administration [24], indicating that
different administration ways of providing hydrogen may result in different hydrogen distributions
in blood and tissues. On the other hand, previous studies also indicated that oral administration of
hydrogen-rich water/saline had very short lasting time [25]. Thus, the protective effects of HRW in this
study may not yet be fully exerted. Therefore, the search for an ideal hydrogen-producing prebiotic
may be an interesting method to solve this concern.
Lactulose is a semisynthetic disaccharide and cannot be metabolized nor absorbed in the
intestine [15]. Like other polysaccharides, lactulose is fermented in the gastrointestinal gut by
bacteria, producing SCFAs. Hydrogen gas is one of its metabolites, which may act as an effective
ideal agent [26]. A higher breath H2 can be detected after oral administration of lactulose [17].
After lactulose administration, the exhaled breath H2 concentration was found to be increased after
15 min and reaching a peak at 45 min in mice; meanwhile, lactulose with antibiotic treatment did
not find an improvement of breath hydrogen levels [27]. On one hand, a proportion of hydrogen gas
may pass through the gut mucosa wall into the blood and be transported to other organs. On the
other hand, hydrogen also can be metabolized by intestinal microbiota. Yu et al. also demonstrated
that lactulose significantly increased the accumulated hydrogen levels, and antibiotic administration
induced a smaller amount of H2 in rats [16]. These results indicate that bacterial fermentation may
play a curial role in the beneficial effects of lactulose in animals. Considering the features of LAC,
it is broadly in line with our expectations that lactulose administration had a continual improvement
in the hydrogen concentrations in the mucosa of the hindgut (colon and caecum). Although higher
hydrogen levels were both observed in HRW (stomach and duodenum) and LAC (colon and caecum)
treatments compared with MC group, it is not representative of all H2 production of HRW or LAC.
Thus, more research needs to be carried out to demonstrate the dynamic changes of hydrogen gas in
the intestine after receiving hydrogen-rich water or lactulose in piglets.
3.2. Fecal Scoring and Diarrhea Rate
Disruptions of the microbiota ecological system under abnormal conditions is recognized as a
major risk factor for various diseases, such as diarrhea and inflammatory bowel disease. In the swine
industry, weaning piglets face enormous stress, leading to perturbations in gut microbiota, and host
physiological and mucosal immune function, such as microbiological, environmental, and dietary
factors. The transition from liquid to solid feeding is expected to result in decreased feed intake
and daily weight gain, and increased diarrhea incidence [28]. Corn and soybean meal represent
over 50% of the total dietary ingredients, which are often contaminated with mycotoxins [29]. Thus,
post-weaning piglets are always associated with diarrhea or loose feces [30]. Consumption of DON-
and ZEN-contaminated feeds will induce intoxication symptoms, including vomiting, abdominal
distress, malaise, diarrhea emesis, and even shock or death [3]. In the present study, lower feed
intake and weight gain [31], fever, and severe diarrhea were observed in piglets fed a Fusarium
mycotoxin-contaminated diet. A lower fecal score has been considered a good indicator of gut
health [32]. Feces scoring was decreased in piglets fed a Fusarium mycotoxin-contaminated diet in the
critical period of days 0 to 7 and days 7 to 14 after weaning. In addition, the MC group had higher
diarrhea rates than the NC group in the first week. These results are consistent with previous studies
in which DON has the capacity to increase intestinal permeability, and cause microbiota dysfunctions
which promote intestinal disorders [3,33]. It is also reported that DON ingestion was associated with
the reduction of mRNA expression of Na+-dependent glucose transport sodium-dependent glucose
cotransporter 1 (SGLT1) [34]. Since SGLT1 is responsible for water reabsorption, inhibition of SGLT1
could also cause diarrhea, which might be the underlying cause of diarrhea in animals exposed to
mycotoxins [34].
A number of studies have demonstrated that prebiotics may selectively increase the population
and/or activity of beneficial bacteria [35], decreasing the incidence of diarrhea. Lactulose is always
used in the treatment of constipation and hepatic encephalopathy in humans [15]. However, at low
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doses, lactulose acts as a prebiotic that improves growth performance and intestinal morphology in
pigs [36]. A previously study on piglets showed that 1% lactulose supplementation had higher growth
performance [37]. Additionally, our previous study also suggested that lactulose could improve
anti-oxidant capacity of piglets fed a mycotoxin-contaminated diet [31]. Although no studies explored
the effects of HRW on diarrhea, a protective effect of HRW was found on DSS-induced inflammatory
bowel disease (IBD) in rats, and intestinal villi damage in mice [10]. The exact mechanisms underlying
the protective effects of HRW and LAC on diarrhea is still unclear, but might be attributed to the
ability of both HRW and lactulose could remedy mycotoxin-induced intestine damage through the
anti-oxidant and anti-inflammatory properties. Therefore, it is not surprising that piglets orally
administered HRW or lactulose had a lower fecal score and incidence of diarrhea than the MC group.
3.3. SCFAs Levels in the Digesta of Jejumun, Ileum, Colon, and Caecum
Shifting of the microbiota composition and quality of intestinal microbiota, followed by the
alternation in SCFAs levels and other metabolites, may have a role in ensuring animal health and
disease [38]. Here, we found a significant inhibitory effect of Fusarium mycotoxins on the production
of SCFAs in the colon and caecum, which have not been previously reported. Ingestion of DON
contaminated diet was found to significantly reduce feed intake and increase diarrhea [3], which would
increase the water levels and reduce the dry matter content in the digesta. In fact, compared with the
NC group, a lower caecum relative weight was observed in the MC group (Figure S1). Therefore, it is
conceivable that Fusarium mycotoxins (DON and ZEN) may have modified the microbiota fermentation
in the hindgut due to changes in the colon and caecum nutrient flow and water content. In addition,
the hydrogen levels in the hindgut were also reduced by Fusarium mycotoxin treatment, which may
support the changes of SCFAs production.
As a prebiotic, lactulose is not broken down by mammalian intestine enzymes, but can be
metabolized by gut microbiota to SCFAs. A previous study in pigs revealed that the inclusion of
lactulose in the diet increased the SCFAs concentration in the large intestine [39]. Increased SCFAs
concentrations were also observed in broiler chickens provided with lactulose supplementation [40].
However, Martin-Pelaez et al. found that 1% dietary lactulose supplementation did not affect caecum
butyric acid concentration in piglets that were orally challenged with Salmonella [41]. Recently, it has
been shown that the dietary inclusion of 1% lactulose did not change the branched-chain fatty acids
(BCFA) levels in piglets [37]. Our data suggests that lactulose modified the hindgut microbiota
fermentation, resulting in higher SCFAs production. So far, the relationship of hydrogen-rich water on
short-chain fatty acid production in vivo and in vitro are unknown. Further studies are warranted to
explore the effects of HRW and lactulose on bacteria fermentation in piglets.
3.4. Microbiota Communities and Populations
It is well known that the dynamic complex intestinal microbial ecosystem plays key roles in
maintaining host nutritional, physiological, and immunological functions [38]. Thus, impairment
of microbiota balance could have many adverse effects on the health of the host. Mycotoxins not
only undergo microbial metabolism in the gastrointestinal tract, but may also affect the communities
due to some toxins exhibiting antimicrobial properties [34,42]. In vitro studies showed that DON
did not influence the growth of Staphylococcus aureus, E. coli, and Yersinia enterocolitica [43]. It has
been reported that consumption of feed contaminated with a moderate level of DON had a slight
effect on cultivable bacteria in pig intestines, and the composition of intestinal microbiota was also
observed in DON-exposed animals [44]. Feeding pigs with T-2 toxin led to a substantial increase
of aerobic bacterial counts in the intestine [45]. Similarly, chronic exposure of pigs to low doses of
DON caused an increase in the number of intestinal aerobic bacteria and modified the dynamics of
intestinal bacteria communities [6]. Piotrowska et al. also reported the effect of exposure of pigs to the
Fusarium mycotoxins ZEN and DON, administered together and separately, on the colon microbiota [7].
After 42 days of experiment, their data found that ZEN alone, and together with DON, had an adverse
232
Toxins 2018, 10, 246
effect on mesophilic aerobic bacteria. The concentration of C. perfringens, E. coli, and other bacteria
in the family Enterobacteriaceae was significantly reduced by ZEN alone, and together with DON.
The functional biodiversity of microorganisms was also affected by mycotoxins, which Shannon’s
diversity index was higher [7]. In our study, cluster results of DGGE profiles obtained from the
jejunum, ileum, colon, and caecum showed that the mycotoxin-contaminated diet drastically affected
the communities, diversity, and population of gastrointestinal microbiota (especially in the ileum and
colon). Moreover, our data also indicated that hydrogen-utilizing bacteria (methanogenic Archaea and
SRB) were also involved in the mycotoxincosis-induced intestinal microbiota dysbiosis.
Previous in vivo studies demonstrated positive protective effects of lactulose on colon
fermentation [46]. Lactulose was reported to increase the number of Bifidobacteria and Lactobacilli
while reducing the numbers of Clostridium spp., Salmonella spp., or E. coli in the pig gastrointestinal
tract [36]. Guerra-Ordaz et al. demonstrated that lactulose significantly improved the performance and
colonic microbial activity of weaning piglets [37]. In a previous study, lactulose was included in the diet
at 1%, 0.2%, 0.4%, 0.6%, or 0.8% at the expense of corn and/or soybean meal. A significant quadratic
response in the Lactobacillus count was observed at 42 days on increasing the level of lactulose [40].
However, the effects of HRW on intestinal microbiota in piglets are quite limited. In a mouse study,
16S rRNA gene sequencing analysis was introduced to explore the effects of AEW on the microbial
composition of C57BL/6N mice. After four weeks of treatment, the relative abundance of 20 taxa
differed significantly in AEW-administered mice [47]. Xiao et al. also reported that hydrogen-water oral
gavage resulted in retention of TAI–shifted intestinal bacterial composition in mice by high-throughput
sequencing [14], which is consistent with our results. In the present, our data showed that both
lactulose supplemental could influence the communities and diversity of bacteria and methanogenic
Archaea in different segments of piglets fed a mycotoxin-contaminated diet. In addition, the shifts of
the abundance of Bifidobacterium and E. coli in the ileum digesta, and hydrogen-utilizing bacteria in the
colon were also attenuated by both HRW and LAC treatments.
4. Conclusions
In this study, we found that Fusarium mycotoxin significantly affected the metabolism, activities,
and communities of gut microbiota, and eventually caused a higher diarrhea rate in female piglets.
Most importantly, both hydrogen-rich water and lactulose have shown protective effects on the
imbalance of intestinal microbiota, reducing the SCFAs production and the higher diarrhea rate induced
by Fusarium mycotoxin-contaminated diet, partly through affecting the communities/populations of
microbiota and the evaluation of hydrogen gas. These results partly support our original hypothesis.
5. Materials and Methods
5.1. Preparation of Fusarium Mycotoxin-Contaminated Maize
The Fusarium graminearum strain 2021 was cultured and conidia were prepared as previously
described [48]. Commercial maize was soaked in tap water for 72 h, and autoclaved at 121 ◦C for
30 min. Then, the maize was incubated in plastic storage boxes with 1 × 106 conidia/kg for 30 days
(15–25 ◦C and 50–85% humidity). The cool autoclaved maize without conidia was used as the control
maize. Finally, uncontaminated and Fusarium graminearum-contaminated maize were dried in an oven
at 70 for 24 h, respectively.
5.2. Experimental Diets and Mycotoxins Analyusis
Fusarium mycotoxin-contaminated maize and uncontaminated control maize were used at
44.5% at the expense of normal maize for the manufacturing of two experimental diets, respectively.
The experimental diets (negative control (NC) and mycotoxin-contaminated diet (MC), respectively)
were formulated according to the recommendation of the nutrient requirement of swine by the National
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Research Council [49] and based on a previous study [50] with minor modifications to the vitamin and
mineral premix.
No antibiotic, hormone, and preservatives were added to the diets. Table S2 shows the ingredients
of the two experimental diets used in this study. The analysis of Fusarium mycotoxin levels in
the two experimental diets were described in our previous study [31]. The NC diet contained
221.10 μg/kg DON, 12.12 μg/kg 3-acetyl DON, 32.95 μg/kg 15-acetyl DON, and 266.26 μg/kg
total DON. The MC diet contained 825.46 μg/kg DON, 212.79 μg/kg 3-acetyl DON, 59.45 μg/kg
15-acetyl DON, 1097.99 μg/kg total DON, and 501.56 μg/kg ZEN, which were each significantly
higher (p < 0.05) than in the NC diet. In the current study, the levels of DON in the contaminated
diet were expected in natural conditions, which is similar with a previous Chinese report showing
the mean DON levels were 753.1–1194.0 μg/kg and the maximum levels reached to 4279.3 μg/kg in
complete pig feed between 2016 and 2017 [51].
5.3. Animals
In the swine industry, weaning piglets face enormous stress, which leads to perturbations in gut
microbiota, host physiological, and mucosal immune function, such as microbiological, environmental,
and dietary factors [28]. In addition, corn and soybean meal represent over 50% of the total dietary
ingredients, which is often contaminated with mycotoxins [29], which will aggravate the post-weaning
stress and induce higher economic losses. Therefore, piglets are a good model to explore the effects
of Fusarium mycotoxins on microbiota. Furthermore, finding a way to minimize the side effects of
mycotoxins on piglets should be valuable for swine production.
Therefore, a total of 24 clinically-healthy female weaning piglets (Landrace × large × white;
initial average body weight, 7.25 ± 1.02 kg) from six litters (four pigs/little) were individually housed
in pens (1.2 by 2.0 m) with one feeder and one nipple drinker. The piglets had ab libitum access to feed
and water. This protocol was approved by the Committee of Animal Research Institute (Certification
No. SYXK(Su)2011-0036, 11 August 2015), Nanjing Agricultural University, China.
5.4. Experimental Design and Sampling
After a six day adaption period, the animals were randomly assigned to four treatment groups
(NC, MC, MC + HRW and MC + LAC, respectively), with six piglets in each group. The piglets were
fed their corresponding experimental diets for 25 days. The piglets in the NC group were fed an
uncontaminated control diet, while piglets in the MC, MC + HRW, and MC + LAC groups were fed
Fusarium mycotoxin-contaminated diets.
Piglets in each group received oral administration with their corresponding treatment twice a day
(1000 and 1400 h) through a 6 × 200 mm nasogastric tube (Jiangsu Huatai Medical Devices Company,
Yangzhou, China). The hydrogen-free water was orally administered at 10 mL/kg body weight (BW)
to piglets in both NC and MC groups. While piglets in the MC + HRW group received 10 mL/kg
BW HRW (Beijing Hydrovita Biotechnology Company, Beijing, China). The HRW was produced by
dissolving high-pressure hydrogen gas into pure water, and kept in 300 mL aluminum pouches at
room temperature. At least 0.6 mM levels of hydrogen were detected in the HRW, and they were
administered to piglets within 15 min after opening. Lactulose (4-O-β-D-galactosyl-D-fructose; formula,
C12H22O11; CAS number, 4618-18-2) was used in this study. A dose of 500 mg/kg BW of LAC oral
solution (Abbott Healthcare Products, Weesp, The Netherlands) was dissolved in 10 mL/kg BW of
hydrogen-free water, and administrated to piglets in the MC + LAC group.
The amounts of LAC and HRW were dependent on the body weight and updated weekly.
One piglet was removed from the MC, MC + LAC, and MC + HRW groups fed with a Fusarium
mycotoxin diet due to poor health condition. Therefore, five independent replicates from each group
were used in this study. On day 25, 30 min after administration of different treatments, piglets were
euthanized by an intramuscular injection of sodium pentobarbital (40 mg/kg BW). The whole cecum
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and colon were obtained and weighted. Digesta samples from jejunum, ileum, colon, and caecum
were collected and stored at −70 ◦C for further analysis.
5.5. Feces Scoring
Piglets were closely observed daily for clinical signs of diarrhea and a scoring system was applied
to indicate the presence and severity of diarrhea as previously described [52]. Feces scoring began on
day 0 on the experimental diets and continued until day 25. Scores were given daily watch and the
average fecal score value per piglets was given. The following feces scoring system was used: 1 = hard
feces, 2 = slightly soft feces, 3 = soft, partially formed feces, 4 = loose, semiliquid feces, and 5 = watery,
mucous-like feces.
5.6. Hydrogen Gas Measurement in Different Intestine Segments
Hydrogen levels in the mucosa samples from different intestine segments were analyzed using
a hydrogen sensor (Unisense, Aarhus, Denmark) as previously described [53]. Briefly, piglets were
euthanized with sodium pentobarbital and placed in supine position. Incisions were made in the
segments of stomach, duodenum, jejunum, ileum, colon and cecum. The digesta were removed and
hydrogen microelectrode (diameter, 50 μm) was penetrated into the mucosa at a depth of 200 μm.
5.7. SCFA Detection in the Digesta of Different Intestine Segements
The digesta samples (0.3 g) was weighed and mixed with 0.9 mL of meta-phosphoric acid
(25%, w/v) and crotonic acid (75 mM) solution. The mixture was vortexed and centrifuged at
12,000× g for 10 min at 4 ◦C, and the supernatant was stored at −20 ◦C until assay. After thawing,
the supernatant was centrifuged at 12,000× g for 5 min, and the supernatant was used for SCFA
detection. The supernatant was detected by using a capillary column gas chromatograph (GC-14A
with an FID detector; Shimadzu, Japan; capillary column: 30 m × 0.32 mm × 0.25 μm film thickness)
with a H2 flame ionization detector and split injection as previously described [54]. The column,
injector, and detector temperature were 140 ◦C, 180 ◦C, and 180 ◦C, respectively.
5.8. DNA Isolation, PCR Amplification, and DGGE Analysis
Total DNA of the jejunum, ileum, colon, and caecum digesta samples were extracted by a
QIAamp® DNA Stool Mini Kit (Qiagen, Germany) according to the manufacturer’s instructions.
PCR products of the total bacteria and methanogenic Archaea for denaturing gradient gel
electrophoresis (DGGE) analysis were amplified with specific primers (Table S3) and separated in
denaturing gradient polyacrylamide gels as previously described [55].
5.9. Real-Time PCR Assays for Quantification of the Selected Bacteria
The abundance of total bacteria, Lactobacillus, Bifidobacterium, Escherichia coli, Enterococcus,
methanogenic Archaea, sulfate-reducing bacteria, and acetogenic bacteria were quantified by real-time
PCR using specific primers (Table S3). Standard curves of each bacterial group were generated using
triplicate ten-fold dilutions of known copy numbers of a target gene cloned into a plasmid vector.
Real-time PCR was carried out on SetpOnePlusTM Real-Time PCR System (Life Technologies, Carlsbad,
CA, USA) by using SYBR Premix Ex Taq (Takara, Dalian, China).
5.10. Statistical Analyses
Data from DGGE gels were calculated as previously described [55]. All statistical analyses were
performed by one-way ANOVA with SPSS statistical software (version 18.0 for Windows, SPSS Inc.,
Chicago, IL, USA, 2009). The differences among treatments were considered significant at p < 0.05.
Differences among treatments were determined using the Tukey-Kramer test.
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Abstract: Deoxynivalenol (DON) is a mycotoxin that affects the intestinal morphology of animals,
impairing nutrient intake and growth. On the other hand, dietary supplementation with functional
oligosaccharides as chito-oligosaccharides (COS) has shown positive effects on the intestinal health
of piglets. Therefore, the objective of the present study was to evaluate the effect of low doses of COS
in preventing DON-induced intestinal histological changes, using a swine jejunal explant technique.
The intestinal explants were incubated at 37 ◦C in culture medium for 4 h and exposed to the
following treatments: (a) control (only culture medium), (b) DON (10 μM), (c) 25COS (0.025 mg·mL−1
of COS); (d) 50COS (0.05 mg·mL−1 of COS); (e) 25COS plus DON (25COS + DON); (f) 50COS plus
DON (50COS + DON). Explants exposed to COS presented intestinal morphology similar to control
samples. DON induced a significant decrease in the histological score as a consequence of moderate
to severe histological changes (apical necrosis, villi atrophy, and fusion) and a significant decrease in
morphometric parameters (villi height, crypt depth, villi height:crypt depth ratio, and goblet cells
density). The intestinal morphology of samples exposed to COS + DON remained similar to DON
treatment. In conclusion, low levels of COS did not counteract DON-induced intestinal lesions.
Keywords: functional oligosaccharides; mycotoxins; swine; explant technique; intestinal morphology;
goblet cells
Key contribution: Chito-oligosaccharides exposure does not prevent the deleterious effects of DON
on piglets’ intestinal tissue.
1. Introduction
Deoxynivalenol (DON) is produced mainly by Fusarium graminearum and Fusarium culmorum
in cereals as wheat, barley, and maize [1]. Processing methods may reduce the amount of DON in
cereals, however, this mycotoxin is not completely eliminated in grains intended for animal and human
consumption [2,3]. In a survey including 15,549 samples of cereals from European and Asian countries,
DON was the most prevalent mycotoxin, with concentrations ranging from 0.250 to 50.289 mg·kg−1 and
a mean level of 0.967 mg·kg−1 [4]. This fusariotoxin is known to affect the functional morphology of the
intestinal tract in animals, compromising the absorption of nutrients by the intestinal epithelium [5,6].
Consequently, DON can result in significant economic losses in animal production due to the adversely
altered animal performance [7,8].
Toxins 2018, 10, 276; doi:10.3390/toxins10070276 www.mdpi.com/journal/toxins240
Toxins 2018, 10, 276
On the other hand, the gut health-promoting effects of chitosan oligosaccharides in swine nutrition
have been broadly acknowledged [9]. Chito-oligosaccharides (COS) are obtained by depolymerization
of chitin or chitosan by the action of acids, enzymes, or even physical methods [10]. Chitosan is
initially extracted from the shells of crustaceans (e.g., shrimp and crabs) or from the cell walls of
fungi. However, it has been suggested that COS produced through fermentation of microorganisms
such as Bacillus spp. [11], using chitosan as a carbon source, can lead to more standardized results
since this biotechnological means of obtaining it is independent of climate and environmental
changes [12]. Radicals of N-acetylglucosamine present in the molecule of chitosan, and in its
derivatives are responsible for diverse biological activities [13]. The results of many studies point to
antibacterial [14] and anti-inflammatory properties [15] in COS in addition to anti-oxidative, antitumor,
and immunostimulatory effects [16]. In pigs, COS modulates the gut microbiota, favoring the growth
of beneficial bacteria [17,18]. In addition, diets supplemented with COS result in beneficial effects on
small intestinal morphology, barrier function, nutrient digestibility, and zootechnical parameters of
weanling pigs [18,19]. Due to these properties, chitosan and COS have been considered as an effective
prebiotic and a potential alternative to antibiotics in pig nutrition [17,20–22].
Although COS-treatment has shown beneficial effects in weaners, so far, there have been few
reports on the action of oligosaccharide derivatives during intestinal exposure to mycotoxins [23].
Given the need to broaden the knowledge about the possible protective effect of functional
oligosaccharides on DON-induced intestinal toxicity in piglets, the objective of the present study
was to evaluate the effects of different doses of COS in pig jejunal explants exposed to DON.
2. Results
2.1. Histological Evaluation of the Explants Exposed to COS and DON
The treatments with 25COS and 50COS resulted in no significant change on the histological score
(Figure 1a). Explants exposed to COS showed moderate edema of the lamina propria and simple
columnar epithelium was preserved (Figure 1c,d). After 4 h of exposure to DON, explants presented
a significant decrease of 21.22% in the histological score in relation to control samples (p = 0.044)
(Figure 1a). Explants submitted to DON showed fusion and atrophy of villi with discontinuous
epithelium exhibiting severely flattened enterocytes with necrotic debris (Figure 1e). COS did not affect
DON-induced lesions, and a significant reduction in histological scores of 31.25% (p = 0.013) and 36.64%
(p = 0.003) was also observed in the intestinal tissue exposed to 25COS + DON and 50COS + DON
when compared with the control, respectively (Figure 1a,f,g).
Villi height was a sensitive parameter of intestinal health; a decrease around 37.29%, 41.45%,
and 37.87% in this parameter was observed after exposure to DON (p = 0.003), 25COS + DON
(p < 0.0001), and 50COS + DON (p < 0.0001) in relation to control samples, respectively. Mitotic figures
were observed in crypt epithelium, and crypt depth was maintained in all experimental groups.
In accordance with the above results, the villi height:crypt depth ratio was significantly reduced in
DON-treated samples and COS + DON-treated explants in comparison to control explants (p < 0.05).
The samples exposed to treatments with COS showed no significant changes on morphometrical
parameters (Table 1).
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Figure 1. Histological evaluation of the explants exposed to chito-oligosaccharides (COS) and
deoxynivalenol (DON). (a) Values of histological scores of swine jejunal explants exposed to control
treatment (), 0.025 mg·mL−1 of COS (25COS) ( ), 0.05 mg·mL−1 of COS (50COS) ( ), DON (10 μM)
(), 25COS plus DON (25COS + DON) (
(
), and 50COS plus DON (50COS + DON) ( ). Values are
mean ± SEM. Means with unlike letters (a, b) differ significantly by Tukey’s test (p ≤ 0.05). Maximum
histological score of 39 points in A.U. (arbitrary units); (b) Explants exposed to control (n = 30);
(c) 25COS-exposed explant (n = 30); (d) 50COS-exposed explant (n = 30); (e) DON-exposed explant
(n = 30); (f) Explant exposed to treatment 25COS + DON (n = 30); (g) Explant exposed to treatment
50COS + DON (n = 30). Histological endpoints with different arrows: simple columnar epithelium
( ), moderate edema of the lamina propria (†), multifocal to diffuse fusion and atrophy of villi
(→), discontinuous epithelium ( ), necrotic debris (*), and severely flattened epithelial cells (
ll
)
(Bar = 50 μm; Hematoxylin and eosin staining).
Table 1. Morphometrical evaluation of the swine jejunal explants exposed to COS and DON
(mean ± SEM).
Treatments Villi Height, μm Crypt Depth, μm Villi Height:Crypt Depth, μm:μm
Control 139.68 ± 8.48 a 129.21 ± 8.53 a 1.09 ± 0.07 a
25COS 121.74 ± 10.50 ab 136.69 ± 16.11 a 0.90 ± 0.05 ab
50COS 116.56 ± 13.71 ab 110.77 ± 3.34 a 1.04 ± 0.09 a
DON 87.60 ± 4.01 b 140.86 ± 18.60 a 0.64 ± 0.06 b
25COS + DON 81.79 ± 9.99 b 131.09 ± 8.18 a 0.63 ± 0.09 b
50COS + DON 86.78 ± 7.50 b 132.34 ± 13.39 a 0.65 ± 0.02 b
Means (n = 30) within a column followed by the different superscripts (a, b) differ significantly by Tukey’s
test (p < 0.05). Explants exposed to Dulbecco’s modified Eagle’s medium (Control), 0.025 mg·mL−1 of COS
(25COS), 0.05 mg·mL−1 of COS (50COS), DON (10 μM), 25COS plus DON (25COS + DON), or 50COS plus DON
(50COS + DON).
2.2. Goblet Cell Density of the Explants Exposed to COS and DON
Goblet cells are present in the intestinal epithelium and are responsible for synthesis and secretion
of mucins. Explants exposed to COS presented a number of goblet cells similar to control treatment.
The goblet cell density in explants exposed to DON was significantly decreased in the villi region
compared to the control samples (p = 0.003). The reduction was more pronounced in the samples
exposed to 25COS + DON (43.46%; p < 0.0001) and 50COS + DON (68.57%; p < 0.0001) when compared
with control group. In relation to goblet cell density in crypts, explants exposed to DON, 25COS + DON,
and 50COS + DON showed a significant decrease of 38.97% (p = 0.008), 42.98% (p = 0.003), and 51.57%
(p = 0.001), respectively, compared with the explants exposed to control treatment (Figure 2).
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Figure 2. Mean goblet cell number on villi and crypts of swine jejunal tissue submitted to different
treatments: control (), 0.025 mg·mL−1 of COS (25COS) ( ), 0.05 mg·mL−1 of COS (50COS) ( ), DON
(10 μM) (), 25COS plus DON (25COS + DON) ( ), and 50COS plus DON (50COS + DON) ( ).
Values are mean ± SEM represented by vertical bars. Means with unlike letters (a, b) differ significantly
by Tukey’s test (p < 0.05).
3. Discussion
Functional oligosaccharides such as COS have been widely suggested as dietary supplements
in post-weaning diets of piglets. While COS have been shown to improve growth performance,
immunological status, gut microbiota, and intestinal morphology in weaned pigs [9], their effects on
mycotoxins-induced intestinal toxicity have not been yet explored. Due to global distribution of DON,
its permanence through feed and food processing, and its known intestinal toxicity, DON is considered
a food security concern [3,5,24]. Studies on the potential protective effect of feed additives on the
mycotoxins-induced intestinal toxicity have been conducted by our research group [25]. In the present
study, we have assessed whether COS can prevent DON-induced intestinal toxicity using an ex vivo
approach. Intestinal explants represent an adequate alternative model to toxicological studies [26].
This technique preserves the histological structure observed in vivo and allows for the reduction in the
number of experimental animals [27]. To the best of our knowledge, it is the first work to analyze the
action of COS facing a fusariotoxin challenge in piglets.
In previous studies, the effects of COS on intestinal health have been evaluated in piglets [9].
The range of COS effective doses is large (30 mg·kg−1~5000 mg·kg−1), and the results are
variable [11,28]. In this study, the treatment with low levels of COS for 4 h induced no effects on
the intestinal morphology (histological score, villi height, crypt depth, and villi height:crypt depth
ratio). In accordance with those results, we demonstrated in a previous study that increasing doses of
COS (0.025, 0.05, 0.10, and 0.15 mg·mL−1) induced no change on the intestinal morphology of swine
explants [29]. Accordingly, no effect on intestinal morphology was observed in weaned pigs fed diets
containing increasing levels of COS (30 to 600 mg·kg−1) for 14 days [18,28]. However, in piglets fed
diets supplemented with 150 and 200 mg COS·kg−1 of feed for a 21-d and 26-d period, respectively,
a significant increase on villi height and villi:crypt ratio was observed in jejunum of animals [17,19].
Although the mechanisms involved in COS action have not yet been fully elucidated,N-acetyl
glucosamine, a basic component of this molecule can play an important role [13]. This radical can
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bind to determined strains of pathogens (bacteria), interfering with their adhesion capacity to the
intestinal mucosa [11,30]. Moreover, in vivo studies indicate that COS is rapidly and efficiently
utilized by beneficial intestinal microorganisms, increasing the proportions of Lactobacillus spp. and
Bifidobacterium spp., especially in weaning pigs [17,30]. Thereby, changes in intestinal microbiota
composition may provide a favorable environment for the proliferation of enterocytes as reported
recently by Suthongsa et al. [19] and Thongson et al. [31]. Thus, short periods of treatment with COS
would be insufficient to stimulate the intestinal cell proliferation and improve gut morphological
parameters in weaned piglets.
Regarding animal feed and human food, the intestine is the first organ to be exposed to the
toxic effect of mycotoxins [32]. In this study, DON induced a significant decrease in the histological
parameters (histological score, villi height, crypt depth, and villi height:crypt depth ratio). The main
histological changes were atrophy and fusion of the villi, loss of apical enterocytes, necrotic debris,
and severe flattening of columnar epithelium. These results agree with previous in vivo and ex vivo
studies that have evaluated intestinal exposure to DON [5,25,33]. DON at the cellular level causes
inhibition of protein synthesis [34], inducing oxidative stress and cell apoptosis [35].
Co-treatment of COS and DON for 4 h did not prevent the lesions caused by DON as observed
in the histological score (villi height, crypt depth, and villus:crypt ratio). It is important to highlight
that studies about the effects of COS on the intestinal toxicity of DON are scarce, and in the
available databases, no study concerning this aspect was found. Previous studies have evaluated the
adsorption capacity of chitosan and chitosan polymers on mycotoxins in in vitro models. Recently,
Solís-Cruz et al. [36], using an in vitro gastrointestinal model for poultry, identified that chitosan
showed a lower binding activity against DON when compared to cellulosic polymers. Additionally,
a poor adsorption efficiency of chitosan polymers for DON and T-2 toxin has been observed in a
buffer system [37]. No results about the adsorption capacity of COS on DON was found. Thereby,
we hypothesize that COS is not effective in reducing DON toxicity in swine jejunal explants due to
its poor adsorbent capacity for mycotoxins. Moreover, it is important to note that short periods of
exposure to COS can be insufficient to influence the intestinal population of Lactobacillus, which can
counteract the adverse effects of DON in weaned piglets [38].
Considering that oligosaccharides from different natural sources show similar prebiotic activities
in animals [39], it is important to note that the protective effect of milk-derived oligosaccharides
(galacto-oligosaccharides (GOS)) has been identified on intestinal barrier function in a DON challenge.
In that work, the pretreatment with GOS was responsible for preventing the decrease of DON-induced
transepithelial electrical resistance in the Caco-2 cell monolayer, while the co-incubation of GOS and
DON did not reduce the DON-induced intestinal barrier disruption. Similarly, when mice received
GOS before DON, villi height of the proximal small intestine remained comparable to the control
animals [40]. Thus, the treatment with functional oligosaccharides before exposure to mycotoxins is an
important factor to consider in future studies.
Mucins secreted by goblet cells form the mucus layer present on the gastrointestinal mucosal
surface and prevent adhesion of pathogens to enterocytes [41]. COS showed no effect on the goblet
cell density of intestinal explants. Similarly, COS-supplemented diets (30 or 100 mg·kg−1) induced
no changes on goblet cell density in piglets fed for a period of 14 and 18 days, respectively [28,42].
In accordance, villi and crypts of swine intestinal explants exposed to increasing levels of COS (0.025,
0.05, 0.10, and 0.15 mg·mL−1) showed no difference on goblet cell density among the treatments [29].
Conversely, 300 mg/kg of chitosan for 21 days resulted in a significant increase on the goblet cell density
in the jejunal villi of weaned piglets fed a supplemented diet and challenged with enterotoxigenic
Escherichia coli during a preliminary trial period [22]. Probably, higher doses of COS are necessary to
induce changes on goblet cells density. On the contrary, DON induced a significant decrease on the
number of goblet cells in intestinal explants. Reduction in the goblet cell density after a challenge with
DON has already been reported in pigs and cultures of swine jejunal tissue [5,33,43]. While the effect
of toxic doses of DON (10 μM) on goblet cells have been related to cell death in intestinal crypts [25],
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subtoxic doses of DON (1 μM) induced a reduction in the mucin production by down-regulation of
the gene expression of these glycoproteins [44].
In this study, COS did not prevent the reduction in the goblet cell density induced by DON.
Interestingly, a more pronounced decrease was observed on the goblet cell density in the villi of
explants exposed both to COS and DON in relation to the other treatments. Previous studies have
shown that chitosan induces a disruption of tight junctions (TJs) (CLDN4, zonula occludens 1 and
occludin) affecting the epithelial permeability in the Caco-2 cell monolayer. These changes were
transient and reversible after chitosan removal [45,46]. Similarly, Xiong et al., [28] showed that the
expression of occludin in ileum and zonula occludens 1 in jejunum and ileum were decreased in
piglets fed a diet supplemented with 30 mg·kg−1 of COS for a 14d-period. Similarly, in in vivo and
ex vivo studies, DON induces a significant decrease in the expression of E-cadherin and occludin
in the intestine of piglets [5,33]. Accordingly, considering our results and these previous studies,
we hypothesize that COS acts similarly to DON on intestinal explants by regulating TJ expression,
resulting in increased epithelial permeability, cell degeneration, and death.
In conclusion, we have shown that the exposure to low levels of COS induced no reduction in
the toxic action of DON on the intestinal histological structure. The use of dietary supplements in
animal feed with the objective of minimizing the toxic action of mycotoxins on intestinal tissue is of
increasing interest. Due to the lack of results in the literature, additional studies to assess the effect of
functional oligosaccharides on DON-induced intestinal toxicity are necessary. Experimental factors
such as exposure time and host microbiota should be considered in future analyses.
4. Materials and Methods
4.1. Animals
After weaning, five crossbred (Landrace × Large White × Duroc) piglets were allocated in
separate bays and received a standard diet from 21 to 24 days of age. Feed and water were provided
ad libitium. A sample of feed was analyzed for mycotoxins by high performance liquid chromatography.
Aflatoxins (B1, B2, G1, and G2), fumonisins B1 and B2, zearalenone, and deoxynivalenol were below
the limit of detection (data not shown). After 3 days of feeding with solid feed, the animals were
submitted to euthanasia using sodium pentobarbital (40 mg·kg−1 of body weight (BW)) intravenously.
The techniques used in the procedures were previously approved by the Institutional Ethics Committee
for Animal Experimentation (number 11361.2014.30).
4.2. Chito-Oligosaccharides
Mild chrysalis flour of the silkworm Bombyx mori L. (0.7 g·L−1) was provided as the only
carbon (chitosan) source and peptone (0.3 g·L−1) as the nitrogen source to Bacillus subtilis DP4.
The fermentation occurred at pH 9.6, at 28 ◦C, under agitation (110 rpm) for 96 h. The bacterial biomass
was separated by centrifugation, and the supernatant was sterilized to be used in the assays as a
crude extract containing 6.48 mg·mL−1 COS [29]. COS quantification was determined by the MBTH
technique [47] using N-acetylglucosamine (0 to 100 μM) as standard.
4.3. Culture of Explants and Exposure to DON and COS
The procedures for obtaining jejunal explants followed the previously described technique [25].
Briefly, jejunum segments of 5 cm were washed with phosphate buffered saline (PBS), opened
longitudinally, and explants sampled using a biopsy punch of 8 mm. Three explants per well were
placed in six-well plates (EasyPath, São Paulo, Brazil) containing Dulbecco’s modified Eagle’s medium
(DMEM-Gibco, Gaithersburg, MD, USA), antibiotics (penicillin/streptomycin—1.25 μL·mL−1, Gibco
and gentamicin—10 μL·mL−1, Novafarma), fetal bovine serum (100 μL·mL−1—Invitrogen, Carlsbad,
CA, USA), and L-glutamine (0.4 μL·mL−1—Sigma-Aldrich, São Paulo, Brazil). Explants were incubated
at 37 ◦C under orbital shaking for 4 h in the following experimental groups: (1) Control: culture media;
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(2) DON: culture media with 10 μM of DON (D0156, Sigma-Aldrich); (3) 25COS: culture media with
0.025 mg·mL−1 of COS; (4) 50COS: culture media with 0.05 mg·mL−1 of COS; (5) 25COS + DON: culture
media with 25COS plus DON; (6) 50COS + DON: culture media with 50COS plus DON. The dose of
DON used in this study was equivalent to an ingestion of feed contaminated with 3 mg DON·kg−1
of feed and was considered toxic in in vivo [5] and ex vivo [48] studies. The concentrations of COS
used in this experiment corresponded to an ingestion of 25 mg COS·kg−1 and 50 mg COS·kg−1 of feed.
Six explants (replicates) from each animal were collected for each treatment. After this period, explants
were fixed in a 10% buffered formalin solution for morphological and morphometric evaluation.
4.4. Morphological and Morphometric Assessment
Samples for histological analysis were dehydrated in increasing concentrations of alcohol,
diaphanyzed, and embedded in paraffin. Tissue slices (5 μm thickness) were stained with hematoxylin
and eosin for morphological and morphometric evaluations. The periodic acid of Schiff (PAS) stain
was used to assess the number of goblet cells in 10 villi and 10 crypts/explant at 400× magnification.
The histological score previously described by Maidana et al. [49] and Gerez et al. [29] was used to
compare histological changes between the different experimental groups. Briefly, the criteria used
were enterocyte morphology, apical denudation of villi, changes in the lamina propia, villi fusion
and atrophy, number of villi, and cell debris [43]. Samples with well-preserved histological structure
showed a maximum score of 39 points, while the minimum score of 0 points was assigned to the
explants with severe and diffuse lesions. For morphometric evaluation, villi height and crypt depth
were measured using an image software system (Motic Image Plus 2.0, Motic Microscopy, Kowloon,
Hong Kong) with 200× magnification as previously described [43]. The villi-height:crypt-depth ratio
was also considered in the evaluation of intestinal integrity.
4.5. Statistical Analysis
A completely randomized design with five repetitions per treatment was employed. Six replicates
from each animal were analyzed, resulting in one repetition. The data were represented as
means ± SEM (standard error of the mean) and analyzed by free software Rstudio version
1.1.442—© 2009–2018 (Boston, MA, USA). Assumptions of residual normality (Shapiro-Wilk’s test) and
homoscedasticity (Bartlett’s test) were checked and the data were submitted to analysis of variance
(ANOVA) followed by Tukey’s test. p-value ≤ 0.05 was regarded as statistically significant.
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